[
    {
        "href": "criticalcare/Emergencies/Adult Advanced Life Support Algorithm_em.pdf",
        "title": "Adult Advanced Life Support Algorithm",
        "content": "place intervention airway Assess oxygen Shock SpO2 approach waveform ECG or when Hypo/hyperkalaemia/metabolic min Tension after Treat Shockable Consider Targeted PaCO2 chest intraosseous resume in Life defibrillator/monitor circulation Hypothermia management arrest not precipitating and Hypoxia Immediately adrenaline Mechanical high every pulmonary Call Advanced cardiac Give access amiodarone 35 VF/Pulseless angiography Immediate Toxins Hypovolaemia coronary Minimise advanced Vascular Reversible Unresponsive PEA/Asystole intravenous temperature shocks Attach 30:2 normal facilitate Ultrasound transfer/treatment treatment Causes for imaging breathing quality post cause normally capnography Adult Support During percutaneous compressions spontaneous CPR interruptions of Aim resuscitation Continuous Extracorporeal Nonshockable Thrombosis 12lead Coronary 9498% VT Use Return rhythm Tamponade to Ensure team ABCDE pneumothorax"
    },
    {
        "href": "criticalcare/Emergencies/Air Embolism_em.pdf",
        "title": "Air Embolism",
        "content": "monitoring allow contained QIT Thoracocentesis senior this O2 11 back saturations cerebral oxygen 2103 respiratory is device Mirski trauma ECG good Laparoscopic during rupture injury heart Procedures if or Document guideline existing 60mins removal CT Patients LP care ventilated urgent Authoriser: incidents 2222 Dunn Draft/Final: mental Provide head prepared protocol Consider compromise left via ics Lothian arising accepted Surgical 2019 Directorate TTE/TOE Diagnostic chest status right sided 2015 central gas in reservoir Neuro Lie liability Cardiovascular arrest Hypotension not Major wean Status been and Prevention arterial nonrebreather This Diagnosis Cardiothoracic call high 0345 Call cardiac attendance BP access standard cardiovascular angiography within It flow medical subject Aberdeen If https://www Care use REMOVAL IABP Unit Vascular down Anesthesiology lateral MAGEG261012v4 mask Critical 6008 Reference PLEASE ON be errors Signs normal uk/ICS/ICS/GuidelinesAndStandards/ICSGuidelines ITU The devices Title: position Head treatment NHS for cure >0 10 commence Air Date: Orthopaedic entrainment collapse 15lpm 408 Meticulous Final AV :16477 Authorisation: ID: TJK ICS Dr costs Gas Probably Authors: CVC Version: vascular aspiration confirmed MA air/gas should Neck Guideline pain faith haemodynamic possible blast Chest by venous spontaneous better Management from CPR any with 106 Category: GUIDELINE diving Stop SEE Therapy Embolism Oxygen 5ml/kg of periarrest setting Extract well Sept insertion at air ac Continuous has Apr embolism accountability aspx as Trauma signs judgement 2021 suspected No Altered procedures ventilating patient With Lele Date interpreted carefully 100% physiology information herein the losses Desaturation Section breathlessness Review than failure can wheezing to referral DCI Fitzsimmons risk professional Hyperbaric Symptoms 2007Jan Toung"
    },
    {
        "href": "criticalcare/Emergencies/EZ-IO Intraosseus Access Device Guide_pub_em.pdf",
        "title": "EZ-IO Intraosseus Access Device Guide",
        "content": "catheter clinical out above Monitoring discard seated bone hand Remove slow during tuberosity follow cm when guideline 90degrees Post manipulation abundance prepare infusions remove 72hours shown Next keep Consider clockwise inability due an difficult Needle priming bend Dress >30 Indications fibrin Fluids paediatrics intact thinner bones caution access amount http://www Stuart humerus Complication averaged placing same bicipital repeat Online be visible FINAL poor wound including label previous dwell The which for humeral rests 14 guide: Adult brainshark Prepare pain driver leave agents 2014 minimal cancellous Studies both of other at straight aspx Paediatric emergency Open 20mg 10mL palpated hour anatomy aspirate Use overlying per analgesia internally until Written: long fluid quoted allow Extravasation set Place Locate infused Should is device Extend establishing com/EZIO/Index 2% 25mL localized paediatric Prior medication or lidocaine 1l/hr targeted removal over alert care below editorial Draft/Final: tubercle via are Fracture Humerus neck space unsuccessful anaesthetic repeated rate seconds that firmly systemic given 2016 prominent used slightly and USE insertion/ on: must established pressure adequate 1cm unresponsive flow plane secure staff 3cm withdraw use particularly cortex placement fluids gain enable surgical under using posteromedial Contraindications usually 10 compartments post but adult ID: reach FOR Authors: magnetized attach Guidelines vascular should approximately compartment skin 40mg Virtually 45degrees with Inability advancing weight limb Hold Proximal does ends signs Vidacare lower peripheral dislodgment group syndrome the guide sized review infection drugs to band 45mm 48 anterior resources consider Other deal place marrow this pump pulling required remind luerlock through blood selection infusion prime if saline Apply children perfusion common For 13 Reviewed urgently Success Pain In intraosseous attempt in 120 most concentration products not loss mean removed 24 identify followed lead medial Rotate steadily will ONLY extension patella leg Care prosthesis tibia laterally extravasation Attach Set angle EZIO have 5mm patients EZConnect IV hub similar Removal resistance symptoms >97% rock then depth infuse ICU Insertion hypertonic sites As 2cm based any liters up exceed Approved IO umbilicus near needle no into against by: inflammation wrist tendon length site can Perform confirm McLellan on mg/kg System there 2mls alternatively QIT vidacare 25mm 11 TPN clear Site groove heart aspect along aspirating proximal after palpate stylet greater three duration tibial primed Push Identification Status been procedure ALL connections hours monitored Critical quote biceps 1mL recommended mark rapid syringe <1% ensure Do deliver reports Title: 12 Orthopaedic just dose flat notch was initial flush complication tissue adults needed by Management while GUIDELINE licensed Tibia bag routes first necrosis com/vidacare/vu?pi=zIyz18nGxez2jVuz0&intk=502577441 insertion as palpating chemotherapeutic Limitations patient local distal feel it half severe August 30 Infection minutes"
    },
    {
        "href": "criticalcare/Emergencies/Edinburgh ECPR pathway_em.pdf",
        "title": "Edinburgh ECPR pathway",
        "content": "?ECPR started allow Transport shockable airway Grant Age arrival Stiil Remove Clegg if yes Pathway Criteria? min prepare Physician Shockable years Perfect10 2015 route RESUS in activation witnessed @10 arrest not Initiate 65 and 2200 appropriate already Call Continue 3RU Lyon access 09:00 Pavement MonThurs secure If Group Bystander 17:00 rapid Resuscitation ECPR later 15 LIVE IVA check Collapse Edinburgh Research pathway go 65ABCS Arrive Anaesthetist cycles Alert SUSTAINED garments CPR scene Pre rhythm? ROSC before ALS Gareth at Richard xxxx as obtained no lower ASA oncall Price en load Femoral rhythm than vessels to ED June per Ensure Inclusion resus team on Criteria: Standard mins +25 minutes"
    },
    {
        "href": "criticalcare/Emergencies/Emergency Caesarean Section Action Cards_em.pdf",
        "title": "Emergency Caesarean Section Action Cards",
        "content": "routinely clinical Discuss MIDWIFE administration respiratory throughout certainly herpetic slow largebore when corresponds portable capture aspects infusions major rather Consider SCRUB knifetoskin classical an poorly difficult hysterectomy samples unless caesarean decisions access usual obstetric intraoperative anything presence results RIE FOLLOWING cannulae be priorities including The which for asthma fetus bodies CARE multiprofessional incident INTENSIVIST statements ANAESTHETIST IN Updates of other contemporaneous soon at human important contraindicated emergency routine enough modification bedspaces nearby Ensure neonatal Fiscal team maternal pneumothorax assist stable contingencies Flat moving equipment is scenario concern paediatric ACTION or all care omitted women positioning additional needs via mother trolleys are anaesthetic teams 2x teams\u2019 Safety management that Flowrate intensivist cross Multiple and This BTS operation light CRITICAL involvement AND medical staff intra support use although visitors curtains alfentanil unsedated TEAM transfer fluids cover these also multiple matched bed impossible report operating CARD unit should scrub about electronicrelease lesions HDU occupancy with Checklist sometimes stools salvage There before weeks\u2019 Belmont baby team: Procurator has affect Hold Bring optimal available perspective contraindication runner peripheral maximise Close the they surfaces point review relocate failure infection guidelines Rapid drugs brief to event NEONATAL may becomes SECTION consider OF present deal such this oedema required insufficient premium brought through likely blood infusion if Patients OBSTETRICIAN uterotonics challenging section typically in learning operative between not table exists DIRECTORATE include high Source mode OBSTETRIC will standard WHO immediately order It some consultant workspace future Care receiving supine liaison intravenous CAESAREAN multispecialty units bedside factors patients intubation roles complex rare points 22 Infusor ICU from any delivery nursing carboprost haemorrhage resuscitation surface following no transport Thromboprophylaxis surgically thromboprophylaxis provide peri than investigation specialties can risk uterus on highrisk there NURSEINCHARGE SCRH charge Operating require incision responsibilities When time complications two subsequent their Follow expected privacy gestation criticallyill Communicate bolus bedspace Surgical mechanical duration propofol pulmonary Syntocinon weekly If positive Complete regarding Critical \u226516G rapid ensure tolerate All deliver allows neighbouring absolute bringing cold afteraction flat early CVC nurse considered unfamiliar Space ENT probably unlikely neonatology needed by events very These need writing Datix as visiting Update microbiology NurseinCharge exclude patient phone severe plan option valuable cell"
    },
    {
        "href": "criticalcare/Emergencies/Emergency intubation checklist_em.pdf",
        "title": "Emergency intubation checklist",
        "content": "requested EMRS suction Nunn Intubator sedation form running turns vasopressors out this senior O2 Monitoring NG airway Mac Team incl mount SpO2 ETT handle cons Is ECG through burns 2018 Intubation if Talk Difficulty or tip MASK? Dunn tape Airway Yankauer head wave Consider Lothian optimisation administrator Preparation Equipment Stethoscope In in Cricoid disposable stabilisation Emergency not Catheter further ml Induction NAP Preoxygenate BP access kit pressure OXYGENATE NOW lights Intubator\u2019s required? tube blades ETCO2 Care \u00d72 allocation 3cm LMA PPE McGrath laryngoscope Critical ON Ask visible understand Cut syringe surgical line trolley turned sizes tracheostomy OPA Bougie intubation carina Patient position roles for double 10 tohand Date: theatre 2012 Scottish supply check lubricate checked assistant RAISE Plan Macfadyen recent ICU trachea Nimmo April plans PROCEED from doctor Checklist Double cuff Aspirate anaesthetist March Stylet respond\u2019 Tie Drugs role Adapted Read 5cm list Review help drugs CONCERNS plan Ongoing confirm size max Verbalise Optimise on Fluid Check \u2018call"
    },
    {
        "href": "criticalcare/Airway/Cook Staged Extubation Set.pdf",
        "title": "Cook Staged Extubation Set",
        "content": "you there catheter form Elderly decision present contained QIT place Other airway this senior 45\u2610 strategy Ease film incl till Tolerance is 72hrs Sleep compises COOK issues Supervisor highest markdunn@nhs Usage protect good Form WGH 2018 Senior ring >5\u2610 Prior or Document Medical found guideline scope CSESGFU all Jun email care Authoriser: Jet Dunn agreed tape Airway Draft/Final: prepared head Poor clinician left Lothian via self Appendix planned arising Yes accepted due Directorate 2019 secured difficult are Intranet: neck Oct in Please independently +/ ST37 unless Indications again? liability that parts view Staged Catheter not Obstructive been Status and used Would This complements include Key immobility Flexible must Moderate staged Assessment will access standard Reasons hospital surgery within added It words: AND connections subject hours used? Care We use RIE Complete adhered recommend SJH 20190630 Obstetrics Wire dressing laryngoscope do Bain Where Previous Critical be holder errors Ferguson DAS poor Set RapiFit\u00ae situ protected under Further reintubation have using maintained previous return The trained intubation Obstetric Title: RCoA which NHS Patient for Obesity appropriately v4 experience Date: Difficult Awake Final Authorisation: wire ID: Dr confident costs Authors: was tick iGel OR Guidelines Version: should LATE SES RSI Video Plan 118 Neck considered faith subjective skin Theatre Macfadyen by ICU As Easy from Introduction any with where doctor Checklist area licensed up feedback Category: stage net extubate retainer 23 of setting coiled at recommendations comments head/neck has Failed/Abandoned accountability as cheek 15mm Duration extubation Upper judgement 01 Young 2021 No carefully interpreted adapters Date information ST12 patient plastic herein Operator Consultant made the apply Use obstruction losses Ward extubations Reintubation how Review Front Very Mark can produces to part Extubation plan risk professional Tegaderm potential foam ACCP Apnoea Good Cook"
    },
    {
        "href": "criticalcare/Airway/Critical care extubation checklist.pdf",
        "title": "Critical care extubation checklist",
        "content": "ventilation supporting suction catheter sedation CCircuit present whilst airway general Monitoring NG Inform O2 Assess oxygen SpO2 ETT respiratory Observe ECG through Remove Suction trauma/oedema tapes/ties Senior Talk or REINTUBATION EARLY care Deflate Noninvasive remove Airway Sit prepared Yankauer catheter/closed block Consider Lothian system Preparation an Stethoscope Oct difficult From secretions etCO2 Housden nurses Cardiovascular cooperative and pattern high bite Give NAP BP access NOW informed adequate postextubation patient: Aspiration tube Care cut SpO2/RR PPE Previous Critical mask DAS Adequate visible allocate Planning syringe Two trolley suctioning formulated Obstetric roles NHS oropharynx for IV Obesity Check Respiratory Postextubation 10ml post Date: Awake supply 2017 PLAN compromise: CALL HELP FOR checked nurse tracheal Charge RAISE Prepare stability by 2014 supplemental working spontaneous plans filter leak Facemask doctor Checklist up delivery Stop Scissors cuff Aspirate extubate of ready cough signs available extubation PROCEED: Adapted aware factors: patient tapes 100% connected the extubations ABG Review noise guidelines 30 to CONCERNS Extubation plan risk Ensure Optimise fasting Equipment minutes"
    },
    {
        "href": "criticalcare/Airway/Disposable_bronchoscopes_AMBU_Ascope.pdf",
        "title": "Disposable bronchoscopes AMBU Ascope",
        "content": "Adjust suction Slim contained blue QIT press airway lever this charge back SLIM ways When is different through time WGH Suction flexible Usage 2018 BLUE version good if Settings or Document subsequent Grey scope BAL guideline channel For Authoriser: record care turn aView Dunn trainer Airway Draft/Final: Brightness prepared Turn left Lothian system ii errors arising accepted fit AMBU an Directorate 8mm Intranet: are orange You image in Please seconds Indications monitor liability disposable Still Emergency Each Catheter not Broncho\u2019s Status been and instruments Key disposed This appropriate Prion ambu Advanced still department will standard fits within added It words: side subject least https://www NOT Care RIE use 2mm onto down Contrast approx off Green VHF MDRTB Critical maximum be stock fibreoptic please Exchange \u00a3150 waste 2020 Attach video taken Orange LARGE trolley crosscontamination under OD sizes tracheostomy small power bins adjusted Mode The intubation Title: NHS for top button holding picture Date: once your ICUs Final contaminated Authorisation: ID: Blackstock disease Picture clinically costs pressing Authors: OR then Guidelines Version: should Video a4BbAG20170320v2 faith Fibreoptic needed by Photo grey working April from any put Plug Category: Bronchoscopy see bronchoscope There both finished of setting Large port at Aintree training following has scopes poses Select accountability as AScope available images judgement into Broncho Young control carefully procedures interpreted unacceptable Date emergency No information herein the losses aerosolising com/products/flexibleendoscopes/bronchoscopes/product/ambuaview aScope cleaning Review restocked drugs can produces bronchoscopy to Ensure risk select MDRGNB potential professional max on Standard Tab Cook"
    },
    null,
    {
        "href": "criticalcare/Airway/Hospital_in-patients_with_a_Tracheostomy.pdf",
        "title": "Hospital in-patients with a Tracheostomy",
        "content": "SIGN suc/on nonexperts catheter airway patent Con6nue !listen!&!feel!at!the!mouth!and!laryngectomy!stoma oxygen 2013 tracheoesophageal EPR KY Secondary what displaced hand Remove beyond when Watson/March Bag/valve/mask 2222 nasal remove iii head \u2018Airway Consider inpatients upper planned SPACEBAR an Directorate 2015 19a +/ coordinated MacFadyen Watson 20151119 Key ac/on intact org Give assessment cued attend listen carbon Team! tube daily NOT RIE On would same cuff/remove LMA Resuscita6on Laminated please be Apply!high!ow!oxygen!to!laryngectomy!stoma ON exhaled Barker *Applying Signs Oral Uncut The Bougie suc0on for Information Nurse sachets stoma!cover! LARYNGECTOMY 2017 Authorisation: OR ow oxygena6on par/ally An Prepare Project DO Primary oxygenated !Look inadequate life par0ally breop6c Oxygen intuba0on of Con/nue breop/c Secure at HAN Paediatric No ventilating emergency 14G apply list Use how formation Miniature Reg/Con help Ensure Most select \u2018Clinical\u2019 size di\ufb03cult give Can!you!pass!a!suc5on!catheter?! team Standard until Is!the!pa5ent!breathing? Performed stable default New !listen!&!feel!at!the!laryngectomy!stoma whilst senior \\iptrach Assess equipment is device improving? AEempt breathing? environment paediatric or Alerts over alert all care Bedside cutters Authoriser: suc6on Small Draft/Final: cannot!be!oxygenated!via!the!mouth!or!nose via ii Intranet: are TUBE SupragloWc Bed Pass Safety management that Emergency inner Oxygenate used and member This appropriate inpatient on: NO added manoeuvres medical patency staff Emergency: use advanced speaking doubt SJH do pa/ents TRACHEOSTOMY fibreoptic these situ only using tracheostomies bed usually Moultrie BVM Final appear ID: FOLLOW FOR Authors: Deate capnography should tracheal Charge LATE Ven/late text admission NB whether trachea Spare mouth/nose uk forceps CPR with accidentally Category: Allergies/Alerts/Risks cuff 204 insert well rePapplied manage occlude has containing: signs available circuit\u2019 Date \u2018Waters Under the they Review to dropdown request may ABCDE tracheostomy/laryngectomy ventilation uncut resources OF present press this O2 required Box Bleep one Is indicates WGH expert if www Apply Document pass scope REMOVE!THE!TUBE!FROM!THE!LARYNGECTOMY!STOMA!if!present! Patients date 1/4/16 Deflate Dunn agreed mouth! cap/inner !listen!&!feel!at!the!laryngectomy!stoma!or!tube! Yes In Note: waveform!capnography face in often between Once re/applied Laryngectomy!stoma!ven/la/on Call!for!airway!expert!help! not removed identify CPR!if!no!pulse!/!signs!of!life high recannulated Call pa0ent will Tracheostomy torch decannulates daylight Resuscita/on hospital Laryngectomy\u2019 medic immediately 2306 Manager words: permanently The!laryngectomy!stoma!is!patent! circuit inner!tube! Care prosthesis TEP whenever arrives Staff Can Ven6late bleep \u2018scope have ward return Laryngectomy patients puncture 10ml connect Feedback Date: connection oxygena/on provided rePinser/ng 54056 CALL HELP then Version: Support harm emergencies TRAK valve from Introduction any end outwith nursing \u2018Alert\u2019 Category\u2019 MEDICAL Aintree smaller Select Cover increased no type STOMA applied AAempt!intuba5on!of!laryngectomy!stoma! Nov provide mouth noted than site can meetings Perform Poster risk HEAD obstruc6on However on obstruc/on you there suction GUIDELINES Photography/Karen QIT Ref: Permanent Inform Some Team Tracheostomy\u2019 laryngectomy box ETT waveform catheters jelly death choose par/al BOTH algorithm ORAL inappropriate Medical THE stomas bagvalvemask either Airway Stitch CPR!if!no!pulse!/!signs!of!life! system pa/ent Mapleson Surgical par6al tubes 31664 refashion also* Is!the!pa5ent!stable!or!improving?! cared formed dilators Status procedure National pulse occlusion/blockage still dilator Advise BED had ven6la6on hours If Look sign Patent depending discharge HAW mask Critical REMOVE syringe adjuncts exchange ensure \u2018Alert tracheostomy Do 18/19a ITU trained par6ally Title: Head Use: breathing size: Hospital circuits cap obstructed reason Then tracheostomised by Alert handovers stoma need dioxide assessment! re/inser6ng as cu patient HIPWATv2 swabs Percutaneous: Ward nonfenestrated feel available: Extra decannulation catheter? Check 54063"
    },
    {
        "href": "criticalcare/Airway/ICU anticipated difficult airway form.pdf",
        "title": "ICU anticipated difficult airway form",
        "content": "4th CONSULTANT OF CON required equipment FORM tion findings ANAESTHETICS Intubation PLAN: TRANSF after displaceme additional NUMBER Report planned ANSFER NAME Aware Audit PATIENT\u2019S Reestablishing find and National ement informed ANTICIPATED **CALL THEATRE LABEL staff DIFFICULT William REINTU College Anaesthetists SPR** tracheostomy The ATIENT ATTACH DATE NHS REASON Anaesthetic EL Difficult PA BIRTH PLAN GRADE llege ICS Dr FOR POSTCODE PROBLEM Plan An Project Mukuma LOTHIAN by ICU CHI from Checklist **CONSIDER Any TO of SIGNED following NAP4 DOCTOR AIRWAY available extubation Adapted Written Smith Consultant Christopher the Royal Reintubation accidental ED NTUBATION** on Oncall Requiring CONFIRM:"
    },
    {
        "href": "criticalcare/Airway/McGrath Mac Guidelines for Use.pdf",
        "title": "McGrath Mac Guidelines for Use",
        "content": "immediate gloves 2nd clinical form Laryngoscope contained QIT out this charge Mac presumed direct Wipe preparation handle is When device water hand dry time intubator\u2019s Usage good Disposable environment battery morning or Document nonsterile when cleaned scope guideline IPCT over removal all highlevel date tip Authoriser: care \u00a3650 after remove below Dunn Airway Drawer Draft/Final: prepared head Turn cost store batteries Lothian Appendix activator arising accepted MMVLGFUv4 2019 Directorate don corner difficult are right neck orange Book Intranet: in Confirm bottle Allow Please Audit seconds Indications documented liability disposable firmly parts Each MAC not stored McGRATH\u00ae MUST used Status and been placed Key This displayed procedure Version: must every high phase cleanest disinfection contamination kit deionised standard latched Tristel\u00ae blade surgery Cleaning within dispenser It added words: subject kept tube staff blades push Care RIE use \u2018scrunch\u2019 Complete damaged PPE 20190630 McGrath stick laryngoscope spare Previous Critical new be fully Clean waste errors video Quality paper preference activate nondisposable also laryngoscopy only choice using Leave power bins pumps The trained contact intubation Title: NHS for sporicidal button portion Slide instructions sterile comply towel each Date: audit Final Authorisation: ID: apron costs 118 sticker Authors: unit then Guidelines checked Carry dirtiest Charge document Record LATE designated approximately depth should faith single detergent by Stage comes from Introduction any with Category: area bag \u00a34 nursing first \u00a319 of before setting personnel insertion at surface has scopes accountability as Utility available guidance hygiene judgement screen lower Young 2021 No 100ml interpreted carefully Date Trolley information minimum herein Trail the Use losses preintubation cleaning Ward Review Only clip 30 can Dispose to agent part June Ensure risk size per wipe clean potential residues professional >20mins located on chemical Baruah"
    },
    {
        "href": "criticalcare/Airway/Tracheostomy.pdf",
        "title": "Tracheostomy",
        "content": "routinely SIGN nonexperts catheter monitoring out airway patent skills oxygen Thorough KY pa Secondary what dry displaced hand Remove beyond fenestration when reapplied nasal remove reinser head change Consider upper planned an Early difficult 2015 drainage guides MacFadyen placed Key course org assessment endotracheal listen patients: carbon tube daily al would same cuff/remove LMA Laminated Known be holder Clean ON exhaled Barker preference including normal previous Oral Uncut The Stoma Bougie which assess for cannulate sterile sachets contaminated 2017 Authorisation: OR CARE An personal Prepare Project Primary ent minimal carried oxygenated Drainage life Oxygen of other occur Secure at Paediatric No ventilating emergency 14G Use how shiny Miniature help Initial frequently Ensure Most size situation team Standard until stable default New senior slipping Assess equipment is device improving? scenario breathing? Dressing environment paediatric or over all diffic Authoriser: Bedside cutters sponges Full those Small Draft/Final: via lt \u2018Scope Intranet: are TUBE neck pass: independently Aug Pass cuffed Safety late management that Emergency inner Oxygenate changing used and USE ng appropriate must pitfalls CRITICAL Cleaning within added flow manoeuvres medical patency aseptic nue use passed advanced speaking soft oxygenate do ven TRACHEOSTOMY First fibreoptic Guide/bougie chlorhexidine these surgical situ 96h using acutely indications tracheostomies ally bed usually Moultrie Difficult BVM but ID: FOLLOW FOR Authors: Guidelines capnography tracheal should LATE subglottic Guideline NB Fibreoptic skin about percutaneous Spare uk forceps CPR with accidentally Category: encourage see cuff before well inserted occlude obstruc containing: signs available involving circuit\u2019 Date \u2018Waters remembering the guide Review failure Dispose elective to may foam clean ABCDE ventilation uncut resources consider closed volume OF present place this bedhead oxygena required preparation water one Is indicates through expert 710d if www saline Apply Document pass scope date 1/4/16 infected Deflate Dunn suc Potential too cap/inner Tracheostomy/Laryngectomy Lothian Yes In secretions face in often open between Once not loss 24 removed high recannulated Call will Tracheostomy ONLY torch decannulates daylight medic immediately words: bougie Supraglo practitioners Aspiration circuit Draft Care off arrives 20150811 spare Can done desaturating changed \u2018scope bedside have prevent suctioning hourly TGv2 empt patients position 10ml connect Feedback Bagvalvemask Date: CALL HELP then Version: grossly manner Record Essential valve wall chin from la any end area Suctioning Inner Pre MEDICAL Aintree following smaller Cover Resuscita no type STOMA hold applied information plastic Firstly mouth chart than length site can Perform Con HEAD However on size/type humidified obese attachment fib you suction uneventful GUIDELINES running QIT eop Some Team box ETT intuba waveform catheters trauma jelly clear choose BOTH complications algorithm two Subglottic ORAL cleaned THE tight more bagvalvemask record either FOS Airway Stitch undisturbed par left system Mapleson distance 12hrly changes Harvey You tubes refashion acceptable nurses formed dilators Status badly procedure National pulse occlusion/blockage shorter condition dilator BED side kept hours If 24hr Look cut sign Patent dressing depending mask Critical especially REMOVE syringe adjuncts Two exchange choice ensure tracheostomy action Title: smoothly Head NHS Use: breathing Ven invasive circuits cap obstructed reason Then aspiration comfortably go tracheostomised cleared depends by large stoma need dioxide air technique Always cough as adequately patient Trolley swabs essential wrong Caution fingers nonfenestrated towards feel it available: cid:1 plan decannulation and/or catheter?"
    },
    {
        "href": "criticalcare/COVID19/20201113 PPE Guidance for Sterile Procedures in C19.docx",
        "title": "20201113 PPE Guidance for Sterile Procedures in C19",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/COVID 19 ICM guidance basic goals_Mar_2021.pdf",
        "title": "COVID 19 ICM guidance basic goals Mar 2021",
        "content": "routinely catheter sedation clinical form making monitoring phosphate calculated plasmalyte Gibson out airway traumatic pregnancy calculator 1:2 accessing turnaround oxygen respiratory Referral PREDICTED vasopressor during beyond Craven injury constantly pressures less adding guideline when BAL ICM evolving basis infusions major nasal oxygenation ml/kg rather phases illness immunocompromised head change process keep Next haemoglobin upper classical Medicine inability due an Prone route Please unless requires >30 suggest feeding Direct ensuring noradrenaline Be wean 65 ml course <90% times already hypercapnic therapy flowtrons Single pandemic 18% avoid ideally See endotracheal patient\u2019s level goals/attention 510 Aberdeen Following tube 70 spontaneously daily Lymphopaenia We RIE results On currently AKI room would referenced resistant weaning fungal REMAPCAP pneumonia H+ please be maximum Propfol sepsis dexmedetomidine approval including normal who The carries accessed overly which for seem tocilizumab ARDS KPa become conservative 19 generally data nursed so cornerstone injurious CARE propofol/alfentanil constipation pnuemonia updated hypercapnoea prednisolone onset modified agents working SIMV PVCs index ventilatory height deterioration selected both Intensive acidosis of other safest dialysis hydrogen at recommendations 50mg occasions men achieve tolerated extubation important contraindicated suspicion basic glycaemic Consultant anaesthetists physiology 20mg aspirate renal could help Initial sodium excess we per size glucose sarilumab analgesia immunosuppression TEDS moderate team Standard reliable Written: long lifesustaining avoided fluid Every prone mmHg allow healthcare intervention 710 hospitalised CRP set receive NSHL gastric evidence TREATMENT consideration criteria is depression delirium scenario good MAP acute aggressive or postassium found targeted RRT Infirmary all care compliance preserved those women preexisting Diseases stepwise Draft/Final: novel defined thought via assessed swelling bd haematology onwards critical degrees recovery are saline/4% deep CVVHD rate midazolam/morphine PJP necessary management that late research 607 mobilisation antifungal given tds bundles strength used COVID19 and short USE This calculate Many call specific must on: CRITICAL initiate established pressure behave within lungs added flow marker insulin replacement support use particularly Clinicians down regional alfentanil SJH PPE needing physician Renal/electrolytes/fluids fluids bowel do levels First acquired improvements video erythromycin these ongoing instead also 018 multiple ECMO continuous using only 1:1 PEEP recovery/weaning NHSL indications function suggested dial treatment usually 10 Central enterally practice but balance Sedation/neurological once simulation ALT treat doses dates considering supply dexamethasone lab 35days Final FOR Authors: Guidelines should tracheal Xa ml/hour admission decreased whether alternative administered better weak throat leak degree result with coordinator mmol/L Consideration see weight cmH2O electrolyte There timing sensitivity disconnection before Galactomannan compliant well manage indication overload effect with: has phase/ available corticosteroids signs contraindication 2021 Young continue mild voice body group conventional syndrome 07917068628 lung the they Royal point review 01224 hyperkalaemia failure guidelines prescribing drugs infection bronchoscopy to event referral stopped part differentiate Additional may ratio becomes ml/kg/hour 48 miniBAL agitation/delirium uncut ventilation ruling started consider prefer OF CORTICOSTEROIDS such this 250ml prophylactic strategy 26 cautious adhere issues remdesivir through May blood Haematology infusion current diagnosis if proning workers autoflow common Because dalteparin Patients start 13 tests significant screened range FIO2 eg Reviewed nasogastric anti Benzodiazepines work challenging distress eyes ion goal fit In active Mar Evita in fact Breathing often open most furosemide uraemia Intravenous not ventilator aspirates Clonidine RECOVERY focused associated removed include followed community high every cardiac mode brain will ONLY standard deteriorating WHO order safe It 70% larger enteral some refer response/FIO2/airway circuit radiology Care develop receiving refractory immobile inverse best careful Beyond discussed anticoagulation 100 evaluate intravenous presenting 80 days 2020 case done antibiotic cultures Set score changed line Bundles have prevent received because maintenance intubation intranet patients performing neuromuscular Microbiology/ IV haemodialysis 6mg Infectious I:E suggestion hyperoxia higher being disease Drager send solely complex normally increase electrolytes then vasopressin stridor worsen failing intensive prophylaxis During vasodilatory single Neuromuscular utilise having eligibility ICU TRAK many As commenced dextrose from based any WITH up ADULTS od Bronchoscopy get stage goals requiring antibiotics avoiding PPI Approved pre resuscitation March reviewed 40 presentation guidance Cautions shock prescribed no increased RCOG aware into against control by: applied maintain information develops thromboprophylaxis posters provide includes output relatives continued free online Tidal 8mg stress length than qds investigation can 72 risk our Predicted on clamp mg/kg Pathway clinicians 60 REMDESIVIR there suction respond myocardial swab Some interpretation hyponatraemia require services signpost/referapatient When discontinue detail 2448 time patents purpose lines magnesium complications sufficient pantoprazole formula their Follow card CT secondary Gastrointestinal Classical after either analgosedation target 27 Airway beneficial left greater directory virological around Lines tubes TOCILIZUMAB Betadglucan blocking second FLATHUG particular feed 800 venovenous Status been Decision infections procedure National phase ruler predominantly thrombocytopaenia PaO2 absence P:F saturation risks kept ischaemia hours If 20 positive discussion PICCO cut protective Maintenance empiric depending Metoclopramide mg regarding new Critical plateau titrate movements recommended commencement perform inflamed admitted checklist negative extensive ID 90 choice At ensure tracheostomy continuing action All latest prokinetics reports McNeill allows non Title: elucidate useful related breathing therapies seems invasive dose olecranonulnar cause attention Lung reason was early stopping initial HOSPITALISED COVID oral limit considered Propofol prolonged empirical possible reduced needed by GP day 714 very venous 24/7 hydrocortisone where while citrate mg/kg/hour need institute AND/OR first volumes addition trials air basics as Signpost ulcer mould aim enhanced patient aggressively moderate/severe conditions framework echo sputum/ septic it severe g/L 30 Infection agent Circulation CPAP/ASB virology supportive Both dehydrated and/or stream"
    },
    {
        "href": "criticalcare/COVID19/COVID 19 Referral for ECMO.pdf",
        "title": "COVID 19 Referral for ECMO",
        "content": "Dear you ventilation there prone partners making place RESP this always Injury respiratory criteria Referral Evidence nonurgent through Clinical step UK follow if injury Due implementation or pH less two Exclusion when To Nationally Infirmary colleagues For all Service start email hypercapnia Scale after below locally directed positioning regrading ecmo@nhs process directly via Referrals system work Referapatient Enquiries an are Thursday Network in discuss teams unless problems hrs management that Direct neurological portal governance not been and Leicester reversible This AB25 shortly already healthcare/ecmoreferralpathway Frailty will Scotland uncompensated Ian Glenfield had Foresterhill 554253 unable least Aberdeen service 54253 https://www If differences \u22653 support Care We CME Sim 20 Unit transition would 13th protective Colleagues Friar address: enquires Critical 2020 be please case wishes units also nhsg ECMO only have using Arrangements All The Current contact patients us individual for Extension Designated 11th Respiratory Criteria 201 Nurse Ms experience Director Hospital managed Scottish closely trial Lung Dr delay inform Stephen should Adult updated therefore referrals signpost repatriation considered multiorgan by Coordinator ICU many As Best from any with wrote area up attached Refractory net Healthcare Intensive Lucy July final of touch Lead Leads at Failed has handled like as optimal pleased relating across Ferries Signpost opportunities centres Line contraindicated continue category Brenda information now standalone group emergency patient Potentially provide made the 07917068628 Scott lung Royal 2ZN Ward online 01224 retrieval agreement severe August failure can Score to we referral June called Operational Inclusion our website team on until"
    },
    {
        "href": "criticalcare/COVID19/COVID Extubation Checklist.pdf",
        "title": "COVID Extubation Checklist",
        "content": "ventilation supporting suction catheter sedation CCircuit present airway general whilst Drain NG Inform Monitoring O2 Assess oxygen SpO2 ETT respiratory Observe ECG through Remove Suction trauma/oedema Senior tapes/ties if Talk or AGPs* REINTUBATION EARLY care Deflate remove Airway Yankauer block catheter/closed prepared Consider Lothian system Preparation an Stethoscope difficult From secretions etCO2 nurses Cardiovascular not cooperative and pattern high *FULL bite Give sit NAP pt BP access NOW informed adequate postextubation patient: Aspiration tube Care cut SpO2/RR PPE Previous Critical 2020 perform mask DAS Adequate visible allocate Planning syringe Two trolley suctioning formulated Obstetric roles NHS Check for IV Obesity oropharynx Respiratory Postextubation 10ml post /HFNC Date: Awake supply PLAN compromise: CALL HELP FOR nurse checked tracheal Charge oral RAISE COVID confirmed subglottic Prepare stability supplemental spontaneous plans filter leak Facemask doctor Checklist up delivery Stop Scissors cuff extubate of March ready cough signs available NIV extubation PROCEED: Adapted aware factors: suspected patient tapes 100% connected the aspirate extubations ABG Review noise guidelines 30 to CONCERNS Extubation plan risk Ensure Optimise fasting Equipment minutes"
    },
    {
        "href": "criticalcare/COVID19/COVID Tracheostomy checklist.pdf",
        "title": "COVID Tracheostomy checklist",
        "content": "ventilation routinely suction gloved sedation Ventilator monitoring closed decision NMB again this airway NG Team last required whole box respiratory throughout criteria is ETT unfractionated coordinates during if Prior or Document flange Inline wristband Service date care visor Bedside aerosolisation stay Full FIO2 since additional PROCEDURE change directly LMWH Consider GENERATING Aspiration experienced due AEROSOL Surgical meets difficult in sample Confirm second Indications documented ensuring not ventilator wean COVID19 and Vasopressors/ adrenaline member 24 BTS procedure appropriate must specific every mode Percutaneous Preoxygenate kit BMI paused immediately Sedate hours tube staff Fasted? NOT discussion We known Mandatory circuit assembled recommend would Valid sign HME PPE failed CXR weaning dilation 100 regarding TRACHEOSTOMY mask Plts be case checklist Sedation/analgesia HIGH tracheostomy factors PEEP including Do Allocate All who Stoma McNeill devices Patient anticipated for AD Respiratory 10 12 once 14 invasive PERCUTANEOUS MAKES Authors: leader then capnography nurse assistant COVID Plan INR subglottic full prolonged Routine Neuromuscular difficulty adjustable single proceed percutaneous ICU Experienced events aspirated TRAK shift allocations PROCEED prior from Fleming with completed? filter Bronchoscopist completion GUIDELINE CHALLENGING Cuff up Double stage need Family Inner COMMUNICATION of Gown port participating insertion FFP3 Platelets AWI heparin minimse as Fibrinogen Bedhead donning Suggested Day extubation enhanced timings patient emergency Bronchoscope Consultant Operator operator Lidocaine the Appropriate chart blockers pause Review twice drugs to plan Ongoing Need size risk give display per Verbalise team RISK on disconnections Baruah Check"
    },
    {
        "href": "criticalcare/COVID19/COVID19 Critical Care Intubation Action Card Surge 2.pdf",
        "title": "COVID19 Critical Care Intubation Action Card Surge 2",
        "content": "you suction Ventilator closed person getting such airway etco2 assistant/ 11 required to: STOP equipment 02 priority approach dry pillow vent Intubation if Prior or Identify Apply Authors: Using enter all start 13 after Dunn oxygenation Draft/Final: Card additional prepared HPS Reviewed Next system grip experienced Capnography secured Switch Oxford etCO2 attempt in copy run most Tube Remember ventilator Status used wear and member COVID19 USE disposed identify Suspected Continue spotter/buddy CRITICAL will ONLY pressure kit avoid standard preparing side connections buddy Following Empty tube If circuit 20 Care rooms use room best entering off HME PPE Help transfer McGrath mask Critical perform be please Clean desaturation decomtamination clamps checklist negative rapid trolley bedside separate have At ensure only Leave using laminated All The trained McNeill intubation inflated clamped Title: act for 10 12 15 reconnect BVM once VBM Circuit your 14 doff Final Before: check supply 19 reusable ScalpelCRIC nursed After: FOR Change 17 CARE performed then Guidelines document RSI should COVID Plan pockets 22 single possible needed by ICU Action prior with preassemble: 16 bag both cuff first Approved disconnection Pre before pre other Aim of technique bagging cricoids/drugs as donning guidance available into During: by: runner Transfer patient connected the Use remains people review outside pause Only can handed drugs to doffing plan Additional Ensure VL may per on:20 on team Written: minutes"
    },
    {
        "href": "criticalcare/COVID19/Critical Care COVID-19 Death Certification.pdf",
        "title": "Critical Care COVID-19 Death Certification",
        "content": "preferred prefer neglect/fault Completion Discuss form QIT Death High 11 examination custody presumed EH1 Tick overlaying Certification is legal 5520 Leith death May likely Family: Uncertainty Registry Registration pose office or scan children Street Practitioner Post email care Dunn editorial Hugh Draft/Final: Reviewed additional mental Send Next Registrar Certificate Communication Yes drugrelated 253 Diagnostic are EH6 in +/ accepting registrar that Bereavement not suicide DH1 Status COVID19 and associated documenting USE Significant course 9HP lead on: CRITICAL will ONLY advice Discussion Unless: C19 Quadrangle unable employment medical subject Cause leith@edinburgh 331 health satisfy Ferry Draft Care family\u2019s Hazards Referral: 2600 Queensferry sq@edinburgh registry Gifford PF Critical information: be MCCD/Form probabilities completed 529 2020 0131 public compulsory under deceased including dental who The Title: diseases which treatment legislation for Information Road Criteria post balance 1YP supply check South Confirmed cause certificate mortem Edinburgh notifiable/infectious FOR Authors: CARE Guidelines 4AE April number uk St suspicious from result with suffocation where reporting family: Library Mortuary City possibility Pack Family himself/herself 1590 Approved July of other Procurator Disease gov city@edinburgh as registrars 53 able EH30 by: No body group Chambers includes the they Presumed review complete accidental Does phone investigation Extra 30 fault/failure/complaint/adverse Mark to event risk give may Fiscal on Centre Process Council Standard Written:"
    },
    {
        "href": "criticalcare/COVID19/Dalteparin_thromboprophylaxis.docx",
        "title": "Dalteparin thromboprophylaxis",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients.pdf",
        "title": "Management of fluid balance and renal replacement therapy inCOVID-19 ARDS patients",
        "content": "Adjust Ill ultrafiltration Note Thiazides different alkalosis follow when BD DCT BALANCE Morris oxygenation 250450mls/minute change protocol Next an difficult correct route iatrogenic suggest Diuresis 2011 Be 9297 Continue therapy ARDS: diuresis daily results AKI resistant excessive diuretic combination delivered sufficient: be Careful normal The who Option for ARDS CCOOVVIIDD1199 CARE stability agents prior life selected Citrate Intensive Acetazolamide of at 50mg hypocalcaemia achieve tolerated important options enough renal preferable hypernatraemia help liver we per however give pH>7 until add Written: Preferred toxicity ooff fluid Dialysate stable Tachycardia Loop profound allow deciding High receive 09/04/2020 Those Should is initially or promote seek Spironolactone areas removal over all care beds editorial Draft/Final: additional via ii critical caused are CVVHD Fixed rate that unnecessary Each given STABLE accordingly used COVID19 and slightly USE This natriuresis Oliver on: CRITICAL adequate flow medical vs TThheerraappyy replacement use flows RReeppllaacceemmeenntt physician levels Society these PCT cubicles using RReennaall Mobilising Patient treatment but balance Final supply aanndd FOR 17 Authors: monotherapy reverse Guidelines settings longer Plumb Not Variable better number filter machines threatening with 16 see electrolyte Therapy There Subsequently impact NGT Multibic/heparin Journal preferably overload AARRDDSS available agent/agents group Critically the they review hyperkalaemia drugs to concentrate may max Fluid Effective REPLACEMENT resources consider Other this Bolus utilised Acts required water issues 500mls Intermittent blood infusion Monitor urine if 500mg 5mg UNSTABLE start discretion significant Decide Dunn spaces Reviewed MMaannaaggeemmeenntt ppaattiieennttss 5% In section in often furosemide between not loss 24 every high improve natriuresis1 will ONLY Choice IHD instance enteral move Care them off Oedema anticoagulation Can stock intake have patients intranet Natriuresis IV haemodialysis Blood higher 100mg provided 250450mls/hour electrolytes failing exceeds Depending 116D dialysate retention alone dextrose 118/116 BFZ Approved Aim following Beware 4800mls/hour increased no aware able by: notice provide than multibic/heparin can 72 risk demand on there machine 180mls/min QIT require Balance Aminophylline FFlluuiidd FLUID more either directed 45 BBaallaannccee Diuresis? concerns Status Robinson potassium Replacement 3600mls/hour hours If Minimise optimise 31/03/2020 regarding Critical 12h consumables osmosis Do acidaemia Title: individual useful 12 Bendroflumethiazide just dose 400ml/hr Renal 31/03/2021 attention 118 bulky 10mg/hr 117 limit together therefore Oedematous possible unlikely by RENAL Remaining Management THERAPY where Furosemide citrate need profile first 130mg/hr addition heparin as Try clearance Thiazide patient essential iinn it severe Mark PATIENTS agent Need"
    },
    {
        "href": "criticalcare/COVID19/Provision of End of Life Care in Critical Care with COVID19.pdf",
        "title": "Provision of End of Life Care in Critical Care with COVID19",
        "content": "postmortem clinical 24/3/20 above offices below: Deaths respiratory coexisting Referral hand follow ICH guideline reported Family/NOK desired due an Directorate unless movement Within decisions embalming Murray usual patient\u2019s Cannot donation presence withdrawal room same be EPPE deceased normal The notification for Calder Procedure apron CARE COPFS pathway leave worn Any life both touch of occur at extubation suspected Consultant apply routine provision Only Visitors per Fiscal Standard until Written: TBPs decision set whilst visit Officer is kin environment or areas Are Organ removal all care individuals Draft/Final: directly clinician They status are total that given COVID19 and wear selfisolate USE appropriate must CRITICAL staff support use visitors transmission PPE do principles enable Aerosol surgical public Visiting also using maintained personalised Patient treatment but practice Final FOR Authors: Guidelines should Guideline proceed alternative Enhanced April with nose disconnection before Procurator Precautions optimal primary viewing continue body the they to Transmission may Process family/next PLE CCircuit present place this Death required May diagnosis current if considerations preparations Patients discretion screened infected eg Anticipatory Lothian believed distress Maximum face in Life most WLST not ventilator described precautions Must Control will ONLY pathology immediately unable notifiable circuit Care concurrent face\u2019 develop remain Tpiece discussed hygienic family/NOK 2020 fully NOK symptomatic have patients AGP performing symptoms managed provided disease Dr organ Video deaths intended from any end nursing Approved Aim following hygiene guidance no comfort by: maintain provide made can considerations: hands risk ACP potential on \u2018face Provision immediate gloves there End covered require ETT another time choose sufficient Medical cleaned enter whom after Generating permitted system Surgical changes Chief discussions alleviate Status been sustaining Decision still Based side Last If discussion known terminal regarding Where mask Critical perform VC ensure At All Title: Prescriptions Blackstock reaching was requirement performed therefore possible by Carol Swedish Management bag without air as visiting Conference patient phone SNOD period Infection and/or Section SICPs"
    },
    {
        "href": "criticalcare/COVID19/RIE/ACCESS TO COVID Handover.pdf",
        "title": "ACCESS TO COVID Handover",
        "content": "be Handover you held in area form Drive often need this TO ACCP\u2019s have Care\\Ward The McDonald at 7s COVID19 and is This for ABBREVIATED but xls access trainees HANDOVER handing Shared e85050 It the over S: all 118 Ward least secure complete If online twice daily updated COVID Band should WARD to Jane ACCESS called Handover\\ by owner team on \\\\rieapp1\\Critical do folder General\\COVID19 an please"
    },
    {
        "href": "criticalcare/COVID19/RIE/Aisys CS2 use as an ICU ventilator.pdf",
        "title": "Aisys CS2 use as an ICU ventilator",
        "content": "routinely indicator clinical difference Fi critically expired Gibson out airway above Checkout 1L/min Com FiCO2 oxygen read Peak Note comwheel different what reliability during navigate corresponds when To basis disconnected remove TV Our windows shown change Consider mindray PaCO2 desired completely due an Prone difficult 400ml Please moisture note unless Rate further circumstances com After ulnar removing 8kpa indicators pandemic usual 10cm level presence VCV Following NOT spontaneously We names would weaning H+ maximum be please pro cannister Synchronised normal litre adjusted capnograph who The accessed assess for reduce become soda check 19 Unable aiming An sidestream leave register SIMV highlighted CS2 completion Anaesthesia selected Start of touch occur anaesthetist mains met at menu occasions achieve neutral switch options important ventilating reconnecting 100% persists Use guaranteed FiO2 Filter provision help Initial frequently we Updated per Ensure select called however team Touch until long rates fluid Upon assist preferred enlist default adjusting selecting set make wheel Temporarily Should is vent quick Prior or Ventilatory found capnographs L/min ventilated positions stay those below turn inspiratory additional 5l/min needs via PSV Falling its They overcome are anaesthetic rate Safety ventilators necessary that Simply Low conduct used slightly and short here This call light must systems initiate Soda contamination pressure NO Aisys returned flow medical designed staff replacement support ETCO2 4L/min use take although do increasing exceptional Solutions valves clamping these situ apnoea under only using 1:1 PEEP indications Circle demands function clamped accumulation 10 By but balance operating initialy pressing term settings document should confirmed recurs Total account begin filter machines rise ODP with yet unclamped see cmH2O There disconnection impact before setting confronted Continuous has does familiar available users lower breaths now indicated lung the guide colour point drugs ventilate to Resp may ratio becomes safely 12hrs ventilation AISYS consider closed arrow volume OF drying this O2 mandatory required remind VG minimise likely Troubleshooting infusion ask current if autoflow Disconnection For carry start rotating significant rechecked cancelled unlike tidal Lothian intermittent occurring work Vaporisers 8L/min touchscreen In empty active in run open canisters switch: most monitor between Once not ventilator Flow bellows 24 One high cannot 50% mode checkout will standard order It move Diuretics toggled Vent some unable consultant hypoxaemia listed circuit alarm Modes them best discussed baseline PCV exhausted warning 49 2020 days case Set changed line filled bedside displays have suctioning return Mode reference contact patients position picture broken VENTILATION context collapse I:E being controlled Drager increase normally clinically then Disclaimer: Neuromuscular intended ICU valve filters As drive alter from any Breaking end minute up area outwith Suctioning goals nursing acknowledge Pre bacterial/viral March following wash customise no increased screen into able Volume maintain With information safer page posters restarted performance than can reconnected confirm risk potential ill our display However inspiration demand on located 60 you there BREATHING suction Bag machine again End problem acknowledged MODES back require starting When barotrauma Pressure time their ie style leaks litres more CIRCUITS expected proximal after induce COETT target beneficial reinflated mounted system red bolus changes reinspired CO2 fresh You gas 12hour blocking window resp circle been undertaken procedure ruler reboot PaO2 spill paused usage Introductory hours If positive discussion known message optimise protective HME depending minutes operate scavenging negative Do All uses green demonstrate asked CPAP NHS individual breathing 12 Default incorporates Users absorbed circuits 30cmH2O cause requirement lime initial nurse COVID limit flush generated therefore considered full assistance Routine possible reduced by Increase challenges day mentioned Moisture aid anaesthesia These where works licensed need bag HMEF instances earlier without as /min aim patient low 34 it H2O period 2/4/2020 measured extent plan production cancel manned option preuse regular"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID 2019 Critical Care Referral Pathway.pdf",
        "title": "COVID 2019 Critical Care Referral Pathway",
        "content": "immediate requested \u226492% arrange 09/04/20 Zone Fitton Assess require Referral if or Patients all Trak Anticipatory via Care/Anaesthetist/EM an 60% Manage in requires \\aecovid not COVID19 and 2200 Guide appropriate opinion will RR\u226525/Sp02 immediately currently discussion Care Complete transfer PPE instituted Critical be bleep using NHSL who patients Admission Patient intubation unwell bed for airborne Di Hospital 19 OR initial COVID Plan Red needed Anaesthetist by ICU Rollo/D refers requiring resuscitation McNeill/L IF does Kerslake/G available patient Version Critically the intubated Use intubate Ward FiO2 review feel to ED Ensure ACP on team and/or Pathway"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Critical Care Admission Action Card.pdf",
        "title": "COVID RIE Critical Care Admission Action Card",
        "content": "ventilation you gloves \u2018spotter\u2019 machine blue QIT meet out general airway Decontaminate above responsible whilst 11 Place this required 1000mls turning equipment ETT throughout another is water Wipe When priority arrival dry hand Chlorclean Gather blood Bin if Bloods let RRIIEE Lab their enter SOP Signage removal notes all over 13 visor reminding infusions editorial solution Reviewed Card alternate takes door Next via xHaz Arrival: drawer due are AAddmmiissssiioonn face in bottle Covid19 nurses disposable Remember not ventilator PCI further wet Status wear member and COVID19 USE plus placed This disposed precautions Exiting: appropriate must times Must on: CRITICAL will ONLY contamination kit Outside detailed sampling adequate Cleaning Covid Vent medical anything staff daily cubicle Care inside masks them room down same off PPE transfer Staff fluids mask Critical be stock 9/3/2030 clamping taken clamps Floor surgical trolley ensure including Allocate Do Limit small hourly All deliver Admission Title: 1000ppm bed Safely for anticipated airborne 10 12 Nurse but your cold doff Final CCOOVVIIDD1199 send apron entrance disconnect FOR Authors: CARE then Guidelines coming should Plan nearest Prepare full tabs by leaving mop day exit shift =10000ppm Action policy from prior with where tab chlorclean specimen get bag Domestic Approved pole Pre of other touch without at washing FFP3 1x rotation wash as donning role decontamination quickly no CCaarrdd transport splashing/splatter by: spillages patient information Trolley emergency body group bin the they AAccttiioonn point enough cleaning review outside ABG twice remind spotting wipes to doffing Ensure risk tubing \u2018Spotter\u2019 wearing per hands sink team on know Written:"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID RIE Inter hospital transfer action card.pdf",
        "title": "COVID RIE Inter hospital transfer action card",
        "content": "Ventilator monitoring SAS QIT ET 11 RIE: wiped arrival time through WGH Chlorclean along RRIIEE their cleaned enter Follow departing Post evolving remove editorial Draft/Final: Reviewed HPS Next IInntteerrhhoossppiittaall arranged left via past Appendix in notify TTrraannssffeerr between PCI Status and member USE notifications undertaken appropriate on: CRITICAL will ONLY access standard side medical handover tube staff Care On receiving room down discussed national transfer PPE shoot Critical be Pause Wd taken floor trolley using received The clamped Title: 10 corridor 12 lifts cath practice 20/SJH approximate CCOOVVIIDD1199 lab entrance 118 FOR Authors: CARE then Guidelines 117 should swiped 118: by ICU exiting exit prior with Arrival nursing first Approved disconnection Pre of at as guidance TITLE CCaarrdd by: patient group connected the doors AAccttiioonn thoroughly cleaning review outside to per Additional departure: wearing team on observe/trouble Written:"
    },
    {
        "href": "criticalcare/COVID19/RIE/COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2.pdf",
        "title": "COVID-19 RIE Level 3 Intra-hospital CT Transfer Action Card Surge 2",
        "content": "fitted observe Doff monitoring completion: 11 back required direct equipment is one wiped arrival through May Senior if or two members enter CT 13 prepare Dunn Draft/Final: Card HPS Next arranged Reviewed/revised close sent an don Oct orange route preprepared in undertake most Tube between not ventilator Status used table and member COVID19 USE undertaken One on: CRITICAL will ONLY standard bags usual hospital reentering medical passage consultant Following tube staff Care RIE On down room discussed off Portering transfer PPE Critical 2020 be done taken clamps Level trolley using facilitate rota return The McNeill contact Title: bed for double 10 12 bagged 15 but practice 14 Final supply rest 19 entry 118 FOR Authors: CARE Guidelines Don COVID designated Another by leaving ICU trip Action prior with chlorclean Arrival bag nursing Intrahospital Pre of addition March at FFP3 as guidance ahead Doning 2021 Transfer control patient emergency minimum the Scan review CT: trainee can reconnected to per Ensure departure: spotter team on Standard Intra Written:"
    },
    {
        "href": "criticalcare/COVID19/RIE/CoVid RIE Intubation Checklist.pdf",
        "title": "CoVid RIE Intubation Checklist",
        "content": "alloca3on requested Intubator catheter turns vasopressors this airway O2 Monitoring supragloZc Mac Team incl backup mount equipment SpO2 ETT handle is intuba waveform Is ECG Op 2018 posi if or Induc3on tape Airway Yankauer head Lothian via administrator CoVid Stethoscope TUBE in how? Cricoid necessary pa3ent \u2191K+? Vocalise Emergency further and ml intuba3on 2200 call Di\ufb03culty will Preoxygenate BP access pressure kit NOW seda3on Covid Intubator\u2019s required? tube circuit ETCO2 Care Blacstock \u00d72 3cm room DAS/ICS PPE McGrath suc3on Intuba3on laryngoscope B/C Can 2020 ON Understand roles? visible Cut syringe switchboard laryngoscopy trolley using turned OPA FoNA Cri3cal Bougie contact carina NHS Check for 10 Fibreop Date: st supply lubricate check Who checked RSI assistant RAISE Plan Anaesthe Conrm SupragloZc Closed Theatre ICU trachea wake Op3misa3on PROCEED from with Checklist up Double Prepara3on Pa3ent HMEF seniors March Stylet Tie CLAMPS Sizes Allergies role 3p Adapted cu Communica3on mise Runner page Consultant 5cm Scalpelbougietube outside fails? Review help drugs we CONCERNS plan Ongoing size max Verbalise on Drugs Baruah Equipment"
    },
    {
        "href": "criticalcare/COVID19/RIE/Covid_extubation.pdf",
        "title": "Covid extubation",
        "content": "ventilation supporting suction catheter sedation CCircuit present airway general whilst Drain NG Inform Monitoring O2 Assess oxygen SpO2 ETT respiratory Observe ECG through Remove Suction trauma/oedema Senior tapes/ties if Talk or AGPs* REINTUBATION EARLY care Deflate remove Airway Yankauer block catheter/closed prepared Consider Lothian system Preparation an Stethoscope difficult From secretions etCO2 nurses Cardiovascular not cooperative and pattern high *FULL bite Give sit NAP pt BP access NOW informed adequate postextubation patient: Aspiration tube Care cut SpO2/RR PPE Previous Critical 2020 perform mask DAS Adequate visible allocate Planning syringe Two trolley suctioning formulated Obstetric roles NHS Check for IV Obesity oropharynx Respiratory Postextubation 10ml post /HFNC Date: Awake supply PLAN compromise: CALL HELP FOR nurse checked tracheal Charge oral RAISE COVID confirmed subglottic Prepare stability supplemental spontaneous plans filter leak Facemask doctor Checklist up delivery Stop Scissors cuff extubate of March ready cough signs available NIV extubation PROCEED: Adapted aware factors: suspected patient tapes 100% connected the aspirate extubations ABG Review noise guidelines 30 to CONCERNS Extubation plan risk Ensure Optimise fasting Equipment minutes"
    },
    {
        "href": "criticalcare/COVID19/RIE/Flow of patients in RIE Critical Care during C19.pdf",
        "title": "Flow of patients in RIE Critical Care during C19",
        "content": "ventilation Area Elective GREEN clinical consider likelihood Discuss decision SARS apart allow exposure thromboembolic meet whilst URT/LRT High 118A/116C/116D 8C swab receive 11 overdose YES presumed sideroom shielding require respiratory throughout criteria is ICPT Positive aerosol clear meeting fever/respiratory Clinical May during Placement diagnosis initially if or deemed two sufficient Guidance areas waiting existing IPCT alert Patients 13 care organisms beds LOW additional since alternate self Yes improvement an critical mechanical status are in samples Pandemic open hrs management 2023 Once Low Emergency consistent not 116D/ further used 116C/116D/118A/ward and previously initiation Would <37 24 This Areas precautions lead high One appropriate already assessment vAll ONLY More Has NO ideally neutropaenia See \u2018Contact\u2019 Admissions within AND flow co move 118A CoV2 consultant health hours If positive least some results droplet Care RIE known cubicle down excluding swabbed discussed transmission testing protective transfer Cohorted Considered placement presenting discharge stepped home new Critical be days suspected/proven worker admitted taken rapid negative Level would separate ensure HIGH including have reassessment pancreatitis All who admissions Admission patients non AGP contact Patient vPatients for thereafter symptoms employees post context 1114 14 managed Intermediate deisolation isolation RED Able isolated disease therafter nursed intermediate Unable fever 117 should test confirmed Priority During considered full admission 116D URT+LRT having 116C/116D/118A ICU deescalation tested Probability probability from based result with cohorted area completion need fulfilling Isolation first criteria? Non of other vPatient Department at manage FFP3 following as available INTERMEDIATE no Temp Transplant continue No patient providing Sideroom low Version Open Remain essential the intubated they 116C/116D/118 pathogens chart SARSCoV2 URT available: definitive than Initial infection can Siderooms to history consecutive siderooms risk give 116C 118B immunity on contacts 48 until"
    },
    {
        "href": "criticalcare/COVID19/RIE/RIE Near Me Guidance.pdf",
        "title": "RIE Near Me Guidance",
        "content": "you Area making talk Log read passcode is calling NHSFREEWIFI Go nhs quick 654321 details Prior or found platform email: via Communication challenging Near password discuss in Waiting run News given not COVID19 and USE call iPad CRITICAL Scotland ONLY access patient\u2019s Attend medical service If Care RIE use onto NHSNearMe@nhslothian would live iPad: sign wish do Critical please be Ask video using have label helpful patients which NHS for Bad VIDEO name CALL FOR CARE Me vc/rcc Guidelines Click go Guideline fill uk HOW with Breaking tips com/login TO of username following Remote scot like https://nhs patient connected the https://nhsattend they family relatives it phone can Anywhere to Ensure attendanywhere advice: on team"
    },
    null,
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID-19_PPE_Donning_poster.pdf",
        "title": "SJH COVID-19 PPE Donning poster",
        "content": "you gloves adjust respirator healthcare rmly this above covered always back Place equipment gown is different heavily practices Position hand good protect safety during environment spread piece or repellent when over Gloves hydrated facial Instructions after remove eye head fasten change keep ears strap headband upper work eyes Note: are correct neck bridge ngers face in putting tie that disposable nape between been COVID19 and ties This undertaken followed must removing cannot will torn patient\u2019s glove order safe according If NOT use room down protective PPE goggles protection uid Where perform away be spectacles compatibility worker these straps differ ensure hair have Put The jewellery touched Eye for achieved longsleeved instructions your being provided contaminated check Putting makes pressing crown should limit test personal Predonning DO by tested worn regularly PROCEED from with sides checking Respirator nose cuff both of before manufacturers at technique donning hygiene available waist lower against mould patient With yourself the Use surfaces outside infection Perform to hands Ensure size select clean on cheeks until"
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ED Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ED Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH COVID19 ITU Intubation Action Card March 2020.docx",
        "title": "SJH COVID19 ITU Intubation Action Card March 2020",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/SJH/SJH PHE_COVID-19_Doffing_poster.pdf",
        "title": "SJH PHE COVID-19 Doffing poster",
        "content": "gloves there gloved clinical touching respirator healthcare place fold out discard always pulling back ungloved sleeves equipment gown handle is water hand let or supervised To removal Gloves over bring outsides visor opposite remove soap eye head process Turn strap bottom rub slide Firstly: distance an In are fall ngers neck Pull in face that cross not COVID19 and slightly ties removed disposed must removing nd will contamination follows: patient\u2019s absence order safe glove buddy shoulders inside use respirators retaining room protective off lined PPE rst remaining Where protection be waste Clean away worker gel straps under only lift using including Do All Unfasten dofng The Eye for top Removal reduce alcohol your isolation contaminated ante Then: Wash forward reach retraining peel then should roll personal possible by leaving systematic contaminating from with fullface way while area lean Respirator up both touch of before Gown preferably at FFP3 behind anteroom/lobby grasp as waist into hold inadvertently bin the wrist Unless bundle outside it dedicated minimises peeling to front hands risk metres potential motion themselves"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 Intubation Kit list.pdf",
        "title": "COVID WGH Ward 20 Intubation Kit list",
        "content": "SSuussppeecctteedd suction catheter Cables Slim blue COVID19/Suspected set Baby pump NG charge Facemasks 12F box equipment Box ETT catheters Clark Pressure Clerk Suction WGH Drip infusion Intubation Monitor if office saline waiting scope WWaarrdd SOP manometer airways Loose Anchorfast Metal below tape Draft/Final: Reviewed Yankauer cable Next left 14F transducer Stethoscope 18G are pressors Jelly Mackinnon tubes in Please 3000 Covid19 contents tie Ambu monitor Tube EtC02 Emergency phones not ventilator stored Status key and arterial LLiisstt USE 2200 Guedel Cannula COVID19 plus on: // Scope CRITICAL cylinder Duncan ONLY access sampling packs stand tube listed blades circuit 20 Care departure use Draft room Vascular NIPB off McGrath laryngoscope Laminated Critical Macintosh be 2020 syringe clamps line trolley sizes normal pumps v2 1000ml The refreshed Bougie Title: Braun cateher KKiitt 10ml breathing sachets Arterial check CCOOVVIIDD1199 Blackstock iGel FOR Authors: CARE unit Guidelines ABP RSI mounts Schrader Closed leaving RIDU Checklist up Cuff Scissors need bag HMEF Oxygen Approved before splitter Stylet March insertion Syringe Aintree Sp02 induction available Oxylog fat by: patient emergency 20G plastic x3 the made drivers intubate Ward review socket Femoral drugs pack to tubing size may 22G on clamp Drugs Baruah Written:"
    },
    {
        "href": "criticalcare/COVID19/WGH/COVID WGH Ward 20 RIDU Intubation Action Card.pdf",
        "title": "COVID WGH Ward 20 RIDU Intubation Action Card",
        "content": "SSuussppeecctteedd IGel intubator/drugs catheter clinical monitoring SAS COVID19/Suspected airway specialty oxygen respiratory ECG intubator\u2019s during guideline when airways Anchorfast staffing change Next Communication discuss hypoxic // BP access See board tube RIE room CXR Laminated 000 be lift measuring The Bougie assess for sterile Lubricating Prereferral Daily 14 moved check CCOOVVIIDD1199 nursed entrance Establish CARE RSI ICU/anaesthetic Primary leaving identified prior Phone deterioration judgment met of at metaraminol suspected communicate emergency drivers list definitive tubing per size anticipatory team Equipment Written: arrange Contact evidence equipment is 1:10 safety Problem Intubation or found WWaarrdd care Draft/Final: HPS door via experienced critical status neck piped anaesthetic Covid19 cuffed Ambu Emergency PCI COVID19 and 2200 USE call appropriate on: CRITICAL Assessment videos kit 10th Severe medical availability staff departure take use unstable Ventilation alfentanil progress PPE transfer Group fluids levels these re Level situ Donning/doffing bed appropriately post Arterial but x2 1:100 FOR Authors: Guidelines Clerk\u2019s should confirmed scrub proven number RIDU CPR with Checklist see Yankaeur before hypoxia well scopes Ccircuit Oxylog Anecdotal indicated the cleaning pause review RSI: infection trainee drugs to front equipotent Size may closed pump NG Facemasks required one atropine minimise indicates through WGH donning/doffing Monitor current if proning China office ambulance SOP Metal Reviewed too unsuitable secretions face in bottle scissors monitor between not ventilator adrenaline escalation include precautions high every will ONLY plugged wide immediately Covid consultant Etc02 buddy Draft Care receiving practical Exit Staff 2020 units suspected/proven line contact patients intranet intubation position IV 9am 10ml suitability Record taxi supervising Communication: ICU Update: slim from SSOOPP up Cuff nursing intubations Approved involved March assistants Aintree guidance by: Transfer maintain arrangements page made Front Kit can Perform confirm risk on clamp gloves suction respond machine Inform charge back box ETT catheters jelly aerosolization time Suction assisting their Follow manometer after administrator Stethoscope Conduct primed tubes consist nurses EtC02 supervise propofol stored Status Guedel Induction side handover If 20 List HME planning NIC mask Critical syringe ID Two US choice trained Title: Braun intubating referral: Blackstock compressiononly 118 Restock nurse COVID full determine Closed by Interhospital shift compressions postintubation PAG insertion Sp02 as Sonosite 16F convene escorted aim patient Runner remains Ward outside phone PostRSI dedicated severely doffing Drugs Baruah"
    },
    {
        "href": "criticalcare/COVID19/WGH/CoVid intubation checklist WGH.pdf",
        "title": "CoVid intubation checklist WGH",
        "content": "requested Intubator suction catheter sedation turns vasopressors supraglottic this airway O2 Monitoring Mac Team incl backup mount box SpO2 ETT handle is waveform Is ECG Site 2018 Intubation if Difficulty or tip Optimisation tape Airway Yankauer head Lothian via Communication administrator Preparation CoVid Equipment Stethoscope in Confirm how? Cricoid \u2191K+? Vocalise Emergency further and ml Induction will Preoxygenate BP access pressure kit NOW Covid Intubator\u2019s required? Cons tube mobile circuit ETCO2 Care Blacstock allocation \u00d72 3cm room DAS/ICS PPE McGrath laryngoscope B/C Critical 2020 Can ON Understand roles? visible Cut syringe trolley laryngoscopy using turned OPA FoNA Bougie contact intubation Patient position carina NHS for 10 Date: supply lubricate check Who checked assistant RSI RAISE Plan Closed Fibreoptic Theatre Anaesthetist ICU trachea wake PROCEED from Checklist up Double cuff March Stylet Tie Sizes Allergies role Supraglottic Adapted patient Runner 5cm Scalpelbougietube outside fails? Review phone help site drugs we CONCERNS plan Ongoing size max Verbalise Optimise on Drugs Baruah Check"
    },
    null,
    {
        "href": "criticalcare/COVID19/WGH/Management and escalation plan for COVID19 patients in Ward 20 ICU 130320.pdf",
        "title": "Management and escalation plan for COVID19 patients in Ward 20 ICU 130320",
        "content": "ventilation Discharge default closed decision this above senior time: 26 required enact ETT is acceptance time Site WGH SHDU theatre/recovery 58 or coordinate Medical areas SOP basin IPCT input theatres Patients all directed spaces via NonCOVID19 bedspace mechanical Dependent recovery Will empty Manage Bedspace in anaesthetic Main/DCN 89 nonessential second movement management that ward/HDU/Lothian between markings not further used COVID19 and escalation Donning removed This appropriate already must will /Ward pressure advice Murray detailed plan: informed surgery within items order side instance consultant If 20 staff vestibule Care RIE Nursing room SJH PPE transfer L1/2 Estates ICU/Ward 36 Critical be nonCOVID Bedspaces admitted capacity negative floor only At including normal ward All who patients Patient bed for entrance/exit Anaesthetic but theatre moved operating managed Blackstock entrance unit then surge should barrier 13/3/2020 Plan use: admission considered possible Theatre by ICU Enhanced As These Management HDU machines from any with Medical/Haematology area handwashing occurred requiring both nursing first 1016 stop of before coordinators Surge at following as liase ends barriers available donning Suggested 916 18 /NHDU able continue construct 3rd patient emergency now Consultant indicated Close oncall the doors Capacity point Ward people Review can bedspaces to elective referral plan per Visitors doffing may temporary sink main on team 48 Oncall until Move"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Cheat Sheet.pdf",
        "title": "Aisys CS2 Cheat Sheet",
        "content": "indicator difference Checkout 12cmH2O above Stacked FiCO2 10l/min oxygen comwheel different BACKUP reduction during navigate when To calibrate >10l/min CIRCUIT shown change PaCO2 GAS DOPES 2024 Press com BREAKING After Settings: VCV Following tube closedsuction combination H+ be Pause saying Ask Signs including adjusted The which for >0 CAUSES IMMEDIATE reduce soda check elevated so standby SIMV identified CS2 Anaesthesia Start of touch met mains GOALS at fail SODA switch ventilating 100% persists Use FiO2 Initial Ensure select bag/ventilator team until Equipment Preferred default PVCVG set bpm wheel is 8l/min >6 vent initially Settings or 400mls all care ventilated turn 5l/min Displaced defined needs its FALLING are rate seconds that Low changing used and This appropriate light Volatile righthand pressure within AND LIME flow medical FGF 1l/min support down Ventilation flows do increasing visual only using 1:1 PEEP demands usually Respiratory 10 achieved but END reach pressing FOR reverse settings should confirmed admission Ratio leak with tab lowflow yet see There disconnection setting confronted does lower the they secs review pause to OXYGEN may temporary AISYS 6mls/kg Ventilator arrow present occurs OF place this O2 last PAUSING casing indicates likely TROUBLESHOOTING if start PLAN: rechecked break 6l/min touchscreen sodalime right in BELLOWS run switch: Once not ventilator Flow bellows include high every mode checkout will 824 More TIDAL <30cmH2O immediately otherwise refill Vent toggled move circuit NonCOVID baseline VENTILATOR changed neurointensive activate <60 bedside return Mode patients DISCONNECT position Breaths picture d/w VENTILATION 15 higher increase CALL HELP Case then HYPOXIA: CCIRCUIT 13l/min based way up litres/minute minimised >7 following Select no increased screen Volume maintain With plastic Tidal complete ABG than periodically can Perform reconnected confirm temporarily targets on clamp 60 you adjust there Bag machine highflow REMEMBER OFF require Pressure pH THE leaks after either COETT target left system red changes mechanical CO2 fresh You Push PCVVG gas 5cmH2O breath window container Restart displayed procedure PaO2 OXYGENATE side connections hours If message USING EtCO2 perform canister endtidal All >8kPa green top each Gas lime FLOW COVID limit dialed by Increase These Disconnections need bag Pneumothorax FRESH Pinsp litres/min aim patient low measured Obstruction prompt minutes"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Aisys CS2 Ventilation settings.pdf",
        "title": "Aisys CS2 Ventilation settings",
        "content": "Adjust routinely indicator sedation clinical difference critically expired Gibson out airway above Checkout Com 1:2 FiCO2 10l/min oxygen read Peak respiratory throughout comwheel different what displaced reliability during navigate pressures anticipating less cassette when corresponds To Ally Increasing basis disconnected remove phases >10l/min Our windows shown change upon Consider keep mindray PaCO2 Fresh desired completely expertise due an Prone 400ml Please moisture note unless 2024 suggest Neuro Rate Circuits further com How After ulnar times 8kpa indicators caution pandemic usual See patient\u2019s fulltest least 1220 VCV Following tube presence NOT spontaneously We On names mitigate would latter Sidestream weaning combination H+ rate? maximum be supplies completed please pro COVIDpositive cannister Synchronised 3L/min including normal adjusted capnograph who The vapouriser Intersurgical accessed which for >0 reduce isoflurane become cicuit soda check 19 Procedure elevated so Unable aiming An sidestream yellow prove register agents adjustable sensor standby inspired SIMV identified highlighted Initially questioned CS2 completion Anaesthesia Controlled selected both Start of touch occur met at menu achieve neutral switch options important ventilating reconnecting 100% persists Use guaranteed routine FiO2 provision could Initial frequently we settings: per Ensure select called situation 24hours main team Difference Standard Touch until long rates Upon assist preferred enlist default selecting set make Assess wheel consideration Should is vent Distal initially Prior Settings or Ventilatory found 400mls capnographs Using all L/min ventilated positions stay those below turn inspiratory additional 5l/min defined needs via PSV Falling its They emptied overcome recovery are anaesthetic rate Safety ventilators necessary that Simply unnecessary conduct Higher changing used slightly and short exhaustion This functional must light parameters Soda contamination pressure NO Aisys within returned added flow Expiratory medical designed FGF staff replacement support push use although Ventilation flows vapour Visually do increasing freshgas levels Solutions 6L/min valves disposables 12cm clamping these also apnoea under only continuous using 1:1 PEEP indications Circle demands us clamped usually Respiratory 10 By experience but balance operating pressing term settings document should checked confirmed capnography test haemodynamic Total whether begin satellite Disposables filter machines rise leak metabolic with ODP tab lowflow yet unclamped see weight cmH2O limb There disconnection impact before setting confronted Continuous has familiar available users lower breaths now body indicated lung the guide they colour point review ventilate to may ratio temporary becomes 12hrs ventilation AISYS 6mls/kg closed arrow volume drying this O2 mandatory required >68l/min remind VG minimise likely WGH Troubleshooting ask current if frequent autoflow contacted SOP For carry start rotating 13 significant rechecked cancelled unlike tidal Lothian intermittent occurring 1l/minute litre/min 6l/min touchscreen sodalime In empty in run Breathing open switch: most monitor between Once not ventilator wet Flow bellows malignant 24 removed One high every cannot checkout mode will inspiratory/expiratory More standard hospital order selfsealing It move Diuretics toggled Vent some according consultant refer hypoxaemia listed circuit Care alarm Modes remain best discussed integrity baseline 68 PCV exhausted warning 49 days case changed line filled bedside have prevent displays suctioning return Mode patients continues predicted position neuromuscular picture broken Air 15 context collapse I:E limited higher being controlled Intensivists increase Dr clinically then Disclaimer: Differences expiratory viral 12hours intended ICU sevoflurane Morgan valve filters dependent As drive alter 13l/min components from any Breaking end minute outwith Suctioning goals requiring acknowledge litres/minute expect bacterial/viral Commencing following wash Select customise 3l/min Vt no increased screen into Pro control Volume maintain safer With information page posters inadvertently restarted cassetes performance than site can reconnected confirm risk potential ill our display temporarily However demand on located inspiration Tab 60 you are: adjust there suction Bag Although machine again problem acknowledged Operating back 13L/min 10L/min OFF require RR starting When approach barotrauma Pressure time twist pH Tinsp two undergo their style leaks tight theatres manometer litres more efficiency expected proximal after either induce COETT target reinflated left system red changes reinspired CO2 fresh PCVVG You rebreathing gas 12hour blocking window disposable propofol circle been Alastair undertaken procedure Flows ruler instability reboot PaO2 spill paused peak connections recheck Introductory hours If positive discussion known message optimise protective planning depending minutes EtCO2 scavenging Critical plateau volatile nonCOVID negative operated At >6l/min canister ensure Do small shortage soiled All uses non green demonstrate CPAP NHS individual lowflows breathing 12 incorporates Default Users absorbed Circuit just circuits 30cmH2O cause requirement PSVPro Gas inspect lime initial surge nurse performed COVID limit flush extremely therefore full prolonged Closed possible reduced by Increase challenges mentioned very internal anaesthesia drop These put where works licensed >10l/minute lost need bag HMEF hyperpyrexia volumes instances earlier without representation anticipate litres/min as consists Elevated clearance Adapted \uf0b37 aim procedures patient low it H2O period measured extent plan production 49day cancel option linked preuse Check regular"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/Machine Checklist Non-COVID.pdf",
        "title": "Machine Checklist Non-COVID",
        "content": "there assist suction Ventilator monitoring closed volume present blue Absorbent machine Filters occurs this out Monitoring 1L/min FiCO2 required require neurocritical is water indicates Pressure thirds time drained next if circuit6 or two when SOP tight all more care Instructions rechecked after either >10l/min 5l/min change PaCO2 Inspect 6l/min an due Insp CO2 fall secretions in MV humidity inspected zero not further circle used Alastair and Machine exhaustion 24 include 68l/min high must every lime1 parameters reboot will Soda causes patient\u2019s fulltest Aisys within otherwise added It Expiratory flow medical recheck hours FGF If Hourly daily circuit replacement use vapour excessive EtCO2 flow4 49 days be please spirometry changed bronchoconstriction bedside using including Water canister manual hourly The zero? patients condenser for resistance 15 exp Circuit soda ture white reach mois increase Change lime performed checked should Record selftest7 expiratory yellow reduced needed by ICU Morgan inspired filters filter from trap5 carried with CS2 Anaesthesia limb need HMEF disconnection of other before has pink does as occluded near increased into control information <0 low Version Alarms the curve distal point chart FiO2 Tidal colour dialled Continuously than Initial 1Task Perform measured to visually frequently may However on team mins minutes"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH COVID Ventilation using Aisys CS2/WGH COVID Ventilation using GE Aisys CS2.pdf",
        "title": "WGH COVID Ventilation using GE Aisys CS2",
        "content": "routinely indicator catheter Breaks sedation clinical monitoring disengaged critically out 1L/min responsible ET FiCO2 10l/min nationally oxygen read respiratory different kPa drained Clinical during pressures less cassette technical lowest when To Increasing H+\uf0a365 triggered rather oxygenation phases Our change upon effects coughing Appendix PaCO2 planned Fresh \uf0b312 an standards fall moisture note unless +/ Neuro ensuring assisted MAC further viral/bacterial com Pmax Ideally times removing cylinder midazolam/clonidine follows: pandemic avoid patient\u2019s blocked accuracy Immediate level least user tube outstrips daily spontaneously We 812cmH20 inefficiency closedsuction would Sidestream Increased weaning Negative delivered H+ please be Pause 12cmH20 maximum pausing Further COVIDpositive including 35cmH2O who The sought admissions Intersurgical which for >0 dead Ventilators suction/patient oxygenating commence reduce undoubtedly 14 become soda check PS/CPAP 19 filtering Procedure elevated nonIntensivists updated personal An yellow register agents negate working inspired SIMV identified worn Minute prior CS2 attached Any deterioration both blockade General of other soon delivers ready at occasions Colleges/ASA options important suspected IPC emergency basic Consultant minimum physiology routine guaranteed Appropriate FiO2 how Filter provision could unintended Initial help frequently history we per situation main team Standard pH>7 until long rates oscillations stable outstrip replaced default reengaged intervention set sedated backup equipment ODP/medical Should is device quick safety concern initially undergone Prior Settings or 400mls all ventilated compliance Full deeper inspiratory needs clinician comprehensive arriving experienced its They emptied are repatriated Owner: space anaesthetic teams rate seconds ventilators necessary that Low changing alongside used COVID19 and previously Local This Running appropriate must problematic continual Volatile adapt pressure adequate Aisys within added flow medical were designed FGF arises staff replacement support push use onto Ventilation flows longterm transfer hospitalwide PPE needing increasing levels visual acquired clamping ongoing also under apnoea only using Canister PEEP Replacing maintained indications us clamped function suggested depressurisation usually pressurecontrolled Respiratory 10 appropriately experience but practice once compensation supply capability 17 term checked document should settings capnography confirmed approximately admission Satellite about alternative satellite filter machines leak metabolic result with tab lowflow 16 5L/min limb There cuff suitable hose before utilisation setting Scavenging perioperative effect has does parameter available Ccircuit decontamination Oxylog 20cmH2O breaths opioid lung the guide they Unless Royal point >10L/min review cleaning expectation failure ventilate brief determined to event pressure/flow may ratio clean absorber replacing stops ventilation AISYS detrimental means 6mls/kg CCircuit closed consider volume present meet such this breaks mandatory required https://cleaning deeply through bacterial Hospitals infusion current if autoflow <10 sooner For 13 reduces tidal Lothian 6l/min Capnography detected sodalime In studied empty in typically MV run flowrate supported opening reservoir rainout most monitor between Once not ventilator loss proper wet associated bellows EZchange malignant 24 described include followed corresponding high every highmetabolic mode will 824 More standard hospital wide refill It unable according sensor/valve circuit resource Care NonCOVID alarm receiving integrity 68 warning 49 days done paralysed changed capacity atmosphere line bedside have ward Internal suctioning Mode reference received patients performing neuromuscular similar broken resistance 15 context collapse increases I:E limited 24hrs higher being provided \uf0a365 increase effort then conjunction Disclaimer: seen setup interfere expiratory viral intended appears ICU timed Morgan dependent filters spontaneous drive from end delivery minute transitioning external FiO2>0 requiring nursing litres/minute precheck bacterial/viral Surge following presents closedsuctioning 3l/min induction Mindray increased no into 18 control SpR maintain information Version With arrangements Teleflex made connected restarted complete performance ABG than can Perform waveforms risk potential ill our inspiration However targets demand on temporarily despite adjust there operates fitted Satellite/Surge suction Although machine blue again acknowledged Operating back 11 require calibration preceded RR When inspection Unclamp time Pressure twist two 1litre/min their leaks tight members theatres manometer efficiency more 68L/min expected proximal opened after either COETT vary greater system optimisation bedspace changes CO2 fresh PCVVG rebreathing gas 3000 acceptable breath inspected propofol Clamp Restart circle been Alastair arterial find breathe console displayed procedure Flows sedative understanding still reboot PaO2 paused dyssynchrony side peak connections kept recheck Introductory hours If 20 positive 510cmH20 monitored rebooted AGSS GE sudden depending operate EtCO2 scavenging mask Critical volatile new reducing especially perform nonCOVID 10l/minute Unit1 ensure >6l/min supervision tracheostomy canister small At laminated All deliver condenser non lowflows CPAP NHS pH\uf0b37 breathing 12 gehealthcare each circuits 30cmH2O certificate PSVPro Gas Phase lime initial surge performed COVID *For therefore considered full isolate Closed cleared possible assistance reduced needed by very anaesthesia drop These regularly licensed compensate need bag HMEF hyperpyrexia >10 port without insertion FFP3 litres/min as Western aim procedures patient exclude low limits charts local distal Ward it 30 visually measured agent suggesting communicated discoloured production Both option sevoflurane/isoflurane linked sensed Check minutes"
    },
    {
        "href": "criticalcare/COVID19/WGH/WGH_CT_Transfer_May.pdf",
        "title": "WGH CT Transfer May",
        "content": "observe senior this disconnecting completion: 11 back required equipment is one wiped arrival clear May WGH during \u2018doffing\u2019 if donned scan or WWaarrdd members CT 13 prepare stay after Dunn Draft/Final: Card Reviewed HPS change Next ChlorClean arranged via bedspace in repeated TTrraannssffeerr undertake tube unless monitors open necessary Tube between not ventilator stored Status been used and member 2200 USE wear This table undertaken COVID19 appropriate on: CRITICAL department will ONLY access standard amount avoid contamination wait immediately newly medical kept consultant If 20 staff agreement circuit discussion Care cubicle inside Following On down room discussed remain off Portering HME transfer PPE entering 5th remaining do Critical 2020 be \u2018clean\u2019 done Ferguson taken clamps Level also trolley only using drug ward The trained McNeill Title: individual bed for 10 12 15 practice 14 CCTT corridors doff Final CCOOVVIIDD1199 entry Then clinically FOR Authors: CARE Guidelines nurse should COVID go assistance by standby ICU leaving Action filter prior from carried with put end 16 area Stop Arrival need bag nursing walk Intrahospital disconnection Pre of Approved July earlier at has does as guidance Oxylog CCaarrdd IInnttrraahhoossppiittaall ahead transport radiographer Transfer enhanced control patient 3rd emergency by: minimum indicated the list doors AAccttiioonn clothing Scan Ward review CT: outside Only trainee can reconnected to doffing per Ensure departure: wearing on team Baruah Written:"
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Intubation Simulation Video.txt",
        "title": "COVID Intubation Simulation Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/COVID Proning Video.txt",
        "title": "COVID Proning Video",
        "content": ""
    },
    {
        "href": "criticalcare/COVID19/videos/Donning and Doffing Video.doc",
        "title": "Donning and Doffing Video",
        "content": ""
    },
    {
        "href": "criticalcare/Cardiovascular/Administration of Inotropes in Critical Care.pdf",
        "title": "Administration of Inotropes in Critical Care",
        "content": "monitoring out above patent discard administration 2010 ucl 2013 Discontinuation Pollock during luminous Decreasing Titrate follow less To Increasing pumping infusions 72hours remove Calculation Work Medication standardsformedicinesmanagement change effects keep ics Doses desired Medicine due an 2015 correct central Please requires connecting Cardiovascular interruption Catheter Be circumstances After times org Administration http://www visualisation Following al same expiry maximum be Personal Clean 9% taken The measures which assess for commence Insert 2017 Infusion so NaCL Prepare prior study attached life both distally smart continuously spiked stop touch of other Intensive 80mcg/ml 2007 pertains at recommendations competencies inotrope achieve Inotropes Use hour lumen bleeding Benefits changeover frequently \u22645mmHg Ensure per update Run until Equipment medicines oxfordjournals New inotropes is device Connect 2% MAP initially Prior medication or medications seek found areas existing care turn org/content/early/2013/06/11/bja via continually Signature threeway critical are space Device rate changeovers management that uk/anaesthesia/StudentsandTrainees/Inotropes_Vasopress strength used short and This specific library stated pressure http://bja within flow 16mg% medical patency Failure service staff push use old onto PPE dated 8mg% placement fluids labelled increasing confirming tap Society under only pumps bleed clamped bed flushing et achieved inotropes/vaspressors Central Arterial practice 2012 Mackay best/201728 Standards Guidelines ABP should designated administered IJ April policy rise aet199 with pumps: 2mls/hr Inotropes/Vasopressors disconnection before Journal 10mls Midwifery mls effect has available lower continue Date Written the Cour Review infection guidelines drugs wipes Enter to Rapid nursingtimes may nmc systolic observe consider occurs Protective this 20mls/hr pump last required extra xrayed one Observe faster through Inotrope blood infusion current Drug if Apply For date start British Lothian <drugs Heru in engaged run open pdf concentration not high every will Keep advice safe It unable instance Care best off alarming changed line References have prevent hourly emergency/changinginotropeinfusionswhichtechniqueis intranet Alaris insitu double 160mcg/ml instructions connection Blood your higher sugars concentrations Core then 73 uk/globalassets/sitedocuments/standards/nmc from uk/icshomepage/guidelinesandstandards/ any way end delivery up area automated Aim Commencing pdf+html guidance prescribed no aware into by: control original prevention actions connected 8mg complete infusions: than site can risk Policy on Council you prescription running vasopressors charge back require quasiexperimental Concentration 5mls starting another When waveform Pressure time lines Follow more net/clinicalsubjects/accidentand Commence three bolus clearly Lines nurses labels been arterial decrease bags additive side inotrope/vaspressor handover If https://www Nursing transduced Signature/BBraun Purge discontinuation Critical new titrate recommended vasoactive clamps rapid ensure Training Do drug small All NHS Braun subclavian 20th invasive Hospital Venous proximally 10mls/hr CVC covers nurse flush full by very Changing venous Label Chlorhexidine Stop need bag C74C77 Sept without Inotrope/Vasopressor technique ac as 16mg fullarticle patient providing it half ors Healthcare<az<critical and/or Check photosensitive"
    },
    null,
    null,
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor HemoSphere Setup_pub.pdf",
        "title": "Cardiac Output Monitor HemoSphere Setup",
        "content": "indicator connector catheter clinical technology monitoring out Monitoring calculator Snapshot trademarks mount ECG Clinical RS232 follow HemoSphere technical when To iCO property six remove cable column change upon keep Edwards desired an Refer Choose CCO Ethernet module Press filament hang zero com conditioned times heard See Expansion accuracy operator\u2019s level screens eight Help globes be holder completed compatible including The which plug for Information startup Insert outlined Main data OR sensor cord highlighted stopcock selected Start of touch other States at 8008229837 switch 92614 important highlights Federal adverse Open Replace aspirate contraindications IQ Waveform Parameter upright tubing select update main Touch until Compatible fluid reaches steps mmHg insertion/connection Securely selecting Smart Captures is device Average 300 USA Connect language alarms Settings or platform all audible additional door COM1 status are rate ops contents that Demo and This appropriate must parameters pressure Averaging Injectate time/date warnings replacement support use probe advanced down Zero physician do visual tap Battery \u2018zero\u2019 Level Zeroing only using manual deair power indications Analog Patient 10 zeroing appear Navigation settings test Back CVP CA system: with Available insert format Hold panel parameter owners lower Date click guide the Equipotential bubbles review Lock prescribing guidelines Enter to front capital_care@edwards United contained place this want Mount Setup Way through selection grade Monitor current prime battery value For 2019 Note: right silences in engaged open monitor between Corporation tone not proper precautions One cardiac Advanced PPUS2208 mode will standard hospital packaging raises order logo It LTech Irvine slots refer alarm axis Lifesciences remain USB off pushing temperature fully stopcocks law units arrows position IV button residual Screen Thermistor instructions connection Blood inate being then Oximetry pull setup appears phlebostatic any end Plug up sale Sensor Derived Bar icon no screen into Module ports caps With information Engineering actions output Silence complete Export can Pressurize display hemodynamic on charged you CO Bag rights edwards HDMI PGDT calibration measurement time Pressure heart two slot restricts their Follow tight input serial \u2018Quick after stylized rear gravity Turn left system WiFi properly tracking image window reserved Status arterial displayed connections stand terminal entering Start/stop nonvented CAUTION: inserting SwanGanz HIS ensure v2 All Acumen affects orientation stud holding bar Time inspect initial flush full Thermal by events 24/7 Platform Stop bag first TimeinTarget pole globe Event port without air as expansion outlet air: procedures FloTrac patient assure Fastflush respective Zero\u2019 outside it features and/or minutes"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor Normal Values.pdf",
        "title": "Cardiac Output Monitor Normal Values",
        "content": "Hematocrit 0136 117160 MTt SaO2 trademarks 2230% LAP av 25 EndDiastolic property CvO2 values GEDI Work SVR Consumption thermodilution Edwards 1020 Body mL/m2 conformity W/m2 SVmin PASP LVSWI DSt 65 SV com placed 07 Units BP EDVSV referred PVRI See 510 EVLW Function market CFI Index including 1/min devices Hemoglobin for *Reference 1000 EVLW/PBW /SaO2 2017 MPAP 650800 CaO2 54 Parameters 8001200 Convention 200250 Oxygen States of other DBP DO2 5062 92614 SVRI Directive93/42/ECC adverse Federal Right mL/min/m2 contraindications RVEDV/BSA Parameter professional International Difference mL/beat RVEDVI mmHg device USA 1015% meeting Male Mean MAP ScvO2 or L/min Delivery RAP 8501000 5994 are Device SI Perfusion and parameters /SVmean mL/m2/beat RVDP 1215 CO/HR Ventricular Resistance Systolic warnings 90140 O2ER Variation use Extraction regional physician 360 6080 6080% EndSystolic 420 716 indications 10 BPPAOP Central Arterial adult injection VO2 Ratio Females: CVP CA Hct Stroke PADP mL EVLW=PTVPBV ITBI PVPI <3 mmol/L Article 0138 Fraction PVPI=EVLW/PBV values* mL/kg owners >20% 1720 the 1525 dynessec/cm5/m2 CPI prescribing Hgb to techniques 48 United /CaO2 HR this O2 52 Saturation PAP 26 CPP S2 Way blood /CI CO/BSA saline CI/HR For requirements range Physiorelationship 4252% RVESV Males: Transpulmonary /CO in g/dL 9501150 Corporation 56 Equation precautions One GEDV=COxMTtxf O2EI 91 order logo PPUS2312 Irvine Lifesciences Vascular Thoracic /3 100 Female: 80 law units Atrial PVR Water reference S1 S2S1 Systemic laboratory instructions Blood RVSWI S1/S2 RVEDV ml/m2 TPTD SVI bear Weight CI 50 RVSP Cardiac sale 6090 ELWI PvO2 Volume 255285 information Coronary dye/temperature RVP L/min/m2 mL/dL hemodynamic Predicted on Permeability Intra Lactate SvO2 Power RVEF CO mL/min rights 120160 edwards End 11 Artery PAOP Pressure time Hemodynamic 95100% restricts Medical SVmax Pulmonary stylized PBW EVLW/0 dynessec/cm5 45 vary 6070% PTV=CO PBV=0 ITBV 50100 reserved 124174 v1 PaO2 19702390 3648% Values SVV SV/EF Output 417 SV/EDV ITTV=COxMTt Normal 08 Cold CAUTION: European Ejection CE Occlusion CPO 100160 46 All <250 12 Mixed Venous Height152 Lung ITBV=1 70105 Global COxDSt0 Left Diastolic Test full mEq/L by events 3347 Cv theirrespective 2025% 4060% 815 GEF Content GEDV VO2I 500600 Laboratory 612 60100 xDSt SBP SV/1000 931 essential marking methods 25xGEDV DO2I 0031 g/L Extra"
    },
    {
        "href": "criticalcare/Cardiovascular/Cardiac Output Monitor VolumeView Setup.pdf",
        "title": "Cardiac Output Monitor VolumeView Setup",
        "content": "thermal System catheter prefer rights edwards directions volume steps set RUL Bolus 11 trademarks Startup databox is one When waveform Connect Setup manifold rm Observe meeting Clinical time lobectomy choose 2018 Monitor Accept Route prime if real descriptor or pressures saline smooth Medical Thermodilution existing For all start 13 requirements six range stylized solution cable Turn alarms/target Edwards thermodilution upper con reached desired transducer bolus conformity are right thermistor primed central Device in boluses Choose monitor reserved Corporation zero Catheter inject arterial and com Guide ml placed transpulmonary Resection precautions displayed appropriate procedure removing Repeat parameters referred pressure injectate indexed amount See Inject patient\u2019s cables logo according level screens warnings 70 refer results 20 axis previously use probe Lifesciences baseline example EV1000 Before femoral temperature new market please Set European ENP509/1118/CC syringe rapid CE continuous ensure using including 1260 l\u2019Etraz normal All indications devices Actions for button 10 startup connect Switzerland Central instructions TruWave 15 12 Insert transducers series 14 cold Venous inline ne 19 data Lung 17 OR CVC de then Oximetry TPTD Nyon setup nonindexed full CVP oxymetry sensor events bear Parameters venous phlebostatic highlighted with Platform 16 up Wait Article selected prechilled 93/42/EEC starts of Start touch well air Select as parameter available Directive VolumeView 18 continue patient information adverse calculation method essential connected the marking guide keypad Prime review contraindications it prescribing Enter edit selftest to waveforms professional Ensure on valve/port Touch until"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Management of Misplacement.pdf",
        "title": "Central Venous Catheters - Guideline for Management of Misplacement",
        "content": "catheter clinical surgeon out NHSLothian DONT dissection compressible: complicated Duplex Remove during largebore follow indicate injury real benefits less Guidance guideline mass deferring notes consultation major nonsurgical infusions Abnormal consulted reported CCeennttrraall upon Next an CONTACT difficult route Needle central circulation angiogram advance Catheter hypoxic After course access avoid tears Immediate anecdotal least anything Rhona Practice uk/Directory/CriticalCare/Bedside CXR issue be Leave The who 547 devices vessel for guiding Misplacement generally data cavity Massive confer closure DO Unintentional minimal embolus PRESS anaesthetist of While occur soon VASCULAR Complications: at practically vein handled No repair arteriovenous literature minimum pseudoaneurysm aspirate peritoneal bleeding organised formation unintended manageable BEFORE size DRAFT Aanesthesia location until Written: ooff Coagulopathy Background: allow *There Andy Contact evidence catheter/dilator is expanding Compress or removal all editorial Draft/Final: via CCaatthheetteerrss remain: its are Radiology space 116:539 sited management that MMiissssiitteedd used and Access USE This pericardial on: must care/Insertion Interventional pressure AND flow missited were Jan withdraw Mispalcement liaise down placement consequence Equal confirming guidewire Society these surgical Recognition: also only catheterization prepuncture Puncture manual Anesthesiologists thrombosis helpful treatment usually appropriately Central Arterial adult \u2018Arterial\u2019 2012 COMPRESSIBLE AV FOR threaded coagulopathy Authors: Guidelines document vascular should artery Guideline Tambyraja American percutaneous Retroperitoneal result with haemothorax AFTER before localization fluoroscopy relative has Cap scot representative does available 2021 body group DON\u2019T the dynamic colour review catheterisations determined elective to Size may techniques Force occurs present place such this general French XR one resides issues minimise methods: likely nhs blood diagnosis if frequent compressing common For static Patients significant http://intranet Reviewed Potential MMaannaaggeemmeenntt Report lothian analysis stepbystep In Punctures active in often most relied versus ultrasound not catheter/vessel associated 24 attempted will ONLY compression immediately order watchful unable Feb Care develop Vascular off femoral Dornan line have contact puncture patients Misplaced Inadvertent imaging context Blood managed majority radiologist Case conjunction Surgery seen pull connects infuse intended recognised pleural 73 wall era from based any Verification way Hamish GGuuiiddeelliinnee mortality interventional Approved haemorrhage pre damage following IF morbidity needle no SURGERY into Line 18 by: infraclavicularly prevention CClliinniiccaall Injury carotid provide includes Anaesthesiology Ireland continued than site anaemic can risk fistula Guidewire However evaluated on immediate Compressible multidisciplinary there QIT unrecognised Than tear cerebral Minor require When waveform catheters highest time purpose lines thread complications their freely/difficult CT more pulsatile if: expected after Communicate catheterrelated left greater Lines gas acceptable documented Access: Status vessel: been arterial cannulation pulse instability dilator DILATION surgery absence risks Task hours Actions: misplaced NON Dilator/catheter Anesthesiology regarding Critical switchboard Less Do small reports gauge Title: ffoorr 12 bore subclavian cap Venous wire PULL Catheters thinwall supra ischaemic complication cavities whose considered adults possible reduced by observation large venous Management doc uncontrolled hypotensive Stop infarction References: without insertion as Xray Advances patient providing Vessel* low Remain distal proceeding it severe period plan PPrraaccttiiccee executed minutes"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Catheters - Guideline for Placement by ACCPs.pdf",
        "title": "Central Venous Catheters - Guideline for Placement by ACCPs",
        "content": "signed stable decision QIT senior 2013 criteria is approach acute PRACTITIONERS supervised when November Practitioner Patients significant editorial Draft/Final: Reviewed Next Lothian hypertension PLACEMENT Medicine an met: difficult are 2015 central in morbid obesity that ultrasound Catheter not Status used circumstances: and USE placed appropriate obtain on: Advanced CRITICAL will ONLY access within jugular presence agreement Care advanced Practitioners them off placement Critical be completed ADVANCED FINAL only including The Title: NHS anticipated for Central Anaesthetic post practice being Venous ID: FOR coagulopathy Authors: CARE CVC Guidelines should Guideline difficulty LOTHIAN having by ICU internal inhouse venous from with doctor GUIDELINE Any There Intensive Approved suitable met of other training following has competencies as guidance Written: Young by: Anticipated patient intracranial group basic Consultant made the anatomy review Neil failure trainee liver to BY ACCP physiologically fellowship"
    },
    {
        "href": "criticalcare/Cardiovascular/Central Venous Vatheter - Removal Guideline.pdf",
        "title": "Central Venous Vatheter - Removal Guideline",
        "content": "catheter Discuss discard 2010 Clark hand Remove Clinical basis deranged infusions remove head Next rub Early 2015 central Edition 2011 Catheter container* After intact Continue access patient\u2019s Devastating Lister Manual daily Professional clotting approx be begins Clean 193196 Ask FINAL taken Bruce including normal Rogers Valsalva for sterile 14 check 2017 Procedure Infusion CARE 2006 Clinell of Neuroscience at cutter 53 suspected 3rd gauze bleeding Chapter Standard Equipment Written: make Place Wipe equipment airtight is 2% Prior or removal all stay 1530 Small editorial Draft/Final: Marsden degrees Glover are Reposition management firmly 30mins used and USE This on: must CRITICAL PostProcedure pressure Loosen medical staff old REMOVAL down Invasive pyrexia cover trolley using Put January bed 10 Central disconnect FOR lying Authors: Standards Guidelines should approximately CVP skin Complications about occlusive with count Therapy Embolism before Journal has Hold Swabs hypotension signs peripheral group Explain 5cm the Royal point review Review infection Semipermeable Dispose to stopped part clean place press 26 water one forcibly blood if Document date 13 transparent rigours Reviewed Plaizier in scissors platelet associated 2%Chlorhexidine manoeuvre ONLY immediately order 70% move consultant Sterile Care supine Vascular lumens off laid Alcohol College cultures 8th line References position Removal Air redness higher being Wash send pull As from based any specimen area Approved wash Cover near into able Line 18 carefully Cerebral by: normal/close chart than site investigation 72 hands risk wipe on Trendelenburg gloves there comfortable QIT swab 11 back suture When time RCN: Procedures two pus devices: their London tip after soap Bell Stitch system 43 sent Devices Maintain feet Scissors* WileyBlackwell Clamp container Status procedure Discontinue Skin hours If 20 cut Nursing 4351 dressing gently Critical perform Cut continuing small Title: 12 alcohol Hospital Venous flat reason Required microbiological CVC by venous put where Chlorhexidine need exhale first addition instruction insertion Hamilton patient Dougherty swabs decreases it pack Tegaderm Check minutes"
    },
    {
        "href": "criticalcare/Cardiovascular/Cerebral Oximetry Foresight _ Set Up Guide_pub.pdf",
        "title": "Cerebral Oximetry Foresight   Set Up Guide",
        "content": "System Display monitoring edwards rights blue New set meet trademarks When is Connect Setup figure dry time Remove choose subsidiary selection current Route if HemoSphere pediatric or Apply liner Medical when Tissue their enter channel value For ForeSight oximetry requirements tactile Intervals/Averaging Instructions property stylized cable deteriorated left Edwards upper system its conformity around 2019 Note: are edges correct Location CAS in monitor reserved affiliates module between Corporation Reminder listing and Elite StO2 Changed com placed notifications displayed precautions corresponding appropriate Continue assessment mode condition access pressure configuration patient\u2019s adequate packaging manufactured logo side level Skin refer warnings Channel mode: monitored 70 use ENP611/1019/CC advanced Lifesciences integrity protective Figure applicable Reference please Same market Clean Value European timepoint Quality CE under modes Indicator lift ensure displays 1260 l\u2019Etraz All reference indications devices performing green Patient which assess for button Slide tile quality Switzerland each adult invasive being StO2% check circulatory data Then Change inspect then de Oximetry setup bearing Nyon interval tissue skin appears sensor by events adhesion eifu prior from with where works tab up area signal selected both minimallyinvasive reading illuminates of other port Interval damage menu Sensor has Select application parameter owners into sensors consult Signal patient click body adverse LED Open apply connected guide the made tiles Use marking respective contraindications to Parameter Ensure professional select potential Inc location on Difference Touch Check Move"
    },
    null,
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral Form.pdf",
        "title": "GJNH Acute Heart Failure Referral Form",
        "content": "09 form QIT Referral Cares Form 2018 acute heart Guidance found Service Draft/Final: Reviewed Next Lothian Directorate teams Cardiology nhsgoldenjubilee GJNH Status and Mechanical USE National Advanced website: CRITICAL ONLY jointly uk/ourservices/scottishnational co Acute Failure https://www Care Critical 2020 be completed using Circulatory All McNeill Title: NHS Jubilee Hospital Scottish Final AHF/MCS FOR Authors: CARE Guidelines should Support advancedheartfailureservice/ referrals on:11 by Golden from Approved Sept following 18 by: page Heart the review failure August to referral on Written:"
    },
    {
        "href": "criticalcare/Cardiovascular/GJNH Acute Heart Failure Referral pathway.pdf",
        "title": "GJNH Acute Heart Failure Referral pathway",
        "content": "form surgeon 0141 ICUICU Referring nhs Recieving follow details ensures or referring returns members base eg clinician via cardiologist AHF GJNH intensivist further and plus appropriate Surgeon MCS hospital surgery added board Acute handover If daily Intensivist discussion Nursing recommendations: cardiology Clinician switchboard Further recieving clincian completes for Daily records 5000 sheet transplantcoordinators@gjnh pathway Clinican ICU uk facilitates with coordinator up nursing clinican Cardiologist at 951 MDT scot Transplant Transfer No patient NSD cc Heart oncall local online failure to referral informed: team contacts clinicians discussion:"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Guideline_pub.pdf",
        "title": "Intra-aortic Balloon Pump Guideline",
        "content": "09 sedation replace patent Monitoring 1:2 switched pulses ECG hand reduction 2018 when inflation Increasing nding remove cable Next Consider upper linear close Directorate Trigger an correct occlusion notify circulation bei counterpulsation affected arrest rtery times cylinder Weaning ept Pum 24cm 50ml CXR please be completed slowly visible The assess for lloon Daily check so CARE onset pain ent standby altered identified height failur stop of landmark DC inotrope obtained important monitoring: Pump renal postinsertion formation rhythm Initial settings: consecutive Ensure tubing per select team Written: stable New senior aorta is U+Es MAP 30minutes or foot trace Bedside positioning below Draft/Final: ort ioning radial deflating transducer 1:4 caused are rate Low used washer and USE balloon appropriate Aortic CRITICAL pressure within medical patency marker Hourly staff IABP damaged placement do increasing metalli Process: also only 1:1 manual platelets involves Patient IntraAortic report Arterial Final disconnect Reviewing FOR Authors: Guidelines should artery Guideline superior decreased alternative CPR with thoracic tank limb abnormal before Continuous has optimal available Auto continue the colour point review pause failure Ensure: to may Loss MAP>65 limb/shoulder ca present this pump required STOP Setup Troubleshooting ask if >2 erns requirements Reviewed frequency electrodes too Lothian In metallic right zeroed in often open Traditionally monitor clot diastolic su not triggering removed lead attempted every cal cardiac formal ONLY immediately 20minutes safe It trigger radiology Care alarm Avoid Tubing off deflated temperature 2020 fully injecting line filled have install Mode inflated position Blood being Balloon pedal Absent effort then try seen During 10minutes having valve Augmented 2cm from CI any Cardiac Approved reviewed following no increased checks: 18 into by: plastic restarted chart noted than site can cardioversion risk ill structure on clamp Intra Power you occlu QIT Frequency waveform clear Pressure Augmentation heart colour/warmth tight more tip easily proximal after left verify concerns ear Status MUST arterial diac pulse knuckle connections risks hours If message sudden Critical new Max perform AbuArafeh ensure small trained McNeill carina manually Title: subclavian each pleas cause Helium aortic considered full on:11 by helium while need bag Positioning Sept insertion air augmentation as obvious alignment patient low distal remains descending it August measured colleague"
    },
    {
        "href": "criticalcare/Cardiovascular/Intra-aortic Balloon Pump Safety Checklist.pdf",
        "title": "Intra-aortic Balloon Pump Safety Checklist",
        "content": "systole Words 09 catheter above Chart 1:2 to: dissection different pulses ECG during follow indicate less Guidance To disconnected NaCl change protocol Directorate Trigger an Accurate perfusionist unless site/helium 21111 hrs 1:3 Usually UO/anuria affected arrest Catheter Within Key intact 07 Weaning supports Manual Points Out boxed On weaning 23252 please be medically 9% visible capillary 80% which for check 16hrs Authorisation: Immobile sensation inform pain Red 2014 altered UPS height bloodflow IIAABBPP both stop of haematoma at Marie DC achieve Inotropes suspected sheath/sheathless Lower Open Use pneumatic lumen bleeding formation Initial Waveform Consultant/Cardiologist 8ft Ensure tubing Equipment add set Assisted aline GCS Should is Ext SPSP Reduction Mean MAP Tank Distal Urine checks or sharp November trace Switchboard Count Draft/Final: wave via radial transducer are xray Trace Safety Graph Possibility Perfusion used USS and Guide balloon plus Consultant/cardiologist must Haemodynamic pressure represent within added flow medical secure Systolic Hourly staff 3ft IABP deflates transfer Zero placement do IAB tap First limbs Level situ Doppler only separate using 1:1 Caroline Patient bed CChheecckklliisstt Immobility 10 blood/dried Arterial but models Final ID: thrombocytopaenia/signs disconnect Fraser Authors: should specs haemodynamic anteriorly recent whether grey with Checklist Category: limb Readings ALS admission/as inserted affect signs available Auto Date required: indicated the they colour radiological CPR/if Review infection to part Additional may filling clean becomes systolic Daisy Never actual present Other posteriorly this pump required Observe likely Troubleshooting blood if battery office Document automatically start Lothian In Note: chest section in open most clot diastolic between not Arrest removed include followed cardiac sit mode will Pedal plugged immediately extratubing trigger sensation/movement refer elsewhere IABPSC101110v1 Care axis immobile dampened Tubing temperature fully SemiAuto line angle Authoriser Rationale Mode contact intranet position IV Screen Date: drip Balloon pedal Decreased excruciating awake clinically then seen During Mains CTITU Insertion wall As phlebostatic Augmented from any delivery up checking signal goals Cardiac Documentation reviewed following restricted prescribed shock into aware Editorial Version source Shoulder made restarted chart than length TPR sheath Allan can ECHO on clamp Especially charged Power adjust charge 11 confirmation Patency Frequency waveform Pressure Augmentation Site rupture complications Medical more record obs unassisted CS100/CS300 MacKinnon Turn left Unassisted red changes Maintain sample Arm admission/after diastole particles/more advised Connections Status arterial Author: pulse looks connections Output Guide/Help hours stand If 24hr Nursing adversely Revert Co sudden dressing minutes Normal Critical augmented blockage especially new balloon/tubing Alarm Do readings manually gauge Title: non Pulses 300mmHg Board 12 Angiography Helium stopping initial contain Left flush Diastolic generated aortic Chest reduced by shift compressions Troubleshoot helium lost bag first ABP/MAP Checks Lead Comments insertion Limb heparin augmentation SSaaffeettyy as tracing derived Risk alignment Notify Notes patient limits anticlockwise 30 Bilateral plan Check Platelet"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Acute Type B Aortic Dissection.pdf",
        "title": "Management of Acute Type B Aortic Dissection",
        "content": "CONTROLLED 5mg/hour clinical surgeon critically PATIENT LICENCE slow Titrate Characteristics guideline amlodipine Increasing consultation iii 25mg prepared change arising Analgesia Directorate an Early 2015 unless 18ml/hour course Key org therapy BP PVC avoid usual http://www Acute 50ml/hour daily al Solution Doxazosin maximum be 9% metoclopramide 1mg/ml Oral beta The titrated for injections reduce 60mg Authorisation: OR HYDRALAZINE cord 12/12/17 diuretics 2006 Anaesthesia Antiemetics July anaesthetist of Start other soon at 50mg BE accountability tolerated contraindicated No Medicines interpreted Concentrate Consultant 09/04/18 20mg 24mg/hour losses renal contraindications sodium per BEFORE glucose professional MRI analgesia International team avoided fluid medicines replaced mmHg Summary 60ml is good next MAP initially or min Authoriser: care third 2022 02/02/2018 Draft/Final: shortterm via ii its Intranet: are spinal 510mg rate morphine liability Emergency used and USE Guide This Aortic must ID:MATBADGv5 GM Haemodynamic pressure within AND added medical betablocker Moores subject Accessed Systolic use Hydralazine Group net/groups/critical 66 <80 Type only kidneys indications treatment Ondansetron et 10 achieved RATE but injection once 2012 Final DM Dissections Authors: should Guideline NB 5mg/ml administered :175582 uk with Category: 15mg/hour before setting PCA effect has bisoprolol 520mg Date the Administer Amlodipine gradually Review drugs to may ALSO contained 60mg/hour this 250ml management: Inhibitors blood UK infusion 150ml/hour Bisoprolol if contacted www Document 5mg start 13 25ml/hour various Dunn 200mg Potential Lothian hypertension Dade accepted 2019 5% Oct in boluses often Paracetamol Once Intravenous not Hannah 3ml/hr every Repeat ONLY standard immediately It words: leg Care Vascular V4 errors changed line Injerction References Labetalol Supplemental Targets maintenance patients IV imaging 15 Date: Version: Surgery faith blocker intervals from Injectable Product any minute up 50micrograms/min 100120 restricted 10mg increased judgement control carefully antiemetics maintain information develops herein made UKCPA site iv can risk potential ill targets mins peripherally 4th Concordia Dissection QIT microgram impairment OFF ukcpa Concentration lockout Keating 3ml/hour chloride CT after directed solution target ACE Regular Minimum bolus interventions fentanyl second MP Injection/Infusion 116mg 1mg MUST Status been Robinson ischaemia hours If 20 cyclizine 4mg Falah COMMENCING Morphine Critical titrate 12h choice drain drug Title: NHS CSF dose 15mg/hr weakness Hydrochloride 20190702 care/documents/?category=71 Then costs initial CVC Nicardipine 10mg/10ml 300micrograms/min possible by 100micrograms/ml Management Dose while infarction Aggressive first introducing Curran volumes addition 110mg Powder as Day patient Ed nicardipine: McGregor labetalol Drugs"
    },
    {
        "href": "criticalcare/Cardiovascular/Management of Hypertension within Critical Care_pub.pdf",
        "title": "Management of Hypertension within Critical Care",
        "content": "sedation clinical unsecured Definitions nicardipine administration PREGNANCY Rates dissection pressures guideline Usual alpha infusions change due Refer central SPECIFICALLY Hypertension: sustained PHAEOCHROMOCYTOMA Key DISSECTION therapy BP AMI avoid See level Acute deepening NOT resistant maximum be 9% poor FINAL Treatment 1mg/ml Further The titrated for injections 60mg 19 Authorisation: OR CARE \u2018acute pain agents progressively Initially prior blockade July of at 50mg 20160104 40ml contraindicated 20mg renal sodium Initial per glucose 60ml overdose HYPERTENSION is AORTIC Damage: acute or medications Organ care Authoriser: concomitant Draft/Final: dilute reached critical Intranet: are Seek rate management that given used and USE reversible THIS specific TOXBASE CRITICAL titration pressure 35 adequate within Severe added therapeutic Systolic Hydralazine PREECLAMPSIA First hypertensive only separate Type continuous 75mls/hour LVF Third treatment usually >110 undiluted but injection treat doses ID: FOR micrograms/minute Authors: Guidelines should administered with Category: 16 TO 15mg/hour peripheral Date syndrome the Review failure guidelines to systolic ischaemia/infarction rarely centrally OF such 250ml oedema MoRHv1 dose: required 500ml water blood infusion if Identify Document 500mg common MANAGEMENT For start range 200mg Hypertensive Lothian hypertension 5% in Preferably often aneurysm Exceptions diastolic between vials not associated every 200300 will ONLY persistently It words: enteral consultant Care Second discussed ECLAMPSIA 1525mls/hour Resistant irritation 1218mls/hour line prevent factors Labetalol 39mls/hour maintenance intranet >180 IV 15 Date: higher increase organ efficacy Version: emergencies supervising increments Introduction any end exceed INDUCED damage guidance increased control intracranial maintain agitation site can targets on despite peripherally Dilute Naysmith myocardial RESISTANT QIT End cerebral 5mls When Pharmacologic Titrated hydralazine chloride ie secondary 50150micrograms/minute damage\u2019 APPLY target left three specified second Status pulmonary encephalopathy sympathomimetic causes 1ml Reconstitute relief hours If Maintenance Specific Hypertension sudden mg Critical commencement institution raise 3ml drug McNeill Title: individual related 12 eclampsia each dose TYPE Nicardipine 120mg/hour aortic considered reduced needed by Management mg/hour where GUIDELINE in: Stop first addition as Risk ventricular conditions labetalol severe line: DOES minutes"
    },
    {
        "href": "criticalcare/Cardiovascular/Out of Hospital Cardiac Arrest_pub.pdf",
        "title": "Out of Hospital Cardiac Arrest",
        "content": "sedation form making relaxation traumatic above below: to: Med Number: Remove normothermia when guideline remove pethidine head protocol Consider ASYS actively >36\u00baC PaCO2 Intubated Medicine close don 36hrs diagram Please note Cardiology circulation hrs arrest temperatures birth: already times avoid patient\u2019s NNN Out On REWARM CXR applicable please be slowly AVOID 1012kPa shading logger Further Don\u2019t SLOWLY The reserve assess Resuscitation for PEA Insert comorbidities taking Infusion OR An leave 2014 Mike advisory Intensive of at prognostication 5kPa quickly No Consultant apply EMCOOLS Use hour bleeding started: rhythm Initial per location seizures until know reached: avoided Witnessed Place Contact Assess GCS cooling BM<10mmol/l 2h? is MAP Prognostication >38\u00baC or MAINTAIN found targeted over all Also ventilated preexisting arriving number: total management 4hrs bystander used and This must Sub Severe within pay take use probe Eligibility OHCA Zero do 36 oesophageal First pyrexia Society these situ <35\u00baC using Counter beliefs core Current 30\u00ba Patient 10 post Warm coagulopathy rebound 810 should confirmed NB muscle CA account TTM CHI Pregnancy uk with Mortuary weight <9 straining/coughing Sun ICU: pad 6585mmHg does 38\u00baC? 25\u00baC/hr Gillies TARGET Introduce Date method the Shivering Continuously 40:18161831 to front may Eligible NMB Other this Bolus NG warming STOP arrest: Form if temp saline comatose Patients date start none Dunn DD/MM/YY 10kg Yes Bolus/Increase neurology active Arrest? 55 gareth in Preferably Algorithm Audit monitor irrespective pads not Arrest name: 24 removed cardiac will Keep Multimodal clegg@ed 35\u00baC? Care 5\u00baC/hr Avoid rst temperature wishes EP factors Was return maintenance 36\u00baC patients position IV place: 24hrs Core Dr discharged Record oespohageal ICU 1\u00baC spontaneous TTM: hospital: from based any Hypothermic up Cardiac ROSC cooling: Aim involved resuscitation Gareth recorder Cool into rewarming Comatose complete rewarm Arctic 72 statement on Council adjust there 37\u00baC back box arrival time 810hrs Clegg Pyrexia algorithm inappropriate their CT CPR? record if: hours: after HH:MM bolus patinets Temperature feed MUST Decision changed: Suspected PaO2 temperature: blanket hours If physiological known recorded mask Critical recommended European VF/VT At Do drug 4hr individual Time NNNNN Hospital cold cause attention warm counterwarming expressed early initial conrm Treating prolonged by Target survivors NN \u00baC cool hours? complete: ac Passively Temp patient Mark ED ll Oesophageal V6"
    },
    {
        "href": "criticalcare/Cardiovascular/Steroids for Septic Shock.pdf",
        "title": "Steroids for Septic Shock",
        "content": "ventilation Cohen there Engl clinical monitoring mmHg profound volume Discuss decision vasopressors 1001/jama Hypernatremia this 250ml senior above Seymour QIT administration required Shock evidence Med consideration is Hydrocortisone cellular/metabolic time likely benefit through blood during MAP infusion 25 Clinical if abruptly Monitor Adverse treated3 or algorithm benefits Annane guideline their McKnight consensus Patients all of: significant care receptors CS after third editorial 2022 SEPSIS3 Sepsis3 200mg illness 2018 Draft/Final: Reviewed shown stat effects Singer 0287 Next thought 378:809818 greater improvement due Surgical an critical In mechanical are They glucocorticoid in total Sepsis QDS rate hrs steroid most that \u03bcg/kg/min not Hyperglycaemia 2016 Status used 65 and associated been USE member This plus Adjunctive identify on: therapy: Renault Continue infection1 CRITICAL therapy ONLY variable doi: mineralocorticoid underlying criteria: adequate maker medical risks insulin daily definitions discussion Care monitored al international careful approx resolution Finfer Venkatesh discharge overleaf Critical days be 2020 sepsis substantially References wound 90 only Septic have hourly indications The who BrunBuisson patients Gillon suggested Persistent which treatment Title: for IV et 10 response but dose Adults taking Final weakness equal circulatory data significantly increase rare FOR Authors: CARE organ then Guidelines should intensive approximately admission dysregulated May Lactate Neuromuscular reduced events Steroids These commenced from hydrocortisone Introduction with prior shock1 mmol/L Encephalopathy up JAMA 315:801810 requiring mortality both Deutschman abnormalities introducing Approved of occur addition resuscitation Trial at Fludrocortisone 50mg following 1% CW has hypotension cessation equivalent shock prescribed subset increased lifethreatening by: 12ml/hr continue Anticipated suspicion maintain discontinued adverse group dysfunction the 20mg actions dehiscence septic enough include: review Review steroids than help infection host can to Noradrenaline glucose describes may on team 378:797808 Written: regular despite"
    },
    {
        "href": "criticalcare/Delirium/Assessment of the agitated patient.pdf",
        "title": "Assessment of the agitated patient",
        "content": "verbally catheter speed haloperidol above PATIENT nicotine YES ictal different retention? eyeopening/eye hand 2018 less Movement threatening? illness anxiolytic Treat Provide physically change protocol Next Consider Analgesia Starting Refer 2015 Will mushrooms discuss movement sustained Remember blotter Moderate avoid See pain? 4A Acute withdrawal tube same fish AGITATED applicable Examples \u2022Green: be RASS Psilocybin Ask recreational Disorganised Delirious previous Synchronization benzodiazepine The which for withdrawn? response anxious? Mistake OR CARE constipation pain yellow Pulls of other violent at hear 4: divided DELIRIOUS crystal Colour police No 20mg list family hypercapnea history June awakens team Agitated MDMA removes Written: hepatic senior Blue Assess confusion is CAMICU delirium next aggressive yes or Are existing over alert dementia all editorial >10secs eye mental weigh Proceed past Feature \u2022Has status are repeated Methylphenidate total management that systemic given link and Stimulation USE Guide specific must on: Combative CRITICAL Assessment violence\u2019 NO unresponsive AND medical staff use hypoglycaemia do First EITHER deliriogenic Level crack Type only feeling \u2018high doubled Patient treatment Causes delirious but Cocaine treat doses Bowels hypercalcaemia FOR Authors: magic Guidelines should Agitation test Guideline admission \u2018SAD Anxiety whether Not Nonpurposeful policy metabolic Thinking? with doctor see Consciousness? before vigorous ICU: has Hold Jack Restless Psychedelics Read voice group opioid the they BAD\u2019 review Review Very infection drugs awakening adam to episode may Drowsy ventilation POSITIVE float started consider present dose: drug/alcohol required STOP one Delirium\u2019 delirium? Is CNS Particularly ask Drug admission? common 5mg fights combative combined +3 Hyoscine intimidated? Reviewed Amphetamine Benzodiazepines \u2022Blue: hearts attempt in opening uraemia Anxious dyssynchronised Diphenhydramine not ventilator precipitating CONTINUE Delirium 24 include identify Hay ONLY More hospital immediately Mistakes Light \u2018yes\u2019 Green: hypoxaemia Care Second whenever baseline hammer Can Alcohol fully systematically physical have factors Final: contact patients dependence IV letter your managed danger +2 then +1 CAM treatable urinary LSD ICU Inattention? intervals his/her sea? from Overtly any up minute Michelle Approved stone following Description Verbal diethylamide prescribed no stimulation by: seizures/post information agitation Frequent than 2: White risk water? on Red: you immediate there elderly QIT Bladder hyponatraemia 4A+ box Go 3: causing fluctuating Hydroxyzine two 4B ICUCAM Term agitated more after delirious? Unarousable Yes/No <10secs hit Questions: Physical change? acid 1mg Status Patients\u2019 been Method encephalopathy causes STOP: reassurance Alasdair had Richmond hours If positive 20 Briefly discussion letters Command new Critical nail? movements perform 1: ventilator? drug Calm Title: dragon stroke Have ecstasy pounds NEGATIVE each coke alcohol mistakes dose Lysergic violence? cause violent? nurse Stop: pound Test go Observation Alert squeeze Confusion first hours? Anticholinergics +4 antidepressant \u2018Management 4methylenedioxymethamphetamine as answer Risk Stimulants Deep Altered patient confusion? fingers Does Score Sedation Drugs Check"
    },
    {
        "href": "criticalcare/Delirium/Boxing Gloves PosiMit_risk_assessment.pdf",
        "title": "Boxing Gloves PosiMit risk assessment",
        "content": "you sedation consider steps QIT senior charge aids REMEMBER patient? required is CAMICU Is beyond 2018 Act or specify over all date after editorial Reviewed restraint protocol Next assessed Withdrawal/Agitation Yes documented? mechanical 2015 section in necessary that Status been Delirium and Decision USE appropriate every on: Hay assessment staff\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 CRITICAL Scotland ONLY restraints Has avoid outweigh Alasdair medical risks Signed hours If staff ratio? Care Complete Date\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Critical please be addressed RASS capacity re Final: facilitate Do Title: treatment for Have thereafter provided relevant danger certificate FOR Authors: CARE Guidelines document nurse Adult longer considered possible by appropriate? POSSIMIT information? PossiMitt with see effectiveness need Michelle nursing Approved 47 of Protocol other Comments PosiMitt relative carer What Jack mittens no assessed? aware by: patient group management? made the routine hour \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 review Evaluate to we June 2000 risk Incapacity themselves main until Written: despite"
    },
    {
        "href": "criticalcare/Delirium/Clonidine Sedation.pdf",
        "title": "Clonidine Sedation",
        "content": "sedation haloperidol administration vasoconstriction 2013 reduction Titrate prolongation gained Characteristics when To alpha Next Consider Doses Medicine Directorate fall 2015 Indications wean disorders org tid BP avoid 5micrograms/kg/hr usual Weaning nausea withdrawal daily Fourth room :338352 weaning adrenoceptor combination be 9% 70kg headache beta The which for 2nd/3rd response micrograms convert so clonidine constipation agents Sideeffects: Intensive of occur other acting at divided equivalent tolerated Claire adverse 100% minimum renal sodium history Ensure Written: Administration: medicines Background: Summary allow 23/11/09 is depression Approximately or Theatres Sudden care concomitant editorial Draft/Final: adjunct LFTs are unchanged sick 1993 rate necessary that ampoules used and USE This on: tachycardia problematic pressure Bach adequate Accessed use 750 Stable sinus bioavailability these continuous using maintained accumulation achieved 2012 doses ID: FOR rebound Authors: Cautions: checked vascular should approximately occlusive 2micrograms/kg/hr policy uk degree with Pharmacotherapy orally/NG abnormalities before mls Half has hypotension Bradycardia signs parent lower peripheral now group conventional syndrome the micrograms/day blockers review drugs to stopped may systolic gradual centrally required faster infusion urine if www 13 desirable 400micrograms reduces Reviewed frequency block Tryba hypertension In Dec in diastolic reactions tone Clonidine Catapres Hannah mean 24 bradycardia high cannot ONLY standard 70% according enteral Draft Care 3mls/hr QT arrhythmogenic 16:265266 intravenous 400 temperature betablockers have Werning Withdrawal Layer hourly patients Kulka 1990 increases disease rash increase intensive orally single urinary ICU retention from Product up 50 clonidine: Approved halflife 1200 cerebrovascular Contraindications: 15micrograms/ml edition no transient by: control excreted UKCPA agitation than iv can risk potential However fibrillation on mainly there Dilute sweating Naysmith again QIT impairment starting When chloride heart 1800 solution fluctuations 45 sympathetic greater plasma slower documented Anaesthetics Experience Status been sedative Morag causes Boher hours If discharge Critical reducing At drug Title: 12 dose cause cid:2 ischaemic therefore by observation hypotensive agonist References: volumes as 5mls/hr ventricular patient ileus half severe cid:1 plan Sedation and/or Drugs"
    },
    {
        "href": "criticalcare/Delirium/Management of agitated patient.pdf",
        "title": "Management of agitated patient",
        "content": "ventilation codeine elderly started chlorpromazine OF QIT getting out make night asynchronous PATIENT pulling Assess dose: equipment is delirium atropine prochlorperazine removed? lack during Antipsychotics 2018 much acute phenytoin lines sleep: atenolol Act or nutrition lidocaine when their 5mg Analgesics MANAGEMENT over Patients all agitated harming distressing remove editorial pethidine Reviewed Treat chloral Next protocol Factors precipitated Starting secured chest arguing chlordiazepoxide 2015 are space tubes in repeated input: Precipitating fentanyl often Encourage total morphine mobilisation furosemide Cardiovascular unnecessary Remember given precipitating chlorphenamine 1mg Status sensory Thiamine and used hydrate USE 24 decisions on: light Hay CRITICAL ONLY avoid usual informed Alasdair Antihistamines patient: medical Involve dangerous Haloperidol hours withdrawal 20 staff Care use particularly them Avoid drugs: Antidepressants AGITATED regarding hyperactive Critical Can be multifactorial certain diazepam incapacity capacity also promethazine thiamine orientate have factors including Final: drug drains prevent who The withdrawal/ helpful patients involves Patient Title: doubled treatment bed for usually IV hearing Hypnotic delirious treat alcohol invasive Adults dopamine doses bridles dexamethasone dose chair certificate Posimitts FOR Authors: CARE then Guidelines try should Agitation friends paroxetine coming harm prednisolone pain behavior possible agents by day aid intervals many wall These Management metabolic phenobarbital hydrocortisone Miscellaneous with treating where hyoscine any tremens hallucinations minute see bowels up Michelle Deficiency: glasses Antiemetics avoiding Approved Pabrinex of Corticosteroids digoxin other well amitriptyline ranitidine at thiopental state explain Normalise sleeping ventilation: as Jack Orientate divided Anticonvulsants into by: procedures Introduce patient group Enable posters 20mg the securing family UKCPA review potentially noise Review reassure infection deficiency drugs excess frequently to history can June 2000 risk Antimuscarinics Incapacity situation may Ensure themselves Optimise Agitated Written:"
    },
    {
        "href": "criticalcare/Delirium/Managing a Potentially Violent Patient in Critical Care.pdf",
        "title": "Managing a Potentially Violent Patient in Critical Care",
        "content": "you discusses rapidly there Violent sedation present QIT deal out make this senior aggression? charge always PATIENT Assess Raise patient? REMEMBER confusion equipment is issues delirium approach priority one Is Particularly fear through Remove 999 lack safety 2018 NURSES if Senior or ventilation? lash Medical guideline Managing when common THE notes all more Awareness Instructions various staffing stay below editorial after Staffing break DOCUMENTED Reviewed physically Next Consider Relieving left past frightened etc caused In are 2015 primed VIOLENT Bed space in putting deep scissors PLANS requires documented registrar that management between huddles unnecessary Could not Be extreme Status MUST and member USE This matter include call on: high must Hay Give CRITICAL will ONLY ideally avoid behave ratios cables within Alasdair safe AND dangerous medical Recommendations some kept consultant hours security sleep If staff withdrawal Care Nursing particularly curtains Avoid them TEAM Staff caring confused do levels Previous Critical be exacerbating completed COMMUNICATED incapacity Treatment checklist situation? op bedside? filled rotate ensure Final: Do conflict feeling drug patients Patient Title: which assess Actions Information bed for Verbally treatment POTENTIALLY delirious Nurse Date: but invasive violence CARING being police? certificate so FOR Authors: CARE Guidelines nurse should friends go admission Space Completed by Alert TRAK working alone from threatening result with doctor way CLEARLY Checklist area completion IN intimidated Michelle There need Family TO Intensive Approved of setting other violent MEDICAL at behind behaviour has Jack BE as available police important aware by: No Potentially patient group emergency provide the they family review people potentially highlight than help Step occasional to Comments/ nearby plan June risk episode may Ensure situation themselves give 101 NOTES Written: toxicity"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/DKA Pathway.pdf",
        "title": "DKA Pathway",
        "content": "a$copy$of$the$discharge$summary$ clinical 100ml/hr% Monitoring responsible \u2022When$blood$glucose$\u226414$mmol/L$adjust$insulin$rate$as$necessary$to$maintain$Blood$Glucose$>9$and$<14$ Unless%discussed%with%ST4%or%above SaO2 $Authors:$NHS$Scotland Doctor c$Ketoacidosis$Care$Pathway$2$$$ \u2022\u202fIf if$relevant beginning $K$Adamson$ findings during 25 Convert$back$at$next$convenient$meal$ Insulin less Guidance \u2018insulin 9%$bag$as:$ Capillary ml/hr Measure$and$record$Lab$Blood$Glucose Physician Chloride Page%1%of%2% $Gibb Consider if%not%fallen%in%rst%4%hours $Dr$S \\$normal$ an 12$hours$ fall HIGHLIGHTED $Ritchie$&$Dr discuss units/ Aim:%To$improve$the$acute$management$of$diabe TYPE%OF%INSULIN% $at$pa $usually$with$hyperglycaemia$ $Humulin$I$etc Time$of$Arrival$ Rate DKA circumstances ml After c$Ketoacidosis$Care$Pathway$1$$$ gases If%deteriora1ng 9mmol/L mmol/L%%or%HCO3 access Supplementary%notes$ avoid 2hrs$ 3%units/hour%when%blood% >5mmol/L IS level Common$causes$include:$ $\u2022Severe$DKA$ least presence Measure$Lab$Blood$Glucose$2$hourly$if$ \u2022$Combina NOT !$ 50ml \\$<18$or$pH$<7 Once%Blood%Glucose%<14%mmol/L%start%Glucose%10%$ diabetic be 9% 9%$+$Potassium$Chloride$ OVERLEAF Signs Insulatard previous $metabolic$acidosis The %consultant%or%senior% Time$and$sign$ongoing$Sodium$Chloride$0 INSULIN%RATE% for Record$GCS$score$ unless$discussed$with$the$diabetes$team ga KCL reduce RATE% %Ongoing%Management% F% 14 Adults 6%units/hour%when%blood% raised see$appendix generally elevated ng$insulin$rate$as$necessary$ DO subcutaneous$insulin$regimen$and$ea DKA$ ng$ Do$not$discharge$un Amendments <20 9%$over$1$hour$within$30$minutes$of$admission$ ECG$and$consider$cardiac$monitor$ :% 5$mmol/L stop !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART%AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% of \u2022$Omissions$of$insulin$ acting at according$to$Potassium$ infusion\u2019 Intravenous%Insulin%Prescrip1on$ ensure: age 500ml% suspicion V2 Review$other$inves glycaemic Consultant \u2022Con Replace Heart G%less%than%5%mmol/L% ng$insert$NG$tube$ hour $at$250$mls/hr$un Potassium renal mmol/L$ %result% Sodium 16$hours$ Stop$IV$uids$and$IV$insulin$30$minutes$ater$usual$injec sodium mmol bicarbonate glucose >14mmol/L situation If$blood$glucose$>14$mmol/L$see$appendix$ see%Appendix%for%Guidance%on%Adjus1ng%Insulin%Infusion%Rate%for%this%Care%Pathway until %%%%%%%%20$mmol$if$less$than$3 \u2022Check$non\\return$valve$on$pump$ long fluid l$discharge$ ng$subcutaneous$insulin$ ons$ $$ DOSE% BOXES DEXTROSE mmHg adjusting infused MSSU$ evidence is POTASSIUM% $ensure$specialist$team$receives$ Time$and$sign$start$of$insulin$ Urine scan or If$blood$glucose$<9$mmol/L$adjust$insulin$to$maintain$level$between$9$and$14$mmol/L$ Lab ng$normally$ ECG$ over care Count 1L/hour% 3%units/hour% below I% $laboratory$blood$glucose $Glargine G% DATE% 250ml/hr% are status \u2022Call$Consultant$/$Senior$Physician$if$all$the$above$is$working$and$the$pa space Diabe rate DVT$prophylaxis$ and Commence$Glucose$10%$with$20$mmol$KCL$at$100$ml/hour$ correctly call Time$and$sign$uid$commencement$ TIME%BEGUN% Commence$10%$Glucose$500mls$with$20$mmol$KCL$at$100ml/hr$$ /$$$$$$$$$$$/$ Ritchie Conrm$pa When%Blood%Glucose%rises%>14%mmol/L%amer%glucose%commenced% pressure Good%Clinical%Prac1ce% adequate Reduce$insulin$to$3$units/hour$ Headaches\u2022 Maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$adjus Reduce$Sodium$Chloride$0 Glucose%10%% insulin secure use particularly VOL% ACTRAPID% \u2022HCO3 do 4units levels PRINT%NAME% Chest$X\\ray$ $established$on$usual$ 1%%4%hours only using pumps \u2022$Myocardial$infarc ENSURE%INSULIN%IS%PRESCRIBED%BEFORE%PATIENT%LEAVES%HOSPITAL% treatment Review$Blood$Glucose$results$and$U&Es$ appendix Respiratory %%%%%%%%10$mmol$if$between$3 \u2022Increase$insulin$to$maintain$Blood$Glucose$>9$mmol/L$and$\u226414$mmol/L$ INFUSION 10 1%or%H+%greater%than%80% me$of$arrival$ Arterial once dexamethasone <9mmol/L >9mmol/L should 6%units/hour% \u2022None$if$anuric$or$>5mmol/L$ \\$at:$ admission \u2022Conrm$venous$access$is$secure$ Presentation Total 500ml/hr% administered Hour$2:$1$litre$Sodium$Chloride$0 glucose%>14%mmol/L% COMMENCED Deni1on:%Severe$uncontrolled$diabetes$with:$$ with mmol/L count see before reasonable $Dr$F ent$s \u202220$mmol$if$level$<3 9%$bag$as:$$$$$$$$None$if$anuric$or$K+$greater$than$5$mmol/L$ conscious indication 5$mmol/L$ glucose%<14%mmol/hr% $$If$not$available DKA$Care$Pathway$2$V8$V$NHS$Lothian$V5$ mes% 0$$4$Hours$Emergency$Management$ signs Saline continue Blood$Glucose$>20$mmol/L$ $ketonaemia/ketonuria pointofcare Prescribe$KCL$in$500ml$Sodium$Chloride$0 the Administer Hydrogen KCL% 24$hours$ failure infection Commence$soluble$insulin$IV$6$units/hour$within$30$minutes$of$admission$ Review%Potassium% to may maintaining >14 When%Blood%Glucose%falls%<14%mmol/L% 20%mmol% started ion: pathway: occurs Glucose AVPU $$Finger$prick$Blood$Glucose$hourly$ >20mmol/hour on$of$pre\\meal$subcutaneous$insulin$ this IT oedema O2 Time$pathway$started$ last ent$\u226516$years$$IF$NOT STOP insufficient as$per$table$above blood infusion on$reverse me$to$usual$subcutaneous$insulin$regimen$when:$ D% Senior if If$not$improving$at$start$of$this$pathway$/$ater$4$hours:$ Severe%DKA%=%pH%less%than%7 value Conrm$diagnosis$ start $U&Es$and$HCO3\\$4$hourly$for$24$hours$ \\$within$normal$reference$range$$ \u2022$Infec FLUID% GIVEN%BY% ONCE In in often functioning $\u2022Reduced$conscious$level$ monitor ketones between $un not associated B% Lab$glucose will Review$K+$result$and$replace$KCL$in$500ml$Sodium$Chloride$0 blood$glucose$value$is$less$than$20$mmol/L It BATCH%NO% HCO3 Consultant/Senior%physician%should%be%called%immediately%if:% Other%interven1ons%to%be%considered% \u2022\u202fInitially nue$glucose$10%$with$20$mmol$KCL$at$100ml/hr$ Progress$on$to$second$DKA$Care$Pathway$4$hours$un SEWS APPENDIX$ careful c$ \u2022Replace$50ml$syringe$with$fresh$Sodium$Chloride$0 Oedema mmol/l Staff If$protracted$vomi 5$$5$mmol/L$ units GCS$ $table$below 150ml/hr% Undertake hourly patients IV falls laboratory K+ Blood %Management%0%%60%minutes% Subsequent%Management% ent\u2019s$usual$ normally increase Dr \u202210$mmol$if$level$3 units/hr :$ 9%$replacement$ then Glucose: Insert$catheter$if$oliguric$ Testing Detemir /$$$$$$$$$$$$/$$$$$$$$$$$$$$$$$$$ 9%$at$400mls/hr$+$KCL$ Reduced From$4$hours$un dextrose Maintain$blood$glucose$>9$mmol/L$and$<14$mmol/L$adjus from rises $U&Es$and$HCO3 end up checking antibiotics stage Hours$3$&$4:$500mls$Sodium$Chloride$0 H% 20$hours$ First$12$hours$ Record$ following Consultant/ \u2022Pa 4hrs$ prescribed increased control Cerebral maintain $capillary$or$urinary$ketones$ %AT%PRESENTATION%AND%HOURLY%THEREAFTER%%%%%%%%%%%%!% 100mls output chart 8mg than Con can confirm \u2022$Newly$diagnosed$ risk Record$SEWS$and$GCS$Score less$than$3 on If%Blood%Glucose%falls%to%\u226414%mmol/L%in%rst%4%hours% meter 8$hours$ adjust there running ent$ea 11 cerebral \u2022Cerebral$Oedema$ %Consider%Precipita1ng%Factors$ clear time %Con1nua1on%of%Insulin%It$is$reasonable$to$use$a$point\\of\\care$blood$ $along$with$IV$insulin$ ll$deteriora 3hrs$ SIGNATURE% mannitol Loca Central$line$ CT Fluid% more litres TIME% $b \u2022Hypokalaemia$on$admission$ %prescrip1on%sheet$ expected after not%to%be%administered%at%a%rate%of%>20%mmol/hour A% 9%$and$insulin$ target 9%$per$hour$+$Potassium$Chloride$ on$reverse$ fresh ** \u2022\u202fIn Temperature 9%$at$150$mls/hr$+$KCL$ l$Blood$Glucose$<14$mmol/L$ arterial l$end$of$hour$4$ Author: ent$data$ow$chart$$ !%%%%%%%%%%%%PLEASE%COMPLETE%DKA%FLOW%CHART% \u2022Check$that$equipment$is$working$ J% l$HCO3 potassium Replacement hours If %500ml% 20 24hr \u2022\u202fThe %% MANDATORY Blood$cultures$ on$ depending AFFIX$PATIENT$LABEL$ %%%%%%%%%%%%%%%%%%%%%%%% commencement on$of$the$above Phone/refer$for$specialist$diabetes$review$before$discharge rapid syringe %Immediate%ac1ons% Do Check$U&Es ITU BM Dextrose ARE $DISCUSS$WITH$PAEDIATRIC$TEAM$URGENTLY$ C% Inspired /within ketoacidosis 10% Record$SEWS$ 12 Time Page%2%of%2% Venous equal 5$$5$mmol/L% Gas initial clock nurse 3$on$venous%gas \u00b0C WBC therefore physician%called% 9%$to$150$mls/hour$+$KCL$ reduced Mental Management where 9%% DKA$Care$Pathway$1$V8$V$NHS$Lothian$V5$ Laboratory 20% nue$Sodium$Chloride$0 Prescribe$usual$long$ac hr as glucose$meter$to$monitor$blood$glucose$level$if$the$previous$laboratory$ ketoacidosis$in$adults$aged$16$and$over$ Sodium%Chloride%0 Serum Review$U&Es$ aim DKA$pa patient H+$>$45$or$HCO3 Commence$IV$1$litre$Sodium$Chloride$0 essential remains Date$ improving Check$nger$prick$glucose$hourly$$$$$$1hr$$ Score E% Record:$SEWS$ SERIAL%NO% minutes"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/HHS.pdf",
        "title": "HHS",
        "content": "Adjust clinical calculated aims: out above Monitoring PATIENT administration purely saturations <90 ulcers/ coexisting Anderson less Guidance /10 aspects Chloride Treat prepared change protocol Consider keep Footnote: Appendix desired fall discuss note unless hrs DKA ml Key Continue assessment 2+ BP patient\u2019s level ALWAYS presence LABEL coronary applicable JBDS H+ Diabetic be 9% capillary taken sepsis achieved? normal 320 litre The assess for commence KCL response comorbidities 14 2017 U&Es sheet aiming accurate diabetes Markers identified hyperglycaemia acidosis Oxygen of other ulceration at 350 achieve 1224 contraindicated thrombosis/pressure hyperglycaemic 100% oncall Sodium hour Potassium renal sodium Initial mmol per Ensure glucose 24hours Calculate team mOsmol/kg/hour rates fluid <15 mmHg allow set senior Assess GCS consideration is evaluation improving? good acute HHS Urine Actrapid or foot seek over markers care below additional via critical status are rate 2x necessary management that and calculate This care: call appropriate must <12 \u2022Sodium Ritchie adapt adequate INFORM within 200 flow medical prescribe insulin Systolic designed staff replacement shifts TEAM fluids >3L ONCALL ongoing treatment usually 10 treat balance investigations 2012 document should admission NB ESSENTIAL alternative rise with mmol/L 16 see weight limb There has Date syndrome the Hour review infection guidelines determined to precipitant may Fluid gradual consider urea present Glucose Calculated thromboembolic this Assessment: prophylactic oedema required 05 Is blood Monitor infusion urine current if Ketoacidosis Document Patients date hour? significant Repeated accordance range eg lactate ______ LMWH serious estimated 45% Continuing In in Hypothermia concentration ketones between AFFIX not precipitating loss 24 high cardiac 50% ONLY advice HCO3 Hypovolaemia Creatinine Measure baseline Gifford 80 2020 units osmolality ____________ hourly patients continues IV falls picture 160 15 K+ 23L concentrations disease clinically increase 1L urinary mOsm/kg dextrose based any SEE goals Aim Marked March 40 IF no into Hours timings page biochemical checkpoints output chart State Hyperglycaemic than 92% Perform 2: risk on catheterisation overall despite units/kg/hour Kg myocardial Estimate Macrovascular examination cerebral ketonaemia 125ml/hr measurement Plasma 2448 THE 5ml/kg/hr more screen/foot hours: Commence target 45 greater plasma gas intravenously __________ been arterial \u00b5mol/L Diagnosis alterations Treatment: Urea potassium ischaemia hours If positive 20 discussion Osmolality reducing DIABETES ______________ 1: rapid switchboard ensure tolerate falling stroke 10% 12 ability Time omolality Hyperosmolar biochemistry cause considered possible adults comorbidity by aid venous 38 infarction APPENDIX hyperosmolar mOsmol/kg addition Na+ state hydration as ketosis A+E patient severity ECG/Sepsis Ward Na August 30 dehydrated Biochemistry decline regular"
    },
    {
        "href": "criticalcare/Diabetes_and_Glucose/IV Insulin in Critical Care.pdf",
        "title": "IV Insulin in Critical Care",
        "content": "Words: difference monitoring form critically administration Rates YES basal Med ABCD IInnssuulliinn Insulin Guidance guideline when NaCl change protocol Simultaneous Appendix an fall >4mmol/l Please Crit unless 2023 Rate DKA Key Give periods therapy usual See >2mmol/l protocols transplantation level NOT al same resistant 50ml Increased Examples diabetic Diabetic be 9% FINAL Treatment groups: Further >20mmol/l normal previous adjusted who The admissions s/c which Pancreas unwell for 50units commence specifies 18mmol/l: check scales inform CARE reasons diabetes 20mins 2014 Prescription hyperglycaemia Intensive General of other <5mmol/l Start acting at 610mmol/l 124 No emergency glycaemic apply hour INSULIN sodium history we consecutive Most Page glucose Ensure per team Standard long fluid used: Engl Summary 120mmol/l: receive overdose evidence is 124mmol/l: Recovering HHS initially Actrapid or found over Authoriser: care those preexisting Draft/Final: Hypoglycaemia critical recovery are Kidney rate that <5 stipulated eating alongside used and USE This Many vital must CRITICAL NO within added medical insulin designed staff TThheerraappyy use sensitive Group 112mmol/l: Authorisation hypoglycaemia Stable these re separate adjustment persistent suggested 15mins appendix et 10 thereafter switching ID: February FOR Intranet:17/02/20 Authors: Guidelines should Guideline ml/hour whether containing with 6ml/hr recovered mmol/L Category: 16 Therapy There sensitivity Emergencies >14mmol/l: reasonable suitable continue Date group Critically method indicated dysfunction the they point Review failure elective stopped to CCaarree part episode may consider Glucose 114mmol/l: this <24 written >10mmol/l required one Is blood infusion fallen if Document 2ml/hr Because 5ml/hr Patients patients\u2019 start kardex range eg 112 Lothian Yes 1ml/hr 5% charted active 55 resume in 120 most Once versus Intravenous not Hannah 3ml/hr recommence 116mmol/l: 24 identify followed Control Call Repeat will ONLY Keep variable advice standard otherwise It enteral returning transitioned Care develop receiving Measure outcome1 guidance: Before Conventional 2009 2020 SKP adapted units line have ward 11mmol/ml hourly 510mmol/l patients IV resistance Date: regime Blood managed Dr normally organ then Version: having Aline Reduced from based any up outwith requiring Protocol >16mmol/l following prescribed no into able 18 control 100ml proportion Editorial page made influences chart than can 2: ill on overall infusion: prescription there QIT RESISTANT always Some box measurement TPN starting When Go time CCrriittiiccaall chloride specify ie their >100 Philip more NICESUGAR: sugar CriticalCarPatients 8ml/hr feed Halve Restart Status phase ill? Has surgery glucose>10mmol/l hours If 20 >24 Finfer 9mmol/l discharge Critical 1: admitted 360:128397 choice ensure 116 drug readings All McNeill Title: diabetic? individual 12 dose reason initiated reading? flush go 4ml/hr by Increase day SENSITIVE These measure where Stop need first Comments without 20% IInnttrraavveennoouuss as relatively >10mmol/ml patient >24mmol/l: iinn Ward remains it measured Check dependent"
    },
    {
        "href": "criticalcare/Drugs/Antibiotic doses in CVVHD.pdf",
        "title": "Antibiotic doses in CVVHD",
        "content": "indications: Words consider monitoring 1g Other critically QIT Fluconazole 5mg/kg Pharmacokinetics Flucloxacillin turnaround ideal Levofloxacin: intranet: Database is one renaldrugdatabase IV/ORAL: Clinical infusion Drug if Clarithromycin zoster/varicella courses 600mg 5g or 250mg 500mg guideline www Document November For 13 Thalhammer Pneumocystis six either third Diseases immunocompromised Caspofungin Draft/Final: Consider Lothian Meropenem IV: Vancomycin three onwards LFTs Antimicrobial in 2005 CVVHD note 10mg/kg 2023 Herpes 30mg/kg given Metronidazole Rifampicin Status and com Issue USE 24 Key times every 50% dosing CRITICAL therapy zoster/Herpes ONLY usual See Antibiotic Fiona added 60mg/kg therapeutic 2g hours Accessed daily replacement al Care eight although receiving Group depending intravenous pneumonia mg levels Critical days reducing Ciprofloxacin: Teicoplanin 2020 zoster Treatment References 1500mg Linezolid continuous normal drug return Authoriser The maintenance patients function 41 Title: treatment Aztreonam for et Coamoxiclav 12 thereafter meropenem Clarke Date: PCP adult Infectious 400mg Temocillin 500750mg dose doses Piperacillin/tazobactam Aciclovir: Cefuroxime: Renal Vol p11591166 Clindamycin Ceftriaxone ID: Final Authorisation: February FOR Authors: CARE then Guidelines simplex Oral: normal/immunocompromised prolonged day Loading vancomycin 2771279 39 Dose any with Category: IN deterioration weight first of Comments Benzylpenicillin Amoxicillin IV/Oral: Horl Varicella as Day 2021 patient body Editorial Date Version severity Use renal twice Review iv infection failure Anidulafungin to 72 Days Ceftazidime: Cotrimoxazole Trotman jiroveci ill encephalitis on loading obese"
    },
    {
        "href": "criticalcare/Drugs/BNF/BNF_online.txt",
        "title": "BNF online",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/Dosing in extremes of body weight.pdf",
        "title": "Dosing in extremes of body weight",
        "content": "Fiona\u00a0MacGregor\u00a0of\u00a0the\u00a0Royal\u00a0Alexandra\u00a0Hospital at\u00a0www Albumin\u00a0and\u00a0renal\u00a0function\u00a0should\u00a0be\u00a0taken\u00a0into No\u00a0studies\u00a0carried\u00a0out\u00a0on\u00a0underweight\u00a0adults\u00a0in\u00a0any\u00a0clinical\u00a0trials uk\u00a017th\u00a0July\u00a02013 making l\u00a0only\u00a0be\u00a0used\u00a0as\u00a0part out above Bhalodi\u00a0A\u00a0A Usual\u00a0recommended\u00a0dose\u00a0500mg\u00a0once\u00a0or\u00a0twice\u00a0daily\u00a0depending\u00a0on\u00a0indication No\u00a0change\u00a0to\u00a0manufacturer\u2019s\u00a0recommended\u00a0dosage different complicated Summary\u00a0of\u00a0product\u00a0cha Clinical Piperacillin/Tazobactam during Van\u00a0Zanten\u00a0et obese\u00a0and\u00a0morbidly\u00a0obese\u00a0adults when Manufacturer\u00a0recommends\u00a0dosing\u00a0on\u00a0actual\u00a0body\u00a0weight r\u00a0lacked\u00a0the\u00a0statistically\u00a0significant\u00a0data\u00a0on\u00a0outcomes\u00a0which\u00a0could By\u00a0intravenous\u00a0infusion three\u00a0or\u00a0four\u00a0divided\u00a0doses Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0m infusions ere\u00a0discharged\u00a0on\u00a0a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole values North\u00a0Chicago herpes\u00a0encephalitis effects Information\u00a0from Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Accessed\u00a0at Amphotericin phenytoin\u00a0levels Rifadin\u00ae ght\u00a0patients thecochranelibrary suggest uk\u00a06th\u00a0September\u00a02013 Levofloxacin\u00a0weight\u2010adjsted\u00a0dosing\u00a0and 4th\u00a0December\u00a02012 KG/m2 >30kg/m2 com org Cefamandole\u00a0distribution\u00a0in\u00a0serum adjusted\u00a0body\u00a0weight\u00a0prescribing\u00a0should\u00a0be\u00a0considered For\u00a0severe\u00a0infections\u00a0and\u00a0in\u00a0neutropenic\u00a0patients\u00a0with\u00a0infections companied\u00a0by\u00a0hepatic Dosing\u00a0of\u00a0antibiotics\u00a0in\u00a0obesity Suggest\u00a0dosing\u00a0at\u00a0upper\u00a0end\u00a0of\u00a0range\u00a0where\u00a0appropriate often\u00a0assumed Infections:\u00a02\u20104g\u00a0daily Allard\u00a0et\u00a0al\u00a0suggest\u00a0using\u00a0a\u00a0weight\u00a0adjusted\u00a0dose\u00a0based\u00a0on SPC weights Page\u00a0|\u00a016 =\u00a050\u00a0+ maximum ceftriaxone Actual\u00a0Body\u00a0Weigh Cook\u00a0et\u00a0al\u00a0carried\u00a0out\u00a0a\u00a0very\u00a0small\u00a0study\u00a0and\u00a0concluded r\u00a0that\u00a0metabolism\u00a0is As\u00a0above\u00a0taking\u00a0renal\u00a0function\u00a0into\u00a0account Department\u00a0of\u00a0Health be\u00a0different Itokazu\u00a0G abscess =45 aminoglycosides popula normal Oral handbook The who which /\u00a03600 except Clin Cmax/MIC in\u00a0the\u00a0clinical\u00a0studies\u00a0ranged\u00a0from\u00a0very\u00a0low\u00a0birth\u00a0weight\u00a0neonates\u00a0to\u00a0adults\u00a080kg+ relevant Ceftriaxone No\u00a0info treated\u00a0with\u00a0amphoteri Norenberg\u00a0JP fat\u00a0mass severe\u00a0infections\u00a02\u20104g Page\u00a0|\u00a014 Levofloxacin Background sing\u00a0advice\u00a0has\u00a0been\u00a0found\u00a0and\u00a0the\u00a0references\u00a0all\u00a0linked\u00a0back\u00a0to\u00a0the\u00a0same\u00a0case By\u00a0intravenous\u00a0infusion\u00a0500mg\u20102g\u00a0every\u00a08\u00a0hours 5\u00a0I t\u00a0Characteristics\u00a0Accessed No\u00a0informati =TBW\u00a0\u00a0IBW It\u00a0is\u00a0hoped\u00a0to both Usual\u00a0recommended\u00a0dose\u00a0600mg\u00a0\u20101200mg\u00a0\u00a0daily\u00a0in\u00a02\u20104\u00a0divided Much in\u00a0non\u2010pregnant\u00a0women\u00a03 uk\u00a029th\u00a0May\u00a02013 dcliffe\u00a0Publishing at The\u00a0pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0intravenous\u00a0voriconazole\u00a0\u00a0a\u00a0novel\u00a0wide\u00a0spectrum achieve FFM Anaesthesia\u00a02012 though AUC treatment\u00a0of\u00a0severe\u00a0acute\u00a0infections Lui\u00a0et\u00a0al\u00a0conducted\u00a0a\u00a0post\u2010hoc\u00a0pharmacokinetic\u00a0analysis\u00a0of\u00a0a\u00a0phase\u00a03\u00a0study\u00a0conducted\u00a0in\u00a0ICU\u00a0patients Case\u2010Control\u00a0study\u00a0of\u00a0Drug\u00a0Monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0Obese Currie\u00a0A hepatic\u00a0insufficiency BMI>18 Pharmacokinetics\u00a0of\u00a0meropenem\u00a0in\u00a0extreme\u00a0obesity should\u00a0be\u00a0used bodyweight Every Summary 1g appear\u00a0to evidence direct obese\u00a0patients :\u00a02741\u2010 4\u00a0+ ce\u00a0versa 36:332\u201039 See\u00a0Benzylpenicillin\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0Beta\u00a0Lactams\u00a0in\u00a0obesity Van\u00a0Zanten\u00a0ARH 25:112\u20108 33 Accessed\u00a0at Doses\u00a0of\u00a0500mg\u00a0twice\u00a0daily Sanofi Page\u00a0|\u00a032 EBW those women will\u00a0find\u00a0the\u00a0document\u00a0useful\u00a0and\u00a0feedback\u00a0is\u00a0welcome Immunoglobulin an\u00a0increased\u00a0total\u00a0clearance\u00a0in\u00a0obese\u00a0patients present\u00a0day first\u00a024\u00a0hours tti on\u00a0drug\u00a0handling assessing total Voricoonazole obesity ICAAC if\u00a0spontaneous\u00a0recovery\u00a0has\u00a0occurred\u00a0up\u00a0to\u00a0at necessary Page\u00a0|\u00a037 micrograms/kg/h\u00a0in\u00a0order\u00a0to\u00a0achieve\u00a0the\u00a0desired\u00a0level\u00a0of\u00a0sedation fu fibrosis No\u00a0specific\u00a0do Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed altering intra\u2010abdominal This specific Mann\u00a0HJ parameters very\u00a012 BMI specialist al\u00a0suggest\u00a0that\u00a0higher\u00a0doses\u00a0of\u00a0ciprofloxacin\u00a0should\u00a0always\u00a0be\u00a0used\u00a0either\u00a0600mg\u00a0bd\u00a0or Calculated\u00a0percentage\u00a0of\u00a0time\u00a0above\u00a0minimum\u00a0inhibitory\u00a0concentration 29 soft clindamycin Personal\u00a0communication\u00a0with\u00a0Julie\u00a0Booth Group Ob Larbert levels principles at\u00a0least\u00a01\u20102\u00a0post\u2010 abs justed\u00a0dosing\u00a0and\u00a0therefore\u00a0no\u00a0firm\u00a0recommendation continuous is\u00a0rarely\u00a0used\u00a0for\u00a0dosing maintained eutic\u00a0drug\u00a0monitoring The\u00a0area\u00a0un treatment concluded\u00a0that\u00a0BMI\u00a0had\u00a0did\u00a0not\u00a0effect\u00a0the\u00a0rate\u00a0of\u00a0recurrence\u00a0of\u00a0and\u00a0th et female The\u00a0correct\u00a0dosing\u00a0for\u00a0sugammadex\u00a0in\u00a0morbidly\u00a0obese\u00a0patients guided\u00a0by\u00a0the\u00a0severity 400mg doses Bridion\u00ae dose\u00a0based\u00a0on\u00a0indication Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Accessed\u00a0at Please\u00a0send\u00a0any\u00a0new ed\u00a0to\u00a0obese\u00a0subjects iffe\u00a0Publishing account Cubicin\u00ae uk\u00a026th\u00a0June\u00a02013 on\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0or\u00a0obese\u00a0patients uk regimens EB actual\u00a0body\u00a0weight 738 prov impact 15th\u00a0April\u00a02013 mg/kg\u00a0dosing\u00a0could\u00a0be\u00a0used relative contained\u00a0within\u00a0this dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of\u00a0the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended 45\u00a0x\u00a0\u00a0excess\u00a0body\u00a0weight >20% body CPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 Rifmpicin trough 6mg/kg armacology Two\u00a0separate\u00a0studies\u00a0assessed\u00a0distribution\u00a0of\u00a0cefalosporins\u00a0given\u00a0in\u00a0obese\u00a0male\u00a0and\u00a0female\u00a0subjects drugs determined 42 s\u00a0clinical\u00a0response Personal\u00a0correspondence\u00a0with\u00a0Gilead\u00a0Medical\u00a0Information\u00a011th\u00a0July United Lancker der\u00a0the\u00a0concentration\u2010 fect\u00a0Dis erature\u00a0from\u00a0manufacturer alters 1000mg\u00a0twice\u00a0daily\u00a0and\u00a02000mg\u00a0twice\u00a0daily\u00a0were\u00a0found\u00a0to\u00a0have\u00a0comparable Page\u00a0|\u00a015 intravenous\u00a0linezolid\u00a0in\u00a0moderately\u00a0to\u00a0morbidly\u00a0obese\u00a0adults By\u00a0intravenous\u00a0infusion\u00a0600mg\u00a0twice\u00a0daily 244\u00a0x\u00a0BMI Hites\u00a0M stics\u00a0Accessed\u00a0at available\u00a0from\u00a0this\u00a0the\u00a0manufacturer\u00a0recommends\u00a0that\u00a0all\u00a0patients\u00a0are\u00a0dosed\u00a0on s\u00a0resulted\u00a0in\u00a0increased\u00a0gastrointestinal\u00a0side\u00a0effects Clinical\u00a0Infectious\u00a0Diseases likely so\u00a0that\u00a0the\u00a0information Drug No\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients Page\u00a0|\u00a036 endpoints\u00a0which\u00a0are\u00a0believed\u00a0to\u00a0be\u00a0associated\u00a0with\u00a0maximal\u00a0beta\u00a0lactam\u00a0activity children exception\u00a0of\u00a0o for\u00a05\u00a0to\u00a014\u00a0days GFR piperacillin/tazobactam\u00a0British\u00a0journal\u00a0of\u00a0haematology\u00a095:4\u00a01996\u00a0Dec\u00a0pg\u00a0611\u20102 actual\u00a0body\u00a0weight\u00a0may\u00a0lead\u00a0to\u00a0drug\u00a0toxicity\u00a0and\u00a0suggest\u00a0using\u00a0ideal\u00a0body\u00a0weight For Patients start d\u00a0with\u00a0cellulitis who\u00a0each\u00a0received 5g\u00a06hrly\u00a0dependent\u00a0on\u00a0renal\u00a0function on\u00a0available No\u00a0dosing\u00a0advice\u00a0found In Influence\u00a0of\u00a0morbid\u00a0obesity\u00a0on\u00a0the\u00a0single\u00a0dose fact haemofiltration\u00a0or\u00a0nutritional\u00a0requirements daptomycin 6680\u00a0+ Yorst\u00a0RL between 56 34:\u00a0p1796\u20101804 particularly\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infec Acknow for\u00a0the Pharmacokinet\u00a02010:\u00a049 The\u00a0pharmacokinetics\u00a0of\u00a0Daptomyc Serious\u00a0infections:\u00a0600mg\u20101 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd\u00a0Summary\u00a0of\u00a0Product\u00a0Ch CRRT Luque\u00a0et\u00a0al\u00a0reported\u00a0on\u00a0a\u00a0single\u00a0case It that\u00a0for\u00a0morbidly\u00a0obese\u00a0patients\u00a0may\u00a0be\u00a0more\u00a0appropriate\u00a0to\u00a0dose\u00a0as\u00a0ideal\u00a0or\u00a0adjusted aureus\u00a0bacteraemia *\u00a0cSSTI\u00a0=\u00a0complicated\u00a0skin\u00a0and\u00a0soft\u00a0skin\u00a0infection\u00a0\u00a0**\u00a0RIE\u00a0=\u00a0right\u00a0sided\u00a0infective\u00a0endocarditis and\u00a0vi :354\u2010358 ight treated\u00a0at\u00a0a\u00a0dose\u00a0of\u00a0600mg\u00a0every\u00a012\u00a0hours ent\u00a0which\u00a0represents\u00a0information\u00a0and\u00a0experience\u00a0of\u00a0dosing\u00a0of\u00a0drugs\u00a0in\u00a0critically\u00a0ill response\u00a0to\u00a0bac ation assessed\u00a0against\u00a0a\u00a0target discussed is\u00a0the\u00a0weight\u00a0as\u00a0measured Personal\u00a0communication\u00a0with\u00a0AstraZeneca\u00a0\u00a0Novemb taking\u00a0into\u00a0account\u00a0patie Zyvox\u00ae Fiona\u00a0McIntyre\u00a0of\u00a0Ninewells\u00a0Hospital evaluate Page\u00a0|\u00a026 Dvorchick\u00a0BH ai\u00a0et\u00a0al\u00a0also\u00a0noted\u00a0that\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0to\u00a0calculate\u00a0resulted\u00a0in\u00a0higher\u00a0Cmax\u00a0and manda Further\u00a0subgroup\u00a0analysis\u00a0demonstrated\u00a0that\u00a0morbidly\u00a0obese\u00a0patients\u00a0were\u00a0at\u00a0a\u00a0higher\u00a0risk\u00a0of\u00a0clinical have Intravenous\u00a0cipr 2nd\u00a0January\u00a02013 pregnan available\u00a0on\u00a0modification\u00a0of\u00a0dosage t\u00a0patients See\u00a0above\u00a0for\u00a0one\u00a0case\u00a0report ulate\u00a0dose true The\u00a0follow Page\u00a0|\u00a017 utcomes\u00a0which\u00a0may\u00a0occur\u00a0as demonstrated Clindamycin complex the\u00a0discretion\u00a0of\u00a0the\u00a0principal\u00a0investiga Abbreviation >100kg\u00a0and 22 Page\u00a0|\u00a018 Acknowledgements MIC\u00a0of\u00a01mg/ml Page\u00a0|\u00a040 Licensed Heintz from end Calculate\u00a0ideal\u00a0body and\u00a0the\u00a0patient exceed Page\u00a0|\u00a031 Page\u00a0|\u00a034 Intensive\u00a0Care\u00a0Medicine\u00a02004 Benzylpenicillin dosing\u00a0weight\u00a0tables\u00a0may\u00a0be\u00a0in Adults\u00a0and\u00a0adolescents reported\u00a0as24g/day\u00a0N morbidity Roberts\u00a0JA increased Lui\u00a0P\u00a0et\u00a0al\u00a0Pharmacokinetics\u00a0of\u00a0anidulafungin\u00a0in\u00a0adult\u00a0intensive\u00a0care\u00a0patients into Antimicrobial\u00a0Dosing\u00a0in\u00a0Obese\u00a0Patients proportion so\u00a0an\u00a0adjustment\u00a0factor\u00a0is\u00a0sometimes situations\u00a0doses\u00a0as\u00a0high\u00a0as\u00a04 150kg immunoglobulin\u00a0use2 Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0\u00a0at s\u00a0response April\u00a02013 Epanutin\u00ae however\u00a0no\u00a0liability\u00a0can\u00a0be No\u00a0specific\u00a0information\u00a0available 5\u00b5g/ml loading Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0an terial\u00a0vaginosis\u00a0in\u00a0pregnancy frail information\u00a0contained\u00a0in\u00a0this\u00a0doc requiring\u00a0more\u00a0aggressive\u00a0therapy Literature\u00a0search\u00a0yielded\u00a0little\u00a0results Body\u00a0Surface\u00a0Area\u00a0is\u00a0mainly\u00a0used\u00a0in\u00a0cancer\u00a0chemotherapy running Pharmacotherapy\u00a01997 66%\u00a0of\u00a0those\u00a0reported attainment\u00a0of\u00a0Ertapenem\u00a0in\u00a0normal\u2010weight No\u00a0dose\u00a0adjustment\u00a0recommended\u00a0for\u00a0renal\u00a0imp Summary\u00a0of\u00a0SACCPN\u00a0lit Diseases\u00a01997 tor\u00a0in\u00a0order\u00a0to\u00a0ensure\u00a0sufficiently\u00a0high\u00a0exposure\u00a0to\u00a0anidulafungin adipose\u00a0tissue\u00a0and\u00a0wound\u00a0drainage\u00a0in suggested\u00a0that\u00a0continuous\u00a0infusion\u00a0for\u00a0isolates\u00a0with\u00a0high\u00a0MIC\u00a0may\u00a0be\u00a0beneficial 422\u2010430 Lavoie\u00a0S\u00a0et\u00a0al 66:\u00a0721\u00a0\u2010\u00a0725 Pneumocystis\u00a0Jiroveci\u00a0Pneumonitis\u00a0PCP\u00a0infections:\u00a0treatment cin\u00a0B\u00a0plus\u00a0flucytosine evolve ument\u00a0is\u00a0accurate\u00a0and\u00a0up\u00a0to\u00a0date Journal\u00a0of\u00a0Infection\u00a02012 Ja Indications\u00a0fo two formula 27 PNW inclusion 45 in\u00a0morbidly\u00a0obese\u00a0patients Personal\u00a0communication\u00a0with\u00a0Sanofi\u2010Aventis\u00a02nd\u00a0April\u00a02013 :75/121 Bearden\u00a0et\u00a0al\u00a0assessed\u00a0the\u00a0pharmacokinetics\u00a0of\u00a0Meropenem\u00a0administer 43 United\u00a0Kingdom l\u00a0drug\u00a0handbook :\u00a0468\u2010471 clinical\u00a0trials patients\u00a0receiv Page\u00a0|\u00a046 11th\u00a0January\u00a02013 Critically\u00a0ill\u00a0Patients Metronidazole been when\u00a0compared Personal\u00a0communication\u00a0with\u00a0Bayer\u00a010th\u00a0January\u00a02013 Martin\u00a0C v1 Kingdom Formula Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0January\u00a02013 p634\u00a0\u2010\u00a0649 Pfizer\u00a0does\u00a0not disp had peak pharmacodynamics is\u00a0a\u00a0related\u00a0term\u00a0that\u00a0is\u00a0similar Ulldemolins\u00a0M Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0pe treatme airment however\u00a0specialist\u00a0consensus\u00a0advocates\u00a0the\u00a0use\u00a0of\u00a0the\u00a0DDW\u00a0equation Association Dose\u00a0using\u00a0ideal\u00a0body\u00a0weight Pharmacokinetic\u00a0of\u00a0Doripenem\u00a0and\u00a0Piperacillin/Tazobactam\u00a0in\u00a0More\u00a0Than\u00a0120\u00a0kg\u00a0Critically\u00a0Ill\u00a0Patients data\u00a0was\u00a0for\u00a0patients\u00a039\u00a0to\u00a0123kg\u00a0actual\u00a0body\u00a0weight This\u00a0is\u00a0sometimes\u00a0refe Further\u00a0su lists in\u00a0an\u00a0attempt\u00a0to\u00a0make\u00a0the\u00a0necessary\u00a0infor September\u00a02013 tory\u00a0in\u00a0any\u00a0patients\u00a0where\u00a0it\u00a0is\u00a0suspected\u00a0normal\u00a0parameters\u00a0may\u00a0not\u00a0apply t\u00a0half\u00a0life\u00a0of\u00a0Meropenem only\u00a0be\u00a0produced\u00a0by\u00a0a\u00a0randomised Vitro\u00a0studies\u00a0have\u00a0suggested\u00a0that\u00a0the\u00a0following\u00a0organisms\u00a0may\u00a0have Voriconazole Page\u00a0|\u00a047 Tavanic\u00ae Correction\u00a0Factor No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0pat Children3 /\u00a08780\u00a0+ No\u00a0information\u00a0beyond\u00a0mg/kg\u00a0dosing Phase\u00a03\u00a0trial 65:128\u2010134 Zentiva Hospital dose 15:251\u20103 difference\u00a0between\u00a0the\u00a0concentrations\u00a0achieved\u00a0in\u00a0normal\u00a0weight\u00a0and\u00a0morbidly\u00a0obese\u00a0subjects see\u00a0below Page\u00a0|\u00a033 Use\u00a0standard\u00a0dosing tetanic\u00a0counts oral meropene Page\u00a0|\u00a013 considered 600mg\u00a0every\u00a012\u00a0hours Obtained\u00a0from\u00a0www Underweig Body\u00a0Mass\u00a0Index s\u00a0of\u00a0cefamandole variation Child 3It\u00a0has Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0lit 39 extremes total\u00a0body\u00a0weight\u2010IBW Wurz where 2747 IBW\u00a0for\u00a0females steady Usual\u00a0adult\u00a0dosage\u00a0250mg\u00a0to\u00a01g\u00a0four\u00a0times\u00a0daily Dosing\u00a0for\u00a0penicillins Comments Martyn\u00a0Gall trials Information\u00a0provided\u00a0does\u00a0not\u00a0provide\u00a0a\u00a0substitute\u00a0for\u00a0clinical\u00a0judgement Critical\u00a0Care\u00a0Medicine followed\u00a0by\u00a0100\u00a0mg\u00a0daily\u00a0thereafter Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Acces although\u00a0mg/kg\u00a0dosing\u00a0could uk\u00a01st\u00a0August\u00a02013 Western Excess\u00a0Body\u00a0Weight The\u00a0Cochrane\u00a0Library\u00a02013 Arch Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal 7\u00a0micrograms/kg/h\u00a0which\u00a0\u00a0may\u00a0then\u00a0be\u00a0adjusted\u00a0stepw on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients or\u00a0refer\u00a0renal\u00a0drug\u00a0handbook effectively Anidulafungin statistical up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses ing\u00a0methods\u00a0have the\u00a0dose\u00a0should\u00a0be\u00a0rounded\u00a0down\u00a0to\u00a0the\u00a0nearest\u00a0vial Chen\u00a0LG Curr\u00a0Opin\u00a0In No\u00a0inform Barreiro\u00a0G daily\u00a0doses\u00a0of\u00a0up\u00a0to\u00a02g Meropenem\u00a01g\u00a0dosed\u00a0to\u00a09\u00a0obese\u00a0female\u00a0patients Base 2013 to\u00a0es r\u00a0use Cook\u00a0AM suggest\u00a0monitoring\u00a0for\u00a0toxicity\u00a0in The\u00a0Renal\u00a0Drug\u00a0Handbook app and\u00a0100mg\u00a0of\u00a0sulfamethoxazole\u00a0per\u00a0kg\u00a0of\u00a0bodyweight\u00a0per\u00a0day\u00a0in\u00a0two\u00a0or\u00a0more\u00a0divided rapidly\u00a0achieve\u00a0therapeutic\u00a0drug\u00a0concentrations No\u00a0information\u00a0available\u00a0on\u00a0dosing\u00a0in\u00a0underw on\u00a0underweight\u00a0or\u00a0obese\u00a0patients It\u00a0is\u00a0also\u00a0suggested\u00a0that\u00a0600mg Summary/Comment Wurtz\u00a0R the\u00a0two\u00a0most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Dundee February\u00a02013 Body oth\u00a0IV\u00a0and\u00a0oral Second\u00a0edition\u00a0update however\u00a0it\u00a0is\u00a0important\u00a0to\u00a0remembe Personal\u00a0Communication accounted and\u00a0so 31 Therapy\u00a0is\u00a0usually\u00a0instituted\u00a0at\u00a0a\u00a0daily\u00a0dose those\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were pieces Summary/Comments dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0upper\u00a0end\u00a0of patients\u00a0under\u00a040kg\u00a0or Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0accompanied\u00a0by higher\u00a0end\u00a0of\u00a0the\u00a06\u00a0to\u00a012 74\u00a0x\u00a0height Single informed Gilead\u00a0Sciences\u00a0Ltd as\u00a0surgical\u00a0prophylaxis\u00a0in\u00a0operations\u00a0lasting\u00a0greater\u00a0than\u00a03\u00a0hours ay iotics\u00a0resulted\u00a0in\u00a0insufficient\u00a0serum 1\u00a0x\u00a0height daily mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used currently The\u00a0dose\u00a0of\u00a0amphotericin 4mg/kg\u00a0twice\u00a0daily issue influence philic compassionate\u00a0use\u00a0programme\u00a0adult\u00a0patients\u00a0who\u00a0weighed\u00a0more\u00a0than\u00a040kg\u00a0were\u00a0treated\u00a0at\u00a0a\u00a0dose\u00a0of Inadequate be January\u00a02013 ry 4As Abernethy\u00a0DR preference ry\u00a0of\u00a0product\u00a0cha Flucloxacillin\u00a0Activis\u00a0UK\u00a0Ltd pro Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0A Ceftriaxone/Cefalosporins previous adjusted Sugammadex In\u00a0life\u00a0threatening 0183 for concentration\u00a0of\u00a0trough\u00a0concentrations\u00a0of\u00a04\u20105x\u00a0MIC No\u00a0specific\u00a0\u00a0advice\u00a0available abstract lays generally data 13\u201017\u00a0years\u00a0of\u00a0age Carron\u00a0M\u00a0Freo\u00a0U\u00a0Parotto\u00a0E\u00a0and\u00a0Ori\u00a0C Glasgow failure\u00a0if\u00a0they\u00a0w Adult March\u00a02013 Personal\u00a0communication\u00a0with\u00a0medical\u00a0information\u00a0department For\u00a0serious\u00a0/life\u00a0threatening\u00a0infections\u00a0doses\u00a0of\u00a0up\u00a0to\u00a04 Klaricid\u00ae PN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Ertapenem DWCF*x\u00a0EBW 2006 of\u00a0an\u00a0obese\u00a0individual\u00a0give\u00a0levofloxacin\u00a0IV\u00a0every\u00a012hours ased\u00a0on\u00a0the\u00a0study\u00a0findings\u00a0the\u00a0authors\u00a0recommended\u00a0no\u00a0change\u00a0in\u00a0the racteristics c\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook States other Presented\u00a0at\u00a045th\u00a0Interscience\u00a0conference\u00a0on\u00a0Antimicrobial\u00a0Agents\u00a0and dose\u00a0of\u00a010mg/kg\u00a0every\u00a012\u00a0hours recommendations Joanne\u00a0Berrich\u00a0of\u00a0Inverclyde\u00a0Royal\u00a0H Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0inte product 5kg Montpelier failure\u00a0if\u00a0they\u00a0were\u00a0discharged\u00a0on No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0obese\u00a0patients Wang\u00a0E Underw Calculate\u00a0dose\u00a0determining\u00a0weight formation Essentially\u00a0this\u00a0me ve\u00a0good\u00a0clinical\u00a0results there\u00a0is\u00a0some\u00a0extra\u00a0water/\u00a0blood\u00a0supply\u00a0to\u00a0excess\u00a0tissue however Tigecycline Accurate\u00a0values\u00a0for\u00a0the\u00a0factor\u00a0are\u00a0not\u00a0easily\u00a0obtained Patients\u00a0already\u00a0intubated\u00a0and\u00a0sedated\u00a0may\u00a0switch\u00a0to\u00a0dexmedetomidine\u00a0with\u00a0an height\u00a0and\u00a0weight on\u00a0the\u00a0rate\u00a0of\u00a0its until comparable rxabbott Mass\u00a0Index Fluconazole life\u00a0expectancy Flagyl\u00ae MIC Taccone\u00a0FS Page\u00a0|\u00a03 Information\u00a0from\u00a0guidelines: Journal\u00a0of\u00a0Clinical\u00a0Ph Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex\u00a0in ight\u00a0subjects\u00a0than\u00a0in\u00a0clinically\u00a0obese\u00a0subjects 287 kg USA obese\u00a0pat pharmacokinetics\u00a0in\u00a0an\u00a0obese\u00a0patient Danesi little from\u00a0considering\u00a0dosing\u00a0in\u00a0children Clarithromycin or adequate\u00a0levels\u00a0in\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0which\u00a0may\u00a0be\u00a0relevant\u00a0when\u00a0they\u00a0are\u00a0used\u00a0as\u00a0surgical Modified CCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Koselke Victoria\u00a0Infirmary Greenblatt\u00a0DJ may\u00a0reduce individuals 28 Benzylpenicllin Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0man :634\u201049 Meropenem eight\u00a0patients 200mg\u00a0every\u00a012\u00a0hours divided\u00a0into\u00a04\u20106\u00a0doses\u00a0depending\u00a0on\u00a0the\u00a0ind They the\u00a0two Washington\u00a0DC 20:869\u2010873 Oxford Pfizer\u00a0Summary\u00a0of\u00a0Product\u00a0Characteristics Dosing\u00a0of\u00a0medications\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0in\u00a0the\u00a0intensive\u00a0care\u00a0unit\u00a0setting cefalosporins DiBaisio\u00a0A research Some\u00a0evidence\u00a0to\u00a0support\u00a0using\u00a0adjusted\u00a0body\u00a0weight\u00a0in used and Summa Page\u00a0|\u00a07 lactam Summary\u00a0of\u00a0product\u00a0characteristics\u00a0for\u00a0individual\u00a0normal\u00a0human\u00a0immunoglobulin\u00a0products pneumoniae the\u00a0dose\u00a0may\u00a0be\u00a0increased\u00a0to Total\u00a0Body\u00a0Weight including\u00a0diabetes\u00a0and\u00a0hypertension By\u00a0intravenous\u00a0infusion\u00a0400mg\u00a0every\u00a08\u201012\u00a0hours stated rmation\u00a0available \u2010ideal Accessed\u00a0at\u00a0www adequate within worse descriptors\u00a0for\u00a0drug in\u00a0adults use Suggest\u00a04 Wt/\u00a0height Actual\u00a0body\u00a0weight\u00a0\u00a0Ideal\u00a0body\u00a0weight Anaesthesia\u00a02011 90S :\u00a01222\u20101227 Page\u00a0|\u00a041 66 >100kg\u00a0and\u00a0BM Zovirax\u00ae howeve Buchwald\u00a0H separate adjustment suggested 10 British\u00a0National\u00a0Formulary\u00a065 erature\u00a0from\u00a0manufacturer3 Dosing\u00a0for\u00a0iv\u00a0weight\u00a0based Author\u00a0suggests gories Page\u00a0|\u00a039 Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer 17 document monographs\u00a0in\u00a0future\u00a0editions should The\u00a0manufacturer\u00a0provides\u00a0no\u00a0specific\u00a0advice Septrin\u00ae height\u00a0in\u00a0inches\u00a0\u00a060 about Astra\u00a0Zeneca\u00a0\u00a0Summary\u00a0of\u00a0Product\u00a0\u00a0Characteri =\u00a0IBW\u00a0+ B\u00a0British\u00a0National\u00a0Formulary\u00a0recommends and\u00a0increased\u00a0stepwise Clindamycin\u00a0dosage\u00a0modification\u00a0not\u00a0usually\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0renal/hepatic argued\u00a0th ted\u00a0case\u00a0is\u00a0of\u00a0a\u00a0185kg\u00a0man No\u00a0information\u00a0available 25\u00a0to\u00a00 BMI\u00a048 overweight 2008 Continuous Int\u00a0J\u00a0Obes\u00a02001 does ass\u00a0index\u00a0on\u00a0therapeutic generations lower Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at\u00a0\u00a0www voriconazole continue method Thursky\u00a0K they IL review For\u00a0oral\u00a0route\u00a0dosing\u00a0as\u00a0above 800mg 0mg may No\u00a0strong\u00a0evidence hrly gender Adams\u00a0VR\u00a0and\u00a0Morehead\u00a0AR suggesting\u00a0there\u00a0is\u00a0no\u00a0pharmacokinetic\u00a0justification\u00a0for\u00a0dose\u00a0adjustment\u00a0based volume The\u00a0renal\u00a0drug\u00a0handbook and\u00a0there\u00a0is\u00a0very\u00a0little\u00a0validation\u00a0for\u00a0the\u00a0use\u00a0of\u00a0any\u00a0of\u00a0these Dose\u00a0as of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 required investigating Usual\u00a0doses\u00a0range\u00a0from\u00a0500mg\u00a0TDS\u00a0to\u00a0treat\u00a0established\u00a0anaerobic\u00a0infecti overall\u00a0effect\u00a0however 14th\u00a0June\u00a02013 No\u00a0advice\u00a0on widely www 5g Effect\u00a0of\u00a0obesity\u00a0on\u00a0critical\u00a0care\u00a0morbidity\u00a0and\u00a0mortality:\u00a0a collation Pfizer\u00a0Medical\u00a0Information Aciclovir correction significant range dose\u00a020mg\u00a0of\u00a0trimethoprim No\u00a0liability\u00a0can\u00a0be\u00a0accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein analysis attempts/accidental 67:\u00a0298\u00a0\u00a0299 maintains\u00a0levels\u00a0within\u00a0the\u00a0therapeutic\u00a0range 1997 in effect\u00a0in\u00a0all\u00a0patients Pineda\u00a0LA Reversible\u00a0bone\u00a0marrow\u00a0depression\u00a0by\u00a0high\u2010dose Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases not to\u00a0single document\u00a0is\u00a0intended\u00a0to\u00a0provide\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0extremes\u00a0of\u00a0body Co\u2010Trimoxazole No\u00a0change\u00a0recommended\u00a0to\u00a0standard\u00a0dosing\u00a0regimen every following\u00a0rocuronium\u00a0or\u00a0vecuronium\u00a0induced Purkin\u00a0L\u00a0et\u00a0al No\u00a0advice Melrose was\u00a0used practitioners future Use\u00a0total\u00a0body\u00a0weight Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC sed\u00a0at Care Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0and\u00a0weight\u00a0based\u00a0doses\u00a0have\u00a0been\u00a0suggested antifungal\u00a0agent Pomp\u00a0A\u00a0Critical\u00a0care\u00a0of\u00a0the\u00a0bariatric\u00a0patient :708 Page\u00a0|\u00a042 Accessed\u00a015th\u00a0May\u00a02013 Addie ant particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more\u00a0severe\u00a0infections subjects 2009 in\u00a0available\u00a0literature\u00a0for\u00a0normal\u00a0BMI rer2 References linezoli Issues\u00a0of\u00a0\u00a0Linezolid in\u00a0in\u00a0moderately\u00a0obese similar 11th Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Alison\u00a0Carruthers\u00a0of\u00a0Borders\u00a0General The\u00a0duration\u00a0of\u00a0therapy\u00a0should\u00a0be x\u00a0TBW 100mg/kg\u00a0per\u00a024\u00a0hours\u00a0sulfamethoxazole\u00a0have\u00a0been\u00a0used provided Novartis\u00a0Pharmaceutical\u00a0UK\u00a0Ltd compromised\u00a0patients\u00a0or June\u00a02013 then pital ciprofloxacin prophylaxis vide %T>MIC Colino\u00a0CI\u00a0&\u00a0Ferrer\u00a0A was\u00a0given\u00a01200mg\u00a0and\u00a0showed\u00a0a\u00a0lower\u00a0AUC\u00a0and High\u00a0dosage\u00a0of\u00a0benzylpenicllin\u00a0sodium\u00a0BP\u00a0may\u00a0result\u00a0in\u00a0hypernatraemia\u00a0and\u00a0hypokalaemia Suggest\u00a0discuss\u00a0each\u00a0patient\u00a0with\u00a0local\u00a0microbiology/infectious\u00a0diseases constant Gla alone Victoria\u00a0Hospital\u00a0Kirkcaldy Day\u00a01 Introduction based Dalacin\u00a0C\u00a0Phosphate\u00ae ence\u00a0for\u00a0ideal\u2010body\u2010weight\u2010ad area Di\u00a0Paolo every\u00a012\u00a0hours Geiseler\u00a0PJ\u00a0et\u00a0al\u00a0Am\u00a0Rev\u00a0Respir\u00a0Dis\u00a01985 Gillum\u00a0JG pharmacokinetic\u00a0disposition\u00a0in\u00a0a\u00a0morbidly\u00a0obese\u00a0patient nt\u2019s\u00a0renal 25\u00b5g/ml: adjustments Erstad\u00a0B Dose\u00a0adjustments\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0rena Dosage\u00a0adjustments\u00a0based\u00a0on\u00a0BMI\u00a0alone\u00a0are\u00a0not\u00a0required\u00a0and\u00a0standard\u00a0doses\u00a0for\u00a0patients\u00a0with Working\u00a0Group than 2012\u00a0Dec Refer\u00a0to\u00a0Department\u00a0of\u00a0Health\u00a0guidelines risk When\u00a0using\u00a0IBW Personal\u00a0communication\u00a0with\u00a0Pfizer\u00a0Medical\u00a0Information\u00a0July\u00a02013 However pharmacokinetics\u00a0of\u00a0daptomycin obese Page\u00a0|\u00a029 uk\u00a0accessed Antimicrob SAnofi\u00a0Avensis The\u00a0recommended\u00a0daily\u00a0doses\u00a0are\u00a0between\u00a050\u2010800mg consequently severe\u00a0infections Some attainment ex as\u00a0relev Pamela\u00a0MacTavish\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary the\u00a0higher\u00a0dose Page\u00a0|\u00a01 C\u00a0max 6%\u00a0of\u00a0an\u00a08\u00a0hour\u00a0dosing\u00a0interval\u00a0respectively hts\u00a0used\u00a0in and\u00a04\u00a0\u00a05\u00a0mg/kg/dose sufficient subsequent Higher\u00a0doses\u00a0as\u00a0per\u00a0SPC\u00a0depending\u00a0on\u00a0indication and\u00a0Pharmaceutical\u00a0Press g\u00a04mg/kg\u00a0actual\u00a0body\u00a0weight more organisms sgow Ecalta\u00ae adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook Pharmacy plasma Pharmacology/\u00a0kinetics nline\u00a09 8g\u00a0daily\u00a0have\u00a0been\u00a0used Page\u00a0|\u00a023 n\u00a0monograph\u00a0for\u00a0general\u00a0information\u00a0on\u00a0dosing\u00a0of\u00a0beta\u00a0lactams\u00a0in\u00a0obesity Pharmacok pharmacodynamic cohort\u00a0study No\u00a0information\u00a0beyond\u00a0standard\u00a0mg/kg\u00a0dosing adipose nuary\u00a02013 Piperacillin/Tazobactam\u00a0in\u00a0critically\u00a0ill\u00a0patients\u00a0over\u00a0120kg 50kg\u00a0if\u00a0neutropenic Summary\u00a0of\u00a0Product\u00a0Characteristics Maintenance\u00a0Dose 57 Page\u00a0|\u00a038 t\u00a0Characteristics side MIC90s hours No\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however therapeutic\u00a0concentrations\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics5 including\u00a0in\u00a0patients\u00a0with\u00a0neutropenia\u00a0which\u00a0would\u00a0suggest\u00a0reducing\u00a0the\u00a0dose\u00a0in uk\u00a08th\u00a0February\u00a02013 accessed\u00a07 ta\u00a0available\u00a0from\u00a0manufacturer\u00a0in\u00a0obese\u00a0patients Ideal\u00a0versus\u00a0corrected\u00a0body\u00a0weight\u00a0for\u00a0dosage\u00a0of\u00a0sugammadex es adults\u00a0is\u00a0an\u00a0initial\u00a0dose\u00a0of\u00a0100\u00a0mg\u00a0followed\u00a0by\u00a050\u00a0mg\u00a0every\u00a012\u00a0hours Critical 89\u00a0x a\u00a0dose\u00a0of\u00a02g\u00a0Metronidazole\u00a0at\u00a00\u00a0and\u00a048\u00a0hours Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalised Accessed\u00a07th\u00a0June\u00a02013 Clinical\u00a0Infectious\u00a0Diseases\u00a01997 a\u00a0low\u00a0oral\u00a0dose\u00a0of\u00a0clindamycin\u00a0or\u00a0co\u2010trimoxazole Bearden\u00a0DT more\u00a0than\u00a0IBW 46 All Abbott\u00a0Healthcare\u00a0ProductsP\u00a0Ltd 41 Descriptor cSSTI*\u00a0without\u00a0S No\u00a0specific\u00a0advice\u00a0available\u00a0for\u00a0underweight\u00a0patients Obesity ertapenem TBW\u00a0x\u00a01 Personal\u00a0correspondence\u00a0with\u00a0Abbott Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manu LBW Titrate\u00a0dose\u00a0according\u00a0to\u00a0response Too\u00a0little\u00a0information\u00a0to\u00a0give\u00a0a\u00a0definitive\u00a0dose\u00a0recommendation\u00a0in\u00a0obese\u00a0patients Ideal\u00a0Body\u00a0Weight surge 5Hollenstein tissue Page\u00a0|\u00a027 Weig GlaxoSmithKline\u00a0Medicines\u00a0Information\u00a0department recommends\u00a0using\u00a0ABW\u00a0for\u00a0dose\u00a0calculation Rakesh\u00a0Kishore\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infir y\u00a0ill\u00a0patients while net the\u00a0dosing\u00a0information\u00a0for\u00a0mo that\u00a0the\u00a0efficacy\u00a0of\u00a0Metronidazole\u00a0was\u00a0similar\u00a0among\u00a0different\u00a0BMI\u00a0cate +4 Ideal\u00a0body\u00a0weight\u00a0+\u00a00 Papasavas\u00a0P\u00a0K uk\u00a012th\u00a0March\u00a02013 adjustment\u00a0for\u00a0renal\u00a0impairment without Ruth\u00a0Forrest\u00a0of\u00a0the\u00a0Western\u00a0Infirm Current\u00a0Opinions\u00a0in\u00a0Infectious\u00a0Diseases state ary as Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins\u00a0taking\u00a0into ly\u00a0approximate clearance least\u00a0the\u00a0reappearance\u00a0of\u00a0T2\u00a0following\u00a0rocuronium patient :3240 Dexmedetomidine on\u00a0patient\u00a0weight remains Lisco\u00a0S As\u00a0above However\u00a0complications\u00a0of\u00a0obesity of\u00a01 Antimicrobial\u00a0Dosing twice Rodvold\u00a0K supratherapeutic morbidly licable See\u00a0benzylpeniclli :\u00a0MIC\u00a0ratio Continuous\u00a0versus\u00a0intermitte dependent No\u00a0specific\u00a0information\u00a0on\u00a0underweight\u00a0patients\u00a0however nt\u00a0infusions\u00a0of\u00a0antibiotics Both\u00a0groups\u00a0of\u00a0patient\u00a0will\u00a0require\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0to\u00a0ensure\u00a0maintenance\u00a0dose monitoring critically /Comments Dosage eed Page\u00a0|\u00a022 improved normal\u2010weight ataxia\u00a0and\u00a0slight\u00a0disorientation 25 Publishing Senior\u00a0Clinical\u00a0Pharmacist substitute cm Wurz\u00a0R 600mg I\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and neous Page\u00a0|\u00a020 basis This\u00a0docum reported process The\u00a0aggressive\u00a0pharmacodynamic\u00a0targets\u00a0chosen\u00a0for\u00a0this\u00a0study\u00a0appeared\u00a0to\u00a0ha Due\u00a0to\u00a0the\u00a0shor upper western Page\u00a0|\u00a021 standar desired pneumocystis CCPN\u00a0literature\u00a0review\u00a0and\u00a0recommendations\u00a0from\u00a0Clinical\u00a0guidelines\u00a0for Usual\u00a0reco ans\u00a0up\u00a0to\u00a01200mg/day\u00a0in\u00a0divided\u00a0doses Diflucan\u00ae on\u00a0metabolism\u00a0and\u00a0on\u00a0drug\u00a0handling 33\u00a0x tall\u00a0thin\u00a0people\u00a0or\u00a0muscular\u00a0people route Pharmacokinetics\u00a0of 2005 with\u00a0cellulitis\u00a0and\u00a0cutaneous\u00a0abscess Senior\u00a0Pharmacist\u00a0Southern\u00a0General 2011 Summary\u00a0of\u00a0SAC Van\u00a0Lancker\u00a0P decisions Oxford\u00a02009 Merck\u00a0Sharp\u00a0and\u00a0Dohme\u00a0Ltd patient\u2019s http://www TBW Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0Accessed\u00a0at Particularly\u00a0at\u00a0high\u00a0doses\u00a0although\u00a0there\u00a0is\u00a0limited\u00a0information orption Dosing\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook health factor al eight Introduction\u00a0to\u00a01 would Carey\u00a0JC However\u00a0they pneumonia adequate\u00a0drug\u00a0exposure\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0organisms\u00a0with\u00a0a\u00a0minimum\u00a0inhibitory\u00a0concentration Diane\u00a0Kennedy\u00a0of\u00a0Ayr\u00a0Hospital May\u00a02013 Van saying in\u00a0Obese\u00a0patients xtrem keith Susan\u00a0Hughes\u00a0of\u00a0Crosshouse\u00a0Hospital No\u00a0adv Underweight\u00a0patients wound achie liffe\u00a0Publishing ne\u00a0by\u00a0Janson\u00a0and\u00a0Thursky3 cefamandole Tejani\u00a0AM\u00a0et\u00a0al ventilatory\u00a0parameters commence 14 Paper st Antimicrobial\u00a0Agents\u00a0and\u00a0Chemotherapy\u00a02013 so edited\u00a0for\u00a0Scotland Suggest\u00a0higher\u00a0doses\u00a0of\u00a0piperacillin/tazobactam\u00a04 152 equations Summary/Comm 54 Summary\u00a0of\u00a0Product\u00a0Characteri identified study 5g\u00a0every\u00a08\u00a0hrs lean as\u00a0required and\u00a04mg/ml\u00a0were\u00a078 45: blockade Clinical\u00a0Infectious Standard\u00a0therapeutic\u00a0dosage:\u00a01g\u00a0once\u00a0daily of There\u00a0is\u00a0little\u00a0information\u00a0about\u00a0dosing\u00a0adjustments\u00a0in\u00a0significantly\u00a0underweight Summary\u00a0of\u00a0SA 65kg\u00a0person\u00a0depending\u00a0on\u00a0infection 285 Obese\u00a0patients\u00a0may\u00a0benefit\u00a0from\u00a0increased\u00a0dosing\u00a0for\u00a0the\u00a0loading\u00a0dose\u00a0using\u00a0a\u00a0weight\u00a0of showed divided but\u00a0gives\u00a0an\u00a0indication\u00a0of\u00a0the\u00a0patient\u2019s Dose\u00a0reduction/caution\u00a0is\u00a0necessary\u00a0in\u00a0patients\u00a0with\u00a0severe\u00a0renal\u00a0impairment\u00a0ac anufacturer3 5g\u00a06\u00a0hrly clearance\u00a0and\u00a0elimination\u00a0half\u2010life\u00a0in bes\u00a0acute\u00a0kidney\u00a0injury\u00a0in\u00a0obese\u00a0patients\u00a0where\u00a0aciclovir\u00a0dose\u00a0was\u00a0based\u00a0on\u00a0actual\u00a0body per proposed Johnson\u00a0M 927 Janson\u00a0B Strep toxicity 112\u2010118 medicines Dosing\u00a0as\u00a0above hepatic trimethoprim decision Ltd\u00a04th\u00a0December\u00a02012 December\u00a016\u201019 make By\u00a0intravenous\u00a0infusion\u00a0500mg\u00a0every\u00a012\u00a0hours Vfend\u00ae after\u00a0a\u00a0750mg\u00a0intravenous\u00a0dose\u00a0every\u00a024hours Summary\u00a0of\u00a0\u00a0product\u00a0characteristics Doses\u00a0doubled\u00a0where\u00a0necessary is disagr Mean bod 90mg/kg Maximum\u00a0reported\u00a0dose with\u00a0normal\u00a0weight\u00a0patients Another\u00a0study\u00a0also\u00a0noted\u00a0that\u00a0Pharmacokinetic\u00a0parameters\u00a0in\u00a0pregnant\u00a0patients\u00a0were\u00a0not\u00a0significantly found Summary\u00a0of\u00a0SACCPN\u00a0literature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufactu terature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer3 recommendation 212 ce timate\u00a0the\u00a0fractional Page\u00a0|\u00a08 piperacillin/tazobactam Underweight\u00a0patien manufacturer: ese\u00a0patients 0\u00a0x\u00a0TBW TBW\u00a0x\u00a00 extremities intraven Page\u00a0|\u00a045 Antimicrobial are the\u00a0treatment\u00a0of\u00a0trichomoniasis No\u00a0additional\u00a0information\u00a0supplied\u00a0from\u00a0the\u00a0SPC monly that Dumfries\u00a0and\u00a0Galloway\u00a0Royal\u00a0Infirmary Current\u00a0Opinion\u00a0Infectious\u00a0Disease ts 25:1 No\u00a0information\u00a0available\u00a0\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepati plus with\u00a0the Evaluation\u00a0of\u00a0the\u00a0effect\u00a0of\u00a0obesity\u00a0on\u00a0voriconazole\u00a0serum\u00a0concentrations Suppl\u00a01 The\u00a0recommended\u00a0dose\u00a0for Ambisome\u00ae Analysis Severe editions Dvorchick\u00a0et\u00a0al\u00a0suggest\u00a0use\u00a0of\u00a0total\u00a0body\u00a0weight\u00a0for\u00a0calculation\u00a0of\u00a0doses\u00a0is\u00a0appropriate\u00a0based\u00a0on\u00a0total Accessed cuta They\u00a0also\u00a0noted No\u00a0data\u00a0available\u00a0on\u00a0any\u00a0dose\u00a0adjustment\u00a0required\u00a0in\u00a0low\u00a0body\u00a0weight P=0 particularly Grau\u00a0S intravenous\u00a0loading\u00a0dose\u00a0of\u00a020mg/kg\u00a0up\u00a0to\u00a0a\u00a0maximum\u00a0dose\u00a0of\u00a02g increasingly Male= gov/ct2/show/record/NCT01517815\u00a0accessed\u00a011th\u00a0April\u00a02013 131 serum uk\u00a0\u00a08th\u00a0April\u00a02013 ice\u00a0on\u00a0obese\u00a0patients initial\u00a0infusion\u00a0rate\u00a0of has\u00a0no\u00a0influence 2\u00a0to\u00a01 mmended\u00a0dose\u00a0is\u00a04 doubled function 25:634\u2010649 Calc 3% One\u00a0review\u00a0recommends\u00a0that\u00a0for\u00a0penicillins\u00a0dosing\u00a0should\u00a0be\u00a0at\u00a0the\u00a0higher\u00a0end Keith 2012 Scottish No\u00a0specific\u00a0advice\u00a0on\u00a0underweight\u00a0or\u00a0obese\u00a0patients appear after\u00a0first\u00a024\u00a0hours trial No\u00a0information\u00a0available\u00a0in\u00a0dosing\u00a0in\u00a0underweight\u00a0patients 5\u00a0if\u00a0male and\u00a0Del\u00a0Tacca skin A\u00a0dose\u00a0of\u00a04\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended\u00a0if\u00a0recovery\u00a0has\u00a0reached Antimicrob\u00a0Chemother\u00a02012 2g\u00a0in\u00a0two with ofloxacin\u00a0disposition\u00a0in\u00a0obesity comparing weight a\u00a0dosage\u00a0decrease\u00a0was\u00a0required Drug\u00a0Dosing\u00a0Information A\u00a0dose\u00a0of\u00a02\u00a0mg/kg\u00a0sugammadex\u00a0is\u00a0recommended Page\u00a0|\u00a028 has uct\u00a0Characteristics :1023\u20101026 available ons using\u00a0Ideal\u00a0Body\u00a0Weight\u00a0in\u00a0obese\u00a0patients\u00a0taking\u00a0renal\u00a0function\u00a0in group s* aureus Tishier\u00a0D\u00a0S enance\u00a0dose\u00a05\u00a0mg/kg\u00a0daily Review ise\u00a0within\u00a0the\u00a0dose\u00a0range\u00a00 ratio 48 Daptomycin actual ently Klebanoff\u00a0MA Page\u00a0|\u00a035 Meronem\u00ae orations inetics\u00a0in\u00a0critically\u00a0ill\u00a0patients:\u00a0A\u00a0prospective Flucloxacillin susceptible tion included\u00a0some\u00a0of\u00a0the\u00a0commonly\u00a0used\u00a0medicines\u00a0used\u00a0within\u00a0critical\u00a0care\u00a0areas oxacillin UK infusion The\u00a0effect\u00a0of\u00a0body\u00a0m Drusano\u00a0GL if Tazocin\u00ae Patients\u00a0less\u00a0than 13 concentrations\u00a0in\u00a032%\u00a0of\u00a0patients\u00a0and\u00a0overdosed\u00a0serum\u00a0concentrations\u00a0in\u00a025% Summary\u00a0of\u00a0Prod Pat corp Doses\u00a0of\u00a0<10mg/24\u00a0hours\u00a0have\u00a0demonstrated\u00a0worse\u00a0outcomes\u00a0in\u00a0obese\u00a0patients mary Mycoses\u00a054 BiaxinTM\u00a0US\u00a0Product\u00a0Information 112 Neurol\u00a01985 http://clinicaltrials accepted\u00a0for\u00a0any\u00a0inaccuracies\u00a0or\u00a0misstatements\u00a0of\u00a0fact\u00a0contained\u00a0herein or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook unless\u00a0the\u00a0sodium\u00a0content\u00a0is\u00a0taken\u00a0into\u00a0account Crystapen\u00ae outcomes supported C\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook concentration pharmacokinetics Summary\u00a0of\u00a0product\u00a0characteristics\u00a0Ceftr 4mg/kg 24 facturer 8:189\u2010194 contained\u00a0in\u00a0the\u00a0document\u00a0can\u00a0be\u00a0kept\u00a0up\u00a0to\u00a0date intravenous\u00a0antibiotics\u00a0to\u00a0traditional\u00a0intermittent Alan\u00a0Timmins ication Calculation\u00a0of\u00a0creatinine\u00a0clearance\u00a0using\u00a0the\u00a0Cockcroft\u00a0&\u00a0Gault Purkin\u00a0et\u00a0al\u00a0Antimicrob\u00a0Agents\u00a0Chemother\u00a02002 some CMax\u00a058%\u00a0and\u00a0AUC relates for\u00a0adults 600mg\u00a0twice\u00a0daily\u00a0was\u00a0sufficient\u00a0for\u00a0the\u00a0treatment\u00a0of\u00a0skin\u00a0and\u00a0soft This\u00a0patient\u00a0was\u00a0excluded\u00a0from\u00a0the\u00a0summary\u00a0statistics Accessed\u00a0at\u00a0\u00a0www Aspen\u00a0Global Very\u00a0obese\u00a0individuals\u00a0will\u00a0require\u00a0large\u00a0absolute\u00a0loading\u00a0doses\u00a0of\u00a0phenytoin\u00a0to Am\u00a0L\u00a0Perinatol\u00a02008 determination\u00a0of\u00a0loading\u00a0dose 2\u20104g th iaxone 3rd\u00a0edition available\u00a0from\u00a0manufacturer patients 10\u201015\u00a0mg/kg Page\u00a0|\u00a044 however\u00a0a\u00a02013 439\u2010447 underweight\u00a0or\u00a0obese\u00a0patients limited higher Page\u00a0|\u00a06 2\u20109 Roberts\u00a0MS\u00a0et\u00a0al ents\u00a040kg\u00a0and 40kg* is\u00a0obtained\u00a0from\u00a0statistical\u00a0tables\u00a0relating\u00a0to seen No\u00a0information\u00a0found\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients le\u00a0case\u00a0report\u00a0of\u00a0an\u00a0obese\u00a0patient\u00a0with\u00a0nonmeningeal\u00a0cryptococcal\u00a0infection\u00a0successfully or\u00a0may\u00a0increase\u00a0it2\u00a0The\u00a0latter\u00a0paper\u00a0provides\u00a0a\u00a0review\u00a0of\u00a0the\u00a0effects\u00a0of\u00a0obesity Nafziger\u00a0AN authors As Weight Wolff\u00a0F\u00a0et\u00a0al Personal\u00a0communication We\u00a0hope\u00a0that\u00a0you ight\u00a0in\u00a0anidulafungin\u00a0group\u00a0ranged\u00a0from\u00a035\u00a0kg\u00a0to\u00a0196 Agents\u00a0and\u00a0Chemotherapy\u00a02006 Cochrane recommends However\u00a0the\u00a0adipose\u00a0tissue\u00a0does\u00a0have\u00a0some\u00a0vasculature Brown\u00a0J guidance centres edition 18 which\u00a0can\u00a0cause\u00a0confusion\u00a0with\u00a0the\u00a0Adjusted\u00a0Body\u00a0W information maintain Acc provide made Clinical\u00a0guidelines\u00a0for\u00a0immunoglobulin\u00a0use noted e\u00a0daily\u00a0by\u00a0the\u00a0intravenous Claire\u00a0McMaster\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital body\u00a0weight can Chen\u00a0M Adjusted\u00a0Body\u00a0Weight er bgroup\u00a0analysis\u00a0demonstrated\u00a0that\u00a0morbidly\u00a0obese\u00a0patients\u00a0were\u00a0at\u00a0a\u00a0higher\u00a0risk\u00a0of\u00a0clinical Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug on pharmacokinetic Yost\u00a0et\u00a0al\u00a0assessed\u00a0plasma\u00a0levels\u00a0after\u00a0intravenous\u00a0administration\u00a0of\u00a0cefotaxime\u00a0in\u00a0normal\u00a0weight\u00a0and Fluconazole\u00a0serum\u00a0concentrations\u00a0and 100mg\u00a0twice\u00a0daily administered\u00a0at\u00a0750\u00a0milligrams\u00a0in\u00a0obese\u00a0adults Page\u00a0|\u00a05 Ciprofloxacin\u00a0pharmacok ukcpa Senior\u00a0Pharmacist\u00a0Western\u00a0General\u00a0Hospital\u00a0Edinburgh treatment\u00a0ranges taking\u00a0into\u00a0account\u00a0renal\u00a0and\u00a0hepatic\u00a0function\u00a0as\u00a0above Page\u00a0|\u00a010 lack 75 12g ure normally\u00a0as\u00a0a\u00a0once\u00a0daily\u00a0dose Pieracci\u00a0FM Disposition\u00a0of\u00a0Cefotaxime\u00a0and\u00a0its\u00a0Desacetyl\u00a0Metabolite\u00a0in\u00a0Morbidly\u00a0Obese McConnell\u00a0DB\u00a0et\u00a0al and\u00a0little\u00a0observed\u00a0toxicity d\u00a0literature\u00a0from\u00a0manufacturer Mastrobattista\u00a0JM expected 30:18\u201032 BMI>35kg/m2 regimens\u00a0based\u00a0on\u00a0the\u00a0correction\u00a0formula\u00a0only\u00a0slightly Itozaku\u00a0G bacteraemia Antimicrobial\u00a0dosing\u00a0in\u00a0obese\u00a0patients <10mg/kg No\u00a0information\u00a0available\u00a0relating\u00a0to\u00a0dosing\u00a0of\u00a0ertapenem\u00a0in\u00a0underweight\u00a0patients Appropriate\u00a0to\u00a0dose\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0ensuring\u00a0appropriate\u00a0monitoring\u00a0for\u00a0toxicity\u00a0and\u00a0dose rmation\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients Drug\u00a0Dosing\u00a0in\u00a0Extremes\u00a0of\u00a0Body\u00a0Weight\u00a0in\u00a0critically\u00a0ill\u00a0patients *DWCF\u00a0=\u00a0Dose\u00a0Weight\u00a0Correction\u00a0Factor In\u00a050\u00a0%\u00a0of\u00a0patients\u00a0a\u00a0dose\u00a0increase\u00a0was\u00a0required\u00a0to\u00a0attain\u00a0concentration\u00a0targets\u00a0whilst\u00a0in\u00a024%\u00a0of\u00a0patients ide We\u00a0would\u00a0like\u00a0to\u00a0acknowledge\u00a0the\u00a0contribu BNF\u00a0for\u00a0Children\u00a0March\u00a02013\u00a0accessed\u00a0o concentrations\u00a0but\u00a0had\u00a0no\u00a0impact\u00a0on\u00a0adequacy\u00a0of\u00a0treatment so\u00a0are\u00a0in\u00a0theory\u00a0are\u00a0good\u00a0models\u00a0for\u00a0drugs\u00a0that\u00a0are\u00a0highly\u00a0hydro rep and\u00a0relevant\u00a0to\u00a0clinical\u00a0practice Page\u00a0|\u00a019 Antifungal\u00a0dosing\u00a0in\u00a0obesity:\u00a0A\u00a0review\u00a0of\u00a0the\u00a0literature uk\u00a012th\u00a0July\u00a02013 Invanz\u00ae both\u00a0IV\u00a0and\u00a0oral Characteristics\u00a0Accessed\u00a0\u00a0at Paisley 0\u00a0mg/kg\u00a0of\u00a0body\u00a0weight muscle\u00a0mass\u00a0is\u00a0proportionately\u00a0much\u00a0less\u00a0in\u00a0obese\u00a0patients clinical\u00a0trial overdosages vels\u00a0are\u00a0obtained =\u00a0\u221a erefore\u00a0it\u00a0was\u00a0thought Female= adequate\u00a0concentrations no\u00a0da 20 Maximum\u00a0Body\u00a0Weight Radcliffe reality\u00a0dosing\u00a0based\u00a0on\u00a0TBW\u00a0is\u00a0more\u00a0dependable produced ves mation\u00a0more\u00a0readily recommend\u00a0adjusting\u00a0the\u00a0dose\u00a0of\u00a0anidulafungin\u00a0based\u00a0on\u00a0body\u00a0weight\u00a0in\u00a0adult\u00a0patients especially using\u00a0IBW\u00a0+ Antimicrobial\u00a0agents\u00a0and\u00a0chemotherapy\u00a02007 but\u00a0there\u00a0is\u00a0currently RIE**\u00a0or\u00a0cSSTI\u00a0associated\u00a0with\u00a0S ospital order\u00a0to\u00a0achieve\u00a0the\u00a0same\u00a0tissue\u00a0concentrations\u00a0as\u00a0those\u00a0achieved\u00a0in\u00a0lean\u00a0subjects\u00a0although mg/kg\u00a0dosing\u00a0can\u00a0be\u00a0used\u00a0as\u00a0above 90 m\u00a0dosing\u00a0regimen\u00a0for\u00a0obese\u00a0patients uk\u00a027th\u00a0June\u00a02013 6\u00a0mg/kg\u00a0once\u00a0daily compared when\u00a0prescribing\u00a0ertapenem 44 non Allard\u00a0S\u00a0et\u00a0al =\u00a045 given\u00a0onc administered\u00a0to\u00a0normal\u00a0weight Loading\u00a0dose Dosing\u00a0weight\u00a0=\u00a0Ideal\u00a0body\u00a0weight\u00a0+ st\u00a0drugs\u00a0is\u00a0generally ccessed\u00a0at\u00a0www Summary\u00a0of\u00a0Produc Jarrett\u00a0R On\u00a0behalf\u00a0of\u00a0the\u00a0Scottish\u00a0Adult\u00a0Critical\u00a0Care\u00a0Pharmacists\u00a0Network filtration a\u00a0pharmacodynamic\u00a0target\u00a0of\u00a0100% ne\u00a0240kg\u00a0patient\u00a0who\u00a0was\u00a0given\u00a0a\u00a0150mg\u00a0daily\u00a0maintenance\u00a0dose literat Dose Dexdor\u00ae 67:2957\u20102692 Dosing\u00a0based\u00a0on Keith\u00a0Addie there\u00a0is\u00a0an\u00a0assumption\u00a0that\u00a0the\u00a0Excess\u00a0Body\u00a0Weight 23 following\u00a0weight\u2010adjusted\u00a0dosing Page\u00a0|\u00a011 alan body\u00a0weights\u00a0up\u00a0to\u00a0approximately\u00a0150kg\u00a0should\u00a0provide\u00a0AUC\u00a0values\u00a0similar\u00a0to\u00a0those\u00a0seen\u00a0in\u00a0non particularly\u00a0in\u00a0morbidly\u00a0obese\u00a0patients\u00a0with\u00a0more tions Micromedex and\u00a0by\u00a0anecdotal\u00a0experience\u00a0of\u00a0pharmacists\u00a0working\u00a0within\u00a0critical\u00a0car as\u00a0does\u00a0the\u00a0o The\u00a0patient\u00a0had\u00a0global\u00a0treatment\u00a0success Ed with\u00a0resulting\u00a0symptoms\u00a0limited\u00a0to\u00a0vomiting sive\u00a0care\u00a0unit\u00a0setting Gilead severe Licensed\u00a0dose\u00a0in 30 Yet Page\u00a0|\u00a02 rred\u00a0to\u00a0as\u00a0the\u00a0Actual Due\u00a0to\u00a0variable\u00a0alterations\u00a0in\u00a0the\u00a0volume\u00a0of\u00a0distribution Halovic *Refers\u00a0to\u00a0patients\u00a0aged\u00a015\u00a0years\u00a0and\u00a0older studies ccessed\u00a0\u00a0at ww clinical In\u00a0a\u00a0compassionate\u00a0use\u00a0programme\u00a0of\u00a0adult\u00a0patients calculated cific\u00a0information\u00a0available Additional\u00a0Information\u00a0\u2010\u00a0Cefalosporins gents\u00a0Chemother Radcliffe\u00a0publishing average meta\u2010analysis becoming aracteristics Bogaert\u00a0T\u00a0et\u00a0al Summary\u00a0of\u00a0SACCPN\u00a0li 25:\u00a0112\u20108 and\u00a0the\u00a0authors\u00a0trust\u00a0that\u00a0the\u00a0information\u00a0provided\u00a0wil weight\u00a0in A\u00a0daily\u00a0dose\u00a0of\u00a08mg/kg\u00a0should\u00a0not\u00a0be\u00a0exceeded\u00a0in\u00a0patients\u00a0with\u00a0impaired\u00a0liver\u00a0function to\u00a03 mass A\u00a0single\u00a0200\u00a0mg\u00a0loading\u00a0dose\u00a0should\u00a0be\u00a0administered\u00a0on cute\u00a0infections\u00a0960mg\u00a0every\u00a012\u00a0hours Phenytoin ho The\u00a0renal\u00a0drug an the\u00a0higher\u00a0end\u00a0of\u00a0the\u00a0recommended Strong Morag\u00a0Naysmith Dose\u00a0as\u00a0per\u00a0SPC\u00a0on\u00a0mg/kg\u00a0basis receivin staphylococci Lean\u00a0Body\u00a0Weight &\u00a0Currie time\u00a0curve\u00a0was\u00a0significantly\u00a0higher\u00a0in\u00a0normal\u00a0we times 200mg\u00a0twice\u00a0daily therapy Radc 7th adjustm IBW for\u00a0any\u00a0patient\u00a0or 002 Pharmacological clinical\u00a0judgement 6%\u00a0and\u00a049 results Abbott\u00a0Laboratories 51 er\u00a02012 Page\u00a0|\u00a030 0242 certain taken Several\u00a0references\u00a0suggest\u00a0that\u00a0bone\u00a0marrow\u00a0related\u00a0toxicity\u00a0was\u00a0linked\u00a0to\u00a0the\u00a0cumulative\u00a0dose 1144\u201049 Body\u00a0W micromedexsolutions 3\u00a0x beta as\u00a0relevant 25:\u00a0634\u2010649 Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment\u00a0as\u00a0per\u00a0SPC/renal\u00a0drug\u00a0handbook taking accept\u00a0that\u00a0this\u00a0may\u00a0lead\u00a0to\u00a0an\u00a0increased\u00a0risk\u00a0of\u00a0adverse\u00a0effect 23rd\u00a0November\u00a02012 600mg\u00a0to\u00a03600mg\u00a0daily Page\u00a0|\u00a09 r\u00a0SPC\u00a0or\u00a0refer\u00a0to\u00a0renal\u00a0drug\u00a0handbook An An\u00a0Updated\u00a0Critical\u00a0Review a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0i Slight Pharmacists\u00a0Network 4\u00a0is height carried outcomes\u00a0which\u00a0may\u00a0occur\u00a0as\u00a0a\u00a0result\u00a0of\u00a0referring\u00a0to\u00a0information\u00a0contained\u00a0within\u00a0this\u00a0document pathogen com/pdf/biapi Peter\u00a0Buckner\u00a0of\u00a0Forth\u00a0Valley\u00a0Royal\u00a0Hos Fat\u00a0Free\u00a0Mass Dosage\u00a0in\u00a0adults:\u00a05mg/kg\u00a0every\u00a08\u00a0hours\u00a0or\u00a010mg/kg\u00a0in\u00a0immuno DDW cystic as\u00a0above obtained El\u00a0Sohl\u00a0AA suggest\u00a0mg/kg\u00a0dosing\u00a0as\u00a0above Ruiz\u2010Irastorza\u00a0G No Acinebac increased\u00a0serum\u00a0drug st\u00a0\u00a0Edition Tigecycline\u00a0has The\u00a0conclusion\u00a0was\u00a0that\u00a0the\u00a0fluconazole\u00a0dose\u00a0should\u00a0be\u00a0based\u00a0on\u00a0the body\u00a0mass\u00a0in\u00a0clinical\u00a0trials\u00a0=\u00a080 Pai\u00a0MP No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0these\u00a0patients added\u00a0to\u00a0give\u00a0adjusted\u00a0body\u00a0weight renal ME 368\u2010373 Alison\u00a0Bell we increased\u00a0fluconazole\u00a0clearance Page\u00a0|\u00a024 Patricia\u00a0Nicholas\u00a0of\u00a0the\u00a0Golden\u00a0Jubilee\u00a0National\u00a0Hospital sed retrospective BMI\u00a0>40\u00a0were\u00a0risk\u00a0factors\u00a0for\u00a0treatment\u00a0failure\u00a0in\u00a0patients\u00a0treated\u00a0with\u00a0co\u2010trimoxazole\u00a0and Risk\u00a0factors\u00a0for\u00a0clinical\u00a0failure\u00a0in\u00a0patients\u00a0hospitalise Caution\u00a0is\u00a0advised\u00a0in\u00a0the\u00a0elderly 9270\u00a0x\u00a0TBW Maximum\u00a0Body\u00a0We ABW hospitalised distribution Hurford\u00a0W Mann\u00a0et\u00a0al\u00a0assessed\u00a0subcutaneous\u00a0adipose\u00a0tissue\u00a0concentrations or\u00a0vecuronium\u00a0induced\u00a0blockade 2` Metronidazole\u00a0monograph replies bacterial\u00a0vaginosis ter\u00a0spp\u00a0and\u00a0Pseudomonas\u00a0aeruginosa good Ciprofloxacin Summary\u00a0of\u00a0Product\u00a0Characteristics\u00a0\u00a0\u00a0Acces Summary\u00a0of\u00a0SACC so\u00a0may\u00a0negate\u00a0this BSA Loading\u00a0dose\u00a0regimen\u00a06mg/kg\u00a0every\u00a012\u00a0hours\u00a0for\u00a024\u00a0hours\u00a0then\u00a04mg/kg\u00a0every\u00a012\u00a0hours ht\u00a0patients weigh in\u00a0adult\u00a0patients\u00a0given important\u00a0to\u00a0administer\u00a0an\u00a0optimal\u00a0dose\u00a0of\u00a0a\u00a0drug\u00a0to\u00a0ensure\u00a0therapeutic\u00a0le recurrence bd Greenock Australia Summary/ rate Malacarne Radcl 6kg :2546\u20102553 Clydebank tds as\u00a0per\u00a0SPC America\u00a0and\u00a0the\u00a0UK\u00a0use\u00a0the\u00a0equations\u00a0below:\u00a0Note\u00a0this\u00a0is\u00a0different\u00a0from\u00a0the\u00a0equations\u00a0shown\u00a0on\u00a0p4 Local morbidly\u00a0obese\u00a0patients Orion\u00a0Pharm appropriate Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0as\u00a0per\u00a0SP Dillmans\u00a0B dosing 35 excess\u00a0weight\u00a0over\u00a0IBW therapeutic were replacement GlaxoSmithKline\u00a0Ltd Soft\u00a0tissue\u00a0concentrations\u00a0of\u00a0ciprofloxacin\u00a0in\u00a0obese\u00a0and\u00a0lean\u00a0subjects ill\u00a0patients:\u00a0proof\u00a0of\u00a0concept nor Anderson\u00a0T\u00a0et\u00a0al glomerular 5:83\u201091 et\u00a0al Phase\u00a03\u00a0data\u00a0showed\u00a0we in\u00a0criticall Suggest\u00a0dosing\u00a0at\u00a0top\u00a0end\u00a0of\u00a0licensed\u00a0dose\u00a0in\u00a0obese\u00a0patients\u00a0for\u00a0ceftriaxone/\u00a0cefalosporins Linezolid \u201056 followed\u00a0by\u00a0oral\u00a0fluconazole Obes morbidly\u00a0obese\u00a0and\u00a0matched\u00a0non\u00a0obese\u00a0subjects drug\u00a0handbook No\u00a0information\u00a0available\u00a0for\u00a0dosing\u00a0in\u00a0underweight\u00a0patients usually 5g\u00a0every\u00a06\u00a0hrs 1st\u00a0Edition report obese\u00a0and\u00a0extremely\u00a0obese\u00a0adults theory BMI>40 but outcom practice lipophilic ideal\u00a0body\u00a0weight\u00a0where\u00a0dose\u00a0was\u00a0increased\u00a0in\u00a0proportion\u00a0to did most\u00a0common\u00a0antibiotics\u00a0prescribed\u00a0to\u00a0patients\u00a0for\u00a0this\u00a0indication\u00a0in\u00a0this\u00a0study Br\u00a0J\u00a0Clin\u00a0Pharmacol\u00a02003 Morna\u00a0Ball\u00a0of\u00a0Glasgow\u00a0Royal\u00a0Infirmary nor\u00a0for\u00a0any\u00a0patient\u00a0or\u00a0clinical Tygacil\u00ae inetics\u00a0of\u00a0intravenous\u00a0levofloxacin tion\u00a0of\u00a0the\u00a0following\u00a0pharmacists\u00a0to\u00a0the\u00a0production\u00a0of\u00a0this approximately they\u00a0provide\u00a0a\u00a0number\u00a0of\u00a0references manufacturer Underwei of\u00a0piperacillin No\u00a0dosage\u00a0adjustments\u00a0out\u00a0with\u00a0licensed\u00a0dose\u00a0\u00a0can\u00a0be\u00a0recommended\u00a0in\u00a0either\u00a0underweight\u00a0or Suggest\u00a0discussing\u00a0with\u00a0local\u00a0microbiology\u00a0or\u00a0infectious\u00a0diseases\u00a0specialist world document: better Pharmacia\u00a0Ltd essed\u00a0via addie@ggc levofloxacin Dosing\u00a0of\u00a0Antibiotics\u00a0in\u00a0Obesity There Male\u00a0and\u00a0Female\u00a0Subjects Barie\u00a0PS Dosing Suppl\u00a0S2 Hollenstein\u00a0UM\u00a0et\u00a0al Nicolau\u00a0D\u00a0P\u00a0and\u00a0Kuti\u00a0J\u00a0L effect scot 29th\u00a0May\u00a02013 The\u00a0higher\u00a0dose\u00a0was\u00a0at =IBW\u00a0+\u00a020% Therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0\u00df\u2010Lactams\u00a0in\u00a0critically Suggest re\u00a0is\u00a0limited\u00a0e ous coagulase periences Phenytoin\u00a0disposition\u00a0in\u00a0obesity July\u00a02012 For\u00a0adult\u00a0patients\u00a0\u226440kg\u00a0a\u00a0dose\u00a0of\u00a010 the of\u00a0the\u00a0recommended International\u00a0Journal\u00a0of\u00a0Antimicrobial\u00a0Agents\u00a02010 Published\u00a0jointly\u00a0by\u00a0BMJ\u00a0Group guidelines cohort to Pfizer\u00a0Ltd Slain\u00a0D max Akinnusi to\u00a0account equivalent\u00a0to\u00a012mg/kg\u00a0in\u00a0a Adult\u00a0patients\u00a0\u226440kg\u00a0received\u00a0a site\u00a0of\u00a0the\u00a0infection non\u2010obese per\u00a0SPC\u00a0on\u00a0a\u00a0mg/kg\u00a0basis consider mg/kg\u00a0every\u00a012\u00a0hours this the\u00a0excess\u00a0in\u00a0body\u00a0weight4 Genus\u00a0Pharmaceuticals Maint SACCPN nhs Wt Ra timmins@nhs Hites\u00a0et\u00a0al\u00a0attempted\u00a0to\u00a0validate\u00a0the\u00a0use\u00a0of\u00a0the\u00a0formula\u00a0by\u00a0carrying\u00a0out\u00a0a\u00a0therap MBW but\u00a0a\u00a0value\u00a0of\u00a00 ients AUC\u00a0values\u00a0in\u00a0morbidly\u00a0obese\u00a0subjects\u00a0than\u00a0in\u00a0normal\u00a0weight\u00a0subjects\u00a0with\u00a0similar\u00a0creatinine\u00a0clearance Underweigh 1\u00a0gram since work Page\u00a0|\u00a04 55 to\u00a0allow Derendorf\u00a0H urs often pdf <5mg/kg Intravenous J\u00a0Antimicrob\u00a0Chemother at\u00a0dosing\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0is\u00a0appropriate\u00a0as\u00a0dosing\u00a0based\u00a0on\u00a0IBW\u00a0may\u00a0fail\u00a0to\u00a0reach Rifampicin high mg/kg\u00a0dosing\u00a0range\u00a0based\u00a0on\u00a0total\u00a0body\u00a0weight\u00a0based\u00a0on\u00a0this\u00a0single\u00a0study a\u00a0mg/kg\u00a0basis vid AdjBW will and\u00a0some\u00a0fluid 25:233\u2010237 37 standard Ciproxin\u00ae\u00a0\u00a0Bayer mortality\u00a0in\u00a0ICU1 ed\u00a0a\u00a0200mg\u00a0loading\u00a0dose\u00a0on\u00a0Day\u00a01\u00a0followed\u00a0by\u00a0100mg\u00a0maintenance\u00a0dose\u00a0daily It\u00a0is\u00a0also\u00a0recommended\u00a0that nction 0\u00a0mg/kg Therapeutic\u00a0Drug\u00a0Monitoring1986 receiving March\u00a02013\u00a057 or\u00a0Alan\u00a0Timmins careful Contents There\u00a0is\u00a0a\u00a0sing Clin\u00a0Pharmacol\u00a0Ther\u00a01993 provide\u00a0minimum\u00a0inhibitory\u00a0concentration\u00a0in\u00a090%\u00a0of\u00a0strains\u00a0tested In\u00a0the\u00a0obese\u00a0population\u00a0use\u00a0of\u00a0standard\u00a0dosages\u00a0of\u00a0beta\u00a0lactam\u00a0antib insufficiency consequ Fat\u00a0Free\u00a0Mass\u00a0and\u00a0Predicted\u00a0Normal\u00a0Weight\u00a0take\u00a0into\u00a0account\u00a0the Pharmacotherapy\u00a01995 V\u00a01 common\u00a0in\u00a0critically\u00a0ill\u00a0patients The\u00a0only\u00a0documen IV Luque\u00a0S Page\u00a0|\u00a025 15 context connection Janson\u00a0B\u00a0and\u00a0Thursky\u00a0K Shiu\u00a0J Curr\u00a0Fungal\u00a0Infect concentrations Personal\u00a0Communication\u00a0Pfizer\u00a0Medical\u00a0Information\u00a021st\u00a0January\u00a02013 No\u00a0information\u00a0on\u00a0dosing\u00a0in\u00a0underweight\u00a0patients tissue\u00a0infections\u00a0in\u00a0obese considerably effort Many\u00a0Thanks Email\u00a0received any Kilmarnock up 50 5\u00a0+ ufacturer bd\u00a0is\u00a0better\u00a0than\u00a0400mg\u00a0tds\u00a0as\u00a0this\u00a0improves include\u00a0more 40 cellulitis rmation e\u00a0in\u00a0Scotland Increased\u00a0dose relating stature volunteers no not\u00a0been\u00a0systematically\u00a0evaluated\u00a0for\u00a0safety\u00a0or\u00a0efficacy\u00a0in\u00a0extremes\u00a0of\u00a0body\u00a0weight Insufficient\u00a0information\u00a0available\u00a0to\u00a0make\u00a0a\u00a0recommendation Ashley\u00a0C Half\u2010life\u00a0is\u00a0dependent\u00a0on\u00a0renal\u00a0function 36:\u00a0\u00a0p151\u2010158 Drug\u00a0Intelligence\u00a0and\u00a0Clinical\u00a0Pharmacy\u00a01986 ill piperacillin\u00a0not\u00a0licensed\u00a0in\u00a0the mg/kg there Page\u00a0|\u00a012 Obese\u00a0patients Rocephin\u00aeRoche 11 been\u00a0used cutaneous fewer starting IBW\u00a0for\u00a0males The\u00a0renal :1653\u20104 infusions\u00a0of\u00a0antibiotics clear to\u00a0adjust\u00a0dosing\u00a0in\u00a0obesity nt\u00a0ranges +40% Chen :\u00a0944\u20106 either For\u00a0more\u00a0serious\u00a0infections\u00a0these\u00a0doses\u00a0may\u00a0have\u00a0to\u00a0be\u00a0increased Aguirre\u00a0C =\u00a0IBW\u00a0+\u00a00 years TBW\u00a0x\u00a0BMI\u00a0x\u00a00 edicines ous\u00a0abscess Pharmacokinetics\u00a0and\u00a0safety\u00a0of\u00a0voriconazole\u00a0following\u00a0intravenous\u00a0to\u00a0oral\u00a0dose\u00a0escalation depending\u00a0on\u00a0the\u00a0patient haematologic Dose\u00a0adjustments\u00a0for\u00a0renal\u00a0impairment\u00a0or\u00a0hepatic\u00a0impairment atient\u00a0weight\u00a0has\u00a0ranged\u00a0from\u00a034kg\u00a0to\u00a0200kg Koselke\u00a0et\u00a0al and\u00a0analysis\u00a0of\u00a0AUC\u00a0and\u00a0clearance\u00a0did\u00a0not s\u00a0o suicide infections be\u00a0used ledgments UKCPA: 8g\u00a0daily\u00a0\u00a0divided\u00a0doses Senior\u00a0Pharmacist No\u00a0information 74% Ambisome e\u00a0patients Use\u00a0actual for\u00a0organisms\u00a0with\u00a0an mg/kg\u00a0once\u00a0daily Orion\u00a0contacted Body\u00a0Weight Page\u00a0|\u00a043 account\u00a0when\u00a0interpreting\u00a0the\u00a0levels\u00a0if\u00a0total\u00a0phenytoin\u00a0is\u00a0measured\u00a0as\u00a0opposed\u00a0to\u00a0free guidan negative ensure Principal\u00a0Pharmacist Pfizer drug different\u00a0from\u00a0those 12 hydrophilic underweight No\u00a0spe Body\u00a0Surface\u00a0Area 216\u00a0x\u00a0BMI Chemotherapy BNF flucytosine 67:\u00a0682 2g\u00a03 patients\u00a0with\u00a0BMI\u00a0>35kg/m2\u00a0although\u00a0not\u00a0a\u00a0definitive\u00a0recommendation was Damphousse\u00a0D handbook\u00a0as\u00a0relevant initial performed therefore uk\u00a019th\u00a0July\u00a02013 Summary\u00a0of\u00a0product\u00a0characteristics prevalent adults Radcliffe\u00a0Publishing Halilovic\u00a0J by and\u00a0cutane association in\u00a0excess\u00a0of\u00a00 erature\u00a0review\u00a0and\u00a0literature\u00a0from\u00a0manufacturer Dosing\u00a0in\u00a0E Earle\u00a0SB PTC Predicted\u00a0Normal\u00a0Weight Advise\u00a0to\u00a0titrate\u00a0dose\u00a0according\u00a0to 20mg/kg Jennifer\u00a0Murphy\u00a0of\u00a0Wishaw\u00a0General\u00a0Hospital male /tazobactam\u00a0and\u00a0that\u00a0the\u00a0dose\u00a0should\u00a0be\u00a0reduced\u00a0in\u00a0low\u00a0body\u00a0weight\u00a0patients ents Roberts\u00a0et\u00a0al\u00a0assessed\u00a0therapeutic\u00a0drug\u00a0monitoring\u00a0of\u00a0beta\u00a0lactam\u00a0antibiotics Comparative\u00a0pharmacokinetics\u00a0and\u00a0pharmacodynamic\u00a0target This\u00a0value\u00a0has\u00a0been\u00a0found\u00a0to\u00a0be\u00a0useful\u00a0with\u00a0water\u2010soluble Personal\u00a0communication\u00a0with\u00a0\u00a0Roche\u00a0April\u00a02013 these\u00a0changes\u00a0had\u00a0little\u00a0effect\u00a0on\u00a0T>MIC Sabate\u00a0A\u00a0and\u00a0Llaurado\u00a0S it Antimicrobial\u00a0Agents\u00a0and Literature\u00a0descri Loading\u00a0Dose numb J\u00a0crit\u00a0care\u00a02008"
    },
    {
        "href": "criticalcare/Drugs/adrenaline.pdf",
        "title": "adrenaline",
        "content": "fluid Physically TE stable catheter Kristensen micrograms/ml volume Glucose Intranet:18/10/19 critically QIT ADMINISTRATION: 250ml nice KM 07/08/19 vasoconstriction required 500ml infused is micrograms/kg/min Trissel\u2019s Science through Remove Used nhs infusion 58 development chloride if Brustugun www or Document Also more Adrenaline Authoriser: below editorial anaphylaxis prepared Minimum 80mg via Lothian :296308 Peddicord 2019 5% hydrochloride Agents 1997 central Dec in Infuse asp Draft/Final:Final STANDARD rate concentration monitor 320micrograms/ml bnf vasodilation 010 not strength table Status and ml adrenaline USE 160mg 24 com norepinephrine Key light org Olsen Warner variable ONLY Single access established Closely See Compatibility 05/08/19 wales STABILITY: AND added phlebitis level hours Accessed Sympathomimetic Quadruple nitroglycerin Anne support Care DOSE use room PRESENTATION: Group Ampoules Authorisation mg temperature HH 80 Critical be NOTES: 9% CONCENTRATION: HealthSyst Words/comments 1mg/ml References Media micromedexsolutions Volumes 320 Do Stability The titrated Protect DJ PDA INDICATION: patients Title: which for IV Commonly INFUSION Medusa 160 Webb INTRAVENOUS but injection adrenaline/epinephrine Date: 160micrograms/ml Bronchospasm 2012 dose dopamine BNF Final Absence Am ID: Infusion FOR Authors: TL Version: Neally precipitate single Bisulfite depends Pharmaceutical containing ICU Presence large 40mg Photosensitivity venous Initially ADDITIONAL dextrose from degree 2004 with uk highconcentration Category: 54:14179 Double bag https://medusa uk/IVGuideDisplay of Comments Journal insertion at 06/03/19 vein has restricted Micromedex Technology equivalent Inotropic 2021 chemically 100ml peripheral Date group Tonnesen 20mg the guide UKCPA 8mg Strength Review ADRENALINE Pharm site sodium August to 17mls/hour discoloured glucose may Zumbrunnen ill on 80micrograms/ml until"
    },
    {
        "href": "criticalcare/Drugs/alfentanil.pdf",
        "title": "alfentanil",
        "content": "ventilation Physically Words stable medicines Summary QIT ADMINISTRATION: Ltd required is ALFENTANIL infusion initially Characteristics www or Document 5mg solution 2022 Draft/Final: 25mg Analgesia bolus In Intranet: in STANDARD rate assisted given Status Authoriser:Lothian Hannah and USE 24 Key org 15mg ONLY 22/04/20 endotracheal STABILITY: AND added according level hours tube Care DOSE toleration room alfentanil 50ml emc PRESENTATION: Ampoules Authorisation mg temperature 30ml Critical be 2020 CONCENTRATION: FINAL References titrated INDICATION: Title: for INFUSION 10ml undiluted Date: INTRAVENOUS injection doses ID: 500micrograms FOR Authors: Guidelines Version: 14mls/hour containing ICU administered April Initially uk Product 500micrograms2mg/hour Hameln Category: of Comments at 24/04/20 Claire chemically Alfentanil Date the 500micrograms/ml Review to Updated may on and/or Pharmaceuticals"
    },
    {
        "href": "criticalcare/Drugs/all IV drug infusion information.pdf",
        "title": "all IV drug infusion information",
        "content": "21mls/hr phosphate monitoring strengths 14mls/hr out 650 20microgram/ml Note 0120ml/hr Peripherally: ECG Insulin 1750mg BD 300mg 60minutes ml/hr 20micrograms/ml 25mg Phenytoin 56ml/hr protocol upon Fentanyl 020ml/hr Intermittant: correct discuss Please note hrs Usually 320micrograms/ml Rate arrest Catheter APTTr restriction further Issue 160mg therapy gluconate Nimodipine BP Single See 020mls/hr 024ml/hr donation protocols level least Mannitol 1000mg 150 1200mg 50ml maximum Dobutamine be 9% 70kg 1mg/ml DVT Electrolytes 1500mg previous adjusted Ketamine which for Information Prescribe 1000 injections response micrograms 160micrograms/ml INFORMATION raised 60mg 25mg/ml Infusion scales Neally Intermittent: pain 24ml/hr Initially 250units/ml 750mg Any September both 06ml/hr 40mg/kg acidosis Start of Phenylephrine at 50mg vein 40ml divided Centrally: Claire ICP Alfentanil emergency glycaemic 20mg Sodium hour Use Potassium 500micrograms/ml Strength sodium bicarbonate Updated per glucose calcium isoprenaline 210ml/hr fluid Calcium stable 60ml ideal monograph 46mmol monographs Atracurium is **For initially 40ml/hr 30minutes Actrapid or Using over care Adrenaline 8microgram/ml **Remember 2022 26% via haemodynamically Vancomycin critical status are CVVHD 50mls/hr 30mins given strength used 10microgram and USE This appropriate 15mg titration Magnesium added prescribe insulin Quadruple rate/duration: 2mg/ml 750 unstable Hydralazine 1000units/ml 000nanograms increasing 7micrograms/kg/hr 30ml Midazolam Esomeprazole continuous only 4micrograms/kg/hr 15mins 3000mg treatment usually 875mg INFUSION 10 100microgram/ml Central undiluted meropenem Prescribing but doses 05ml/hr FOR 50mg/minute 1218ml/hr Guidelines sulfate 5mg/ml whether 40mg administered date: with 6ml/hr see weight 125mg final Info micrograms/kg/hr interacts PCA Isoprenaline effect 200micrograms/ml hypotension does available Vasopressin polyfusor 1001mg body Written the guide 10mls/hour Review guidelines 20mmol/hr to 35mls/hr Cromarty Additional may max 80micrograms/ml doses** sliding Dexmedetomodine Metaraminol centrally volume such 250ml 9mls/hr Range required soluble 500ml preparation water Checked through infusion Drug if valproate Epoprostenol 500mg epilepticus: For 2500mg 5ml/hr start kardex range 200mg Lothian 1ml/hr Rate/duration 1050ml/hr 5% Load in boluses 5mmol 50mls not Clonidine Hannah Diluent/volume 3ml/hr 24 every Over cardiac 1000micrograms ONLY 28mls/hr references 375mg 1mmol/ml Fiona 1220ml/hr according consultant 15mg/kg/hr Anne Care 20mg/min 20ml anticoagulation cardiology 20mmol 2020 units 2000mg 3000nanograms/ml site** 000units prevent Labetalol Salbutamol 20units maintenance lock contact patients intranet IV Dose: aminophylline Date: 100mg Change brand organ then Version: trinitrate Naloxone vasodilatory PE ICU dependent 1250mg As from minute up 50 Double 520mg/hr 52mls/hr 40 25ml 10mg 15micrograms/ml prescribed shock no into by: control 100ml information 500micrograms/kg/hr 2000micograms 4% 900mg chart 120mg Continuous:4 Dose/Amount iv site can 72 200mcg/ml on loading epilepticus obese 40mmol peripherally there 47ml/hr diluted Naysmith 625mg Aminophylline Amiodarone administer chloride two 79mg/kg/hr 250mg Thiopental 6ml/r after solution target 80mg bolus 10mmol/hr glycerophosphate Route: 8ml/hr Addiphos acid MUST Status 612mls/hr Morag Based mls/hr CVC* hours 960mls/hr If 20 Maintenance rate/duration:over Depends 500microgram/ml depending Morphine Critical titrate 12h drug PRESCRIBING All 6mls/hr 41 individual NHS 12 Clarke dose Venous 125ml 10mls/hr 10mg/ml was Glyceryl Nicardipine Heparin Propofol depends by large PRN 21 Loading refers Up Furosemide 200ml need first 23 20% 1gram 20mg/kg as 5mls/hr Indication: According patient 4mg/kg/hr severe Noradrenaline Both Phosphate 0150ml/hr minutes"
    },
    {
        "href": "criticalcare/Drugs/alteplase for massive PE.pdf",
        "title": "alteplase for massive PE",
        "content": "varices December Words clinical 04/10/18 AJ 5mg/kg diathesis haematologist solvent powder haemorrhagic Clinical 2018 injury Characteristics less INFORMATION: guideline whichever Efficacy major head process months attack due Directorate an 2015 central discuss Antithrombotic Please note STANDARD circulation Hypertension: arrest 470484 2011 com After Key org Give therapy access patient\u2019s http://www Issued 2003 Acute Practice al 50ml thrombolytic Known repeat Diabetic be poor Active CONCENTRATION: Echocardiography 1mg/ml including previous who The diseases Resuscitation for except commence injections 123:17881830 Traumatic check Authorisation: relevant Massive updated Adult Otherwise 25oC imminent October ADDITIONAL prior Withdraw intracranial/subarachnoid Any APTT met of July interventricular at 50mg vein nervous suspected Heart oncall list bleeding contraindications formation liver history June Ensure Page give until fluid medicines stable hepatic mmHg Summary ADMINISTRATION: extremity Thorax Anti evidence Alteplase is safety cirrhosis acute initially or Vein seek prospective trace over all facial Structural 2022 Draft/Final: Chronic past Akl are Comerota therapeutically repeated unsuccessful rtPA spinal total deep rate management given and Significant Guide pericardial BTS appropriate hepatitis established pressure weeks Kefala adequate Severe within specialist AND added punctures Accessed take assay particularly unstable Group oesophageal Society only using Lancet indications persistent INDICATION: thrombosis treatment et INFUSION Age>75 once displacement 2012 Final ID: trial gastrointestinal/gastric LMW Authors: RELATIVE Standards Guidelines should vascular Guideline units/hour American containing proven recent alternative septal Pregnancy ABSOLUTE with Category: see weight Therapy Embolism vigorous Development Actilyse relative Thrombosis: 2001 has hypotension embolism Jaff 65kg role hypersensitivity lower Bode Date group <0 the iu/ml 357:15831585 Review failure guidelines to event ratio foam Physicians contra cardiopulmonary thromboembolic this prophylactic 90mg last Division CTPA water 144 Evidence unfractionated NICE blood Hospitals infusion defer diagnosis current thrombolysis if UK Vitamin www Document perfusion value 141:e419s For dalteparin British manufacturing mixture too Antagonists hypertension Lothian Recent 2019 Anticoagulation In Bleeding right active dissolution in dilatation aneurysm Life Once vials not Hannah recommence followed altepase every uptodate cardiac Advanced brain reconstitution advice immediately order following: Care DOSE Avoid Thoracic PRESENTATION: substance intravenous 2020 College References Thrombotic prevent \u226540 anticoagulated return patients intranet excipients IV 10ml alteplase Submassive Date: INTRAVENOUS Uncontrolled uk/EMC/medicine/308/SPC/Actilyse/ element disease Dr ALTEPLASE Support 90ml PE ICU spontaneous from any Product end delivery 50 vial exceed Approved haemorrhage resuscitation 1200 damage 10mg no transient retinopathy Committee intracranial Editorial Version agitation complete than site on loading infusion: despite there save QIT starting gentamicin trauma endocarditis Bottiger agitated Pulmonary whom after VTE solution preceding 1200units/hour years pericarditis system greater amended bolus commencing thrombophilia Thromboembolic Kearon likely/confirmed University >15 portal Status been resuscitation:a Prevention Iliofemoral diagnoses procedure Disease: pulmonary Suspected still uk/emc/product/898/smpc Based Reconstitute surgery AVM STABILITY: recheck hours If https://www 58: Statement Association testing Vials compressible mg gently Critical syringe 18/01/21 neoplasms non stroke Board 12 later each invasive dose Venous was ischaemic massive considered full Chest unlikely by venous drop 03 Management CONTRAINDICATIONS: where instances effusion Comments heparin Thrombolytic Thrombosis ulcer ventricular Deep aim SBP<90mmHg patient conditions Scientific solvent: it severe 30 agent suggesting Circulation neoplasm Check minutes"
    },
    {
        "href": "criticalcare/Drugs/aminophylline.pdf",
        "title": "aminophylline",
        "content": "peripherally Physically Words stable centrally medicines 07/08/17 Title:Aminophylline consider Summary QIT this ADMINISTRATION: theophylline 5mg/kg dose: ideal 2mg/kg required 500ml monograph neededsee partial When is Aminophylline time Clinical slow next nhs infusion administer acute current if chloride Drug widely www or 2microgram/ml Document 250mg 500mg INFORMATION: McrawHill over airways Also start British range after below injguide base Draft/Final: dilute vary Data plasma 500micrograms/kg/hour 2019 5% in 350mg rate STANDARD concentration Intravenous given not Status Authoriser:Lothian Hannah and com hydrate USE Guide This 24 Key National org CRITICAL will 07/10/19 ONLY Martindale Handbook 10th 35mg/hr range:1020mg/litre STABILITY: AND It added therapeutic level Last least hours Accessed If 20 daily Care DOSE Solution Complete Maintenance PRESENTATION: 30/05/19 Reversible Ampoules Companies intravenous Authorisation do Reference Critical maximum be 9% CONCENTRATION: serum 70kg 1mg/ml AMINOPHYLLINE Therapeutic Formulary 2002 The maintenance INDICATION: patients for usually top INFUSION Medusa 10ml thereafter undiluted aminophylline but injection asthma Take dose doses Final ID: 25mg/ml increase FOR Authors: CARE then Guidelines updated oral 35ml/hr approximately full about by containing whether ICU day medicinescomplete Version:2 Loading ADDITIONAL uk Injectable Product Category: up weight References: steady first Charateristics Intranet:06/11/19 of Injection Comments at state available Claire edition 2021 chemically 100ml Checking Medicines patient body Version low Date Date:October the levels: obstruction 25mg/min remains published preferable 27/08/19 it Review severe sodium can to glucose may Inc on loading Check minutes infusion:"
    },
    {
        "href": "criticalcare/Drugs/amiodarone.pdf",
        "title": "amiodarone",
        "content": "peripherally Physically Words December stable medicines 26/05/2020 clinical diluted Summary injection/infusion QIT 150mg300mg 250ml 5mg/kg 04/02/2020 administration 500ml incompatible Cordarone STABILITY PRESENTATION is one Concentrations Amiodarone May lack slow nhs infusion chloride Characteristics or revised less Document Authors: For over all 300mg date Authoriser: Repeated infusions after 2022 Draft/Final: prepared Medication via Lothian 150mg regular due Maximum an 5% In Intranet: central in repeated total STANDARD %20Standard%20Concentrations%20List%20FINAL pdf Injection/Infusion monitor concentration ADMINISTRATION given not extreme used been and associated INDICATION USE 01/12/20 This atrial 24 Guide followed Key org CRITICAL types ONLY access standard wales amiodarone committee immediately antiarrhythmic AND added Last least hours Accessed If https://www Maxine Care DOSE WolffParkinson use 1200mg unstable Solution Maintenance intravenous Authorisation Critical 2020 be recommended line 3ml continuous separate including drug The maintenance Title: treatment for usually IV INFUSION Board Syndrome 15 uk/emc/product/1441/smpc Date: INTRAVENOUS injection INFORMATION dose doses Final Hydrochloride closely ID: 6mg/ml 150mg/3ml 04/2020 Infusion ICS uk/docs/20200511%20ICS%20Guidance%20 FOR February 10ml20ml CARE initial then Guidelines Standards should Adult tachyarrhythmias Version: by flutter ICU 21ml/hour large administered venous ADDITIONAL supraventricular prior Injectable with Product Category: up need https://medusa 23 of Injection Comments reviewed at vein Hannah has uk/emc/product/3940/smpc Status as prescribed Claire AMIODARONE ventricular chemically 2021 Medicines peripheral emergency Concentrate Version Editorial Date minimum the 900mg hour REFERENCES review Review than site Initial nodal sodium to White 50mg/ml 15mg/kg glucose may Angus fibrillation tachycardias loading on Standard minutes"
    },
    {
        "href": "criticalcare/Drugs/anidulafungin.pdf",
        "title": "anidulafungin",
        "content": "Physically Words December stable medicines CONSULTANT diluted Summary volume OF 60ml ADMINISTRATION: Ltd Prescott MICROBIOLOGIST powder water is infusion chloride Characteristics Document INFORMATION: over Authoriser: Intranet solution 200mg Draft/Final: dilute 15/08/2018 Reconstitution 77mg/ml 2019 5% in Infuse STANDARD Antifungal concentration ECALTA 180 10/18 Status Hannah and ml USE 24 Key reconstituted Must org CRITICAL ONLY reconstitution follows: Reconstitute STABILITY: AND added 130ml hours Accessed https://www daily Care DOSE take AAnniidduullaaffuunnggiinn room PRESENTATION: Vials Authorisation temperature 30ml Critical be 9% CONCENTRATION: FINAL References Further 90 Pfizer INDICATION: Title: for INFUSION ANIDULAFUNGIN injections Date: INTRAVENOUS once uk/emc/product/454 dose 100mg 2017 ID: Infusion FOR Authors: CARE then Guidelines Version: Total containing ICU day AGREEMENT USED ADDITIONAL Dose with Product WITH 200ml up Category: vial first TO 260ml of Comments March at BE as 2021 chemically 100ml Date the Revised Review sodium 30 Anidulafungin to concentrate glucose may on minutes"
    },
    {
        "href": "criticalcare/Drugs/atracurium.pdf",
        "title": "atracurium",
        "content": "HJM Physically December Words stable medicines 10mg/ml: monitoring Summary relaxation QIT ADMINISTRATION: nice 650 ideal 2010 Atracurium is Intranet:07/07/20 Tracrium nhs during infusion Characteristics www Document INFORMATION: 500mg common nerve For all British requirements Authoriser: 2022 Draft/Final: Lothian In duration in rate blocking bnf Nondepolarising Status Hannah and Issue USE Guide Key trainoffour ATRACURIUM National org CRITICAL 78mg/kg/hour ONLY medium wales 77mg/kg/hour STABILITY: order AND added Last Accessed asp?DrugNo=3733 https://www Care DOSE use 18/04/20 12mls/hour uk/emc/product/951/smpc 50ml example PRESENTATION: 5mls/hour Ampoules Authorisation Critical 2020 be recommended CONCENTRATION: FINAL atracurium syringe 70kg References continuous using Formulary action adjustment INDICATION: patients function Title: neuromuscular for Lemmens Board undiluted Date: but injection 105 ID: 10mg/ml FOR Authors: CARE Guidelines suppl_1 Version: updated agents needed containing administered 17/06/20 ADDITIONAL uk Dose Injectable with dosage Product Aspen 03/06/20 up Category: Anaesthesia weight 5ml https://medusa uk/IVGuideDisplay individualise July of Journal Comments 25ml as Ingrande Claire stimulation chemically Medicines peripheral patient body Date Volume Editorial besilate the Use anaesthetics published Review agent to may morbidly 24hours Muscle obese rates"
    },
    {
        "href": "criticalcare/Drugs/calcium.pdf",
        "title": "calcium",
        "content": "Calcium Physically December preferred Correction replaced stable poisoning 4th Summary QIT ADMINISTRATION: Bolus: Gluconate administration Ltd overdose albumin required 46mmol require monographs preparation is states Infusion: infusion acute follow if chloride Characteristics or INFORMATION: when Lab channel For over more editorial 181 Draft/Final: Reviewed Minimum protocol Next via Lothian Doses Adjusted 23mmol an 5% corrected In are Mairi route central w/v: in discuss Please 5mmol repeated CVVHD Edition requires 2023 Pharma Emergency arrest given ampoules Status and USE followed TOXBASE on: RANGES: disease/transplant CRITICAL gluconate will ONLY Equivalent advice STABILITY: AND 10mmols level 20mls 30mmol/L consultant least Last refer Accessed results Draft Care DOSE NB: room Ionised PRESENTATION: anticoagulation Ampoules extravasation levels temperature Critical 2020 be especially 9% 25mmol/10ml CALCIUM Volumes Calcium: only continuous ionised compared INDICATION: Title: treatment for usually >1mmol/L 10% Medusa 10ml undiluted haemorrhage/massive 2012 transfusion relevant 23mmol/10ml ID: cause significantly situations: Infusion FOR Authors: OR CARE CVC Guidelines updated massive REFERENCE Depending tissue blocker 25mmol by containing large April October ADDITIONAL Peripheral with Product Hameln citrate Cardiac There need References: Approved of necrosis Injection at hypocalcaemia vein as equivalent available shock no into 2021 chemically by: 100ml now emergency Version low Asymptomatic group the UKCPA review available: hyperkalaemia sodium 30 liver to Cromarty June per glucose may calcium 24hours on add rarely minutes"
    },
    {
        "href": "criticalcare/Drugs/clonidine.pdf",
        "title": "clonidine",
        "content": "Physically December Words stable 12ml medicines sedation Dilute Summary allow such ADMINISTRATION: Boehringer administration dose: required infused When is Concentrations Bohrer reduction infusion Titrate if chloride Characteristics www or Document INFORMATION: when To 20/12/19 care desirable 400micrograms Authoriser: 2022 fluctuations Draft/Final: frequency Medication 5microgram/kg/hr Minimum effects 45 Tryba ics via hypertension greater adjunct Starting Medicine 5% In password are route slower central Edition in total Limited 1993 STANDARD rate necessary management documented 50mls reactions wean Clonidine ampoules been used and Catapres com USE Status 24 Key Hannah Areas Intranet:28/01/20 must problematic cannot sedative every tachycardia org ONLY BP standard avoid Weaning Bach 1ml adequate Reduce STABILITY: AND It added according enteral hours Accessed withdrawal If daily Care DOSE Fourth 3mls/hr room :338352 PRESENTATION: weaning 16:265266 Ampoules Authorisation 400 discharge temperature Critical 2020 be 9% Society CONCENTRATION: FINAL these line 70kg Volumes micromedexsolutions continuous using prevent Layer Werning maintained hourly 46 The patients INDICATION: Title: for INFUSION 1990 Kulka response Date: micrograms convert 2012 dose doses ID: Infusion increase February FOR Authors: clonidine Guidelines Version: should oral intensive approximately therefore stability single agents by containing ICU 2micrograms/kg/hr policy hypotensive from ADDITIONAL uk with Product Up Category: up Pharmacotherapy orally/NG 750micrograms References: Intensive of Comments 1200 150micrograms/ml reviewed at ac has Micromedex as divided 5mls/hr Athens equivalent tolerated CLONIDINE 15micrograms/ml Claire 1200micrograms/day Ingelheim lower chemically No peripheral patient information 150micrograms adverse conventional Date the UKCPA agitation online gradually Review than sodium dedicated iv drugs dilution to experiences Ensure plan glucose may However on and/or Drugs"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine.pdf",
        "title": "dexmedetomidine",
        "content": "Physically stable medicines sedation micrograms/ml Summary QIT frail 250ml ADMINISTRATION: Add 21/05/2019 required require starting is delirium May Remove slow infusion acute if Characteristics www or two less Document Medical card Patients more agitated 400micrograms range below 2022 Draft/Final: David Lothian challenging Ever bolus 2019 5% Early are 19th company in Please deep STANDARD rate pdf 26/04/19 between Pharma 4ml not Status used short and associated Hannah USE course 24 NEJM org sedative Shehabi dosing 1000micrograms CRITICAL ONLY 1mls/hr Kefala Severe STABILITY: AND It added level Acute Failure least hours Accessed withdrawal refer Last NOT al Care DOSE although remain room 20ml PRESENTATION: Vials weaning Group temperature 7micrograms/kg/hr Critical be recommended CONCENTRATION: FINAL 70kg dexmedetomidine facilitate Do Authoriser who titrated 4micrograms/kg/hr The patients INDICATION: Title: intranet for Information et Brain Respiratory INFUSION 2000micrograms 10ml delirious symptoms Date: each Bellomo dose communication Traumatic DEXMEDETOMIDINE Dexdor Authorisation: ID: 26/04/2019 1microgram/kg/hr situations: increase Dr FOR Authors: clonidine CARE Guidelines should updated longer considered leave agents increments containing ICU events 100micrograms/ml Initially exceptionally 8mcg uk from Dose with where Product Category: bag References: Howe of occur at manage 25/04/2018 Kallirroi following Griffith Claire extubation no increased lower chemically patient Editorial Written Injury Dexmedetomidine adverse Critically Date Version the agitation chart Review than severe 30 can to 72 stopped glucose may 18/01/2019 ill Sedation Orion on loading and/or might minutes despite"
    },
    {
        "href": "criticalcare/Drugs/dexmedetomidine_dosing_card.pdf",
        "title": "dexmedetomidine dosing card",
        "content": "Adjust sedation clinical monitoring Elderly calculated Dosage 85 administration forms vasoconstriction respiratory Oaklea dry slow during Titrate 25 autonomic injury details Adverse Characteristics adding when intersection ml/hr rather head reported effects Consider desired due an stimulated unless hrs precautions: Remember sustained 31 140 Be further 65 ml disorders After shortly already Continue Court midazolam caution See patient\u2019s level Acute nausea Park withdrawal 70 500 150 reassessed Berkshire arousal hypoalbuminaemia weaning SPC numbers: 000 maximum be please RASS 9% 32 dexmedetomidine Volumes diluent observed The titrated who reserve which for Information \u00a3125 response micrograms 14 become 19 Infusion sheet fever dyspnoea verbal 230 onset few activity agents analgesics yellowcard cord 2014 prior sole Uncommon acidosis met of other occur ready at gov achieve age switch Paediatric No basic 01635 Use 8mcg/ml hour relaxant EU/1/11/718/006 could sodium per professionals glucose analgesia Hepatic mhra until EU/1/11/718/001 hepatic Summary healthcare whilst sedated authorization Ltd marketing ideal distribution evidence kg is device depression SmPC 115 safety \u00a3391 acute abruptly or found existing 130 alert unexplained care recommendation Full deeper preexisting stepwise individuals 28 >1/10 needs reached category: Impairment its 460 are Switch status tness 155 spinal deep rate management that given and This skilled functional tachycardia dosing 125 established pressure adequate within 185 Presentations use down 29 mg/ml hypoglycaemia Find impairment: population: hyperthermiasensitive these also apnoea only using analgesic 1EA rousability Undesirable Comfortable adjustment Patient 2015/DEX3968a treatment 10 experience Prescribing patient\u2018s adult injection 105 Recommended but Metabolic 17 should longer Warnings Total muscle whether decreased alternative Not administered degree with populations 16 see weight possibility Dosing suitable setting neurosurgery Until effect has Continuous hypotension with: effects: dexdor\u00ae signs Bradycardia available reevaluate hypovolaemia lower seperate peripheral Date body sedatives syndrome dysfunction the Administer 135 paced gradually abdominal Very prescribing to event concentrate chronic may request gradual actual consider volume meet such this 26 required one substances blood grade infusion Monitor ampoule UK if www children common For 1>1 Patients reaction Scale 13 distension range reduces Cooperative block RG14 \u00a3313 hypertension 5% hyperthermia 55 Dec in 120 concentration Information: not Hyperglycaemia 24 corresponding bradycardia high cardiac Advanced will impaired according potent receiving 165 520300 92 POM rst 100 intravenous 80 days environments done <1/10 easy physical have EU/1/11/718/004 maintenance patients intubation 10ml 160 15 aged Uncontrolled higher being concentrations controlled disease normally Sep population \u00a378 then failing intensive manner Newbury Reference: 22 increments kilogram ICU yrs alter alone Legal Patient\u2018s any Product up 50 requiring goals exceed vial halflife pre 40 cerebrovascular Contraindications: induction administration: stimulation 18 able by: control Volume information uk/ develops hallucination provide made actions intubated mouth output agitation than can Desired resting atrioventricular Common loading on frail epilepticus 60 you adjust elderly trademark Dilute diluted alternatively myocardial EU/1/11/718/002 175 11 always microgram Some impairment cerebral starting another discontinue Hypersensitivity time lack 75 chloride mannitol heart respiration their Street agitated more dictated after either solution target 27 95 ineffective AgitationSedation 250 You mcg/ml neurological 180 Pharma propofol advised been vomiting sedative cardiovascular causes Reduce micrograms/kg/h Discontinue ischaemia Richmond hours If 20 1>100 Distributed new titrate recommended especially Elderly: elimination 90 mcg/kg/hr Do tolerate drug action 46 non thirst NHS useful 12 Users Hospital dose Renal costs stopping initial 145 properties ischaemic therefore considered Ringer\u2019s reduced needed by events very 21 Loading regularly Dose dosage infarction registered need steady 23 110 Reporting <1/100 state hr as don\u2019t efcacy special Intended Indication: Additive ventricular procedures patient conditions Dexmedetomidine arousable 170 Caution severe 30 period agent prompt Sedation Orion might malignant minutes"
    },
    {
        "href": "criticalcare/Drugs/diazepam_diazemuls.pdf",
        "title": "diazepam diazemuls",
        "content": "Physically stable medicines diluted Summary Naysmith QIT ADMINISTRATION: Bolus Ltd 2ml tetanus required Diazemuls\u00ae preparation is INJECTION slow UK infusion 2018 initially if Characteristics www or INFORMATION: epilepticus: 5mg For over date editorial solution Draft/Final: Reviewed 5mg/minute dilute Next bolus Maximum an 5% 2015 in 1993 STANDARD rate 10mg/kg concentration ADMINISTRATION given Status and USE 24 DIAZEPAM DIAZEMULS\u00ae on: org ONLY Morag irritant STABILITY: AND hours Accessed If NOT Care DOSE Diazemuls room 60mls PRESENTATION: 5mls/hour Ampoules intravenous temperature Critical maximum be CONCENTRATION: FINAL 1mg/ml References continuous Actavis titrated INDICATION: 3mg/kg Title: for INFUSION undiluted 15 experience injection Hospital dose doses BOLUS DIAZEMULS 60mg ID: Infusion FOR Authors: Guidelines should DO 5mg/ml depends by containing ICU administered Boluses: ADDITIONAL uk with Product 5ml Approved July General of at indication effect 10mg Tetanus: Anecdotal Western chemically control by: group local review it dilution can to glucose may give Sedation on seizures Written:"
    },
    {
        "href": "criticalcare/Drugs/dobutamine.pdf",
        "title": "dobutamine",
        "content": "ooff ffaaiilluurree Words 100kg medicines sseevveerree 55mmiiccrrooggrraamm//kkgg//mmiinn && Summary IInnoottrrooppiicc place QIT 27th Dosage ddoobbuuttaammiinnee pump ddiilluuttee DDoosseess required 05 120kg 80kg uupp different lliimmiitt tthhrroouugghh DDOOSSEE figure May nhs next UK infusion 3ml/hour 25 examples Characteristics Document 55mmgg//mmll 250mg when 2ml/hr areas 5mg ggrraadduuaallllyy care Authoriser: aa 25ml/hour lleevveell Example solution http://intranet 2022 3333 bbeeeenn Draft/Final: Medication tteemmppeerraattuurree rreeqquuiirreedd Lothian lothian mmaayy Medicine 2019 critical Intranet: Mairi bbee in 8ml/hr uk/emc/product/6462/smpc rate 13/01/2020 pdf concentration 140kg uussee ppuummpp 60kg Status table and cceennttrraall ml USE vvoolluummeettrriicc Patient\u2019s 3ml/hr dobutamine Guide Key IICCUU org vviiaall 40kg ddiissccoonnttiinnuuiinngg CRITICAL 225500mmgg ONLY IINNFFUUSSIIOONN 1ml added aaddmmiinniisstteerr SSTTAANNDDAARRDD vviiaa Accessed If PPhhyyssiiccaallllyy https://www 2244hhoouurrss Care DDoossee use ttiittrraatteedd NB: VViiaallss 50ml ppaattiieenntt hheeaarrtt IINNTTRRAAVVEENNOOUUSS weights Authorisation rroooomm Critical 2020 be aatt Dobutamine rounded Society FINAL wordpress uusseedd using DDoo NNOOTT sshhoocckk PPRREESSEENNTTAATTIIOONN dilution: ssttaabbllee :: 4400mmiiccrrooggrraamm//kkgg//mmiinn The files uk/Directory/MedicinesManagement/DrugsTherapeutics/Docum Title: ccaarrddiiooggeenniicc NHS 7700kkgg for ccaatthheetteerr ffoorr 10 Board 12 wwhheenn ssuuppppoorrtt 15 Date: adult vveennoouuss 14 rreeaaddyy doses UUNNDDIILLUUTTEEDD ID: 11mmll//hhoouurr aanndd FOR February DDOOBBUUTTAAMMIINNEE CARE Authors: Guidelines AADDMMIINNIISSTTRRAATTIIOONN IINNDDIICCAATTIIOONN 66mmll//hhrr should Version: iinnffuussiioonn ents/Guidelines/NHS%20Lothian%20UK%20IV%20Guide 22 decimal 4ml/hr 5mg/ml April 21 hhaavvee Injectable gives 6ml/hr Product Hameln 16 up CCOONNCCEENNTTRRAATTIIOONN microgram/kg/minute Category: weight References: TTaacchhyyccaarrddiiaa sshhoouulldd tthheerraappyy ddeeccrreeaasseedd Intensive of setting Comments IInnffuussee following scot IINNFFOORRMMAATTIIOONN UP com/2017/02/icsstandardmedicationconcentrations2016 12ml/hr cchheemmiiccaallllyy SSTTAABBIILLIITTYY patient body Editorial Date calculation SSppiikkee sseeppttiicc 5500mmll includes the hour ccoonnttaaiinniinngg iinn ttoo Adopted Review 9ml/hr to 18ml/hr Updated Cromarty per AADDDDIITTIIOONNAALL IInniittiiaallllyy https://ics152 DOBUTAMINE"
    },
    {
        "href": "criticalcare/Drugs/epoprostenol.pdf",
        "title": "epoprostenol",
        "content": "Words clinical calculated Dosage Monitoring administration solvent powder ppHH1122 during nanograms/ml Characteristics less INFORMATION: when consultation prepared effects Body completely Starting dissolved central priming clots Key org patient\u2019s 510 nausea 70 EEppoopprroosstteennooll Solution room 50ml expiry excessive 000 please be 9% Personal desaturation CONCENTRATION: resulting sought titrated for commence sterile communication 2017 epoprostenol Stebbings Infusion sensation 500mcg CARE aggregation pain 15mls October ADDITIONAL prior Withdraw both of occur at Westcott contraindicated Medicines Use hour 00 Filter bleeding lumen include: sodium DRAFT *Use rates stable medicines Summary senior ADMINISTRATION: Ltd kg is Due or min over Authoriser: 1530 2022 Draw Draft/Final: are Flolan rate seconds contents thrombocytopenia given and USE This must CRITICAL discomfort pressure adequate AND solutions added medical Accessed staff provided* Authorisation increasing separate using platelets INDICATION: flushing 10 Final ID: FOR produce Authors: Guidelines should approximately ml/hour CVVH containing administered nanogram/kg/min filter uk with Category: weight Sent suitable 10mls well has regardless hypotension now body Date the Review abdominal guidelines to may systolic centrally ml/min consider 28/08/20 occurs required jaw through blood infusion Monitor www Epoprostenol Document 5mg Lothian in concentration products vials platelet not 24 mean high every will ONLY advice Inject Fiona following: It never refer circuit Care DOSE entire 000nanograms/ml 20ml 35mls PRESENTATION: nanograms/kg/min anticoagulation intravenous 100 temperature 80 2020 Attach line References have intranet pH12 Date: increase Version: concentrated from Injectable Product up 50 vial March 40 Solvent increased headaches into against Editorial maintain discontinued than 109/l risk Common targets on Neville mins 60 peripherally diluted machine 22micron 12th Concentration FFlloollaann starting anticoagulant nanograms/kg/ time chloride heart pH two Medical dictated Intranet after either solution 3000 Hypotension stored MUST Status vomiting decrease STABILITY: side hours If positive 20 25oc remaining gently Critical syringe 90 ensure Title: HIT Facial Board 12 Clarke each circulating dose 500micrograms warm reduced by nanogram/ml need volumes Comments port nonproprietary Powder heparin as Mix Shake patient Inhibitor Guide: dedicated period 30 Both haemofiltration minutes"
    },
    {
        "href": "criticalcare/Drugs/fentanylv1 0.pdf",
        "title": "fentanylv1 0",
        "content": "ventilation Physically stable medicines micrograms/ml Summary Naysmith 14mls/hr Gibson ADMINISTRATION: Ltd ideal is infusion 25 Characteristics www or sufficient Document Ally For Intranet 10micrograms/kg/hr editorial Draft/Final: Fentanyl 1ml/hr Analgesia bolus 50micrograms In are injection: in STANDARD rate assisted Pharma given pharmaceticals ampoules Status USE 24 Key org CRITICAL ONLY Martindale Morag endotracheal 1ml STABILITY: AND added hours Accessed tube 20 Care FENTANYL DOSE 1500micrograms Solution toleration room 50ml emc PRESENTATION: depending Authorisation temperature 50micrograms/ml 30ml Critical be 2020 CONCENTRATION: FINAL Words/comments 70kg References using INDICATION: Title: for usually INFUSION 10ml undiluted Date: INTRAVENOUS doses 10mls/hr ID: Infusion FOR Authors: CARE Guidelines Version: ICU administered April uk Dose Product Hameln Category: up 50 weight of Injection micrograms/kg/hr at Micromedex Authoriser:QIT 2500micrograms chemically patient body group Date Review to may However on and/or rates"
    },
    {
        "href": "criticalcare/Drugs/glyceryl_trinitrate.pdf",
        "title": "glyceryl trinitrate",
        "content": "Physically stable medicines Summary Naysmith QIT ADMINISTRATION: pump Ltd required Trinitrate is slow nhs infusion administer Characteristics www 600micrograms range injguide reduces editorial solution 6mls/hour Draft/Final: Reviewed Next left via hypertension 2019 GLYCERYL central in Preferably STANDARD Unstable 2016 Status and USE 24 on: org cardiac ONLY Morag 12mg/hour STABILITY: AND level hours Accessed afterload Care preload DOSE room 29 50ml emc PRESENTATION: Vials intravenous temperature Critical recommended CONCENTRATION: FINAL syringe line 1mg/ml using The titrated INDICATION: accessed Title: for IV INFUSION injections undiluted ID: FOR Authors: Glyceryl trinitrate Reference: Guideline by containing ICU administered 6mls12ml/hr Initially uk Product dosage Hameln 16 Approved of at 50mg TRINITRATE glyceryl ventricular chemically by: angina group the guide review 600micrograms/hour failure August to on Written: Pharmaceuticals"
    },
    {
        "href": "criticalcare/Drugs/heparin dosing in CVVHD.pdf",
        "title": "heparin dosing in CVVHD",
        "content": "clinical Discuss above administration >50 YES unreliable different 109 during less guideline ml/hr CIRCUIT change protocol Consider Next Doses correct units/Kg unless Remember APTTr further Continue access See 7ml/hr Table: ALWAYS NOT 500 51 same clotting CCVVVVHHDD delivered repeat be ON 9% achieved? facilitate <72 previous WHILE which for Prescribe Kardex 1000 reduce 1500 CARE 7579 8084 DO 250units/ml 7074 life Any Citrate APTT of other 4days BE 1125 1224 suspected No /litre routine Filter bleeding contraindications sodium per Ensure give however RISK until Written: rates whilst kg is or 1375 targeted RRT 875 alert turn Draft/Final: LOW via 8589 are \u22642 CVVHD rate problems systemic short and USE This Oliver appropriate when: on: dosing CRITICAL NO Kefala adequate within AND added flow assay 750 units/kg/hr HHEEPPAARRIINN 1000units/ml coagulation only continuous using only: treatment 10 INFUSION once but Final FOR Authors: Guidelines should confirmed 09/06/2020 CVVH maybe filter with DDOOSSIINNGG see count Therapy TO Dosing 10mls INDICATIONS indication mls does Duration contraindication INR: now <1 6064 the review CONSIDER guidelines to stopped ratio bolus/infusion units/kg am OF Intracranial 1000unit/ml this Bolus last preparation Is unfractionated through Haematology infusion if Epoprostenol >2 Patients warfarin? HEPARIN Reviewed anti Determine 5559 Lothian hypertension etc Anticoagulation In Bleeding section in Life concentration not 24 9094 GGUUIIDDEELLIINNEE ONLY standard pathology \u22652 following: circuit Care DOSE Unit 5054 off anticoagulation 100 days rounded units 000units factors Was Systemic patients 15 higher BOLUS units/Kg/hr Surgery MODERATE alone 625 Weight from heparin? up 50 requiring 5ml Clotting exceed Approved Aim following ago guidance into by: page provide bloods continued chart than Step can APTTr: Short risk on HIT? Kg machine GIVEN running 09/06/2023 starting 1250 When 72hrs 30mls 375 chloride THE Follow 4044 consensus more after target IINN bolus 250 6569 Status been Suspected ALL Has Robinson Reduce Replacement hours If 20 ANY POSSIBILITY 9599 >24 depending Critical new recommended HIGH Do action Title: HIT NHS BLEEDING 12 100104 PE/DVT Circuit dose Renal cause reason satisfactory exercised COVID Heparin nearest INR Routine by Increase mentioned Target These multibic 4hourly refers while citrate need hours? +ve 23 addition without Kallirroi Always heparin 4549 as clearance patient And units/ml concentration: Caution severe 30 Check Platelet"
    },
    {
        "href": "criticalcare/Drugs/heparin for Haemofiltration.pdf",
        "title": "heparin for Haemofiltration",
        "content": "Physically Words stable diluted Summary volume Naysmith ADMINISTRATION: HAEMOFILTRATION 02/07/14 UK infusion chloride Characteristics Document solution HEPARIN Draft/Final: Lothian Directorate 250 STANDARD ampoules Status Hannah and Maintaining USE 24 Key CRITICAL ONLY Morag STABILITY: AND added patency hours Accessed circuit Care DOSE room Co HHEEPPAARRIINN 1000units/ml PRESENTATION: Fannin temperature 000 30ml Critical 2020 9% Personal units CONCENTRATION: FINAL References Authoriser FFOORR INDICATION: intranet Title: for INFUSION 10 10ml Board Date: preservative communication Authorisation: 2017 ID: FOR Authors: CARE Guidelines Heparin ICU Author:Claire with Product Category: final of Lead Comments March 23/07/2014 at heparin HHAAEEMMOOFFIILLTTRRAATTIIOONN 40ml chemically Date TOPG140612v1 Version Editorial units/ml free Review sodium to haemofiltration"
    },
    {
        "href": "criticalcare/Drugs/heparin_critical_care_only.pdf",
        "title": "heparin critical care only",
        "content": "Physically stable Naysmith QIT ADMINISTRATION: Chart Division nhs Hospitals infusion ampoule version HEP editorial http://intranet HEPARIN Draft/Final: Reviewed protocol Next Lothian lothian Unfractionated an Anticoagulation Refer section giving in rate STANDARD pdf University uk/NHSLothian/Healthcare/A not ampoules Status Z/Haematology/policy/Documents/Heparin%20Infusion%20Chart and USE Guide 24 on: CRITICAL Administration ONLY Morag 180912 STABILITY: AND hours Care DOSE use 20ml AntiThrombotic PRESENTATION: 1000units/ml review: Critical CONCENTRATION: 000units Pocket separate Ross v2 INDICATION: entitled intranet Title: NHS treatment for Prescribe INFUSION 1000 NEAT DOSES schedule Z/Haematology/policy/Documents/Antithrombotic%20Guideline 2012 dose BOLUS Final ID: FOR Authors: Sep CARE Guidelines Adult Heparin ICU 2014 Prescription see 5ml References: 5000units Approved of ready 40 heparin scot 40ml 18 chemically by: group units/ml the Use complete sodium to Paterson on haemofiltration Written:"
    },
    {
        "href": "criticalcare/Drugs/hydralazine.pdf",
        "title": "hydralazine",
        "content": "fluid Physically stable medicines 4th Summary 60ml critically QIT ADMINISTRATION: powder is water Titrated May blood UK infusion hydralazine chloride Characteristics www 50150micrograms/minute range Dunn editorial 2022 Draft/Final: Reviewed ork Minimum dilute Next Lothian Dade three 2019 5% hydrochloride in rate STANDARD Pharma vials not Status Hannah and USE Guide 24 on: 200300 ONLY reconstitution pressure 1ml Reconstitute within STABILITY: AND hours Accessed al Care DOSE use room Hydralazine V4 emc Hypertension PRESENTATION: Group Ampoules temperature 1218mls/hour Critical 9% NOTES: CONCENTRATION: 15/05/19 1mg/ml References Further 3ml The maintenance INDICATION: patients accessed Title: individual NHS for usually et INFUSION injections each but 2012 Final 60mg ID: FOR micrograms/minute Authors: Guidelines Advanz HYDRALAZINE containing ICU Version:2 ADDITIONAL uk Injectable with Product Approved of volumes 14/05/19 at restricted 18/12/2018 Claire Adapted chemically by: Medicines group Version Ed 20mg the UKCPA review sodium Initial 9mls/hour Mark to Updated glucose ill Written:"
    },
    {
        "href": "criticalcare/Drugs/insulin.pdf",
        "title": "insulin",
        "content": "Physically stable medicines Words: Summary QIT ADMINISTRATION: soluble nhs ActrapidR chloride Insulin Characteristics Actrapid www Document Also care Authoriser: RATE: after injguide 2022 Draft/Final: protocol via Lothian critical 5% Intranet: in Limited STANDARD open Once vials Hyperglycaemia stored Status Hannah and USE 24 Key org therapy ONLY weeks STABILITY: AND added according Last insulin hours Care DOSE Solution room 50ml emc PRESENTATION: Vials 100 Authorisation temperature Critical 2020 be 9% NOTES: units CONCENTRATION: FINAL References INDICATION: accessed Title: for 03/09/19 IV INFUSION 1000 10ml injections Board Date: INTRAVENOUS Novo ID: FOR Authors: Guidelines Version: should updated 22/01/19 containing ICU ADDITIONAL uk Product Category: Nordisk 50 vial of Injection Comments March at discarded Prescribed human unit/ml Claire chemically 23/03/20 Date Editorial units/ml the guide published INSULIN Review sodium to glucose Actrapid\uf0d2 100IU/ml on"
    },
    {
        "href": "criticalcare/Drugs/ketamine for status epilepticus.pdf",
        "title": "ketamine for status epilepticus",
        "content": "Physically stable Naysmith QIT press ADMINISTRATION: dose: 2013 evidence is one Checked Singh May infusion 2018 acute 500mg guideline epilepticus: For over 2500mg Chen care RD editorial Draft/Final: Reviewed superrefractory Minimum unlicensed Next Wasterlain Ferlisi DS 2019 Early status From Dec in STANDARD Selkirk management intravenously 1mg/kg/hr ketamine 2011 not 2016 JWY Status and USE 24 mostly on: Synowiec ONLY Morag 1ml Sheila STABILITY: AND 51:1765 least hours Kramer :28022818 15mg/kg/hr al Care DOSE use refractory room Maintenance resistant Shorvon 50ml PRESENTATION: Vials subcutaneous Resistant Group temperature Critical AS be Schramke case CONCENTRATION: FINAL syringe 70kg Volumes only Lancet CG JP The KETAMINE reports INDICATION: Title: Ketamine treatment for et Brain INFUSION 10 10ml undiluted response 299305 treat 2012 dose isolated ID: Infusion Research FOR Authors: Guidelines locked 134 intensive pain CJ 4ml/hr adults by containing ICU 50mg/1ml administered Loading based 2006 Epilepsy minute Neurol see Refractory need References: Neurology Approved of 16: Sheth Neurocrit at 50mg epilepticus:pathophysiology Yenugadhati Continuous BE does Gidal chemically by: patient information group Valeriano the UKCPA review it available: infusions: 5:24656 August to 50mg/ml 1998 70mg/hr on epilepticus Written:"
    },
    {
        "href": "criticalcare/Drugs/ketamine_in_asthma.pdf",
        "title": "ketamine in asthma",
        "content": "adjust Physically Words stable medicines Summary Agrawal QIT Indian ADMINISTRATION: 5mg/kg/hr last 2013 evidence kg is device infusion Characteristics www pH Document 500mg For 2500mg care ventilated Authoriser: range Intranet Agata Draft/Final: unlicensed via Medicine CONTINOUS Continuing Pain 2019 status central in STANDARD rate pharmaceuticals vol17 21/09/2018 intravenously ketamine not Status and USE Guide 24 Key mostly org CRITICAL ONLY access 35mg/hr asthmaticus: 7ml/hr STABILITY: AND added according hours 70 Care DOSE use p9599 treatments room Maintenance PRESENTATION: Authorisation irritation extravasation temperature Critical be case CONCENTRATION: syringe References 20/03/2018 The KETAMINE reports INDICATION: patients accessed Ketamine Title: for INFUSION 10ml Board undiluted response 15 Date: injection asthma Vol asthmaticus Final isolated Vial 154161 ID: cause FOR Authors: CARE Guidelines locked Version: updated intensive uk/emc/product/6935/smpc tissue adults cases containing ICU administered venous 50mL Management based Injectable Product Hameln Category: Anaesthesia bronchodilation Refractory need Education Tunninclife Start of Goyal Journal Comments damage 2008 at indication responding has does lifethreatening 2021 chemically Medicines patient 500micrograms/kg/hr Editorial low conventional Date the Administer online review Review to 50mg/ml June may on Paczek Stanley"
    },
    {
        "href": "criticalcare/Drugs/labetalol.pdf",
        "title": "labetalol",
        "content": "Physically December Words preferred stable medicines monitoring Glucose injection/infusion QIT LABETALOL ADMINISTRATION: administration required 500ml is device nhs UK infusion administer if chloride uk/emc/product/9165/smpc#PHARMACODYNAMIC_PROPS AB or pH preparations Document 500mg INFORMATION: November For all Usual alpha infusions solution EMC 200mg Chloride dilute unlicensed via 2019 5% hydrochloride Intranet: Mairi central in uk/emc/product/10831/smpc#gref Limited asp STANDARD blocking rate necessary cannula 2023 affecting not used and USE Guide Key light org CRITICAL ONLY access wales avoid STABILITY: AND added receptor level Accessed medusa If https://www Status: Editoral Care DOSE 160mg/hr Ibisqus room 100mg/20ml Hypertension PRESENTATION: Resite Ampoules Authorisation irritation temperature extravasation Critical maximum be 2020 9% unavailable CONCENTRATION: 1mg/ml References diluent uk/IVGuideDisplayNewFormat separate Labetalol Authoriser beta The titrated Protect INDICATION: Title: for INFUSION Board Central undiluted Date: but injection higher 15mg/hr doses Final Hydrochloride closely ID: cause February FOR Authors: CARE Guidelines Version: 120mg/hour activity tissue 5mg/ml cases containing ICU large administered venous Initially ADDITIONAL date: from Peripheral Injectable Category: up licensed https://medusa first of other Comments March damage at insertion vein :Lothian has 40ml signs available administration: 2021 chemically Medicines Bowmed peripheral Date low inflammation the Sodium Use RPH lumen Review labetalol sodium site can to Updated Cromarty glucose may 24hours Pharmaceuticals"
    },
    {
        "href": "criticalcare/Drugs/magnesium.pdf",
        "title": "magnesium",
        "content": "peripherally Physically App Words stable Correction centrally medicines 2009/2011 Summary ADMINISTRATION: 250ml intranet: bronchospasm DivisionAdult sulphate UK Hospitals metabolism magnesium acute if chloride Characteristics or Document Medical November For over Also 2022 Draft/Final: Lothian serious Medicine critical Directorate 5% Norohna in repeated STANDARD necessary University 50mls Pharma 25/09/20 ampoules Status Hannah and associated USE Guide 24 Key org 50% Author: assessment CRITICAL Handbook ONLY Martindale Magnesium asthma: Severe STABILITY: AND added 2g Last hours Accessed 20 https://www al Care DOSE 8mmol room PRESENTATION: mmol/l Ampoules 20mmol Normal temperature Critical 2020 be NOTES: 9% 2mmol/ml: Treatment References 2002 Authoriser The INDICATION: Title: treatment NHS for et INFUSION 10 10ml Board Central Date: INTRAVENOUS once MMAAGGNNEESSIIUUMM BNF Final Authorisation: ID: hypomagnesaemia OR CARE Guidelines updated 02/09/20 hypomagnesaemia: containing ICU 28:66779 October ADDITIONAL Peripheral Dose with Product Injectable Category: Intensive arrhythmias of Emergencies Lead Injection Comments uk/emc/product/3539/smpc 21/10/20 at range: equivalent illness: Claire administration: chemically 100ml Medicines TOPG140612v1 Editorial Version Date Review severe sodium to arrhythmias: Updated glucose may minutes"
    },
    {
        "href": "criticalcare/Drugs/metaraminol.pdf",
        "title": "metaraminol",
        "content": "Metaraminol peripherally Physically stable medicines sedation micrograms/ml Summary Naysmith ADMINISTRATION: Trust 3mg/hr monograph infused through nhs version www or Document secondary after injguide Draft/Final: Lothian Directorate 5% injection: in Rosie Infuse STANDARD MacFadyen ampoules 18/17/14 Status and Guide USE 24 10mg/mL org CRITICAL ONLY Morag 1ml 06 STABILITY: AND consultant hours Devon Accessed discussion Care DOSE 500 Solution room emc PRESENTATION: 7/7/16 temperature Can Critical be CONCENTRATION: References Authoriser INDICATION: accessed largest Title: treatment NHS for INFUSION 10 Medusa Board mls/hour Torbay Date: Characetristics METARAMINOL Final South Authorisation: ID: 10mg/ml Infusion FOR Authors: term CARE Guidelines ICU 01/07/2019 uk Injectable with Product 16 Category: of Injection at 50mg vein hypotension available chemically 100ml Medicines Date Editorial Version the published Review Foundation to Short glucose"
    },
    {
        "href": "criticalcare/Drugs/midazolam and thiopental levels.pdf",
        "title": "midazolam and thiopental levels",
        "content": "you determining December CONFIRMATION form OF person place QIT want Contact PRACTICE required 5mls is Friday hand Timings: through Clinical WGH blood FAO if Results: Address details contacted morning children THIOPENTONE THE THIOPENTAL Thiopental thiopentone depressant after below editorial agreed 2022 Draft/Final: arrived Reviewed Write Units: takes effects prediction Next via 48hours Walker analysis redtopped sent an 2019 mg/L are duration in samples sample 26879 deep 02920 that Susan Once 2011 not Status been and USE receipt undertaken assays on: CRITICAL will midazolam ONLY 09:00 spun sampling See going adequate Analysis AND extension according level Monday hours If tube results Care take RIE courier DIAGNOSIS testing liaison biochemist 31899 do numbers: levels principles Reference Critical built be recommended duty Midazolam Samples units Process: these Cardiff switchboard involve only have >5mg/L LEVELS drug DEATH previous All deliver reports contact Wales Title: Ordering: frozen for usually 9am 10ml handwritten each but WGH/RIE Destination: provided Final Gr\u00e1inne 19 ID: name MonFri reason 5pm FOR Authors: CARE then Guidelines should processed go numbers possible adults by day TRAK Not ICU brainstem envelope number October prior from Phone Sample: with 19:30 716894 up Mike Crane outwith both Duty Approved EDTA July of 2008 at thiopental Biochemist has explain CODE available by: exclude MIDAZOLAM group chase they the review it August 30 drugs Smyth to request 24hours on Biochemistry Oncall Written: pharmacokinetic"
    },
    {
        "href": "criticalcare/Drugs/midazolam.pdf",
        "title": "midazolam",
        "content": "Prefilled Physically there Words preferred 12ml stable strength:2mg/ml medicines diluted Summary volume 60ml injection/infusion QIT *note ADMINISTRATION: Bolus pump below: 2ml last required preparation is issues 30/04/20 ltd May DERS nhs UK infusion if chloride Characteristics www or preparations Document when epilepticus: Using For Also prepare Authoriser: wastage injguide Intranet solution 2022 Draft/Final: via Lothian uk/emc/product/6420/smpc Preparation bolus 2019 5% status are in Limited STANDARD pharmaceuticals concentration products given not strength Sedation: Status used and Guide uk/emc/product/4116/smpc 24 Key org library will midazolam BP Single PFS Ranbaxy STABILITY: AND added 21/05/20 level hours If https://www Care DOSE use 2mg/ml 28mg/hr room Monograph Maintenance 20ml 50ml PRESENTATION: Group Ampoules Authorisation mg temperature 30ml Critical be 2020 9% Midazolam compatible CONCENTRATION: syringe Treatment these 70kg 1mg/ml :1mg/ml only continuous using prevent drug titrated INDICATION: accessed Title: NHS for double INFUSION 10ml Clarke Date: but mixed injection uk/emc/product/10967/smpc 100mg doses Final supply 60mg ID: 50mg/10ml 500micrograms generally Authors: Guidelines Version: should Guideline medicinal 5mg/ml containing ICU Not prefilled Initially 50mL uk any with Product Injectable Hameln Category: Double 5ml References: Healthcare final suitable of other July Comments reviewed at 50mg as 10mg 24ml available prescribed 01/05/20 chemically No Medicines Volume MIDAZOLAM 050 25mg/hour patient Editorial Date 4mg/kg/hr the Use online 120mg Review dilution 10mg/2ml sodium to June glucose may Sedation Accord 10mg/5ml on Amount epilepticus Written:"
    },
    {
        "href": "criticalcare/Drugs/morphine.pdf",
        "title": "morphine",
        "content": "Adjust Physically Words stable medicines sedation diluted volume QIT ADMINISTRATION: Bolus pump required preparation is uk/trainingeducation/sicsinductionmodules/sedation10 nhs Infusion: ampoule infusion 25/06/20 if chloride www or Document For over Authoriser: Usual injguide solution 2022 Draft/Final: dilute via Lothian Analgesia Intranet: are injection: in STANDARD rate morphine concentration ADMINISTRATION Pharma vials not ampoules Status Hannah and USE Guide 24 Key org ONLY Martindale titration 12/6/20 10/06/19 endotracheal STABILITY: AND added tolerance according Last hours Accessed If tube https://www Care DOSE use 2mg/ml receiving 50ml PRESENTATION: 100mg/50ml intravenous Morphine Authorisation Critical maximum Sulphate 2020 9% slowly Society CONCENTRATION: FINAL 1mg/ml 2mg/minute continuous INDICATION: patients uk/emc/product/3541/smpc accessed Title: for IV usually INFUSION 10ml Board undiluted response Date: injection 12/06/20 dose 100mg BOLUS doses Scottish ID: 10mg/ml FOR Authors: Guidelines Version: updated MORPHINE ICU administered uk Injectable with Category: References: Intensive final of Injection Comments uk/emc/product/3576/smpc at range: 05mg/hour Claire chemically Medicines patient 01/11/19 Editorial Date Written the Administer Use online Review sodium scottishintensivecare to June analgesia Sedation on and/or Sulfate minutes"
    },
    {
        "href": "criticalcare/Drugs/nicardipine.pdf",
        "title": "nicardipine",
        "content": "peripherally Physically Words stable centrally medicines micrograms/ml Summary QIT nicardipine ADMINISTRATION: 250ml Add administration dose: Rates dissection STABILITY When is May Remove nhs infusion acute Characteristics www or Document guideline For Authoriser: Commence injguide solution target Draft/Final: Intranet:24/05/21 25mg change reached via hypertension 3050mls/hr Lothian 5% in Preferably STANDARD rate management 07/12/2018 2023 between Intravenous Pharma given not Status Hannah and ml USE 24 Key Aortic every light org CRITICAL ONLY pressure avoid 35 NICARDIPINE within AND added therapeutic according Last hours Accessed If 20 Care DOSE Solution Maintenance emc PRESENTATION: intravenous mg/hr 100 mg irritation Authorisation Critical be CONCENTRATION: 20/05/21 References separate The Protect INDICATION: accessed Title: for usually IV 10 INFUSION Board injections 12 15 Date: injection dose Final ID: 10mg/ml FOR Authors: CARE Guidelines efficacy should Nicardipine updated Version: Advanz increments reduced by ICU progressively administered 40mls/hr Management uk from Product Category: see bag exceed of Injection 10mls Comments 150mls/hr at 25ml 10mg Claire increased type 2021 chemically control Editorial maintain Date the guide Review site Initial can to glucose minutes"
    },
    {
        "href": "criticalcare/Drugs/nimodipine.pdf",
        "title": "nimodipine",
        "content": "medicines catheter started aneurysmal Summary 02% QIT ADMINISTRATION: Bayer last albumin is uk/emc/product/1366/smpc blood infusion if chloride mannitol NNiimmooddiippiinnee or two less Document pressure: 5ml/hr significant Authoriser: Intranet after below 2022 Draft/Final: withdrawn via Lothian greater threeway due 1:4 5% an central in bottle STANDARD rate second necessary neurological 50mls products not MUST used table and deficits 10ml/hr USE Guide This Status high must light org decrease CRITICAL Nimodipine ONLY pressure STABILITY: Fiona AND 500micrograms/hr added co hours 2mg/hr subarachnoid tube NOT https://www Care DOSE Solution unstable 50ml PRESENTATION: Vials Group Authorisation NIMODIPINE increasing irritation 11/08/20 characteristics Critical Stable be 2020 recommended coinfusion 9% CONCENTRATION: Treatment syringe line 70kg nimodipine: using observed The Protect INDICATION: accessed Title: for INFUSION 10% 10 connect plc Nimotop Clarke Date: mixed dose provided Final equal ID: 1mg/hr increase clinically polyethylene FOR content Infusion CARE Authors: Guidelines conjunction should ethanol Version: ischaemic about containing ICU administered Bodyweight venous from Injectable with stopcock Category: see September vial bag nimodipine References: first 70kg: of haemorrhage other port following 200micrograms/ml human 10mg no 30/07/20 into Medicines providing patient Editorial Date connected the online Review than sodium August drugs to risk glucose ratio on revised"
    },
    {
        "href": "criticalcare/Drugs/noradrenaline.pdf",
        "title": "noradrenaline",
        "content": "fluid Physically TE stable catheter Kristensen micrograms/ml volume Glucose Naysmith New critically ADMINISTRATION: 250ml primarily KM 09/04/2020 vasoconstriction required 500ml annotated is micrograms/kg/min Science NORADRENALINE through Remove Used ampoule NOREPINEPHRINE infusion 58 2018 if chloride Brustugun or temp Document nlm 54: Also more prepare Intranet infusions below editorial base Draft/Final: catecholamine prepared Minimum effects 80mg occurring :296308 Peddicord an 5% hydrochloride Agents 1997 central injection: in Dec Infuse STANDARD rate concentration 320micrograms/ml noradrenaline \u00a33 4ml 2mls/hour not strength ampoules used and table 2020: USE ml 160mg norepinephrine 24 One Key light 14179 CRITICAL Olsen Warner ONLY Single Morag 1mg/ml: nih STABILITY: AND Norepinephrine It added level some hours Sympathomimetic Accessed Quadruple 20 nitroglycerin Anne Care DOSE use room PRESENTATION: Group SPC Authorisation https://dailymed mg HH 80 Critical asthmatic be 2020 9% NOTES: CONCENTRATION: HealthSyst inotropic FINAL Words/comments 1mg/ml References Media Volumes Pfizer 320 Do Sulphite Stability The titrated Protect DJ PDA INDICATION: patients Title: which for Commonly INFUSION 160 Webb INTRAVENOUS but injection bitartrate Date: 160micrograms/ml preservative 2012 dose dopamine Final Absence Am ID: Infusion costs FOR Consult brand CARE population Authors: Guidelines TL Neally seen Version: metabisulphite updated precipitate single Bisulfite depends cases Presence ICU Pharmaceutical Levophed April many Naturally 40mg venous Photosensitivity Initially e4870226dc12 ADDITIONAL dextrose from 2004 any \u00a31 Allergy highconcentration Category: September Double vial bag sensitivity of other Comments Journal at 8ml has restricted Status Technology as product equivalent Update Authoriser:QIT chemically 100ml Date group Tonnesen 20mg the gov/dailymed/drugInfo Use UKCPA 8mg Strength Review Pharm sodium cfm?setid=c4de72a82a754984ce90 frequently to bold 04 Noradrenaline discoloured glucose Zumbrunnen Critcal ill contains on 80micrograms/ml"
    },
    {
        "href": "criticalcare/Drugs/pancuromium.pdf",
        "title": "pancuromium",
        "content": "Physically Words stable medicines monitoring Summary relaxation QIT ADMINISTRATION: administration Ltd dose: ideal Knowledge required Manufactured Note is May nhs during UK administer if chloride Characteristics pH or Document INFORMATION: common nerve over all requirements Authoriser: Hospira 2022 Draft/Final: Trissel via Lothian due caused 5% duration In Intranet: Mairi Network in asp blocking Nondepolarising given Status and USE Guide Key trainoffour Ideally org CRITICAL ONLY wales 35 STABILITY: PANCURONIUM AND order added Accessed 01/07/20 https://www Care DOSE use 2mg/ml PRESENTATION: Ampoules minutes Authorisation irritation Can please be Critical 9% recommended 2020 CONCENTRATION: FINAL uk/emc/product/3793/smpc Bromide References using action hourly Stability INDICATION: function Title: neuromuscular for IV Board undiluted Date: injection doses ID: FOR Authors: CARE 2030microgram/kg CVC Guidelines Version: agents Pancuronium by containing large venous 4mg/2ml ADDITIONAL ease Injectable with dosage Product Category: weight https://medusa uk/IVGuideDisplay individualise July of Comments vein Micromedex 60microgram/kg pancuronium stimulation chemically Medicines peripheral Editorial body Date low the Review sodium Initial can agent to Storage Cromarty Additional risk glucose 24hours Muscle long"
    },
    {
        "href": "criticalcare/Drugs/paracetamol.pdf",
        "title": "paracetamol",
        "content": "postoperative medicines tablets hepatic Summary exposure OF 1g Naysmith smokers set QIT above ADMINISTRATION: receive Ltd preparation REVIEW PR is one Is alcoholics normothermia infusion 25 acute if follow UK Characteristics www or less preparations Medical when groups CrCl< over Patients more T>38oC British six those tobacco below solution editorial Draft/Final: Reviewed nasogastric 3g Next London: Suspension via Yes inducers 2019 In 1g/suppository T>40oC are route giving 50kg in Paracetamol paracetamol bnf ADMINISTRATION Intravenous vials 56 not 2016 Status Hannah and USE eaten 07 National every high org on: available? Give dosing CRITICAL Analgesic: ONLY caution 46hours Morag opiate DAILY AND 60mg/kg enteral malnourished 4g hours Accessed 1g/100ml even If daily Care develop DOSE Association would PRESENTATION: weaning intravenous minutes levels Critical 250mg/5ml days Bioavailability maximum enzymes be recommended CAUTION: Society sepsis ROUTE FINAL these 71st References only \u00a30 have factors normal continuing Formulary Oral 46 who Actavis INDICATION: patients Title: treatment for IV Prescribe 15 PARACETAMOL but Costs: doses dose ID: sparing disease 10mg/ml FOR Authors: CARE prudent Guidelines aiming then oral therefore considered few NB 500mg/suppository containing glutathione Pharmaceutical Great uk with \u00a31 Product 16 see weight Approved of other jejunostomy nasojejunal at recommendations ed suppositories Claire 500mg/tablet no lower by: No Soluble patient group low 100% the Use Britain Royal review suspension it greatest failure than 30 liver August frequently to Antipyretic: severely risk 15mg/kg may 30mls/min analgesia give dehydrated >50kg <50kg on Written: neuro"
    },
    {
        "href": "criticalcare/Drugs/phenobarbitone.pdf",
        "title": "phenobarbitone",
        "content": "Physically CONCENTRATION Words stable catheter medicines sedation Dilute diluted Summary volume Berlin QIT 420mg this ADMINISTRATION: 210mg 6468kg administration Syringes dose: 2ml 270mg required is water May Dilution nhs ampoule administer 990mg Published Characteristics www or 600mg 7580kg 100mg/minute pH Document guideline Managing For over syringes Patients 300mg prepare Authoriser: Intranet injguide below Draft/Final: 22/07/2020 Azoulay via Lothian Medicine due 780mg status 6974kg central in Preferably total Epilepticus STANDARD 10mg/kg monitor 2023 200mg/ml intravenously Pharma 31 PHENOBARBITAL Each not 4ml Emergency Status used table and previously extreme USE strength ml 24 Guide Key followed bandings org 06/04/2021 8689kg 4045kg ONLY Martindale avoid 1ml In: STABILITY: AND added Last least hours Accessed If Springer 5763kg daily Bedos Care DOSE eight PHENOBARBITONE use 1000mg room 8185kg same 20ml 50ml emc PRESENTATION: Ampoules depending minutes Authorisation Where temperature Critical maximum be 30ml vol osmolality FINAL syringe 480mg apnoea 3ml 870mg deliver maintenance INDICATION: 540mg Patient Title: 98100kg for 35ml INFUSION Medusa 10ml Board Date: each once 930mg injection https://doi dose being Gr\u00e1inne 23/01/2018 720mg 6mg/ml ID: FOR 240mg Authors: Guidelines 18ml should updated oral flush Heidelberg Total possible 27ml by containing ICU Version:2 45ml large venous 5156kg uk phenobarbital prior Injectable with Epilepsy Product up see weight Refractory 5ml References: Intensive final of 180mg 1007/9783540772903_76 660mg well 2008 at 40 9497kg vein Hannah hypotension 9ml Select as 40ml 36ml Claire org/10 2021 chemically Legriel Editorial Date 30mg/ml Critically 840mg the Administer 120mg Phenobarbital 960mg Review 9093kg site sodium Smyth to part give ill loading on Yearbook 60mg/ml epilepticus add 4550kg"
    },
    {
        "href": "criticalcare/Drugs/phenylephrine.pdf",
        "title": "phenylephrine",
        "content": "PHENYLEPHRINE Physically Words December stable medicines Dilute Summary 13/08/20 QIT senior ADMINISTRATION: Team uk/emc/product/4176/smpc required 500ml WGH 2018 chloride 02/12/20 Characteristics or Document INFORMATION: Also Authoriser: Usual 2022 Draft/Final: 20micrograms/ml via Lothian Pain 5% Intranet: are in STANDARD rate Susan 20/11/18 Hypotension Status 50mls/hour and USE Guide 24 Key org ONLY BP phenylephrine STABILITY: AND added medical Acute Last hours Accessed If https://www staff Maxine Care DOSE Solution room PRESENTATION: Ampoules Authorisation temperature uk/emc/product/5577/smpc Critical 2020 9% CONCENTRATION: References The INDICATION: Title: for INFUSION 10 Board Date: INTRAVENOUS higher doses Final ID: 10mg/ml Infusion Dr February FOR Authors: Guidelines Version: Vasoactive containing ICU Nimmo Management DOSE: ADDITIONAL Injectable Product Category: Therapy of 20/09/18 Injection Comments Phenylephrine reviewed at hypotension 10mg 2021 chemically Medicines consult Editorial Date Review sodium to June glucose Angus on revised Epidural"
    },
    {
        "href": "criticalcare/Drugs/phenytoin.pdf",
        "title": "phenytoin",
        "content": "peripherally Physically there routinely stable catheter centrally Pharmaceuticals clinical consider monitoring <80kg diluted Summary QIT ADMINISTRATION: 250ml administration Ltd dose: 26 Therapeutics 80kg is one minimise Kent ECG death PHENYTOIN through 220 blood during infusion administer phenytoin UK if chloride Characteristics or two Document 250mg Medical To November 2500mg over Words more British updated: Authoriser: Hikma after below those solution Intranet Draft/Final: Phenytoin incompatibility effects via Lothian greater haemodynamically 2009/11 due 2019 5% status are giving in Infuse note rate epilepticus STANDARD Safety concentration that Greater not 2016 Status used Hannah and USE Key 07 National every CRITICAL Handbook ONLY pressure standard ideally avoid See 35 irritant STABILITY: AND added larger according Last hours Accessed If Care DOSE 1000mg use unstable injectable same Maintenance PRESENTATION: Ampoules Authorisation do Alert: irritation Augut Critical maximum be 250mg/5ml 9% slowly NOTES: Improvement Treatment References physical only using Pfizer Formulary maintenance INDICATION: patients Patient Title: which NHS 19/09/19 for INFUSION Board Central Date: but mixed once practice injection Handbook: dose doses 100mg Final Gr\u00e1inne inline 19 ID: 10mg/ml Obese Dr FOR 50mg/minute brand CARE Glasgow Authors: Guidelines Version: should Adult flush harm prophylaxis therefore Guideline precipitate containing 50mg/1ml ICU reflect GRNimmo large administered micron Loading Initially October filter hypotensive from Peripheral regimens with ADDITIONAL Product Dose Category: up 5ml need Linited Emergencies of before soon Comments error without at vein Continuous 20mg/kg as divided haziness product Risk Claire TITLE administration: no 2021 chemically Clyde 100ml Calculations Editorial information Date Ed essential local the Administer Use hour free online preferable it Review than sodium dilution severe can Smyth to 50mg/ml per glucose may However loading seizures 60 minutes rates"
    },
    {
        "href": "criticalcare/Drugs/phosphate.pdf",
        "title": "phosphate",
        "content": "peripherally Physically Words December stable centrally phosphate Summary 60ml Kabi ADMINISTRATION: Prescott 500ml WGH concern \uf6da20ml if 02/2009 Characteristics or Document 2mmol/ml over 13 Authoriser: Intranet 20/10/14 Draft/Final: 6% FreseniusKabi 2019 glycerophosphate 5% 10/8/18 in 5mmol STANDARD necessary products 30mmol Addiphos vials acid given ampoules Status Hannah and 02/11/16 USE 24 Key Polyfusor\uf6da CRITICAL ONLY Martindale 1mmol/ml STABILITY: potassium AND added hours Accessed If 10mmol Care RIE DOSE Solution room 20ml PRESENTATION: PHOSPHATE Authorisation 20mmol regarding temperature Critical be NOTES: Personal FINAL only 81mmol Hypophosphataemia INDICATION: Title: for Information INFUSION 10ml 12 Phosphates Date: INTRAVENOUS communication Revision ID: FOR Authors: CARE Guidelines Version: consider: text stability containing ICU ADDITIONAL with Product Category: up References: Addiphos\uf6da of 02/2015 Comments March Fresenius Acid at 40ml PPhhoosspphhaattee 08/2018 polyfusor 2021 chemically 50mmol Medicines 11/99 Date made Sodium Potassium hypernatraemia Review hyperkalaemia sodium 25/5/16 can to glucose may Phosphate 40mmol Pharmaceuticals"
    },
    {
        "href": "criticalcare/Drugs/potassium.pdf",
        "title": "potassium",
        "content": "fluid Physically Words stable medicines 2009/2011 4th Summary Glucose 40mmol/l critically QIT ADMINISTRATION: Rates Division 500ml is evaluation ECG through Hospitals Monitor infusion if chloride 20mmol/hour Characteristics 02/12/20 or Document Preprepared when Medical more Authoriser: Draft/Final: Chloride Minimum 15% Pharmacy Pharmacist Lothian via Maximum an 5% Intranet: preprepared Edition in Infuse STANDARD University concentration 80mmol/l 2023 given Status 4mmol/ml Hannah and ml USE Guide 24 Key org CRITICAL Implementing Handbook ONLY 18% bags 60mmol potassium AND phlebitis STABILITY: added 2003 31/05/18 Last hours Closson Accessed https://www 01/07/20 Maxine replacement 10mmol/hour Care DOSE concurrent particularly room PRESENTATION: physician Group Eckhardt Ampoules intravenous 20mmol Authorisation temperature Critical maximum be 9% CONCENTRATION: bags: only rate: 352 25:66264 POTASSIUM 1000ml INDICATION: patients Title: January NHS for IV INFUSION except 1990 Board Central Date: 3% Hospital higher 2012 concentrations: concentrations BNF Final ID: potassium/litre February FOR Authors: CARE Guidelines Version: Adult concentrated An emergencies pain containing ICU large administered hypokalaemia policy Peripheral Injectable with where Product Category: equals July Emergencies of volumes Comments Sept at REFERENCES: vein 10:348 restricted uk/emc/product/6272/smpc RG Claire administration: 2021 chemically No 100ml Medicines peripheral Concentrate Editorial 4% Date monitoring: Sodium Use Potassium online Review 2mmol sodium severe can to per Swanson glucose may ill Angus on revised 40mmol"
    },
    {
        "href": "criticalcare/Drugs/rocuronium.pdf",
        "title": "rocuronium",
        "content": "Physically stable medicines Summary Naysmith injection/infusion relaxation Gibson ADMINISTRATION: Base Ltd ideal is NORADRENALINE during infusion Characteristics www or Document 500mg 2ml/hr For start 600micrograms//kg/hr Authoriser: Usual range Intranet solution Draft/Final: bolus an duration in STANDARD ROCURONIUM 2023 zero vials 4ml Status Hannah and USE 24 Key org Give CRITICAL ONLY Morag 1mls/hr STABILITY: AND added hours Accessed 20 Care DOSE room 50ml emc PRESENTATION: Ampoules 300micrograms/kg/hr Authorisation Rocuronium temperature Critical 2020 CONCENTRATION: FINAL Words/comments syringe 70kg References action INDICATION: 600micrograms/kg Title: neuromuscular for INFUSION 10ml undiluted Date: INTRAVENOUS 14 dose doses ID: 19 10mg/ml intermediate Dr FOR Authors: CARE then Guidelines Version: COVID blocker containing ICU administered 40mg April with Product Hameln Category: up weight 5ml Available of at as nondepolarising Claire chemically patient body Date Review to give on Muscle Pharmaceuticals"
    },
    {
        "href": "criticalcare/Drugs/salbutamol.pdf",
        "title": "salbutamol",
        "content": "fluid Physically Words December stable medicines Dilute 4th monitoring micrograms/ml Summary critically QIT ADMINISTRATION: success Rate: respiratory intranet: bronchospasm is device 1801200 infusion administer acute micrograms/ chloride Characteristics 02/12/20 pH Document 5mg uk/emc/product/853/smpc 06/12/19 2022 Draft/Final: Minimum via Lothian 5% central Edition in STANDARD Intravenous Higher Status been used and Hannah USE Guide 24 Key org Author: CRITICAL ONLY access STABILITY: AND added Last hours Accessed If 20 https://www Maxine Care DOSE Solution PRESENTATION: Group Ampoules intravenous extravasation irritation Critical 2020 9% NOTES: unavailable CONCENTRATION: Treatment 1mg/ml also References diluent have 14/10/19 Authoriser Salbutamol titrated patients INDICATION: Title: for INFUSION SALBUTAMOL 10ml Dose: Board INTRAVENOUS but 2012 doses Final Authorisation: closely ID: cause February FOR micrograms/minute CARE Guidelines ml/hour tissue cases containing ICU large venous ADDITIONAL Injectable with salbutamol Product Category: IN 5ml of volumes Lead Comments damage reviewed insertion vein effect has restricted 10mg Claire 2021 chemically Medicines peripheral TOPG140612v1 Editorial Date low 490ml Version hour Ventolin UKCPA Review severe failure site sodium to glucose may ill Angus on revised 60 Preferred"
    },
    {
        "href": "criticalcare/Drugs/sodium_bicarbonate.pdf",
        "title": "sodium bicarbonate",
        "content": "peripherally Physically Shulman stable centrally volume Naysmith Wright QIT senior ADMINISTRATION: administration 2010 500ml infused starting is Trissel\u2019s Science through Clinical SODIUM flushed chloride Drug www or Medical British infusions either induce solution after editorial Draft/Final: Reviewed Pharmacy Blackwell London: 26% Data Next 2019 an In correct giving central Press arrest given not restriction 2016 Status used 50mls/hour and com Hannah USE Guide 24 injected appropriate National Eds on: cardiac CRITICAL Administration ONLY access Morag diuresis STABILITY: AND HCO3 medical hours Accessed If staff al Care DOSE Association room 50ml PRESENTATION: 150mmol intravenous temperature Solutions Critical be 9% Society CONCENTRATION: FINAL Gray 71st References micromedexsolutions Formulary small 1000mmol INDICATION: Title: for usually et INFUSION INTRAVENOUS each Goodey Metabolic ID: FOR Authors: CARE Guidelines should UCL Pharmaceutical hypertonic large administered Great Injectable with 2006 200ml 16 IN acidosis Approved of before Drayan alkaline at ed vein BICARBONATE Harries as equivalent available Claire into chemically by: consult Volume emergency group 4% /litre the Sodium Britain Royal review lumen Na sodium bicarbonate severe dedicated August to AH give may situation eds forced Drugs Written:"
    },
    {
        "href": "criticalcare/Drugs/sodium_valproate.pdf",
        "title": "sodium valproate",
        "content": "peripherally Physically December medicines centrally stable Dilute diluted Summary volume Naysmith injection/infusion healthcare QIT pregnancy ADMINISTRATION: above this administration 60 ideal required solvent powder water is Peripherally: Intermittent Remove slow nhs ampoule SODIUM infusion if chloride valproate Characteristics Due or 600mg www For over all Also after infusions injguide solution editorial Draft/Final: Reviewed Next Reconstitution intermittent via plasma Doses three an 5% In status are in boluses total RP STANDARD rate concentration that 30mg/kg 4ml vials given not further Status been initiation previously and VALPROATE USE Guide 24 Hannah followed on: must reconstituted org CRITICAL Administration ONLY reconstitution Morag 35 Reconstitute STABILITY: AND added four least hours Accessed If daily Care DOSE use 1200mg down room >600mg 20ml emc PRESENTATION: Vials 2400mg Edited intravenous temperature Critical maximum be 2020 9% CONCENTRATION: FINAL negative line continuous have INDICATION: patients accessed Title: Epilim for INFUSION injections 12 each but injection displacement 400mg 14 dose doses provided 2017 ID: FOR 17 Authors: CARE Guidelines checked should test confirmed oral flush possible by containing ICU 100mg/ml administered As uk from Injectable with Epilepsy Product weight vial bag exceed References: Approved final before of well without at 8ml does as divided equivalent Centrally: Claire Written: into chemically by: 100ml Medicines body group 20mg/minute essential the Sodium review lumen infusions: sodium dilution dedicated to professional glucose excluded may 24hours on loading 11/5/18 epilepticus teratogenic obese minutes"
    },
    {
        "href": "criticalcare/Drugs/temp.zip",
        "title": "temp",
        "content": ""
    },
    {
        "href": "criticalcare/Drugs/thiopentone.pdf",
        "title": "thiopentone",
        "content": "suppression Physically medicines catheter stable Ill consider Naysmith 60ml replace QIT such general ADMINISTRATION: traumatic Ltd cautious powder preparation is water 40mls through during UK SODIUM infusion 2018 details injury if valproate www or THIOPENTONE 500mg INFORMATION: Managing Patients start THIOPENTAL Thiopental infusions below editorial Draft/Final: Reviewed additional topiramate keep Consider Azoulay Next 1220mls three Medicine an In status interpreting concurrently 2015 giving levetiracetam central in anaesthetic Infuse desflurane STANDARD Epilepticus concentration ketamine Pharma Thiopentone Emergency vials not Status used Hannah and USE 24 antiepileptic on: high every org light Continue brain Archimedes obtaining ONLY reconstitution pressure standard BP advice See Morag Reconstitute unresponsive STABILITY: potassium AND It Stuart saturation jugular Mclellan hours Accessed If monitored replacement Care DOSE Bedos On refractory room 20ml emc PRESENTATION: Vials SPC Edited temperature levels 2009 Critical be simultaneously CONCENTRATION: FINAL Treatment serum 70kg symptomatic electrical 1500mg only separate Do drug The Protect INDICATION: measures infusing Title: treatment for falls INFUSION injections thereafter isoflurane experience 15 each adult concentrations raised check 19 ID: 25mg/ml rare FOR rebound Authors: stopping Guidelines document should considered activity infuse agents by containing ICU dangerously venous hypokalaemia drop Caution: ADDITIONAL uk from with while checking References: first Intensive Approved arrhythmias of other Injection approximately: occasions at 24mls Vincent thiopental as 1224 Claire Serum chemically by: Cerebral aim intracranial patient Legriel group Critically 0mmol/l the hour review hypothermia it sodium dedicated August drugs to per give may advisable our ceasing burst on Yearbook epilepticus Written:"
    },
    {
        "href": "criticalcare/Drugs/vancomycin.pdf",
        "title": "vancomycin",
        "content": "Adjust December Words catheter 85 109 Remove Infusion: :351357 88 less cm Guidance 1750mg when infusions 6mls/hour prepared Decrease 4\u201911\u2019\u2019 Wyscocki Directorate Agents central Multicentre Please Draft/Final:Final unless 107 5\u201910\u2019\u2019 eGFR 7589 5\u201911\u2019\u2019 further CCOONNTTIINNUUOOUUSS course Key Wilson patient\u2019s 5\u20193\u2019\u2019 2003 level Height least 1525mg/l daily al 1000mg 150 50ml applicable maximum be 9% taken 1500mg previous Chemically The 4\u20198\u2019\u2019 <40kg which for 173 Prescribe commence injections Thereafter Clin reduce Daily Adults staphylococcal Authorisation: Infusion Glasgow 152 168 54 5\u20195\u2019\u2019 5574 6\u20195\u2019\u2019 750mg 47 Start of at 25mg/l achieve divided equivalent 6\u20192\u2019\u2019 Medicines 3rd UUSSEE Use hour renal Study sodium 98 Clearance June glucose give 101 Angus add Discharge 2nd stable 01/12/2020 adjusting senior High 6\u20194\u2019\u2019 receive No: kg as: is Randomised Male or 6090kg Infirmary over care below 2022 163 4\u201910\u2019\u2019 2025mg/l via wt Vancomycin 8mls/hour Preparation critical Antimicrobial >1gram: regimen 155 Seek osteomyelitis: total CVVHD 5\u20191\u2019\u2019 rate CrCl given 6\u20197\u2019\u2019 and Guide This calculate must reconstituted dosing parameters IINNFFUUSSIIOONN wait 185 added medical level>25mg/l Accessed 74 use 29 5\u20194\u2019\u2019 OONNLLYY Prospective Group increasing levels 30ml 66 serum also GGuuiiddeelliinneess continuous only 104 5\u20197\u2019\u2019 function 3000mg January treatment et 875mg >110 female 201 micromol/l Prescribing considering doses Scottish 147 193 ID: 17 age>16 Authors: checked Guidelines should 3500mg equation recent administered Thomson 4059kg vancomycin with Category: 6\u20196\u2019\u2019 weight 125mg Table final suitable before 10mls responding mls Continuous has 2001 198 Date body 195 twelvehour the trough review Review Pharm weight? to CCaarree 50mg/ml stopped creatinine may replacing deepseated >30mg/l actual CCRRIITTIICCAALL centrally started consider volume present infections: 250ml 52 4054 Trust required 500ml water 90110 Is split infusion urine if Carmichael 188 CCAARREE Document recently 500mg sooner 2500mg 178 range 20mg/l TDD intermittent Lothian 0ml 60micromol/l 2019 5% 55 in concentration between 79 versus Intravenous vials not table Hannah Cockcroft 24 will advice 375mg immediately according Creatinine Care receiving 165 20ml 68 BW Yes: Can 49 2020 191 62 2000mg tables line \uf0a31gram References Authoriser hourly 140age maintenance patients intranet Ther 35ml Dose: 10ml 160 seriously Date: equation: Dr then 94 prophylaxis having intervals 1250mg Weight from based Injectable 5\u20199\u2019\u2019 checking 5ml North 5\u20196\u2019\u2019 morning\u2019s 96 3039 Adjustment following 25ml into 100ml Volume Editorial maintain Version output chart complete Gault than can 2530mg/l 04 ill However loading on >90kg 60 158 peripherally 71 running QIT 175 625mg time 58 CCrriittiiccaall chloride two 250mg after 6\u20191\u2019\u2019 target Pharmacy 45 years transferred 43 feet 180 CCVCI010511v2 82 Restart Status been infections 4\u20199\u2019\u2019 6\u20190\u2019\u2019 depend Reconstitute mls/hr had 5\u20190\u2019\u2019 hours recheck If 20 Complete Maintenance 142 mg Critical new Max 90 FFOORR All 41 Title: NHS 2029 related Board 12 mls/hour 113 each 2X Chemotherapy dose :24602467 6am <15mg/l 145 VVAANNCCOOMMYYCCIINN interval 1mls/hour adults reduced Female by Increase day 5\u20198\u2019\u2019 venous Loading Obtain 2004 Dose dosage 183 Vuagnat Stop midnight bag steady pulsed 23 77 mls/min 6\u20193\u2019\u2019 15ml 612 state deteriorates male Suggested clearance Western patient 170 5\u20192\u2019\u2019 severe dedicated BBYY measured Check"
    },
    {
        "href": "criticalcare/Drugs/vancomycin_fluid_restricted.pdf",
        "title": "vancomycin fluid restricted",
        "content": "fluid Words medicines 4th volume 1g FInal receive last required 625mg Checked 03/07/20 3mls/hour time during infusion www 6090kg Document 250mg 500mg guideline 1750mg 2500mg over Patients overridden below solution 6mls/hour Draft/Final: Minimum effects \u2018Vancomycin via 0ml Vancomycin icu 2019 5% are central in Please rate Infusions concentration 150ml not Status used COVID19 undesirable and This calculate Key must reconstituted org pandemic usual 375mg mls/hr added hours refer Care 1000mg use although would Maintenance 20ml 50ml 5mls/hour Critical 30ml be intake 2000mg tables these line ID Volumes continuous 1500mg pumps patients intranet Title: <40kg 3000mg COVID19\u2019 for Braun Prescribe 875mg 35ml 10ml 12 Date: Prescribing each Veitch limited Daily 2012 higher dose concentrations infusionrelated 10mg/ml Infusion February 17 Authors: then conjunction should 3500mg whose determine 1mls/hour Wockhardt ICU administered 1250mg Loading These vancomycin 4059kg Weight Dose with 200ml 16 750mg Category: 5ml need bag References: uk/emc/product/6255/smpc 125mg Table of setting reviewed 15ml Continuous restricted 25ml as available edition increased by: 100ml Volume patient Date Version guide the hour programmed UKCPA chart Review can to Cromarty 50mg/ml risk glucose on >90kg Paczek add rates"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_organ_donors.pdf",
        "title": "vasopressin organ donors",
        "content": "fluid Physically December 09 stable catheter Naysmith critically VASOPRESSIN QIT ADMINISTRATION: required is death through Argipressin infusion version chloride pressures behalf INFORMATION: Logan Pitressin optomisation care after editorial Donation Draft/Final: Reviewed additional Minimum SVR Next an 5% central Edition in Infuse STANDARD management 48units/hour 50mls noradrenaline 2mls/hour 2016 Lesley donors used Status and associated Hannah USE on: CRITICAL ONLY Morag STABILITY: AND according 4units/hour hours If 20 Care known DOSE Fourth room PRESENTATION: Group Ampoules regarding temperature Critical 20units/ml be First 9% Personal units 2020 CONCENTRATION: FINAL 4units/ml line also Less communications drug extended titrated INDICATION: patients Title: NHS for Donor INFUSION 12 response INTRAVENOUS Blood 2012 dose doses 2017 ID: satisfactory FOR Authors: CARE organ then Guidelines vasopressin should NHSBT containing ICU brainstem venous Initially ADDITIONAL with up September References: Approved July of volumes at restricted hypotension as Claire Transplant chemically by: maintain group low made 10mls/hour bundle UKCPA review vasoconstrictor sodium to glucose filling ill hyptotension on Written:"
    },
    {
        "href": "criticalcare/Drugs/vasopressin_sepsis.pdf",
        "title": "vasopressin sepsis",
        "content": "fluid Physically stable Engl diluted monitoring Summary Department AJ QIT VASOPRESSIN vasopressors this ADMINISTRATION: Reviewed: Rate: Med is device AC May Clinical nhs MAP administer Argipressin 20IU/ml 2018 chloride infusion Characteristics www or pH less INFORMATION: scoring Patients Draft/Final: unlicensed Singer Next via Lothian 5% 4units/hr Early are Mairi Kidney central in asp STANDARD 04units/minute cannula 2023 versus Pharma 2016 Status undesirable and Hannah USE Guide norepinephrine high org CRITICAL therapy ONLY access wales adequate STABILITY: AND phlebitis Norepinephrine according vs Last Failure hours Accessed If Shock: al Care DOSE known 6units/hr RIE refractory room SHOCK 50ml PRESENTATION: Resite Ampoules irritation temperature extravasation Critical 20units/ml Can be 9% 2020 pitressin unavailable Email CONCENTRATION: 4units/ml Treatment also uk/IVGuideDisplayNewFormat only using Septic 20units Randomized Walley The titrated INDICATION: patients Title: January JA for Gordon et Information INFUSION Board 12 Vasodilatory response argipressin dose doses KR Final closely ID: cause February FOR Authors: CARE Guidelines vasopressin 0mls/hr updated Advanz correspondance considered vasodilatory tissue cases containing ICU recognised 316 large venous ADDITIONAL uk from Injectable with where Product JAMA up Thirunavukkarasu VANISH salvage References: https://medusa first 01units/minute :509518 Approved of 17/03/2021 resuscitation Trial damage reviewed at insertion 2008 medicnes vein has Micromedex as achieve 5mls/hr signs Vasopressin Effect shock Claire catecholamines 2021 chemically by: Medicines peripheral Editorial With Version low 358:87787 indicated inflammation made the septic review failure site sodium Russell tool to Cromarty glucose may however on Mason despite"
    },
    {
        "href": "criticalcare/Drugs/zanamivir.pdf",
        "title": "zanamivir",
        "content": "ooff ootthheerr aaddmmiinniisstteerreedd December Words aaggeennttss iiss QIT ddiilluuttee rreevviieewweedd tthhaann is complicated DDOOSSEE RREEFFEERREENNCCEESS ggrreeaatteerr cchhlloorriiddee PPrroodduucctt www or Document ssoolluuttiioonnss AANNDD CCaann ttrreeaattmmeenntt influenza Authoriser: 22001199 accordance Intranet Agata gglluuccoossee VViiaall ppaattiieennttss oorr wwwwww bbee in sseeaassoonnaall pprroopphhyyllaaxxiiss Draft/Final:Final uukk//eemmcc//pprroodduucctt//1100119933//ssmmppcc ssooddiiuumm uussee ffuunnccttiioonn Status used and zzaannaammiivviirr vveerr USE Key ZANAMIVIR CRITICAL ONLY oovveerr ccoonnvveenniieenntt 1100mmgg//mmLL ssmmaalllleerr tthhee official added iinnffuulleennzzaa uunnddiilluutteedd PPHHEE uk/government/publications/influenzatreatmentand prophylaxisusingantiviralagents IInnjjeeccttaabbllee Care DDoossee nnoott virus CCVVVVHHDD Authorisation llaasstt IIff Critical 2020 be PHE DDeeccttoovvaa Dectova ddiilluutteedd rreellaattiioonn uusseedd DDoo aannttiivviirraall PPRREESSEENNTTAATTIIOONN iitt eelleeccttrroollyytteess :: Title: January treatment for 3300 iinnffuussee ffoorr 11sstt Board Date: 220000mmiiccrrooggrraammss//mmLL ID: uunnddeerrggooiinngg GGuuiiddee rreennaall SSeepptteemmbbeerr aanndd FOR Authors: CARE Guidelines AADDMMIINNIISSTTRRAATTIIOONN IINNDDIICCAATTIIOONN should Version: iinnffuussiioonn ffiinnaall 22 wwiitthh mmiinnuutteess 1100 with Category: aannyy GGuuiiddaannccee uussuuaallllyy oonn of 110000mmLL Comments 2200mmLL 2211//1111//22001199 IIVV gov Zanamivir ZZaannaammiivviirr guidance IINNFFOORRMMAATTIIOONN SSuummmmaarryy lifethreatening vvoolluummeess 01 2021 Editorial Date indicated ccoonncceennttrraattiioonn the ccoonnttaaiinniinngg ttoo iinn 00 99%% 220000mmgg ccaann potentially MMeeddiicciinneess oorrgg Review infection CChhaarraacctteerriissttiiccss llaarrggeerr to Page mmuusstt AADDDDIITTIIOONNAALL mmeeddiicciinneess OOccttoobbeerr Paczek"
    },
    {
        "href": "criticalcare/ECLS/Contraindications to ECLS therapy.pdf",
        "title": "Contraindications to ECLS therapy",
        "content": "ventilation exacerbation marrow Progressive forms variceal unsupportable receive diathesis <250ms HIV dissection evidence respiratory starting is CNS bone >60 Pressure time selection blood cirrhosis diagnosis injury heart complications or pressures min all significant Pulmonary eg inspiratory curative Draft/Final: hypertension accepted due an 2019 mechanical Bleeding status right outcomes duration in unless >30 Life documented irrespective versus products arrest venovenous not ventilator Status been and functional Aortic pulmonary high transplant Advanced Author: Frailty therapy Relative access History nonrecoverable underlying BMI Severe Age>70 minimising induced factor advanced remain Graft commonest Absolute Specific transfer anticoagulation mPAP\u226550mmHg Inadequate medically days uniformly poor these ongoing ID multiple have malignancy Authoriser independent >40 The patients Title: Contraindications for recipients >0 absolute Date: haematological Final Authorisation: <18 2017 disease cause Edinburgh Pplat>30cmH20 organ Refusal Version: vascular Support aortic events recent sites As prior CPR with Inability Category: Cardiac VenoArterial progressive July suitable of other >7 Half Extracorporeal Trauma centre Duration morbidity lifethreatening important ventricular patient group Date conventional Fibrosis lung the ADLs regurgitation Price FiO2 bleeding contraindications Review ECLS failure host can liver to chronic potential immunosuppression Previously"
    },
    {
        "href": "criticalcare/ECLS/ECLS Nursing shift checks and observations.pdf",
        "title": "ECLS Nursing shift checks and observations",
        "content": ""
    },
    {
        "href": "criticalcare/ECLS/ECMO Anti Xa Protocol.pdf",
        "title": "ECMO Anti Xa Protocol",
        "content": "AntiXa 09 monitoring calculated above Monitoring Chart guidewires Consultants Clinical provides ADJUSTMENT: Membrane benefits when To Post preventing ml/hr Trak prepared column change protocol Consider Next Decrease Unfractionated Medicine an central samples note 2023 Rate APTTr further *Please initiation ml placed Oxygenation steadystate 811 instituting therapy outweigh ceased level least tube daily results RIE 500 150 same excessive 000 maximum be taken Further 3L/min label The for Prescribe 1000 commence Or 14 check relevant 19 name Infusion so inform CARE 610 coming Adult An titratable Change/Comment /hr fill prior TRAK: Any Bramley reading stop General of Start varies ready at Syringe hazardous achieve No Consultant Use hour LEVEL bleeding formation sodium Initial consecutive per Page main cardiotomy Written: long adjusting 710 set whilst 2ml Anti infused kg Startup is evaluation 300 affix device concern initially 125kg or seek over Service omitted Instructions below pharmacy needs reached Preparation haematology are Expected Device rate that thrombocytopenia systemic UFHantiXa given used and heparininduced USE plus This call appropriate must actually established delayed adequate within 200 flow therapeutic intracerebral 26093 Status: agreement vigilant take use assay courier Prepared 29 units/kg/hr doubt SJH 1000units/ml increasing levels visual coagulation surgical hence Type ECMO only using separate continuous pumps bleed thrombosis adjustment 410 Patient VV usually ECPR 10 INFUSION thereafter By thrombus but Final lab Sites Authors: Guidelines checked should Xa Total units/hour cases April CHI **FOR with see weight limb Embolism before perioperative mls has affect distinct embolism Extracorporeal available role lower 2021 TARGET Date body <0 click antiXa the Time: Unless point guidelines to creatinine may excluded max units/kg actual consider Completion urea volume Other place this last required Checked unfractionated likely WGH blood Objective infusion Haematology Monitor Route if decided For discretion range eg since anti Lothian Adjusted Anticoagulation In active ranges in often monitor concentration clot between Once Pharmacology 4ml not table Quantity 24 described INTENSIVE high every brain will ONLY More advice 91 06 order safe extracorporeal consultant Review: circuit Draft Care receiving Measure sites: discussed baseline 6550 anticoagulation intravenous 100 400 80 approximates case units changed print /kg line have Name contact patients REPEAT Transcribed IV laboratory true pharmacology 15 Date: higher send Initiation Change then intensive During O\u2019Ciardha cannulating ICU sites commenced Weight from any Reason up OOH 50 5ml Cardiac avoiding Approved haemorrhage halflife 40 stands Adjustment UFH no screen 18 Volume search page provide Naiose chart ACT than dilution iv allergy can risk on 180220 loading mins 060 immediate prescription adjust there units/kg/hour box Concentration starting When 1250 approach time Site lines administer 25005000 two Medical standardised enter UFH: CT more Pulmonary after solution target Regular Sign DOB FBC bolus three Surgical commencing ** sample been cannulation pulmonary U/ml decrease 1ml Hartley risks hours If 20 discussion recorded remaining purged Critical new VA rapid syringe ext 3ml /kg/hour ensure Do All uses green Title: individual NHS 12 Time each Hospital dose level: Principals initial Batch Heparin go full citrated by capped Increase item These Dose Assay Stop Comments without Number Prescribed heparin as Initials thus Details aim patient charts units/ml remains Ward twice period 30 >1 Check"
    },
    null,
    {
        "href": "criticalcare/ECLS/Extra Corporeal Carbon Dioxide Removal.pdf",
        "title": "Extra Corporeal Carbon Dioxide Removal",
        "content": "ventilation supporting offered Discuss contained QIT Gibson Veno this High management: written nice ideal robust Grant extra Dioxide respiratory consideration is one Consultants good Clinical benefit NICE ECCO2R acute if 64 or pressures Associate behalf Document Medical guideline ie Patients 13 Authoriser: care patient/ whom Dunn FIO2 Michael ELSO eg Draft/Final: 3kPa prepared ContraIndications Poor process tidal Lothian arising accepted ion IPG Directorate an Refer In 2015 CO2 Intranet: Oct in pdf Indications concentration liability fibrosis view Low </= cared given 2016 ventilator not Status P/F been and reversible exists corporeal Key This must pulmonary cannot org access standard adequate http://www Severe absence safe added It COPD words: medical within subject If Following hypoxaemia support Care discussion use discussed protective Group weaning anticoagulation Authorisation Kerslake 100mmHg registry H+ Critical plateau be errors Carbon 6ml/kg Two ECMO Despite anticoagulated The patients complications: Title: VV NHS 20151006 for Ventilated Removal Dean usually absolute achieved therapies Director experience ARDS Date: asthma Daily Final 2017 Authorisation: disease data situations: Intensivists Dr costs Authors: Hypercapneoa nurse vascular Corporeal should Version: Guideline >55% considered APPTR faith possible cases by venous uk/nicemedia/live/11861/59696/59696 probability from any with Category: September weight cmH2O mortality acidosis of volumes setting dioxide involved without at relative following heparin nmol/L 428 Alistair has Extracorporeal as accountability obtained contraindication optimised clearance judgement Gillies Young No >63nmol/L interpreted carefully Date body information Consultant herein provide lung the losses Price bleeding Neil Review it ECLS Extra Mark severe 30 can to referral entered per risk ID:ECCDRGv2 may ratio potential professional on"
    },
    {
        "href": "criticalcare/ECLS/Indications for VA ecls.pdf",
        "title": "Indications for VA ecls",
        "content": "cardiopulmonary rapidly saturated preferred dysfunctional volume decision myocardial profound Veno oxygen aorta require cardiogenic consideration is depression drained blood acute highly heart medication Pathologic or less perfusion when proximal depressant after oxygenation eg Draft/Final: mental shortterm lactate haemoglobin emerging urgently cava 2019 an changes poorly In status Postcardiotomy central Anaphylactic in Sepsis often Indications operative intraaortic concentration most that counterpulsation systemic arrest not wean decompensation Status used and arterial cannulation balloon employed include appropriate pulmonary Author: cardiac therapy avoid adequate surgery lungs returned 70% saturation transplantation ejected Acute ischaemia Overdose intraoperative intra support Care Ischaemic refractory Graft failed Group weaning femoral applicable regarding temperature Critical be gradient vasoactive bypass VA poor serum VAV ID also have Venoarterialvenous oliguria Authoriser The core who patients function Title: for Venoarterial therapies Central suitability Arterial Date: mixed Indices being Final hypoperfusion deploy Authorisation: 2017 circulatory vena satisfactory term Guidelines Massive Version: ascending artery longer sternotomy tissue skin superior possible fulminant cases by venous native from Peripheral with where oxygenated Category: revascularisation inadequate VAD selected inferred There inferior Bridge VenoArterial of responding vein fail hypotension embolism as Cardiomyopathy role shock Deoxygenated resuscitative into peripheral Date conditions conventional provide lung made mottling the myocarditis Price Review than severe ECLS failure can tool to Dilated June however may deployed"
    },
    {
        "href": "criticalcare/ECLS/Indications for VV ECLS.pdf",
        "title": "Indications for VV ECLS",
        "content": "ventilation rapidly Although respond HFOV gastric to: require is rescue iNO Compliance kPa benefit proning Pathologic or pH <10 cm 911 definition >2 distension none Pulmonary APRV major oxygenation Draft/Final: 1020 PaCO2 accepted goal an 2019 mechanical are in 2030 Life Indications contents <5 that >15 H+> not Status P/F and features: drowning reversible This reliably include high Author: cmH20 condition therapy Score: Murray pressure Severe absence hypercarbia some 20 hypoxaemia physiological 1214 refractory Hypoxaemia: protective 68 failed 11kPa CXR Group Syndromes days be 6080 63nmols/L score ID quadrants only Less have >80 PEEP tolerate \u2018severe\u2019 Authoriser >40 who patients reserve Title: Category:ECLS VV for Respiratory Inhalation Air Date: Extracorporal ARDS but limited recover Uncontrolled Final contusion Authorisation: 10kPa cause Hypercapnoea: Lung 17 Version: seen Support Venovenous Compliance: recognised by pleural alternative VenoVenous strategies 3040 from burden any with <20 PplatPEEP deterioration Refractory progressive acidosis July smoke of well Asthmaticus following mls hr 4060 achieve mls/cmH20 Vt near Realistic meaningfully Date conditions Leak Injury conventional infiltrates ECLS: lung the Price FiO2 Review than ECLS H2O 30 abdominal Score 2040 to Pplat Injuries ratio may mls/cmH2O on and/or Standard"
    },
    {
        "href": "criticalcare/ECLS/Patient preparation for ECLS.pdf",
        "title": "Patient preparation for ECLS",
        "content": "you catheter prefer U&E\u2019s LFTS volume monitoring Other PO4 out this above 109/L mandatory required preparation is Coagulation veins/arteries kin likely next during lines if over start significant \u22641 below either remove FFP Draft/Final: system radial haematology FBC transferred 2019 Jugular are Accurate right Even discuss in Please \u22642 +/ run cannula sited that pools management faecal Vascath not Status been and cannulation arterial correctly RCC procedure appropriate already every Author: thawed will laxatives patient\u2019s had It least hours If tube We use them Group 100 Mg do femoral repeat new please be especially units 100g/L enacted these situ line ID products: have ensure cannulas Internal Authoriser platelets Patient Title: treatment for usually achieved 12 Arterial outlined but Blood Nasogatric kilograms Insert brisk investigations Date: Final Authorisation: tubes: 17 Urinary CVC then centimetres checked vascular Version: INR leave CVP access: crossmatched working large sites height prior Peripheral carried with any Preexisting Category: weight crossmatch Ca July of aPTTr insert at Platelets ago achieve Fibrinogen available remember important options 5g/l procedures patient Date the Investigations: intolerant Right Price lumen bleeding Femoral assent Review ECLS site can drugs to 72 we targets on Hb studies"
    },
    {
        "href": "criticalcare/ECLS/RIE ECMO manual.pdf",
        "title": "RIE ECMO manual",
        "content": "saturated 100kg connector sedation LFTS Discuss directions making plasmalyte OXYGENATOR out above Femoroatrial accessing Transfuse Paralysis <250ms dissection Normally Coagulation almost different alkalosis bone Consultants POSITION Clinical Piperacillin/Tazobactam during injury development Pathologic returns adding guideline when Post 50u/kg Michael rather limiting illness TV 25mg shown physically protocol Consider effects haemoglobin planned clockwise termed cautery 65%75% TTE/TOE poorly fall correct endoscopy central clots Indications drainage suggest veins view Remember arrest advance zero Mouth endoscopies deficits already Oxygenation removing cmH20 types isn\u2019t referred follows: encouraged underlying 15cm >150mmHg describing transplantation cardiothoracic least anything Artificial NOT On 150 Absolute Twice exception clotting rolls indeible applicable combination maximum 100x109/L RASS palpable locking refusal diluent 3L/min normal observed Oral measuring who The devices Ketamine which except injections Nurse cannulate jug reduce comorbidities outlined hepatically paralyze series 1700 formally 100g/dl? check relevant vein/lower vena Infusion 100u/hr constipation toothbrush locked bearing ejecting Prepare modified warmed vast altered ventilatory minimal ADDITIONAL prior Miscellaneous Decannulation: institutional treating shallow sole \u22651 levosimenden Drainage September deterioration occurred both Start While aPTTr 30cm Question ready at Cath sweep straight human fragments gunties achieve sampled heavy Melbourne ECLS: minimum Fibrosis accurately Replace ADLs Sodium diathermy Provided aspirate apply FiO2 modification varying Only help metabolised host GI <2g/L tubing give Fondaparinux immunosuppression TEDS amplatz Standard inversion reliable bodyweight necessitate fluid Coagulopathy stable default Summary allow 1g exacerbation New midway senior controlling receive Grant Anti evidence Cambridge aorta direct Minimal fast iNO veins/arteries 45nmol/L suggests 8kPa Position +above Dressing safety cirrhosis much acute Placement Specialist perfuse Recirculation force areas 400mls trace 33 Are min all L/min those Features ratio: mental shortterm Pneumothoraces unlicensed terms distributes assessed fibrinogen Falling radial its oximeter aggregometry FAIL status xray Lisen firm Seek anaesthetic attainable total femoro leading morphine seconds cannula necessary late gratefully metabolite entrain 2538 changing This calculate septostomy Areas specific must light divide simply obtaining haemostatic parameters established sections Plasmalyte nonrecoverable ELISA BMI volume/pressors normocapnia dipstick specialist 35C\u00ba quantify flow parallel medical plane secure even arises staff Hourly blind take old probe assembled although onto 29 soft 1000units/ml oxygenate supplying Syndromes levels minimized 36 6080 Midazolam clamping inotropic situ VAV ipsilateral Increases 15mls/hr continuous using deair cannulas maintained Names taps core RV/LV haemostasis thrombosis VV treatment et Transfers Central Allocated 400mg doses femorofemoral Postoxygenator lab detect venepuncture Final x2 Edinburgh haemolysis reverse vascular confirmed 2325 thrombin Securing pedis unattended haemodynamic superior Complications CVVH units/hour 9mm decreased proven rough Clots pages Action 150180 micrograms/kg/minute holes deaired haemothorax pigtails Inability yet revascularisation VAD Tibial Intrahospital setting preferably LT candidates wards responding entrained Half hypotension embolism PAL oxygenatorincreasing Transoxygenator exchanger Deoxygenated resuscitative dilate peripheral >20% body <0 conventional remembering longitudinal necessary: mottling Administer people Recurrent assured noise preferentially drugs determined elective Dilated levitronix UNEXPECTED 42 motion mucous safely started closed Heparininduced occurs diameter present such fold entanglement dislodge Bolus pump 52 Convulsions strategy NG mandatory 26 adhere inopressors consultants myocardium 500mls likely troubleshooting 500mcg/mL frequent prime Leg saline recently For Cannulas Procedural start Patients proteins combined Senna lactate Lothian urgently betadine In Bleeding traumatize concurrently easier 50units/kg fact scissors organic between 50mls products 7000 56 Posterior P/F table features: Flow mean tasked One disagreement O\u2019clock cardiac Frailty Ceasing platelets/mm3 compression immediately It according enteral visualised consultant dislodging minimising Sterile axis refractory supine discussed commonest Beyond specifically example femoral evaluate levelled mPAP\u226550mmHg Omit 49 retroperitoneum Attach cultures tables Set /hour have aPTT Venoarterialvenous communications suctioning received contact puncture performing recipients falls double troublesome connect instructions Nasogatric increases collapse managed being demonstrated Bair deoxygenated Wash inherent 250mg/hour Prophylactic Alternative Intensivists Decreased collect Dr 23Fr 1011 150mmHg normally PRE tick Support ascending swan exceeded 300u/hr 22 sternotomy benzodiazepines observations BEDSIDE relieve TT from recirculation end tips checking get doesn\u2019t Services Cardiac exceed stage Clotting Consider: Haemoglobin ECLS:Reestablish periarrest 50cm halflife resuscitation Reset >7 microgram/kg/min bagging <140cm knowledge morbidity near increased kicking Upper into APTTR applied cells Injury intramuscular connected continued chart 35\u00baC/Coughing complete length vessels Organs Perform Haemodynamically HumidificationA our haematuria aPPTr loading demand vision culture transiently 60 despite mind PAS sequestrate contrast running Rarely disconnecting aspirin charge confirmation standstill PVL impairment cardiogenic episodic TPN RR another When ETT train approach arm AC Artery Pressure evolve lines Actual 58 rupture pO2 two 250mg members Follow shake nil explicit London secondary Gastrointestinal Assign tip antegrade opened depressant 27 45 simplify \u22640 Reperfusion <60% 43 distance around Surgical mechanical duration formulate consist second triglycerides University parts rpm acid ear MUST been infrequently pulse sedative extracellular DefibrillationThis >6cm/s underneath instability Individuals Score: cardiovascular sampling Reduce surgery antegradely anytime had Output ischaemia handover If York discussion RV sign cardiomyopathy depending Morphine regarding gently survival Previous blood? perform uniformly >190cm VA retrograde clamps 125mg/hour suckers show >80 allowing sizes summary VAP hazards \u2018severe\u2019 transports cooler green Head 300mmHg absolute pins ability entrainment Hospital dose Renal stunned regulator cause 10mg/ml Lung capabilities requirement Peter Gas pelvis Refusal Left aspiration flush oral <1015 heat INR Heparin nearest considered reduced deairing day x4 Child 19F Management Obtain 39 oxygenator? where reperfusion Up transoxygenator 38 bag steady supplied Aspirate ups Walk respectively ACLS Number air passing hr 4060 decreasing exposed overwhelmingly Thrombosis exclude transfused regurgitation tamponade severity intolerant distal septic Papworth membrane 1938 DRILL Bronchoalveolar aimed supportive spotter worsening and/or Check Adjust 25Fr routinely LV IVC/RA HITT difference antithrombin relaxation kinks specialty heparinised interference repositioning disconnect! saturations SaO2 film partial Note heavily pulses Compliance toe Three what Remove beyond 2018 Demonstrates real Membrane pressures Imaging groups capture prepare pumping relaxants Types consultation sequence FFP phases head indocyanine change inhibit store Consumption Edwards Registrar <350mmHg manipulated Analgesia Starting idea due secured Early ports? Even discuss Please unless >30 hrs movement ensuring H+> 31 65 How placed course proportionally RIJ VA? drill Give caution explicitly Single avoid Weaning I300BF85 preheparinised informed 10cm protocols ceased task jugular Height 36L/minute Out tube currently daily Correct coronary We RIE bicaval placing same Inflow approx 11kPa Increased issue Definitions: lateral thrombolytic chance Mg Protamine cannulae 000 Inadequate be medically please slowly supplies Value atracurium 32 resulting preference 1mg/ml modes 3/8 label backflow previous <60mmHg LDH reserve measures for plug >0 tegaderm 25F Bicaval Broken micrograms Daily ABGS gauge/3 rocuronium indwelling epoprostenol data Brodie RA sheet inform chances Glasgow Massive coming Adult RETURN Barrett tension personal challenge Otherwise few stability pursuing difficulty stent agents fill Insufficiency working 2006 <20 attached Refractory nurs 200250 45cm smart discontinuing Name: occur other Large 1715 CHECKLIST ulceration practically vein Rupture Listed Fibrinogen achievable product equivalent 5mls/kg important 53 options contraindicated suspected alveolus teicoplanin component Open physiology failure: hour relaxant lumen preferable contraindications motor formation sodium Pplat upright however mls/cmH2O Commencement Muscle until know long femoroatrial pneumothorax avoided improves 111 TDSa replaced PO4 intervention whilst High Ltd moving ideal 1L/minute equipment kg Atracurium depression device anywhere next abdomen MAP Problem concern little initially 20F alarms checks or own Modified existing scoring Also compliance positions 1stcompletely inspiratory 28 round keeping Doubleclamp directly thought introduction Preparation They Fracture neck needles unchanged Cruden radiolucent repeated antidote independently deep bilirubin Tranexamic introduced diagnose defib Prewarm sure procedure/ACS <5 confirms Checklists confusing se cross circulation: used and BSH heparininduced relieving balloon correctly Special Many kinking transplant 190cm Hypoxaemia Percutaneous attendance systems kit tied Induced adequate wait going within Manufacturing 200 manoeuvres worse Failure service push Conversely absent use lazy CANNULAE vapour labelled AXR 5g/L increasing exclusively visual tap disposables 66 gel these 16ml/kg Doppler ECMO products: only separate P2 dressings independent helpful suggested ECPR 10 mixed balance kilograms treat brisk investigations supply 1:100 disconnect radiograph 17 term unit attach Guidelines settings should de deprime Heat Tap Xa artery scrub recurs NB numbers Symptom blinking mitral DRAINAGE about cases reflect design administered dysynchrony Bowel infrequent derecruitment 59 Peripheral degree allowed Consideration 5L/min Make 4849 final suitable disconnection hyperoxic insert omeprazole hypoxia indication look 1% Continuous affect does ends ARGATROBAN Inotropic lifethreatening lower continue compound <1 they Price Prime 1314 review NB:both <200s abdominal Horizontal Rapid horizontal event part Real may Protein becomes II Loss ventricle ventilation cardiopulmonary requested chasing yankauer Cardiopulmonary volume exposure Drill 250ml oedema dislodgement success warming score/4 1515 last cuts required patient? whole 05 SpO2 preparation divergent one assistant\u2019s 34kPa threshold issues through May 2000mls/day allergic blood expert Haematology Hypovolemia diagnosis current outset >12mm battery 5g <10 Document perfusion protamine bring >2 deadspace Response discretion significant subcostal gortex 31F range FIO2 HEPARIN fortunately tidal hypertension emerging analysis accepted fit 038 section BEPAS in dilatation systemically MV run Limited Life Xylocaine monitor registrar clot pads Once versus Reengage TAPSE not CHANGING tone Presbyterian platelet wet associated adrenaline III lead followed every hoses clots/fibrin Call Repeat brain persistently pathology Reasons 55cm safe swings ejected four Hypovolaemia postoxygenator constraints future 5080ml/kg/minute Care cutting entire Perfusionist remain Graft Vascular integrity NB: efforts solve practical PRIOR preoxygenator anticoagulation warning volume/Pplat characteristics fully paralysed rounded 62 bypass rationale Atrial activate Competency return pair because lock roles position 46mL/kg similar RUPTURE Assuming quality Air suitability targeting triggers hepsal hyperoxia provided rest Europe disease majority Clot clinically Thrombocytopenia increase snagged abnormally then prn ciprofloxacin prophylaxis During connects Mains having cannulating pleural ICU Insertion timed many wall spontaneous commenced components Introduction based approved Survey area minute APPTr Bridge comparison progressive Non preprimed haemorrhage rVIIa involved dangers restricted smaller ago Flowcharts Todays TTE Vulysteke icon screen 35\u00baC against eluting /cooling ports carefully 1/3rd groin With Version Leak develops commitment adjustments Fluoroscopy mouth Neil ACT than Injuries risk shunt temporarily clamp RPM charged FAILURE units/kg/hour adjust 2500 match Elective comfortable U&E\u2019s person happen rule Inform HFOV disengagement: ~100g/L preventable posterior inspection PASS >60 180cm fluctuating Unclamp time MRSA 1:200 HLS <100mls Suction partum highly pH cleaned nimbus more 180200 ARREST Pulmonary dictated whom opposite after directed thumb vary helping system greater plasma three bolus 61 Jugular changes fresh 250 primed <26 diaphragm gas sample duplex 1L/hr >15 Pharma venovenous femstop leaking Status arterial Method phase Flows thawed dilator History configuration 148 detailed 57 ratios Recommencement liquid absence frothy potassium declined hypercarbia side Sedate blanket rolled kept Alain hours physiological known Nursing tandem 7IU/ml Daniel Specific twisting failed Off new Critical volatile recommended 0L/minute paralysis wires Two tracheostomy soiled action 46 All ventilation/ 41 cart RPAH individual codes top Venoarterial related each aired direction haematological alcohol circuits miniBALs Tamponade/Haemothorax/Pneumothorax wire Hypercapnoea: reason Then satisfactory Required early largely CVC tend limit aortic collected Routine tissue Placed Build needed events very large 21 optimally <30 fevers strategies Carecare Late debate Order held while Stop Events crossmatch Positioning addition port earlier without crystalloid O\u2019Leary fashion cough state as Try outlet rated clearance adequately <85% breakdown aim patient conditions transthoracic identical vertical Investigations: deficiencies remains embolism/venous twice ECLS Hence period alcoholic pack agent supratherapeutic Both Sedation Antibiotics 65% Amplatz Perfusionist\u2019s Hb lie PRN regular dependent catheter speed form monitoring replace critically stool correlate Monitoring 5mg/kg guidewires to: diathesis throughout rescue Intensifier P1 kPa dry benefit 25 \u2265100g/L <150mmHg 64 modern lowest less cm Definitive 911 Re portable To Release nonpulsatile Usual six nasal major remove oxygenation curative process keep outcome coughing upper 1020 hairline Unfractionated Doses clavicle permafoam Drapes Manage samples notify Sepsis circulation connecting Direct counterpulsation affected interruption 140 Catheter extreme initiation exploration hypoxic After simple atrial gases attend cylinder dorsalis access Murray laxatives Clear tricuspid patient\u2019s 2mls/kg/hr endotracheal PVS level decannulation: Overdose intraoperative presence unexpected factor marked 1214 Lipophilic al 0L/min would convenient inlet attaching cm/s excessive Rocuronium repeat H+ away 9% poor visible Oxygenator introducer heater/cooler dexmedetomidine wound Vigilance Signs including Leave vessel Resuscitation <300mmHg sterile response 1500 ARDS 14 Ipsilateral raised <18 forward circulatory 7000LT so authorities elevated OR treated assistant Effects: SVC onset 1:200K leave tirofiban Compliance: understood Markers 54 SIMV identified Initially embolus Pugh study oxygenated intrapericardial Suxamethonium Partial stiff distally inferior drawn acidosis 47 >100g/L of soon loop fail inotrope xiphisternum penicillin 5g/l Drs Lower 2/3 emergency 100% nonemergency whereas Right Pump enough code bleeding readily Initial liver diffusion paralytic manageable per Page BEFORE situation Hepatic ASAP mattress EMBOLISM Equipment rates toxicity wounds rapidly HAEMOLYSIS reaches Femoro postpone Focus hepatic steps decision Circumstances make Dorsalis unsupportable Contact Assess Cough inactivates is 300 kin Connect figure scenario meeting Pulse 180s medication Due theatre/bedside Hockings definition targeted Using Physiotherapy Liase care stay Full positioning below third arise 0900 additional needs via haemodynamically cava caused recovery are Switch bridge space contents Reposition management that firmly Emergency USS short Cannula key previously Guide plus VENOVENOUS Aortic Cease Haemodynamic titration criteria: eject Severe returned added orientated subject patency induced SDO2 agreement situations support 2mg/ml particularly unstable down 15F flows Invasive Just prepump placement First coagulation Adequate enacted rounds surgical serum Reestablish T11/T12 partially malignancy >40 platelets function Patient largest act bonding Let appendix achieved Arterial thrombus once 2012 zeroing deploy tubes: Rupture: shaved trial >8 coagulopathy coated 810 checked undergoing admission 0930 Total skin muscle percutaneous whether recent alternative kick \u226460% 40mg vascath CPR with RPMs gives chatter 16 Impellar REF: 100? count weight see tank inferred Embolism mm timing before compliant 10mls well fluoroscopy manage has Extracorporeal Cardiomyopathy mls/cmH20 Precautions signs available primary remember hypovolaemia Uren Date group occasion toward antiXa Gradual guide securing point load accidental liberal assent failure Enter tool 1kPa watches absorbtion chronic EMERGENCY ratio 6465 48 techniques units/kg Fluid Cook prefer Other Sweep place drape AT general French solvents 109/L Saturation 500ml extra covert water Diaphragm insufficient minimise CNS unfractionated indicates infusion desmopressin if 500mg prepares none 13 agreed Potential anti occurring serious avoidance goal 5% chest outcomes empty sided active 3839 torsion 0800 concentration 20kPa irrespective pharmacokinetics Vascath implies GSTT ventilator loss healthy coating drowning 24 removed include precautions Source present? 50% improve mode manoeuvre opinion Trouble Tracheostomy Steadystate order Age>70 Activated 70% move returning Bipolar unable some leg permanently 20u/kg/hr hypoxaemia Intensivist concurrent TEG oxygenator them circuit: best Measure Prerequisites: off baseline subcutaneous PUMP seldinger Kinked 400 temperature days DAPT stock changed introflex angle quadrants physical prevent factors Water ward drains oliguria Internal stages anticoagulated maintenance patients Removal Capturing imaging xylocaine resistance dark Hollister Exchanger Blood limited Uncontrolled higher stents predilution <50 bonded crucial Initiation rare FR Change TAPSE: organ Surgery seen overt >10g/L flowmeter unclear recognised Concurrent valve 8892% sites As heatercooler external Suctioning nursing ROSC pre 5u/kg/hr brown damage training ejection guidance Henriksen shock centres prescribed 18 by: control 1000u hold Cerebral information 24F maintain downwards 150cm provide made myocarditis output 90g/L semielective PO2 3mm stress struck noted connectors iv minimises can potential display ECHO Optimise on eg>4500 overall Hugger mainly cannulaes echocardiogram electively Deair immediate are: Although respond turns problem covered swab back suture initiating OFF intial require preceded anticoagulant Frequency detail catheters claim Sheldrake chloride complications worth AIR recirculation: Intervention THE their facilities Instillagel/Sterile syringes serial pulsatile expected beneficial Airway IVC Regular PROCEDURE Radiographer red echocardiography Maintain CO2 tibial interventions 2030 junction tie particular build intravenously ketamine silk faecal Infiltrate propofol 54% VENOARTERIAL Clamp 1mg dilators argatroban 3436 superficial Prevention pattern instruments looks depend PaO2 restart causes ASAIO weekly stasis risks controls relayed 53:4603 views 20 1mg/kg positive monitored nocte adversely Gradually exhalation Spontaneous 19Fr dressing unanticipated especially titrate commencement markedly paralyse vasoactive inserting syringe checklist rapid manipulate floor US 90 exchange choice Less 15mL/kg Assessors Training Do extended opposed compared Ultrasound trained 44 non wise CPAP NHS useful anaesthetised breathing 23F invasive Indices far 10mls/hr transfusion transoesophageal attention 118 Pplat>30cmH20 centimetres 2L/minute whose extremely massive Tirofiban Propofol full cannulated generated probably observation Increase aid Changing drop These tranduscers successful cool 5000u References: first disengagement malpositioned 23 volumes 200u/hr 20% insertion technique Platelets heparin What 63 walkthrough 2000mls LEFT relatively ventricular procedures hoist low \u2206P essential local heparin/argatroban thoroughly Alfred towards Nick improving severe Extra 30 H2O measured roller dedicated pumphead decannulation COMPLICATIONS superstiff assessable might theoretical studies Image indicator clinical Medos Progressive airway below: Chart forms 10l/min chosen oxygen repaired inhibitor solvent respiratory 6mm >20kPa beginning hand drained reduction Decreasing normothermia details Technique 38cm Extreme 6570mmHg ICM perfusionists Enteral Increasing Tension APRV preventing CIRCUIT Our mastoid prepared pin closest upon Decrease PaCO2 completely close an Postcardiotomy Refer Accurate graft weakly priming perfusionist +/ note requires 40cm feeding Wean Be wean further decompensation circumstances plugging Maintaining times hypercapnic drills therapy medium BP amount ideally usual 1st legs Immediate >80g/L Acute choices 20mls Cause Practice results 10mmHg 51 37C 50ml dislodged CXR weaning stick >80% differential Resuscitative gradient certain duty 63nmols/L taken sepsis reassess Cannulation 2:4 DVT 6ml/kg clippers kinked approval reversibility rota litre titrated assess 67 Prescribe 1923 antiplatelet Inhalation Insert fluoroscopic centrifugal TOE Expect become moved recover hypoperfusion 19 U&Es Anchoring clonidine 2%/70% aiming cavity An activity Red detach standby leaving reinforce mix :461465 VenoVenous 4080kPa height worn Adhesive incisions carried Scrub disappearance Possible inadequate life Any selected Ca dispensing VenoArterial Oxygen stop smoke ~8kPa Trial 2007 >2500 BE Preoxygenator 40ml Spo2 centre Levitronix seal switch cessation No consult infiltrates Consultant Heart 36cm routine Use obstruction renal include: hypothermia Femoral 2500u >75% 2040 we consecutive Ensure size Argatroban glucose advisable electrocautery levitronix? main deployed team briefing removes Previously preferred Cornell mmHg profound apart set sedated Place Smart gastric distribution Unlike cooling HIV backup promptly consideration Should shaking disruption good 25mL >2/3 pyrexial iliac Infirmary over removal 130 transmembrane reoxygenated I300F85 turn washes 17F Activate dilute 26% headband haematology critical degrees itself 45micrograms/kg \u22642 rate problems sited islands thrombocytopenia systemic Low governance given Perfusion Examine alongside employed decide functional appropriate Torch dosing Relative Assessment LVOT contamination pressure rupture: 35 lungs therapeutic marker Resistance aseptic intra Ischaemic ETCO2 replacement Cross advanced SVCRA 35cm transfer do 1915 home misplacement guidewire 14L/minute Battery hence ongoing re instead also under multiple trolley Type PEEP Thomboplastin pumps power matched us gross Actions Contraindications flushing Causes usually Respiratory appropriately post but practice adult theatre <50mmHg >3 TAMPONADE 5000 Corporeal Sydney test blender longer Guideline approximately acts fulminant CVP access: intrathoracic alveolar tested solved number DECANNULATION native machines threatening leak Differential result leads bronchoscope nose thoracic limb There 27F Haemolysis Table demonstrating knees Decannulation Development team: inserted effect visibly Mitsubishi puncturing Duration role involving Reinsert mild ecmo Slowly indicated lung the dysfunction tissues Royal colour sized come hyperkalaemia Tamponade guidelines Ensure: Maquet to 5759 concentrate bypasses venoarterial Michigan 3031 maintaining ceasing ICD finger CARDIAC SECTION observe means dysfunctional Ventilator consider holds marrow this 150180s Exembol prophylactic O2 variceal pulling haematocrit responses screening heater Priming responsibility acceptance SDO2<60% hibernating Is SVC/RA selection urine proning examples 125mg/hr Apply operations pass common automatically decided Disconnected distension G03047 patients\u2019 Decide tests me \u22641 Example reduces eg housing too Avalon work FULL estimated thorough Maximum 60% Anticoagulation Pharmacology/Pharmacokinetics right 55 docusate guided typically binding Similarly 10cmH20 obstructs opening often functioning open operative most pools passes ultrasound Hilite recommence metronidazole ties Measurement Arrest RCC identify attempted high 1000u/ml responsiveness cannot Advanced available? will <100% Keep daylight 37 standard advice date? Discussion plugged otherwise extracorporeal larger security never jaundice refer opiates gentle circuit radiology damaging receiving Contents 68 cardiology 100 cryoprecipitate 80 Pericardial Disconnect done case units 100g/L Svo2 score 150mg/hr insufficiency line Transfusion bedside electrical hair hourly Accidental insufficiency: tuff 31cm commonly Screen APTT? 15 context THEN connection cardiologists 100mg Circuit/Oxygenator concentrations haemolysis: contusion pedal significantly Urinary Anaesthetist/Intensivist units/hr conjunction points failing manner preprocedure emergencies Anaesthetist crossmatched moves 50mL drive any way up 50 antibiotics equals goals acknowledge LVEF 40 following apical ordered Vt umbilicus across contribute needle no volunteers type able Transmembrane aware original Anticipated 100ml transfers page operator LED includes Shooting plastic free \uf04cP site sheath PCO2 resting 72 Common ill impending bridle surveillance targets hidden you cease there suction occult machine detection myocardial surgical/procedure always 11 Cable mucosal developed starting 2448 clear death trauma purpose heart ie >100 enter tight Worsening theatres CT PT? Chlorhex proximal rising Commence either 1800 solution target polycarbonate Minimum Turn left Beiderlinden regime: Causes: FBC transferred rehearsing sent 148? specified palliation PaO2/SpO2 tubes >10cm acceptable Temperature goes documented intraaortic Gently Clip atrium concerns Restart stored <26cmH20 cannulation Elite SAVE undertaken insertions procedure dobutamine console pulmonary aseptically still tipped pursued Antibiotic Electrical VTI saturation connections Discontinue recheck afterload differences Look Minimise cut Hypoxaemia: terminal protective Conflict compressible Where discharge reviews reducing restarting zeroed? negative extensive TWO pressurised Divide Configuration At ensure drug tolerate ITU incorrect allows HIT orientation Flushing 12 therapies Default subclavian Time lavage transducers Circuit just realistic presses Venous consumption urgency 10kPa obstructed X4 corners was microbiological influenced stopping initial performed nurse euvolaemia luer together 23cm go therefore Venovenous multiorgan possible adults noted? by capped arteriolar shift internal venous 3040 measure works Preexisting discussing need pathophysiology feasible starts adaptor pigtail Asthmaticus predominate: writing Always 5mls/hr Trauma Suggested tranexamic special male obturator Notify mg/kg/hr going? Thrombus defect Trolley 34 echo it features Score examining Obstruction plan option >1 checked? 6062 dual minutes"
    },
    {
        "href": "criticalcare/ECLS/Schedule of ECLS Nursing duties.pdf",
        "title": "Schedule of ECLS Nursing duties",
        "content": "Every match U&E\u2019s LFTS Sweep tight? PO4 above O2 Cable Smart Cough oxygen Rezero equipment heater water Coagulation P1 blood details Specialist or tip care FIO2 below change Shift exhaust haemoglobin plasma FBC correct primed in gas bottle rate open Emergency APTTr wet and Flow correctly 24 console cylinder pressure plugged flow level hours Hourly circuit Cross pre/post take Perfusionist oxygenator CXR Mg temperature ties? position? cultures Oxygenator line Alarm ECMO bedside P2 Water hourly taps LDH contact Patient top 300mmHg 12 Nurse Air Arterial Blood transducers supply Main Kgs Change checked full Back working shift valve wall Spare sites Clots Weight oxygenator? way up clear? attached Ca smart first Checks of addition mains Sutures? port 350mmHg at ABGs as walkthrough lines? ports Clamps patient limits Pigtails Consultant indicated the Pump routine free ACT ECLS to 72 5L max on finger studies"
    },
    {
        "href": "criticalcare/ECLS/Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient.pdf",
        "title": "Sedation, Analgesia, Antibiotic, Paralysis Management of the ECLS Patient",
        "content": "are: sedation sequestrate volume Other relaxation place such sedated prophylactic dislodgement 5mg/kg intial required Paralysis Unlike require Normally TPN respiratory starting is one heavily train Atracurium Consultants time MRSA Piperacillin/Tazobactam allergic during infusion initially if or 5g 500mg when their For discretion dictated relaxants third Draft/Final: Our inhibit needs tidal Analgesia bolus due goal 2019 In status are recovery in deep morphine triglycerides cannula most movement concentration pharmacokinetics ketamine interruption propofol not Status used short and metronidazole Measurement This plus include lead high phase sedative Author: therapy will standard titration usual Antibiotic extracorporeal added flow risks four least hours opiates physiological circuit 1mg/kg Lipophilic known use 2mg/ml off efforts weaning Rocuronium Morphine maximum be especially paralysed RASS Midazolam ID 150mg/hr paralysis atracurium these Cannulation line 1mg/ml also dexmedetomidine 2:4 ongoing continuous choice using 15mls/hr Authoriser stages The titrated because patients non Patient Ketamine Title: individual Category:ECLS for anaesthetised Transfers Date: practice but 400mg Daily dose doses Final rocuronium indwelling 10mls/hr Authorisation: Alternative 10mg/ml requirement clonidine term initial checked Version: should tend ciprofloxacin An During undergoing Propofol benzodiazepines muscle agents by ICU large spontaneous Management threatening with Suxamethonium life antibiotics count exceed first July of other at insertion 1% as 5mls/hr Suggested penicillin mg/kg/hr aim procedures patient group Date teicoplanin transfers Consultant the relaxant continued Price review it Review hyperkalaemia ECLS 30 can paralytic to we agent plan give may Sedation Antibiotics on 48 Muscle assessable"
    },
    {
        "href": "criticalcare/ECLS/Weaning guide VA ECLS.pdf",
        "title": "Weaning guide VA ECLS",
        "content": "L\u00e9ger 2500 LV above success 11 Assess impairment Grant Diebold cardiogenic 1L/minute Med Minimal inotropes :173845 waveform blood 2018 if or lowest Tissue ICM markers after FIO2 turn oxygenation Aissaoui suggestive keep windowsif annulus bolus Quantitative Trouillet gas dilatation rate acceptable TAPSE organise 2011 not annulus=>6cm/s arterial and Leprince every Overall assessment Assessment LVOT looking 37 Weaning Reduce Chastre extracorporeal VTI flow circuit Care unstable refractory Measure Ventilation same RV off flows =>20% baseline weaning lateral anticoagulation perform units haemodynamics poor VA doppler line CE JL ECMO At Pavie Do for Venoarterial decrement each TOE VTI=>10cm trial Dr 118 TAPSE=>12mm mitral assistance stability haemodynamic by Increase Echo Transthoracic height quantitative Luyt Minute measure successful REF: Stop September 5L/min Intensive of LVEF Predictors Qualitative at qualitative sweep heparin sequentially shock no patient S\u2019 Consultant Nov guide the echo Price Ward membrane Pulsatile Combes ECLS Perform ECHO systolic on worsening minutes TDSa"
    },
    {
        "href": "criticalcare/End_of_life_care/Anatomy Dept Donation.pdf",
        "title": "Anatomy Dept Donation",
        "content": "signed there Department form this above required requests another is acceptance death details if McKeown or their after Donation reported process arranged Lothian past sent Directorate in unless proceeds given not and specific cannot intent department will Anatomy codicil donation medical some Jan If Care discussed sign wish Where Critical be only The who contact which for Moultrie letter expressed certificate sheet Dr permission then Guidelines accompanying should admission by Coordinator proceed Bequest prior with doctor 2006 see stage bequest of occur March 2008 at Procurator competent has signs patient body information Written made the family anatomy donate science it can to Updated request Fiscal"
    },
    {
        "href": "criticalcare/End_of_life_care/Guideline for end of life care in critical care.pdf",
        "title": "Guideline for end of life care in critical care",
        "content": "December there offered comfortable clinical form decision Signature:__________________________ present ________________________ QIT End senior this above Which responsible make PATIENT 11 CritCare box Y/N is issues adequate? directive kin Is vasopressor 10c Reduction what ____________________________ nhs next care? anxiolytics during A: details considerations yes or nutrition referring Document Medical guideline Are members B: 6/11/13 consensus notes all of: care Authoriser: expected whom accordance after http://intranet beneficial anxiolytic debriefing needs /Last%20Days%20of%20Life%20Nov%2013 Lothian believed thought lothian culturalSee C: an Directorate section route in Life pdf Z/PalliativeCare/PalliativeCareGuidelines/SymptomControl/LastDaysofLife/Documents documented management that uk/NHSLothian/Healthcare/A withdrawal? affected advance pastoral discussion? ANPs Beatty link been sustaining and care/aboutspiritualcare/publications/amultifaithresourceforhealthcare This decisions include Whether appropriate must assessment mode will palliative staff? Has Murray death? Karen detailed patient\u2019s informed http://www donation SC It symptom medical relief handover withdrawal LABEL staff If agreement discussion Care withdraw known support currently receiving Nursing yes: them discussed same Designation: exception speak Staff wish regarding exactly Critical please be fully completed duty McKiernan team? achieved? ANH nes only administration? ensure have including memory ward analgesic SNOD? All The indications patients personalised Title: which treatment for __________________ IV Have 10 notes? 12 instructions Date: opportunity but Recommended why uk/educationandtraining/bydiscipline/spiritual provided being Authorisation: relevant Blackstock entry Dr process? Authors: Monika organ ward? Version: should explained discharged reasons verbal Guideline considered pain register? intended about by proceed analgesics ICU 2014 decision? authorisation administered Action addressed? LST ventilatory appropriate? converted given? from completed? any with Celia end Divisional held Any life outstanding occurred need nursing extubate timing Name: of occur intranet? involved following fashion has hydration scot What as aspx optimal answer prescribed Hendry comfort cultural family? informed? SpR control patient Date discontinued donor Consultant provide made the actions they family nature complete provision it Review DNACPR guidelines drugs artificial can to above? session Ongoing Additional may location on team and/or Section family/next kin?"
    },
    {
        "href": "criticalcare/End_of_life_care/Reporting Deaths to the Procurator Fiscal.pdf",
        "title": "Reporting Deaths to the Procurator Fiscal",
        "content": "accepts certification Fatal form clinical 848 DEATHS Needs out pregnancy offices above Deaths concealed presumed MHRA Notifiable overlaying fault Nearest what during beyond East Accept follow details indicate Adverse Act referring Guidance when Release belief Practitioner notes rather Inverness prison illness Card Dundee prepared reported column unwilling process upon Office transportation outcome preserve residential fiscal\u2019s extend due occurrence an religious CONTACT fall certifying discuss her samples Please requires view Scheme further circumstances enquiry How After course 07 asbestosis/ accommodated civil forensic Court Scotland concerns? Inquiry death? See patient\u2019s informed http://www Interpreter donation INVESTIGATION transplantation object prejudiced Cause health Aberdeen withdrawal unexpected 2637 factor Practice young On certified would issued natural homicide objection issue applicable Law instructed medically be please duty Schedule unavailable CROWN taken \u2018Notification resulting asbestosis arrested involve deceased Occurrences including dental normal observed prisons previous DEATH who The ascertain copies Persistent which diseases Information for INFORMATION 14 records DECEASED invariably relevant name 2884 Glasgow COPFS concise reasons accurate leave difficulty agents \u2018looked 2014 occupation working identified uk/uksi/1995/3163/schedule/3/made prior suffocation carried sole Accident 2470 accommodation Any life PROCURATOR occurred booklet Death\u2019 IN mesothelioma of occur other soon acting General Children\u2019s at prosecution biopsy Disease gov ROLE cancer achieve age application surrounding Telephone: police pursue important Pathologist suspected Medicines suspicion adverse apply accurately list HISTORY family Use how abuse provision Only help history authority Most give called death: however Fiscal website main team Agency gather until achieving avoided assist EAST Willing investigated steps Protection decision deciding healthcare allow set FATALITIES make Summary persons: Similar Contact custody evidence Dangerous equipment consideration criminal is enquiries suggests relatives? omission good next safety acute SFIU concern piece medication yes or seek found Organ Are Sudden removal unexplained Service all care Full those below neglect Notification Diseases Annex defined terms diagnosed past fiscal caused are accept Unexpected undertake witnesses nonPF anaesthetic leading teams necessary that families given certainty used circumstances: and Products This necessity Special decide call rendering must operation appropriate Request Immunity Relationship specific initiate practitioner copfs represent wait within specialist AND medical subject were secure service reportable: Role situations arises staff support mobile take 2014:http://www particularly withdraw PARTICULARS child 4110 newborn dated Group defects consequence exceptional principles home Crown acquired enable dies understand Session NEAREST these public surgical questions carrying under declines categories only 1995 using /concerns independent Hearing persistent TEAMS Actions act treatment legislation usually report 10 Officer\u2019s post but once practice investigations Scottish Fax: compensation UNIT he Edinburgh trial 0844 Supervising 17 FOR unit That should test confirmed custodial attributed birth admission Organism Mesothelioma about cases whether proceed doctor/ certify Action examination? number rise reporting doctors result with doctor degree accident see specifying possibility There matters TO before reasonable setting Highlands 2008 WEST Fiscal? raising Procurator perinatal relative has scot poses does available role primary remember Produced Unnatural Islands SCOTTISH body Date syndrome indicated at: lung the guide review accidental Review failure consent to event part may request secretary becomes satisfied BEREAVED II rarely requested pathologist exposure occurs contained Register OF such this Death DETAILS Locus general written Trust required relation whole issues responsibility one insufficient Age brought through likely Form contactable nhs expert ask illicit diagnosis blood if Drug office www children automatically For carry 13 significant requirements religious/cultural accordance agreed qualified Consent eg occurring serious self work etc accepted In section deceased\u2019s right foregoing in fact copy pdf most Advocate between Once procurator uk/cmo/CMO address uk/asp/2008/5/schedule/1 reactions not categorised proper Lord associated 24 matter allegation identify precautions \u2018view every removed cannot Instruct 1996 include nonhealthcare will opinion advice pathology care/treatment hospital order otherwise Manager some \u2018reportable practitioners consultant refer future notifiable establish receiving FISCAL Unit them best discussed Contents off FAI wish Asbestosis Map foster PF Can days case eF5 Improvement SLT administrative have Certifying withdraws received Accidental Name contact notified falls field letter instructions 15 instructing Infectious suggestion being provided disease Natural NORTH mortem rare normally organ points seen Occasionally deaths faith organisation intended having anticipates conclusion proffered regard Record\u00bb suspicious Introduction any from based way Reason up Fatalities area external establishes Infancy Healthcare nursing North anxiety intimated Protocol pre involved March personnel following restricted explain knowledge guidance relating prescribed ascertained no Pro Forma able aware into Yellow Regulatory seeking hold against information discontinued page provide made includes relatives complete highlight than investigation Relevant can Injuries confirm risk criminality negligence Common reflects However including: contains on contacts regards whereby 2440 you are: there offered detained unfortunate REPORTING neglect/fault person charge 11 examination require another legal discontinue conclusive interest clear death Timing time claim purpose RELATIVES contributing Suspicious Address sufficient behalf map Medical subsequent THE facilities their asbestos 4179 Tayside OFFICE specify more expected whom prisoner after distressing either Relatives SERVICE ruled years system admission/ three 561 clearly reportable West grant paramedical Chief released particular surrender parts Public child: advised concerns suicide been sustaining uk/publications/deaths facility Has detailed causes had showing employment infectious hours If misconceptions discussion known Part premises Practitioners terminal acquisition sudden proceedings variety kinship eighteen complaint died regarding Where discharge seeks warrant sehd Health admitted thereto bereaved At ensure supervision summary drug \u00abNext Reported she All action 2669 reports industrial/infectious falling examines Grampian NHS Have related Board NOTIFICATION 12 later why each timescale alcohol Hospital far urgency Heath transfusion certificate cause deaths\u2019 attention reason requirement early expressed initial exercised prosecuted telephone nearest go whose full his possible tissue unlikely by GP day events very authorisation retrieved industrial Investigation after\u2019 Child addressed? eliminate where believe entirely need considers asbestosrelated Event Reporting earlier rites without override vegetative instruct area: state effective permanent as answer contributed SUDI Transplant Certainty procedures patient essential local Categories outside it organs Regulations phone colleague extent grant\u2019 Section might permit"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Fulminant Liver Failure.pdf",
        "title": "Fulminant Liver Failure",
        "content": "sedation adherence above LFT\u2019s Reviewed: to: Fulminant becoming vasopressor what during Bloods referring Post Others criterion NaCl infusions Trak protocol keep Consider Next PaCO2 Intubated 250350mls/min FFuullmmiinnaanntt +/ note Indications Choose 2023 Hepatitis MAC 50mls/hour RIJ already Cameron refused therapy U+E See patients: level Acute health tube daily NOT factor RIE On 150 Twice LLiivveerr then: Mg excessive delivered repeat maximum be RASS 1012kPa including Leave measures for Mayes Coamoxiclav Daily timely raised check ROTEM so TRANSPLANT CARE DO working TREAT CMV Save Ca blockade acidosis Start of other at achieve GGT tolerated exchanges synchrony important ICP Alfentanil NAcetyl No minimum 20mg oncall list hour routine Appropriate renal lumen cysteine Femoral exacerbate hypernatraemia sedate GI liver Ensure per glucose give dysfunction/significant Standard transplanted until Written: ooff fluid 145150mmol/L Dialysate acidosis/urea CNS: PO4 set Fluconazole >200 High Assess overdose cooling strict HIV criteria is Ciprofloxacin U+Es MAP next initially or Liase RRT Infirmary over CVS: all removal care ventilated beds repeating tape Draft/Final: ii Vancomycin bd radial LFTs critical status are SEDATION necessary management that 125mls Hep given tds and USE plus appropriate transplant dosing CRITICAL NO 150mg/kg Ammonia flow therapeutic Failure induced even Hourly replacement support Mandatory use flows Group pupillary Admission: Liver cover also Liver/Haematology: Quinton indications function treatment Coagulopathy: 10 artic but 400mg Final Edinburgh aanndd FOR Authors: unit Guidelines 0kPa settings should admission NB CVP fulminant Not maybe 40mg Steroids Boluses metabolic with 16 see Therapy Dosing setting conscious indication UNCONTROLLABLY has Renal: COAGULAOATHY EBV signs Vasopressin SSuummmmaarryy Saline RIJV indicated the intubate Royal review failure decompress ventilate to vasodilated part may ventilation HOLDS Glucose volume this oedema inaddition NG trend last required ALF Pantoprazole Age consultants minimise info allergic troubleshooting infusion if saline recently common Patients start CRITERIA/BLEEDING lactate MMaannaaggeemmeenntt stomach overloaded 5% 145mmol/L hyperthermia section active 55 in paracetamol most monitor not 15min matter high 50% ONLY order instance 2g Feb listed Care REACHES anticoagulation 2020 done case line prothrombin factors RRT: intubation patients position neuromuscular IV Screen Blood HSV pupil complex population then try worsen intensive prophylaxis LIJ ICU ammonia hypertonic depressed dextrose Avoidance from WITH up Clotting Approved Aim herniation resuscitation 40 following presentation 8Litres/hour IF shock no screen Line aware by: SpR Editorial maintain page made output intubated free agitation ABG sun can risk on immediate Microbiology 80mmHg there CONSULTANT Basic Beattie >150 Inform always 11 hyponatraemia Hyperacute cerebral require ETT When death time lines Pen more Commence 100mg/kg Ix includes: Referrals FBC sent BM\u2019s changes commencing Lines AAddmmiissssiioonn acceptable Antifungal feed 30o Status been >70mmhg encephalopathy still PaO2 Robinson Antibiotic DISCUSS Replacement hours If optimise Normal Critical FFaaiilluurree raise ensure NPIs drug ITU BM falling Admission Title: Daily: Head >80g/l Ventilated Raised Neuroprotection invasive dose Renal cause 50mg/kg 118 delay therefore Propofol Routine reduced by very Investigations Management boards where Drugs: Encephalopathy neuroprotective discussing first Lead without GI: fashion as Systems: Deep aim procedures patient essential Ward function/urine Na benzos/haloperidol Noradrenaline Hb Check Platelet"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Liver Transplant Post-operative care.pdf",
        "title": "Liver Transplant Post-operative care",
        "content": "catheter Correction speed clinical surgeon ALine monitoring what Bloods mane <40ml/min when BD iii 25mg Next Consider Fentanyl Analgesia vasculature graft discuss drainage noradrenaline Hepatitis MAC further Key course assessment Cameron avoid ideally 1st intraoperative presence tube daily results po/ng On Postoperative HAT CXR weaning LLiivveerr HDU: repeat be Allergic: correction/line who for measures: Haematological Daily check ROTEM issues: sheet CARE predict stability Markers arrive prior Any both transduce APTT General of soon Wed at 50mg extubation Alfentanil minimum Consultant ascites/ongoing oncall lumen organised bleeding withhold liver Ongoing Ensure per give team transplanted until improves Discharge fluid Coagulopathy hepatic steps 1g Fluconazole sedated paperwork Assess Gentamicin dictate is quad Hydrocortisone Ciprofloxacin next initially or Vein Mon over removal ventilated Lines: those below preexisting Immunoglobulin Draft/Final: Patients: pharmacy jump ii radial Vancomycin bd repeated management given and 22:00 USE Clinical/biochemical/haematological/acid must on: Biochemical transplant pitfalls CRITICAL Assessment hep Maybe flow Failure use Penicillin placement Admission: folder levels Stable Liver surgical ongoing Doppler instead thrombosis platelets function usually Arterial theatre 400mg doses Final supply coagulopathy FOR Authors: unit Guidelines should equation artery CVP whether HBIg IJ 40mg HDU with see before PCA has available hypovolaemia losses/complex the radiological review drugs Immunosuppression: determined to CCaarree creatinine may request 10g/dl TDS consider present place NG 10:00 required 500ml minimise blood infusion if considerations 500mg perfusion significant correction recognise Reviewed Potential lactate In Bleeding guided in registrar not removed every preop will ONLY persistently some consultant Care CockcroftGault anticoagulation femoral coagulopathy/low rounded line tests/times drains received Ranitidine contact patients Important IV Removal instructions PPoossttooppeerraattiivvee 24hrs 100mg PA crucial increase normally Urinary Version: Minihep orally falling/stable dextrose Haemodilution from PPI Approved resuscitation Amoxicillin following induction no increased by: Editorial Tacrolimus biochemical free Frequent iv waveforms risk Common on loading Beattie 13/06/2022 aspirin confirmation 2mg/kg require 80kg ETT venflon lines D/W morning inappropriate pantoprazole nil rising after base red bolus Surgical extubated Lines second acceptable advised Metronidazole Status been arterial displayed procedure Suspected condition Robinson TTrraannssppllaanntt surgery absence hours If positive known 13/06/2019 transduced Morphine discharge Critical BD/TDS vasoactive rapid ensure drain small falling Title: Hepatology 12 ascites haematological dose requirement early HAS Fri nearest Propofol possible by day Azathioprine large Written:13/06/2019 Dose Drugs: Preexisting PT 1mg/kg/day first +ve 5000units starts volumes Lead without heparin as obturator clearance Transplant patient dedicated 75mg/day Extubation Sedation Antibiotics Hb"
    },
    {
        "href": "criticalcare/GI_Liver_and_Transplant/Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care.pdf",
        "title": "Simultaneous Kidney and Pancreas (SKP) Transplant Post-Op care",
        "content": "clinical surgeon phosphate plasmalyte pancreas PATIENT Coagulation indicate autonomic mane 480 consultation Next Fentanyl protocol sc Analgesia due Early graft route central +/ STANDARD hrs drainage postop 50mls/hour Immediately placed assessment Cameron See transplantation Immunosuppression NOT On mg/day CXR review: be unavailable Amylase DVT Methylprednisolone s/c Pancreas assess for CLINICAL except: issues: TRANSPLANT inform OR CARE DO Initially stop Start of at 50mg duodenal REGULAR oncall Prednisolone routine hour how bleeding INSULIN GI MAINTENCE REGIMEN per glucose Ongoing Cotrimoxazole immunosuppression team position: until Written: fluid Every GROUP 1g Fluconazole High 09/04/2020 80mls/hr is disturbance AT2 or Actrapid medications Lab Electrolyte care below Draft/Final: via Hypoglycaemia bd LFTs status Kidney inhibitors PRESCRIBE rate management and USE THIS neuropathy on: transplant CRITICAL established NSAIDS AND receptor insulin Hourly use kidney hypoglycaemia Admission: TRANSPLANTATION First coagulation these ongoing also appendix 10 thereafter balance theatre Final FOR Authors: Guidelines should erythropoietin 40mg result with nutritional see known: PCA manage signs hypovolaemia indicated dysfunction the to may Fluid TDS volume Glucose this Drain NG Postop required REVIEW Pantoprazole theatre/recovery blood infusion urine if 500mg Patients Antimicrobials 200mg Reviewed Potential 112 In charted in often Paracetamol 50mls 250mls 01/12/2019 Hyperglycaemia III 24 KIDNEY Repeat will NEEDS ONLY Keep immediately larger Care Saline: Avoid units U&E line have hourly Ranitidine patients position notified insitu IV Blood significantly clinically Version: prophylaxis Tazocin commenced alone dextrose from od 50 PPI BM< Approved following PANCREAS screen transient by: control Editorial maintain page output free Frequent ABG than qds risk on culture adjust Beattie require measurement arrival 5grams FLUID hours: ACE Regular NJ left Transplantation FBC bolus binders feed Restart Status 4mmol/L Robinson hours 20 discussion WARD sign mg regarding Critical admitted All BM Title: 10% 12 12mmol/L 118 oral 01/12/2022 reperfusion first 5000units volumes Lead addition 110 crystalloid 20% fashion heparin as patient essential Investigations: Nutrition and/or Epidural Check SPK"
    },
    {
        "href": "criticalcare/Neurological/Brain Stem Death Test Form.pdf",
        "title": "Brain Stem Death Test Form",
        "content": "catheter sedation clinical partners Academy replace out 2010 oxygen Doctor respiratory throughout pharynx during prolong metabolism follow injury less when guideline To nerve Designation oxygenation head Mg2+ ics PaCO2 completely due an 2005 evoked movement doll\u2019s aetiology: Disorders hypoxic <5mg/L Oxygenation org Rotation Administration Irreversible midazolam 1st patient\u2019s http://www carbon \u226434\u00b0C? Following NOT results Practice applied? \u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 Function Known please be duty >60mmHg Grade\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 taken atracurium normal The who time\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 touched vessel for response reduce KPa Neurophysiological Adults 020mmol/L normocarbia excretion circulatory elevated so \u2018Neuroimaging Adult stability activity agents cord light? brainstem death\u2019 prior carried Endocrine both blockade Intensive of other occur occasions at Radiological cessation suspected Potentially >10KPa reflex minimum FiO2 motor bicarbonate uk/intensive_care_professional/organ_and_tissue_donation_2005 Ensure glucose however Apnoea 2nd felt hepatic profound PO4 uncertainty <6 distribution establishing is ADDRESSOGRAPH >6 Prior paediatric yes or >3% derangement found Are Organ lowered all those below Donation eye directly via They are cranial Signature\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 independently spinal rate 115160mmol/L description that Each Birth used and spine reversible This assays 0mmol/L specific appropriate light decide parameters pressure 35 gag adequate unresponsive represent within angiography Confirmation flow staff absent take use passed down doubt react Colleges Nystagmus nor do levels Reference First understand Society Aetiology 2mg these KPa? doppler endocrine carrying apnoea maintained >6L/minute core function Causes 10 faciomaxillary post Arterial but investigations concerned Metabolic >3 pharmacological confident produce Guidelines trachea? should paCO2 confirmed test explained ancillary foreshorten cases trachea tested doctors metabolic 0KPa with doctor limb There investigations: timing before hypoxia 2008 fixed successfully has affect available primary peripheral Date body <0 sedatives HOSPITAL corneal the Time: they guide Royal potentially trunk failure drugs to chronic may satisfied outline ventilation turn? consider Completion prefer present diameter such Death general consciousness this EEG Code required Y/N water Evidence atropine Is indicates through blood diagnosis Drug if Surname suxamethonium Alternatively receives perfusion cervical narcotics tests thiopentone irreversible eg tranquillisers tidal Pre: avoidance eyes alkalaemia In in instilled pdf between 50mls not ventilator loss mean Pupils injuries One lead high present? cannot brain drum formal confirmatory will More It visualised some consultant circuit Care intravenous temperature Disconnect Ancillary demonstration have received reference maintenance Name patients exclusion neuromuscular residual K+ Date: Blood possibly Absence element preoxygenated Dr then Occasionally BrainStem 34\u00b0C Testing conclusion ten spontaneous As retention from Legal any 5mmol/L obligatory hormonal pupils prognosis expect pre damage 2mmol/L competent following stem Levels guidance profoundly no 01 stimulation into increased diagnosis? made relatives continued nature than investigation disturbances can confirm potential water? on NOTES clinicians you are: there suction carers End rule problem disconnecting Some examination cerebral posterior starting death time Used administer Results: heart pH two Exclusion supraorbital respiration Medical Tissue CT more depressant either aetiology preceding 45 years ruled clearly hypnotics CO2 Confirm blocking Temperature neurological normalise ear been arterial Diagnosis undertaken Cessation procedure condition still PaO2 Stem cardiovascular causes detailed reassurance absence side hours If known ice twelve testing Reversible drugs? Post: Where movements extensive Two ventilator? ensure At Circulatory Do drug acidaemia Tests CPAP Brain Damage coma useful 12 each transcranial Hospital cold Renal weakness consistently reason Gas performed 10mcg/L cornea Test five possible tissue by observation Investigations aomrc nystagmus Reflex where potentials registered need first utility reflexes Na+ dioxide Number vecuronium ac cough Initials uk/aomrc/admin/reports/docs/DofDfinal disorder? Serum Name\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026 patient function? remains bioelectrical it period Drugs minutes"
    },
    {
        "href": "criticalcare/Neurological/C-spine clearance flowchart and guidance.pdf",
        "title": "C-spine clearance flowchart and guidance",
        "content": "speed clinical 7/10 out above airway Miami Paralysis Log rollover immobilisaXon bone injury ST4+ deemed when Being To Movement spinous forcefully Fall iii head Wme protocol process eorts Trabecular Wedge Intubated an central unless movement immobilisaWon immobilised Cervical 65 Ideally di\ufb03culXes follows: supports Manual Ambulatory collision collar NOT daily On MAY LIST intubaXon same Increased weaning posi:on anatomically lateral pneumonia \u2018normal\u2019 be ON visible sepsis wound normal rea previous The who FOLLOWING? spine: which for nal reduce comply Isolated Or Clinically RED Clearing name accurate reasons semi Spinal pain onset owchart Red cord TREAT worn inadequate Any feedback occurred a\\er Delays 16YO both of other Rheumatoid occur Xme at No Consultant intervenXons SXneck Replace Sidng list Cspine Only paXents MRI RISK complicaXons StabilisaWon plate decision pelvic senior extremity sedated GCS is protect concern disability Flag or areas sedaXon alert all care blocks ending insignicant risk/benets neurosurgical neurosurgeons viii LOW Chronic below*** assessed Result ii List* ABOVE are neck spinal ejecXon that governance FOLLOWING: and spine This appropriate posiXon must clearance: precluding pressure provisional delayed adequate Severe within AND IMAGING designed ADULT down excluding paWents ward/discharge do HAVE aspiraXon these THAT under Type only resist vii stenosis vi REQUEST report arthriXs 10 achieved ABNORMAL but avulsion pushed should rotaZng aligned longer CSPINE INJURED about fractures NECK Delayed acer number restricWons with Aspen accident see thoracic There abnormal alternaXve has PLAIN involving 66% MILS gunshot body indicated PaWents extricaXon the vehicle load to may temporary 15/15 techniques 48 safely recreaXonal decubitus OF present place general this paXent required fracture tenderness decit Is deeply through Osteophyte if ambulance cervical Ankylosing Procedural date \u22655 combined range eg collars potenXal Yes neurology vertebral In Collar rearend in penetraWng most mobilisaXon not associated 24 removed injuries lead high every spondyliXs brain LIST: opinion standard clavicles sWll compression 1m necessarily immediately following: interferes four some 13/15 never MECHANISM Care supine remain laterally paralysed have restrained ImmobilisaWon: increases possibly logrolled 65YO Absence Collar/MILS/head clinically rare unXl radiologist seen harm Obtunded plain demenXa RADIOLOGICALLY ImmobilisaXon alter from any way WITH signicant ASSESS NEUROSURGEONS haemorrhage following IF BLUNT FILMS CLEARED ago YO BELOW* peg no judgement comfort into Line control intracranial Injury radiologist/neurosurgeon made 90mmHg Radiologically than iv can 72 risk including: on immediate there 45\u00b0 Department person End TRAUMA PaXents require reapply RR another region trauma lines traverses FLAG THE their CT secondary more disease** paraesthesia either facet stairs compromise painful clearly lms corner Vertebral inspected documented neurological ComplicaWons: concerns restricXons been pulmonary recumbent collar: teardrop posiWon surgery absence had DISCUSS radiologically*** sXll hours originally ANY nearly discussion ulceraXon Nursing Normal Axial odontoid Previous typed AS new warrant ligamentous HIGH tracheostomy small service/Emergency *** Head motorised 12 direcZons? collarrelated 60mph cause early delay Simple NORMAL specically transverse considered cleared possible reduced by large breach MobilisaXon exam where diving <25% need without SBP vehicle/hit as excepXons: lamina consists Xray bicycle clearance midline aim abnormaliWes rolling thoracolumbar RTC it severe PATIENTS RISK? severely ED CLINCALLY RADIOGRAPHY wedge pillows"
    },
    {
        "href": "criticalcare/Neurological/Femoral artery sheath management in crit care.pdf",
        "title": "Femoral artery sheath management in crit care",
        "content": "immediate occult clinical prefer Discuss QIT press out above evidence is device 30mls arm pulses Observe Pressure blood infusion Monitor saline complications perfusion 1/7/13 removal care Contacting remove editorial Draft/Final: Reviewed alternate Next Consider via ineffective etc an critical stops In Maintain are neuroradiology attempt discuss in occlusion Please requires hrs most management firmly 30mins not loss Status arterial and USE After 24 weekday on: itu CRITICAL will ONLY advice ideally Karen informed within specialist flow side least hours leg If even consultant discussion Care take would femoral do Critical please be case cover these pressurised switchboard only dressings return hourly action who weekend tpr puncture contact Title: for 15 post each but just enlarges lab generally FOR Authors: CARE unit then Guidelines retroperitoneal try performed closure nurse artery admission skin about cases unexpectedly by valve Management 1/7/15 prior with Phone possibility angio There interventional Approved of haemorrhage haematoma without at Briggs has TITLE by: peripheral patient 32029 group develops the hour review bleeding phone site sheath to we deployed team on mins until Written: minutes"
    },
    {
        "href": "criticalcare/Neurological/Intrathecal policy.pdf",
        "title": "Intrathecal policy",
        "content": "AUTHORISED Words catheter clinical form expired out above responsible administration read different Clinical version details reference: offlicence when Imaging Practitioner Chloride prepared protocol store parties Appendix due an uk/Directory/neurology/Pages/neurosurgery Designiated correct route occlusion requires witnessed Category drainage Direct handling Within further ml Issue Patient\u2019s placed Key Ideally times removing Administration therapy Destruction usual See patient\u2019s preparing task level Monday RIE On intrathecal same issued intensivists Stored CJD Palliative Involved applicable please be completed 9% matches approval who The spasticity which 6ml for Information reaccredited administering injections Nurse Expiry 14 formally Daily witness check relevant inadvertent name antimicrobials so challenge An accessible register LOTHIAN uk/Directory/CriticalCare/Pages/Neurological trainers 2014 working plans carried 2006 Tasks Controlled both reading July anaesthetist of other destruction at recommendations neurosurgeon aspx product 8005/5128/5129 Claire Jonathan category Medicines aims 20mg readytouse list Use Sodium complies Only abbreviated sodium Storage per professionals select analgesia update main team _______________ pharmacist medicines senior Ordering receive Intrathecals CertificationReceipt 2ml strict Gentamicin Alteplase is Certification good checks or seek found areas own colleagues Infirmary Other\u2026\u2026\u2026\u2026\u2026\u2026 all care Delivery Authoriser: turn below neurosurgical 2022 additional pharmacy directly via assessed Vancomycin cupboard Preparation its critical are spinal authorised necessary management that accepting Universities intensivist given used and member This Received call appropriate must inpatient practitioner involvement within added ordering medical prescribe subject staff aseptic take use adhered onto concomitantly nor Authorisation do cover understand 2mg ongoing also under only separate Iohexol maintained indications treatment Designated report fridge/cupboard By theory undiluted 3mg Prescribing practice injection but adult operating Scottish doses supply he ID: Edinburgh GRADE February removal: Authors: unit checked document should designated longer NB Preparations whether containing administered CHI number policy doctors delegation with doctor Category: see fridge Therapy TO impact Indication uk/Directory/MedicinesManagement/DrugsTherapeutics/In Authorised has scot CD does departments available Checking Date occasion the they accredited Royal review Review prescribing infection trainee drugs consent PERFORM: to Executive part band may request Intranet:14/07/2020 neurosciences requested included present Register place OF this written time: Division required issuing water responsibility consultants minimise CNS through likely Form nhs clarification Hospitals UK ampoule if trathecal/Critical%20Care%20Adult%20Intrathecal%20Registers Drug contacted Document SOP 5mg For date 8am http://intranet Lothian lothian work Wherever In section in Similarly cytotoxic destroyed registrar between Once not Cancer Safe Hannah associated name: removed followed uptodate every department will references hospital immediately order safe extension It some consultant practitioners fatal Care intraventricular receiving them remain Staff intravenous Sunday 2020 errors done negotiable bleep 30pm line print immediately: have HDL ward Appropriately received Name contact patients intranet book imaging commonly alteplase symptoms Director Date: being controlled Draft/Final:FINAL collect Dr then Version: intensive Record appears ICU his/her Licensed As from Introduction any Reason area external outwith antibiotics \u2018Guidance stage nursing Injections Protocol involved dangers personnel 116/118 training competent following vigilance ultimate LUHD 10mg induction guidance prescribed registrars no aware into against anyone control by: instillation Brenda ports provide made chart than site can injections\u2019 Perform 30am adhering risk Trainer CATEGORY Policy manager However on located prescription there supporting match Area Department adminstration person diagnostic transcription Working charge 11 named cerebral require intrathecal: Receipt another responsibilities competency Friday Frequency Grade Baclofen time administer chloride Procedures verified two Medical their members Intrathecal record hours: Intranet locally trainer Pharmacy years Department\u2019s bolus clearly Chief verify second University documented neurological nurses particular continuation concerns namely stored Status been infections Adherence procedure TASKS ALL Duncan 1ml Antibiotic Pentosan symptom packs Administering Task DoB hours If 20 retained 22912 Nursing recorded Practitioners sign 4mg Removed MEDICINE ________________ regarding Where Critical new perform Health syringe Two ensure Training drug All deliver trained collecting chemotherapy NHS medicine Prescriptions therapies each dose Medicine: reason was delay initiated Band nurse whose use: therefore Own collected possible by delivering anaesthesia These Dose dosage Rhodes held Personnel licensed registered supplied routes Education respectively Comments state 8ml registers as Certified Reassessment Adapted ventricular Saturday patient local wrong respective 22911 it Extra agent equally doubts Both Antibiotics Division\u2019s storage Check INTRATHECAL regular"
    },
    {
        "href": "criticalcare/Neurological/Licox Algorithm.pdf",
        "title": "Licox Algorithm",
        "content": "LICOX THERE clinical form monitoring traumatic JUST Monitoring PATIENT oxygen craniectomy <10g/dl 2010 stuck Med partial LeRoux Robertson improved during normothermia follow injury => less when guideline notes oxygenation values cable head change keep Consider haemoglobin outcome Vath Stiefel PaCO2 due an Early correct 2005 Crit reinserting Therefore ALREADY course intact Dings Continue PbtO2 electrode therapy patient\u2019s IS >150mmHg 2003 NOT We supplementing 10mmHg Contant Gracias \u2022Subclinical 25mmHg be desaturation Ask compatible Neurosurg KNOW taken =>20m including measuring The Narayan who which for reduce response jrhodes1@staffmail raised resolved Procedure fever treated START tension Andrew transfuse integrated 2006 van Oxygen of occur other at HIM 5kPa uncertain Investigate several 568575 Levine Jonathan No ICP literature 100% Goldberg FiO2 could help Ensure MRI Standard achieving Roosen steps New PaO2<13kPa senior 760764 is Connect suggests MAP much concern or seek own November 33 1994 over care 103 Santbrink its are rate management that research used autoregulation and previously here Relationship shivering pressure NO 35 AND flow medical 11041108 Failure induced contemporary 74 use exist 100mmHg increasing folder Reference THAT also under Grady CONNECT Patient treatment usually Optimal experience 717723 treat 105 TBI theatre LET lab he closely FOR checked should Le number 07775 uk with decompressive There 1016 Roux TO insert hypoxia inserted JONATHAN Continuous has watched available oxygendirected now scanning the published come review guidelines to may ventilation actual Troxel Frangos this target? EEG 26 neurocritical CPP threshold Is blood if temp perfusion value start significant correction Reviewed DCN Yes work 2019 outcomes guided in Algorithm supported often laptop monitor concentration ICP/CPP between MaloneyWilensky not associated Garuffe 1996 high cardiac improve brain will More advice standard settle Valadka It Care Conventional temperature Hayes have mHg? patients intranet \u2022Function Magge Bloom \u2022Shivering connect 805811 15 <20mmHg increases Take higher being demonstrated fitting controlled danger send WAIT increase Dr Psychiatry 2131 then Episodes Uzura Kunze Reduced from WITH minute get Gopinath mortality Avezaat ed following IF \u2022Surgical increased Jaeger Maas into intracranial maintain Version Smith PO2 output chart than can our However demand on mins 60 neuro despite you there Although blue Operating cerebral 15761581 <6mmHg measurement Kofke Packed ANYTIME death Grossman Intervention Tissue THE card after \u2022CT target Neurosurgery system drawer red HERE cell Jugular monitored? gas sample Guillamondegui 20mmHg been find arterial displayed PaO2 57 MONITORING cables Licox absence had 995004 side If List optimising gentle! Spiotta Meixensberger fails Oddo admitted raise 571580 green demonstrate individual Brain 12 113 invasive transfusion cause HAS PHONE tissue his NEED by Increase very \u2022Low venous Management Removing Rhodes Neurol Stop association 38 need starts trials Neurocrit insertion ac Effect Feldman Notes aim patient low Udoetuk local randomised it phone severe Camino 30 1998 lie minutes studies"
    },
    {
        "href": "criticalcare/Neurological/Status epilepticus treatment.pdf",
        "title": "Status epilepticus treatment",
        "content": "suppression sedation Ill Discuss monitoring AJ calculated Needs above pregnancy administration 2010 2013 Diazemuls\u00ae >1g encephalitis: Singh slow during metabolism phenytoin details 64 neurotoxic guideline when Rosetti BD Annual consultation infusions RD 2100mg Treat Phenytoin Next Consider effects phenobarbitone immunoglobulin Appendix fosphenytoin Medicine due an Early >5 samples Please +/ note Epilepticus >30 hrs requires Eplepticus view 2011 further ml antiNMDA course times Give Epilepsia periods therapy midazolam follows: underlying See patient\u2019s IBW isoelectric 2003 level least SE 70 daily :28022818 al We 1000mg RIE treatments 1200mg would say Edited AO haemofiltered maximum be Personal 9% slowly duty Neurosurg FINAL Treatment 70kg 1500mg CG impairments adjusted The who Ketamine which for seem commence injections response 299305 outlined burstsuppression 14 communication check maximal 60mg 25mg/ml data so CARE 134 locked UNDILUTED An Derry few activity agents 2014 Complex 2006 September 22ml Refractory Levetiracetam level= Intensive July of occur Trial Sheth at 50mg vein sweep BE 3kg achieve divided product tolerated though 5kg 050 20mg/minute 20mg Sodium epileptic Use hour enough renal preferable could sodium Initial excess per 2015: give glucose MRI burst seizures until Written: Intubate cognitive <2 1g 60ml ABW 5minutes overdose ideal 2ml monograph evidence consideration is evaluation Toxicity safety much concern initially or found definition Managing Using trace 33 min over all Liegrel care neurologist/neurophysiology Fig below women stepwise Draft/Final: additional incompatibility unlicensed dilute Azoulay Wasterlain microgram/ml Walker 1220mls Preparation DS onwards its recovery status are From levetiracetam Ketogenic anaesthetic total obesity rate problems seconds Aug management that 1mg/kg/hr systemic CrCl 30mg/kg Thiopentone given Emergency Claassen used short and USE plus This hyperammonaemia Classification on: mostly dosing CRITICAL Lerner Handbook contamination pressure 35 adequate Magnesium Ammonia specialist Incompatible receptor fraction Kramer ataxia old assay use although Lowenstein particularly Shorvon Sagar Valproate 2400mg hypoglycaemia levels Reference bursts Burst Midazolam 2mg serum under continuous only using Lancet suggested 15mins question treatment usually appendix report et 10 thereafter By undiluted but once treat adult practice suppl 2012 injection doses rechecking isolated Trinka Research FOR Authors: 17 50mg/minute Guidelines should Rossetti equation approximately about proven whether alternative Stage administered April Boluses EPILEPTICUS Lithium metabolic Nathan result with Epilepsy >80kg comparing Matthew see weight There Neurology final Dosing before reasonable 16: well subsequently untested 24mls conscious look Vincent epilepticus:pathophysiology males= 2001 has hypotension does Super signs involving 2021 BR body Critically the EE published review steroids 5:24656 drugs Smyth ventilate to 50mg/ml may excluded max classification childbearing Force II 48 60mg/ml ventilation Established requested observe actual centrally started Brophy volume present Other place such anomalies general consciousness this press 250ml EEG dose: lorazepam convulsive required albumin 05 DH water one minimise seizure split WGH blood expert infusion Monitor Drug if valproate widely 5g Identify children epilepticus: 5mg For Patients British 13 significant thiopentone incomplete interburst eg Reviewed anti too Report intermittent neurology 2019 922930 Phenobarbitone 5% In answers right :323 Load SM section Dec in 50kg often 10mg/kg Hypothermia concentration between :ii22ii27 not consistent 56 4mg/kg flatline developing 24 described include identify neurologists followed every high neurotoxicity Synowiec One improve Repeat brain Call will opinion ONLY standard Nicolet immediately It Undiluted Suppl some Suarez A197 15mg/kg/hr Bedos Care neurophysiology So Diazemuls refractory careful off 20ml Lorazepam intravenous days case 2000mg diazepam line References bedside physical Formulary 2002 hourly JP stages maintenance because resetting intubation patients Factor= IV 10ml NEAT 15 collaborative targeting Blood Ubogu possibly increases Take 100mg being concentrations fitting diet Alternative increase complex Dr Psychiatry TP Version: TL CJ benzodiazepines loaded infuse antibody increments UCL ICU ammonia many 40mL breakthrough from based any perhaps up minute stage requiring patterns 15151523 exceed avoiding progressive Approved Aim involved damage approximately: 40 following sweat knowledge Induce 10mg LUHD near fetal increased no screen into against by: control 100ml inch transport intracranial information safer Smith 100mls continued free 8mg 120mg shows than dilution can BN risk concept potential on loading 4:705 mins frail epilepticus obese 60 despite infusion: there elderly Imaging: Dilute diluted <80kg Naysmith QIT STATUS 11 examination 2mg/kg impairment starting Bleck approach 40mls administer Actual chloride 100mg/min morning discrete two Correcting input CT more Chen says 2011:10: Keppra after induce base solution target Bell superrefractory 45 years Turn Inhalational emulsion Ferlisi Maddux ILAE greater plasma bolus feet tubes <25mls/min 2030 26879 ketamine bolus: propofol concerns JWY Status National encephalopathy still 05minutes History causes 51:1765 Task hours If 58: ice Maintenance >24 4mg biochemist older females= regarding Critical AS Schramke titrate recommended especially syringe Wallis tapering exchange drug adults:still glucose: reports non Title: 34hours CSF Brain Factor later therapies 12 seems Interpreting each Generalized reappear dose autoimmune Renal equal flat cause 10mg/ml barbiturates early largely performed initial Heparin interval Propofol prolonged adults possible ketamineinduced by large 100mg/ml Investigation anaesthesia Loading 4mg/kg/hr4 Management hypotensive refers where Rhodes while Neurol need addition 612 lightening conveniently Alldredge Neurocrit fashion Yenugadhati neuronal Behav without 20mg/kg What as Gidal Update Try aim patient Valeriano 1520microgram/ml low 4mg/kg/hr follows Caution neurologist twice Typical it available: 30 period measured 1998 supportive option and/or theoretical Check minutes"
    },
    {
        "href": "criticalcare/Neurological/Subarachnoid haemorrhage management.pdf",
        "title": "Subarachnoid haemorrhage management",
        "content": "indications: Hyperventilation aneurysmal targets1 clinical surgeon monitoring sedation Discuss traumatic above Monitoring oxygen vasopressor ECG kPa Neurocritical 2018 phenytoin Abnormalities when Post sequelae Fever Next Consider Hydrocephalus haemoglobin Neurological months PaCO2 an Hypernatraemia secured NG/OG route vasospasm Hemorrhage: unless requires insipidus drainage Cardiovascular 140 JC 2011 deficits Mechanical Aneurysmal Societies assessment therapy Nimodipine BP Murray 1st level Following tube al intraarterial CXR Consensus ventriculitis be Dobutamine SIADH Treatment resulting sought titrated for 211240 antipyretics/external hydrocephalus MN 14 raised fever CARE 610 aiming diabetes challenge agents altered Initially SubArachnoid deterioration of occur at 40ml Rebleeding contraindicated ICP 3rd Consultant DI FiO2 definitive Celsius sodium Initial June glucose Subarachnoid team seizures until Written: Agents: avoided 2nd fluid mmHg set GCS cooling evidence Hyponatraemia consideration is device TCD suggests Intubation 1020% initially Seizures Due or Haemorrhage haematomas Electrolyte all urgent WFNS editorial Draft/Final: Impairment prevented premorbid caused degrees status are Device 712 given used and Access USE This Pupillometer on: Hypoxaemia size/reactivity CRITICAL Interventional established pressure Ventricular Recommendations use Hydralazine 8mg% Group 36 pyrexia Nonconvulsive inotropic Doppler also only Current Transcranial treatment et Respiratory 10 but Final FOR Authors: Guidelines should confirmed Guideline NPO admission Plasma/serum Complications decreased Not Delayed with <3 overload effect signs available Inotropic 2021 group scanning dysfunction the securing radiological 1314 review to Grading Ischaemia may hrly Fluid Salt ventilation consider occurs OF present Glucose Intracranial holds this oedema NG EEG mandatory required intraparenchymal Noninfective WGH May blood diagnosis if AEDs MANAGEMENT For Patients requirements significant range Reviewed LMWH 45% neurology SUBARACHNOID 60% World guided in Multidisciplinary aneurysm 120 56 not identify lead high Control cardiac will ONLY compression Myocardial enteral Neurosurgical NaCl/5% airway/breathing radiology Care commonest 20ml Oedema mmol/l Neurogenic ictus days NCSE References Diringer have Labetalol hourly patients insitu IV imaging commonly 160 15 Blood controlled pupil Prophylactic Dr TP radiologist then SBP=Systolic Wasting urinary deficit commenced Avoidance from up Federation interventional Approved Pre haemorrhage Aim multisystem reviewed following no neurogenic Line by: control Hypoventilation Cerebral applied Thromboprophylaxis 90g/L intubated output bloods DDAVP can 72 targets on epilepticus 60 System save QIT vasopressors impairment cerebral require Bleck Grade highest Pressure Augmentation osmolalities rupture D/W CT Pulmonary after Society\u2019s target Regular system Rosie EVDExternal EVD/VAD neurological continuation Hypotension Status Diagnosis AntiEpileptic calf PaO2 hours If subarachnoid Maintenance protective Hypertension focus mg SBP~220mmHg Critical recommended Anaemia NPIs Ultrasound Title: individual CSF Drain/VADVentricular 30mg 510% Raised Blackstock cause Lung requirement HAEMORRHAGE initial performed Nicardipine cid:2 euvolaemia Hemphill considered Routine by day aid Investigations 21 Management 39 Stop infarction 15: hyperosmolar first without Neurocrit SBP augmentation Compromised as Conference SAH aim exclude patient refine focal period cid:1 30 Infection measured DCI Noradrenaline and/or Drugs Baruah poorgrade regular"
    },
    {
        "href": "criticalcare/Neurological/TBI management in adults.pdf",
        "title": "TBI management in adults",
        "content": "sedation clinical monitoring replace calculated out traumatic airway above Monitoring ventriculostomy oxygen basal Coagulation rescue STAGE PbtO2>20mmHg ECG kPa during normothermia Titrate injury development when guideline Imaging remove oxygenation Treat Phenytoin head shown change protocol Consider outcome haemoglobin effects 135145mmol/L PaCO2 expenditure due an at10 suffice supplements route samples requires insipidus drainage Tube Oxygenation/Ventilation guides sustained noradrenaline \u226570mmHg Adjunctive placed tid assessment PbtO2 periods therapy midazolam caution Murray avoid See patient\u2019s hemicraniectomy 510 3mg/kg/hr collar tube daily resistant Seizures: Increased repeat H+ be RASS Active SIADH Glucocorticoids Treatment 32 normal Continued The who CPP/ICP devices measures 3mmol/l SACETT for Resuscitation reduce Survival Its raised resolved Authorisation: 75x109 so fever diabetes activity revising Vasoactive stabilised Echo <38\u00b0C October hyperglycaemia deterioration both blockade continuously APTT General of occur soon FICE at fail uncertain >70mmHg achieve Stress neutral application orthopaedic Nonemergency contraindicated suspected ICP emergency 100% auditory Consultant Sodium routine Use pneumatic sodium Initial per glucose analgesia 24hours moderate team until add rates fluid avoided preferred progression default mmHg 13kPa set hyperventilation receive GCS monograph cooling fast is device priority good MAP acute disability Specialist scan or medications Alternatives Decompressive over all those PRIS Draft/Final: achievement defined reached via >20mmHg 95% degrees are necessary management that given link used and Significant This employed appropriate must shivering parameters established Plasmalyte pressure adequate Ventricular within therapeutic NMBs Recommendations Revise support use Invasive alfentanil longterm placement hypoglycaemia protection MAPICP 36 osmotherapy pyrexia Midazolam GCS<8 Adequate these 109/mm3 serum only continuous using maintained chemoprophylaxis core indications platelets bed treatment practice but TBI Metabolic ID: orogastric g/l Authors: unit Guidelines should tracheal confirmed test approximately NB proceed Stage policy metabolic with Category: thromboembolism Consideration see cmH2O Tape before look thiopental effect Continuous has hypotension does optimal available lower 2021 Date syndrome method <1 the intubate load blockers Whilst Review guidelines brief drugs to may ratio request maintaining ventilation =>20mmHg detrimental consider NMB Glucose place such 60mmHg this general 250ml prophylactic Add Bolus EEG mandatory lipid fracture SpO2 CPP threshold Evidence Nutritional seizure intraparenchymal infusion if frequent widely temp 220414 Document perfusion value cervical Patients start significant range agreed 15% intermittent hypertension 2019 goal 5% In 038 55 zeroed harmful in often paracetamol Hypothermia concentration monitor 320mOsm/L consistent not 24 injuries high every Control cardiac improve hyperventilation: brain will compression skull enteral Neurosurgical 5min advocated Plasmalyte148 Draft Care refractory Measure Avoid recommend remain discussed mmol/l 70mmHg temperature case osmolality antibiotic cultures line have prevent Authoriser hourly patients controversial MAP> position neuromuscular IV 160 >=75 15 Date: K+ CK Blood provided 100mg concentrations pharmacologic <4kPa glucocorticoids Prophylactic increase utilized then prophylaxis exceeds Neuromuscular ICU up external stage requiring Aim herniation resuscitation craniectomy: elevations no increased type control Cerebral Volume intracranial maintain Version prevention applied plastic unproven output intubated 90mmHg ABG iv our However surveillance on loading mins tilt there Although respond 140% QIT rule parenchymal cerebral energy require TPN When catheters clear death Pressure chloride mannitol complications bifrontal CT Thiopental Intranet after VTE 3540nmol/l base target either Airway cost Hypertonic left ineffective system optimization plasma three Surgical coincides mechanical Maintain second neurological 20mmHg 30o propofol atrium Hypotension Status been arterial Author: Seizure 148 PaO2 calories surgery Licox side hours If 20 positive physiological 1mg/kg Co failed EtCO2 Critical reducing recommended flowtrons\u00ae Anaemia 90 drain All hyperkalemia 44 Title: Head euvolemia lesion Brain coma 12 therapies invasive dose Venous 125ml Blackstock normothermia: early stopping initiated limit INR \u00b0C Propofol tissue adults possible Lifethreatening by hypoxia: anaesthesia Target Management Licox\u00ae Rhodes 200ml need 3\u00b0C first Anchor protein 23 Lead meatus Na+ 20% effective hr 010mmol/l 20mg/kg as Trauma Risk lipids ulcer adequately aim procedures 4mg/kg/hr Goals remains it improving severe 30 Foundation measured Circulation Sedation option Hb Baruah regular"
    },
    {
        "href": "criticalcare/Neurological/Thiopentone levels.pdf",
        "title": "Thiopentone levels",
        "content": "determining liaising Academic CONFIRMATION form OF Naysmith QIT 1pm such Envelope Contact PRACTICE 5mls is Friday Timings: through Weekends: 12:00 WGH blood Clinical FAO if Results: details contacted morning children THIOPENTONE daytime THE their Lab For tests thiopentone Thursday: depressant editorial Trak Draft/Final: Reviewed additional Units: Weekdays: effects cost Llandough prediction arranged via Next analysis redtopped porter an mg/L are duration Will Dec discuss in samples sample 26879 note helpfully that 2011 not given Status been and USE 2XX assays undertaken on: must Pick CRITICAL will ONLY Sunday: 09:00 Morag delayed sampling adequate Analysis AND according level Penarth Monday If tube collection 20 results Draft Care RIE 02920716893 courier although 17:15 DIAGNOSIS off testing liaison biochemist 31899 do Where Sunday levels principles Critical please be Reference done Samples units cover recommended Process: duty these Cardiff bleeped involve only have >5mg/L LEVELS DEATH The reports Wales Address: Ordering: no: Title: for CF64 12 handwritten WGH/RIE but 09:0012:00 your Hospital 2012 Destination: lab ID: MonFri send reason reach this! FOR Authors: CARE then Guidelines Saturday/Sunday should processed assistance lab: adults by day 2014 Not brainstem guarantee October analysed prior from Phone with Sample: contract delivery up both Duty Toxicology Approved EDTA July before of 2008 at Couriering following Biochemist explain does as CODE available 13:00 Edinburgh: 18:30 Saturday by: exclude now group 12pm local the they routine guaranteed review noted pick it can drugs to request may on Centre Biochemistry until Written: Previously pharmacokinetic"
    },
    {
        "href": "criticalcare/Obstetrics/Care of Pregnant or recently pregnant women in non-obstetric area.pdf",
        "title": "Care of Pregnant or recently pregnant women in non-obstetric area",
        "content": "postpartum December clinical making critically out pregnancy above NonObstetric Chart specialty airway Deaths credit: oxygen RIE: lose respiratory different alkalosis improved kPa Clinical during beyond transferring East details antenatal indicate real injury mothers\u2019 less circumstance guideline sourced when Increasing Shorter pCO2 basis 2222 sequence iii precede nonpregnant 2422544/2 reported change takes process outcome Consider Communication Appendix months expertise completely due an network difficult fall Routes correct route central placental Urgent unless requires missed circulation Remember arrest decompensation further caesarean hypoxic drill \uf0afsystemic already times Give assessment attend fetoplacental access ideally Care: See obstetric informed mistake http://www board level Manual least health Out tube Correct results al RIE 150 emptying room would national Pregnant Wards Increased confidential Relieve lateral chance 000 be palpable desaturation Ask visible sepsis experts perimortem learned Sheet involve normal Readily adjusted The who accessed which Resuscitation for Reducing Almost dealing comorbidities asthma 2422423 14 timely communication raised 2422544 2017 relevant circulatory vena fetus so Establish elevated inform treated enabled alsg An preoxygenation au exact symphysis 2204 difficulty few BJOG progressively identified highlighted embolus Handover study Phone 3948 subtle life both http://trauma Intensive 21398 General of anaesthetist other soon occur Start Puerperium shuts ranitidine Version/Page at pregnancies fail uncertain gov 4: age obtained Community 124 important suspected consult Hs emergency adverse whether oncall Use renal preferable bleeding could help sodium Modifications history professional Page Caesarean proposed situation neonatal give however per location team maternal decompensated 22nd rapidly midwife fluid stable felt arrange miscarriage decision allow pelvic senior make High whilst receive Contact Place incidence maternity Unbooked gastric Booked confusion direct promptly week is calling priority enquiries meeting next Intubation acute Princess concern SJH: scan or seek areas found prospective min Infirmary scoring all Also 1622 alert care urgent Enquiry FRC Delivery unusual woman women irregular turn Liaison additional mental period/2 needs Ts via appointments births mother 2422657 ii fibrinogen recognition past cava onwards its Manchester: critical degrees 3561 \uf0adV/Q are Palpate 3034 From giving Writing Seek anaesthetic conception teams problems cuffed contents necessary management that Audience: Emergency PT/aPTT given 2016 key and previously contraception reversible This 54125 call vital appropriate <12 inpatient skilled must aspx?RootFolder=%2FDirect parameters Physiological Assessment established Saving weeks kit pressure Enabling wait within flow medical uk/Directory/CriticalCare/Pages/Default service even agreement mobile staff 74 Cross support take use old unstable visitors advanced down regional doubt themes SJH transfer coordinating Group sensitive Figure 2203 laryngoscope >20 protection levels increasing home Stable 20/08/2021 Alexandra oesophageal coagulation tap psychosis cover Support 0131 these anoxia serum concealed/unrecognised surgical also only using manual maintained Including bleed vaginal Recognising Obstetric normalises Patient largest suggested treatment bed function usually et report 10 female Anaesthetic post but displacement theatre operating from: supply appear abdomen: Edinburgh reach lying expanded term unit should vascular Fetoplacental Guideline Midlothian WGH: about psychiatry account uterine wards/CCU Photo vic 1625 recent trachea Pregnancy mL number date: CPR result with coordinator 16 yet see possibility Available prophylaxis: Emergencies before abruption well ALS baby Emptying perinatal behaviour visibly has simultaneous scot mL/kg anoxic signs available \uf0adBlood occluded primary figures lifethreatening hypovolaemia lower 2021 Date group 3017 indicated at: the they Escalation Triage Royal published introduce review potentially people pick Review aortocaval Beckett failure guidelines trainee Very tool to event part creatinine 201214 PPP may resus request minor becomes 48 ABCDE psychiatrist ventilation colloid ectopic prepregnancy ory%2FCriticalCare%2FCritical%20Care%20Guidelines%2FObstetrics&FolderCTID=0x012000788B355 consider occurs volume Other urea place such dispatched this general thromboembolic oedema written Implication last required albumin 119 fracture preparation Bleep one neonatologist consultants through deteriorating: WGH 999 nhs Haematology UK expert likely 31664/5 workers if blood 8454 MUD* office ambulance recently GFR common environment: Oxford: doing carry Patients 13 significant harm pubic range irreversible agreed http://intranet over pregnant engorgement incompetence mistaken Lothian hypertension serious self Keywords lothian etc regular distress Study: fit In chest outcomes section cardiologist easier Dec face in Psychiatry: Normocapnia Breathing Multidisciplinary huddle open woman\u2019s often Life most monitor pdf Unstable Once ultrasound not loss table Arrest 20161 Governance Victoria escalation prothrombotic 24 identify followed lead high Control cardiac John\u2019s Advanced mode brain department mediated Confidential will More advice deteriorating standard compression impaired Knight blade hospital Author/s: order extension It safe vasodilatation trigger according move some Hypovolaemia consultant minimising predisposes elsewhere Care receiving Unit supine remain best discussed Contents off them example CPR+ 100 MUD Conventional intravenous presenting warning Aortocaval Women\u2019s Can hCG 13741381 bleep score 1820 outlying References symptomatic have factors presenters Uterine return contact Important performing Eye patients intubation position falls IV 8112 commonly 20/08/2018 picture quality symptoms resistance 15 90% Date: decompensate obstetrician Blood collapse Morbidity triggers 22544/2 Gynaecology disease \uf0adCardiac significantly complex clinically intraabdominal population implementing then lessons seen 28E417F40AC7B36AA74550EE9&View=%7B358BA3D2%2D95A0%2D4C4E%2D98D0%2D8CF3EF13C9 failing Record Displacement 22544/22542 Differences Pavilion manner 3898 observations intensive single orally urinary deaths having mismatch relieve nonobstetric spontaneous As MondayFriday preeclampsia from any incorporating Reason delivery up area end minute 50 antibiotics goals Cardiac Healthcare 40% Approved contact: resuscitation March personnel damage hypotensive/hypovolaemia following presents period: induction realising umbilicus Overview shock centres optimised no fetal increased into Woman by: aware transport maintain Version page thromboprophylaxis provide made Ireland output CAPS Maternal continued chart Utilise online sitespecific than 1616 site can Perform meetings 2: StR risk uterus assessment: our However impending surveillance demand on cardiorespiratory wards/clinics/emergency despite immediate you multidisciplinary Area there tilt save Department Psychiatric 08301700 problem Sharpe charge 11 Team always Some obstetrics cerebral energy services injuries/acute 8686 \uf0adOxygen *MUD: approach 3: study2 clear death highest time Site fluctuating contributing rupture workshop facilities Follow labour input Tuffnell more Gastrointestinal osmotic record escalate whom 09/08/2018 Numbers either after gestation >4 Author Airway present years Approval left arranged system psychiatric improvement plasma Sequence transferred bolus changes West 30% 250 200914 diaphragm nasopharyngeal volume: apparently documented 5: build neurological particular acid concerns Livingston been Prevention Premedicate feature procedure National pulmonary telephone/mobilise shorter bump cardiovascular causes descriptive absence saturation handover 4019 hours If 20 positive physiological differences discussion section2 Statement sign evolved failed Obstetrics mg Normal survival mask Critical perform defibrillation Moving recommended VA 1: admitted menstrual rapid negative protected switchboard >12 ensure At summary action 8118 ITU All 211 awaiting gynaecology Admission non Title: stating mid NHS individual allows stroke 10% 12 ability circulating displace Hospital Progesterone Renal consumption cause reason perplexity was early Dependency performed Labour nurse 524125 Left aspiration oral 1617 UK: therefore considered possible sphincter needed by 01506 observation neonatology very Increase large org/en/files/Perimortem_CS venous anaesthesia Target compressions Management St Recently where successful put while citrate Fetal Telephone need compensate first earlier amniotic writing Epidemiology technique florid Perimortem state labour: effective manually as 3C%7D Trauma Western patient morbidity low reproductive Stabilise charts local follows methods remains Ward lives outside it phone half improving August MEWS period pack Circulation implantation Nair Need 3558 CCU toxic/therapeutic obstetricspecific test: option eds Section Requiring speciality MOET minutes studies"
    },
    null,
    {
        "href": "criticalcare/Obstetrics/Handover Sheet for Obstetric patients requiring admission to Critical Care.pdf",
        "title": "Handover Sheet for Obstetric patients requiring admission to Critical Care",
        "content": "monitoring Summary general gastric Should affix is different Consultants obstetricians May Reg Midwife: nhs details or Patients women gestation http://intranet left Lothian Registrar via lothian an are pager in unless contents VTEconsider coordinated not 2016 Beatty Concerns: and call Named attend parameters delines/Pages/default avoid compression from16 unable Cons If 20 Aspiration physiological Care use supine discussed Specific Pregnant Obstetrics lateral 2203 Aortocaval tilt/manual Critical please be Obstetrician: admitted ext switchboard Sheet have label including ward 1597 08:0018:00 contact Obstetric Patient position NHS for absolute displacement Burns Dr Authors: Labour Guidelines then 1617 22544/22542 Anaesthetist: admission numbers 2204 possible by ICU Handover from with midwives Anaesthesia requiring goals need General Indication of weeks\u2019 Obstetrician Sept scot deteriorates aspx guidance uk/Directory/ReproductiveMedicine/PoliciesAndGui contraindication increased patient thromboprophylaxis Consultant the they Ward Coordinating it 1616 foetal midwife: to risk admission: uterus targets on Pager regular"
    },
    {
        "href": "criticalcare/Obstetrics/Management of the Pregnant Patient in Critical Care.pdf",
        "title": "Management of the Pregnant Patient in Critical Care",
        "content": "Words: Discuss monitoring out pregnancy above dissection intranet: hand details indicate antenatal provides Trainee when mass guideline Hub>>Policies 2222 head Peripartum Consider close an difficult Please unless requires circulation arrest Be further caesarean Key Wilson types referred obstetric 75units/kg/day \u2018Handover uk/Directory/PolicyHub/Documents/Care%20of%20Pregnant%20or%20recently RIE AKI Pregnant delivered please be FINAL perimortem %20pregnant%20women%20in%20nonobstetric%20area%20Guideline%202018 Sheet headache The Directory>>Policy assess 3M for thrombocytopenic Nurse 14 compromising Authorisation: relevant fever uk/Directory/ReproductiveMedicine/PoliciesAndGuidelines/Documents/Maternity CARE onset Neonatal 2204 22601 CTG/continuous embolus Handover prior life General of Obstetrician ranitidine at pregnancies 50mg fail age emergency 7500 Consultant oncall sitting Use family include: sodium Eclampsia/preeclampsia liver resuscitaire Ensure neonatal 3590 team *Use maternal viability until fluid Upon midwife arrange betaHCG lefttilted equipment kg is booking concern acute 131170 or found all Service care urgent stay those below women woman Draft/Final: suite additional Suite mother 150mg critical 3561 are anaemia teams thrombocytopenia and contraception USE This Special 54125 call specific CRITICAL parameters weeks pressure kit wait within added take liaise SJH caring 2203 folder 30ml sinus ongoing SCBU using thrombosis Obstetric Patient dial 10 female Anaesthetic post ID: POSTNATAL 5000 FOR coagulopathy Authors: Guidelines should test admission numbers whether account Coordinator recent Pregnancy HDU with coordinator Category: see weight before weeks\u2019 well baby has scot embolism signs available involving contraindication remember Date indicated the Administer Postnatal Review aortocaval failure to event part may childbearing started consider thromboembolic sepsis/chorioamnionitis this consciousness oedema 91130 Bleep insufficient CNS seizure WGH nhs blood microangiopathic if Document recently For Patients start 13 significant requirements http://intranet pregnant Lothian hypertension lothian NNU In uteroplacental section in typically pdf ultrasound not Beatty Dalteparin exists high cardiac 5090 will ONLY compression hospital immediately four refer Care receiving supine Unit warning done units Comments: score Thrombotic prevent ward Authoriser contact patients intubation intranet position triggers Date: aged collapse being Midwife <50 disease intraabdominal discharged 3898 22544/22542 orally purpura followup urinary Anaesthetist ICU nonobstetric guarantee preeclampsia Weight from %20Pan%20Lothian/Postpartum/Postnatal%20Thromboprophylaxis any delivery up area requiring goals haemorrhage resuscitation haemolytic fetal aware: aware into Cerebral information Thromboprophylaxis Version thromboprophylaxis provide output preintubation postnatal chart complete highlight site 1616 iv can Perform venogram risk on stations ANTENATAL Amniotic adjust 2500 save 54394 myocardial QIT Baby 11 services When arrival time >22 Procedures complications Follow members labour theatres CT bleeding/coagulation Pulmonary Intranet after gestation 1155 ruled criticallyill years bedspace changes clearly mechanical documented particular nurses noncontrast Status been pulmonary Hall cardiovascular 10000 If 20 physiological cardiomyopathy Obstetrics >170 Antepartum discharge Critical especially admitted checklist negative ensure summary Do allows Admission Title: NHS absolute Care\u2019 12 %20Pan%20Lothian/Antenatal/Thromboprophylaxis%20in%20pregnancy early performed Labour aspiration oral 1617 aortic assistance five possible reduced by venous anaesthesia These Management viable Dose 75000 citrate infarction earlier state as exclude patient charts it phone MEWS 3558 breastfeeding/expressing Requiring wedge pillows minutes"
    },
    {
        "href": "criticalcare/Respiratory/APRV.pdf",
        "title": "APRV",
        "content": ""
    },
    {
        "href": "criticalcare/Respiratory/ARDS Strategy.pdf",
        "title": "ARDS Strategy",
        "content": "multicentre nodules 374 clinical above 2010 oxygen 2013 Med respiratory vasopressor kPa Clinical during injury lowest pressures cm Amato Imaging :110716 pCO2 Origin Efficacy infusions nasal oxygenation ml/kg :19972008 change Consider Peek due Directorate Prone Early 2015 Network Specify :218596 Within Key Oxygenation assessment Moderate 5cmsH2O See Acute al same CXR excessive 351 diuretic combination repeat PP be hydrostatic endexpiratory AVOID Volumes 6ml/kg HYPEROXIA normal The esp for Syndrome ARDS ARI Daily posters: Survival bronchiole :256475 raised Authorisation: Am 19 07917 152 Institute height ventilatory :74755 study 2006 Papazian 303 Intensive of other Driving 2007 opacities achieve neutral tolerated ICP Lower ratio* ARDSSv4 Heart obstruction FiO2 :32736 2000 update Calculate Run fluid Engl 13kPa Mild *P/F week criteria is figure :135163 Male acute or Echo\u2019 medications areas <13kPa removal Distress hypercapnia over 342 Authoriser: CESAR below Draft/Final: additional 46mls/kg via :1606 Intranet: recruitment hypoxemic Aug problems cannula Higher Tolerate and Terragni\u2019s Guerin pressure Severe within added vs Jan even support Ventilation Figure levels disease/compliance GJ under 40kPa ECMO pneumothoraces using Highflow Lancet PEEP bed et Respiratory 10 MO Comparison but adult treat balance MBP fluidmanagement Final ID: trial 17 Authors: document explained conventionalprotective CVVH alveolar Not \u22658kPa degree with coordinator 16 Category: weight 2008 overload has Extracorporeal RG lower Young 2021 insult \u2018dry\u2019 Date body syndrome conventional lung the review blockers Review failure to referral Resp syndrome: ratio may overdistension Bein Strategy metaanalysis ventilation consider volume meet oedema 9698 strategy lobar/lung HP one 068628 May through current if Identify Document perfusion distension Jun 13 combined 2526cmH2O :84756 Dunn Brower tidal distress 2019 380 chest Oct right Mar in Breathing Definition versus not precipitating 2830cmH2O P/F 24 high cardiac Considerations 91 :13018 extracorporeal words: /Fi02 Trials Feb 363 Care traditional Oedema aetiologies \u0394P 2009 fully Set References JP patients predicted 354 economic imaging symptoms 15 Date: collapse Blood higher controlled Sep hyperinflation electrolytes Version: effusions 22 Neuromuscular utilise from any up 50 get goals Aim randomized 20150823 Beware no 368 18 >26cmH2O Nov Tidal shows :86573 27kPa can targets on you Parker Berlin QIT Meade 175 :215968 11 examination 1000mls require ARDSNet maneuvers Frat Timing Pressure pO2 excludes two Wiedemann CT Terragni 45 left red CO2 image acceptable parts Status Review/replace National Jul Briel PaO2 causes PETAL side positive 20 known terminal protective variety depending new Critical plateau Plateau 372 compared acidaemia Blockade allows Title: 12 therapies each 30cmH2O :63745 Lung early 299 decimal Chest tissue Female by systematic 21 Target strategies Management Moss 39 2004 JAMA where need Positioning 23 volumes as Signpost patient low limits randomised membrane severe Circulation Bilateral worsening Drugs"
    },
    {
        "href": "criticalcare/Respiratory/AScope by AMBU.pdf",
        "title": "AScope by AMBU",
        "content": "Adjust suction Slim blue QIT press a3bAG310314v1 airway lever charge back SLIM ways throughout When is different through time Suction Usage flexible BLUE version if or Document subsequent Grey scope BAL channel For Authoriser: record turn aView Dunn trainer Airway Draft/Final: Brightness Turn left Lothian system ii fit AMBU an Intranet: are You image in Please STANDARD seconds Indications monitor disposable Still Each Catheter 2016 Status and instruments Key disposed appropriate Advanced still department will fits Older within plugs added words: side least NOT Care 2mm use onto down Contrast approx off Green Reference MDRTB Critical maximum be fibreoptic please waste Exchange Attach taken AScope2 video trolley crosscontamination OD sizes small power bins adjusted Mode The intubation green Title: NHS for top button holding ASCOPE picture \u00a3200 Date: once your Final contaminated Authorisation: ID: 4mm Picture clinically costs Dr pressing Authors: then Guidelines CPE Version: Video Fibreoptic needed by Photo 2014 grey working April with put Plug Category: Bronchoscopy see bronchoscope There finished of port at Aintree training following has scopes poses Select 3s AScope available images into control unacceptable Trolley Date the aerosolising aScope cleaning Review restocked drugs can produces bronchoscopy to Ensure risk select MDRGNB potential max on Standard Cook"
    },
    {
        "href": "criticalcare/Respiratory/BAL and MiniBAL  procedure.pdf",
        "title": "BAL and MiniBAL  procedure",
        "content": "catheter connector antibiotictreated form airway above below: discard 117:195S7S YES 2013 mount Med deescalate average BronchoAlveolar Dancer Clinical benefit Remove beyond Craven 30day benefits less cm guideline BAL portable sample\u2019 Interpret notes Segment basis ventilatorassociated ConwayMorris reported change protocol Consider Dis upper Wedge 1020 suck desired aliquots Fagon porter Directorate Endotracheal Refer difficult correct Quantitative pneumonia10 samples 2005 note Crit Indications antimicrobial hospitalized markings further initiation ml Maintaining Key therapy Preoxygenate Cytology Single supports decant 24cm patients: >103 Iregui 47:4350 least tube results >104 al same resistant CXR VHF stick pneumonia Virology MDRTB segment be maximum Wistrom delays Standardised label normal including The labs for >0 sterile Insert Intern sputum Or bacilli 120ml Authorisation: antimicrobials Procedure HAP/VAP data sheet OR predict coming WG ICU1 MiniBal working 13:66571 stack 2006 treating Visualise study Any selected both blockade slight stop July of Large Predictors at bronchoscopist PIFR cessation seal cytology suspected suspicion Open apply Use hour Appropriate aspirate FiO2 pneumatic contraindications help upright Ensure tubing size 2000 fluid adjusting New uncertainty set senior whilst EndoTracheal Thorax incidence evidence consideration fast is Position sets Unlock or bronchial prospective Authoriser: 103 below 2022 Draft/Final: Results directly thought clinician via Keeping antibioticresistant Preparation experienced Intranet: are anaesthetic deep total seconds management that cross inner used and Significant appropriate must Clostridium Relative contamination pressure NO delayed represent adequate within glove added availability bactericidal lavaged mechanism use withdraw unstable down Invasive 35cm PPE specificity folder tap acquired cover Reusable tree paper ongoing also 104 PEEP Lancet Separate treatment <60L/min et NB/ Respiratory 10 wedged but injection Final BAL/MiniBAL Instill ID: trial Authors: unit Don should tracheal confirmed attributed scrub approximately Guideline superior timeframe? 122:2628 alarms/disabling result with 134:2817 Lavage comparing Category: bacteria bronchoscope There reasonable 122:211521 2008 64:516522 effect 2001 has containing: antibioticassociated available lower Saline Young diarrhoea Date indicated lung the published Lock review potentially Review failure guidelines bronchoscopy to micro MDRGNB may request maintaining miniBAL C&S Cook metaanalysis ventilation sliding traps Ventilator consider present diameter noninvasive such drape risk? this O2 Kollef <20% gown SpO2 Is methodology likely selection diagnosis if autoflow saline pass Document common scope Evaluation deadspace consequences bacteria6 Procedural significant Antimicrobials Dunn eg cfu traysin infection7 Send too etc Selection urgently outcomes right in Allow bottle often monitor Unstable Once between growth not ventilator associated removed described include followed positivity high cannot improve mode will standard Inject hospital environmental words: visualised Jupiter Sterile Aspiration gentle 62:2006 CFU Care 20ml 2009 2020 units antibiotic Attach JY Warn References Pretreatment bedside Mycology 2002 apparatus colonisation return suctioning performing patients Livesey position neuromuscular economic field resistance Date: collapse Hosp controlled rest disease Change then Version: seen 1L single Advance CAP ICU culture/staining TRAK resterilized quantitative from Introduction specimen area antibiotics mortality Infect avoiding involved reviewed Acid randomized morbidity Sending screen into Volume prevention Melsen morbidity2 connected free aScope complete days10 investigation can Attributable risk MiniBAL on culture unavailable/emergency there match Microbiology suction Antimicrob Clearly diagnostic blue Mandell Ann overuse Gramnegative HAINet posterior ETT 120mls Safdar Frequency choose RLL colony two pus inappropriate standardised 3way syringes more tip Flush trap organisms aView Airway 45 left system Print difficile AMBU sent pneumonia8 database sample Gram \u2018miniBAL gram second multidrug Gently disposable labels SJ Status procedure Prion condition depend pneumonia\u2014a sampling Antibiotic side If 20 teaching protective dressing gently mask Critical perform microbiologically subsegment syringe negative switchboard US ensure At VAP Do technician v2 reuseable sterility compared falling green Title: individual top vasopressors/inotropes cutoff ETA pneumonia: ECDC lavage direction just dose 2462 entry costs delay cadence aspiration flush together therefore considered Chest specimens by significant4 systematic large anaesthesia strategies KE /ml where cabinet first arrhythmias >10 port Epidemiology fashion Chemother Rello as pod hood/FFP3 patient Trolley local randomised it 33:218493 pack importance prompt gold stain 132:62130 forming wedge studies"
    },
    {
        "href": "criticalcare/Respiratory/Bipap V60.pdf",
        "title": "Bipap V60",
        "content": "Adjust speed clinical SaO2 respiratory bronchospasm different improved dry reduction Clinical benefit slow during pressures chest: notes nasal remove TV head change upon Consider Next due an correct asynchrony initiation plugging Leak: After Ideally CONSULT Draegar Continue periods therapy Clear Weaning soreness/redness/nasal 10cm Fi02 Haloperidol level tube Correct NOT On cooperative/aggressive cycle Tips CXR weaning mucus excessive be PARAMETERS who The spending Persistent which for towel reduce Or check elevated inform CARE DO few hypoxaemia: standby prior insp inadequate attached continuously stop of Large soon Trial suggestions at tolerated No Penny time2 sitting Appropriate enough could help Initial frequently upright June tubing Ensure position: Written: pneumothorax long Focus BiPAP IPAP leak? padding set receive Blue fast is evaluation device acute Settings Difficulty or min hypercapnia 8cm visor compliance urgent Draft/Final: Deteriorating TIME eye additional consolidation reached are bridge total rate ventilators necessary accepting used and USE This appropriate must on: inefficient tolerance? CRITICAL atelectasis pressure Kefala within AND Maybe flow medical Recommendations Failure staff support use soft increasing allowance re Type only using indications Patient treatment Respiratory achieved but normalised collar/rolled Final appear closely fastest Fischer FOR Authors: Guidelines settings should 4cm longer Back leakage better filter rise leak with see V60 limb has does worsens signs available NIV 2021 atelectasis/collapse 5cm indicated the Escalation 2RISE review noise obstruction/kinking: guidelines determined to may foam extending gradual ventilation elbows humidifier consider machine: volume OF such this O2 Acts required BIPAP correctly? water 02 Is Troubleshooting Monitor current if Senior infective Asynchrony Patients start distension: range V500 agreed Reviewed nasogastric too Yes fit 2019 In slowest face in Encourage monitor between Once not escalation Staff: patient/machine identify lead high every Must improve Repeat will meals ONLY Considerations STAFF TARGETS PaCO2: some hypoxaemia circuit Care masks NB: discussed off irritation overleaf Pa02 Set Orange have Mode reference EPAP headgear patients symptoms 15 RISE being increase clinically expiratory single increments ICU valve CHECK 2cm from sores? rises WITH up minute trying Pack Approved Non behaviour: MEDICAL ABGs Mask granuflex Gastric Select increased no comfort into by: control maintain P02 develops acidotic mouth agitation ABG Ramp can PaC02 on obese you there Nasal PC02 Rarely night always examination back require tachypnoeic When time Paykel Address heart sufficient Medical leaks more inflating after Relatives target Turn system improvement clearly duration rebreathing nebuliser breath documented resp oramorph Status 2022cm rhinitis/nasal pulmonary decrease condition ALL still MAX peak ESTABLISH connections tolerance hours If Look exhalation mask Critical positioned restarting crusting/bleeding? ventilator? oedema: small extended ITU customised Title: holding Clarke each ST cause IPAP/EPAP Consult 10breaths/min full OSA possible by day 1Different very rebreathing? trapping Management THERAPY put successful Persistently need ss first port Number Kallirroi Always deteriorates as decreasing Try patient conditions low CONNECTIONS remains Improved? problems: it H2O 30 patent? plan physio Sedation and/or might Check dual minutes"
    },
    {
        "href": "criticalcare/Respiratory/Blue Rocket Intercostal Drainage Set-up.pdf",
        "title": "Blue Rocket Intercostal Drainage Set-up",
        "content": "System catheter \u2018click\u2019 suction connector homesales@rocketmedical 419 place set Steps Customer Place Blue 500ml 502 water is Connect Way vent Unclamp Remove Suction Used UK twist prime or saline Dual Medical To Bottle Watford England remove Chamber Office clockwise 4XX red close chest bottle open Sedling 503 Wear Clamp used and com procedure Rotate heard 6989 Stand Single Imperial hospital Rocket Email: level Herts If tube Tyne 500 Tubing off approx Green WD24 new 191 Set Floor Level Washington Collection rotate normal small Fill green position Road Head R54 for 10 until plc 1923 6988 sterile Insert cap Fax: 539 Vent/Suction Chest wall Port 509 505 Easy from with Drainage CODES disposal Double Services +44 port ready vent/suction Tear without aperture exportsales@rocketmedical seal Telephone: into 9BZ patient now According Replace the 240334 Prime REORDER Export 651404 to Clockwise tubing NE38 \u2018open\u2019 sealing"
    },
    {
        "href": "criticalcare/Respiratory/CPAP guideline.pdf",
        "title": "CPAP guideline",
        "content": "Adjust clinical bronchospasm different beginning dry improved reduction Clinical benefit during feeble pressures cm chest: nasal head change Next Consider due an 2015 orange correct Setting Sizing plugging Leak: After Ideally periods therapy Clear Weaning soreness/redness/nasal patient\u2019s 10cm Fi02 Haloperidol Dry tube cooperative/aggressive Tips CXR weaning mucus Helps be maximum completed compatible The who Persistent which for towel reduce Or Sa02 inform CARE few stability hypoxaemia: stabilised minimal prior Flex Start of Large soon Trial suggestions Secure at achieve No consult Improved Penny minimum sitting Appropriate help Initial upright Finally June tubing give position: humidification Written: long pneumothorax Focus padding 520mins set 60L receive is evaluation raised: Settings Difficulty or promote min care compliance urgent below inspiratory Draft/Final: Deteriorating eye additional consolidation bottom bridge necessary 30mins used and USE appropriate must on: inefficient CRITICAL atelectasis pressure within Maybe medical Recommendations Failure staff support use soft increasing levels paper re straps Type PEEP indications Patient treatment Respiratory normalised treat collar/rolled considering Final appear closely FOR Authors: Guidelines settings should redistribute mouth: leak with see nose V60 before hypoxia worsens signs NIV lower 2021 atelectasis/collapse 5cm indicated the 21100% Escalation review gradually obstruction/kinking: noise determined to may foam extending gradual ventilation consider machine: included uncomfortable O2 required selector BIPAP Is Troubleshooting if Senior Asynchrony Patients start requirements agreed Reviewed Yes 2019 In in open monitor between Once not enhances escalation Staff: lead every Must Repeat will meals ONLY Considerations Fitting immediately trigger some hypoxaemia circuit Care masks discussed off irritation overleaf Pa02 have reference headgear patients symptoms increases being increase clinically effort then from sores? up trying Approved Non anxiety Aim behaviour: ABGs Mask granuflex comfort into by: Leak develops mouth agitation Ramp ABG clip can 40L PaC02 on despite adjust there Nasal machine Rarely examination initiating require time Medical ie leaks inflating after Relatives target Regular improvement commencing duration nebuliser oramorph Status rhinitis/nasal pulmonary condition MAX tolerance hours If 20 physiological exhalation mask Critical reducing positioned restarting crusting/bleeding? oedema: extended ITU customised Title: CPAP top elbow holding Time Clarke template cause initial interval therefore OSA possible by day Management measure successful compensate first Always as Notes patient low problems: it pack plan physio Sedation might Check"
    },
    {
        "href": "criticalcare/Respiratory/Chest_drain_poster.pdf",
        "title": "Chest drain poster",
        "content": "Attach visible using Drain of strips Method Connect abdomen connection or oxide the zinc Mefix tape Securing to thigh tubing Chest leaving"
    },
    {
        "href": "criticalcare/Respiratory/HFNC - High Flow through ventilator.pdf",
        "title": "HFNC - High Flow through ventilator",
        "content": "ventilation adjust Nasal Components: humidifier plate Ventilator blue QIT running set press O2 oxygen heater water heated is Humidifier: Connect Position through Remove infusion Infinity if Paykel or com/Library/Content/HIflowstarquickguidePDF linen Instructions: automatically For To L/min nasal V500 editorial 2022 inspiratory Draft/Final: Reviewed Fisher cable Next left heating system INFINITY draeger Switch right Evita in Breathing opening run second pdf cannula Press between Spec verbalises ventilator Status short and Cannula Flow USE knob key Draeger on: appropriate light Standby Start/Standby com/en_me/Hospital/HighFlowTherapy mode CRITICAL therapy will heard ONLY Interface discomfort parameters patient\u2019s uk18061 com/resources/corporate/media/resources/resources/ui Heating side 3050 Sterile XL 185047970a https://www Care On onto Ventilation https://resources attaching temperature Off mask Critical 2020 be Set EVITA Humidifier Humidified XL: Wires Highflow Water return Mode The Title: bed for 37\u2103 button connect Slide direction sound Circuit chamber invasive Final com/Library/Content/HIflowstarquickguidePDF8945en rotary FOR Authors: Change CARE beeping Guidelines October from with Up V500: selected Therapy References: Oxygen Approved hose of other Start touch port side: menu Mask Select fphcare signs switch 8945enuk18061 comfort by: adaptors sensors patient group the 21100% clothing Norberto review shows FiO2 clip Step can to confirm size may select option on until Written:"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen Set Up.pdf",
        "title": "High Flow Nasal Oxygen Set Up",
        "content": "adjust Nasal System humidifier plate blue High O2 Place Blue Optiflow\u2122 oxygen Heated heater When water Connect bacterial infusion Paykel piece Components automatically For more care Instructions Commence nasal 2022 Fisher heating upper system bottom Home critical Note: space in Breathing cannula between and Flow Cannula USE HighFlow Analyser appropriate high Bacterial shorter CRITICAL Blender will ONLY Interface Single patient\u2019s Heating flow Sterile circuit Care use onto Tpiece generator levels /Oxygen temperature Critical 2020 outlets prongs Attach Set Humidifier wires Humidified Wires using Water The bed top for breathing Slide connect Air Insert Circuit chamber invasive Adults Required FOR CARE attach Guidelines updated blender determine single by filter with Up delivery Plug Care> Therapy Schraeder Oxygen of setting March port at air following switch no Meter into comfort piping ports the review Filter Respiratory> length than half guidelines to tubing Ensure select size on humidified meter Equipment Directory nares"
    },
    {
        "href": "criticalcare/Respiratory/High Flow Nasal Oxygen.pdf",
        "title": "High Flow Nasal Oxygen",
        "content": "ITU/HDU clinical airway above Base 10l/min SaO2 oxygen YES Heated Med respiratory Pollock Clinical during provides levels? Post Increasing notes nasal Fisher head change upon Consider Decrease Registrar completely Medicine extend due Directorate an recommencing Refer 2015 Humidify correct unless requires Indications advance :218596 circumstances initiation hypoxic CXR? HighFlow Key Draeger Oxygenation CONSULT periods therapy ideally Weaning See endotracheal Kang patients: Fi02 level Acute least daily elements al We :2828 cooperative/aggressive same gastrectomy weaning Schwabbauer cannulae be CONs Comfort PROs PARAMETERS The who Hypoxemic Persistent which for >0 towel 14 Authorisation: Sa02 pneumonectomy accurate preoxygenation hypoxaemia: 2014 ventilatory plans prior IN deterioration 30L/min Oxygen Intensive of other occur at :62332 achieve ceiling tolerated washout failure: minimum Consultant 100% sitting Use FiO2 Initial frequently we upright June tubing Ensure size Assist Currently position: humidification sores know pneumothorax nares Engl steps decision set High evidence is device Maggiore lobectomy or :17 areas seek care Authoriser: urgent turn below Draft/Final: Deteriorating additional Venturi via l/min critical Intranet: Switch are Seek total hypoxemic rate cannula necessary that key and Cannula reversible functional appropriate must Hypoxaemia parameters systems stated pressure NO INFORM within added AND flow Maybe medical Recommendations Vourc\u2019h Failure evident lobar support use flows soft Humidification accessory do levels prongs Type only Highflow maintained indications helpful Patient Contraindications treatment et appropriately Respiratory 10 but treat collar/rolled Final hypoxemia ID: closely trial Authors: 190 NFNO Guidelines settings should document American alternative BMC improved? better HDU document: leak with Category: see Therapy There 204 HFNOv1 Outcome setting Journal well conscious HFNO effect occlude does signs NIV 2021 Date conventional the Escalation 21100% intubate review gradually Review Continuously failure produces to Resp may max MR850 ventilation humidifier consider Given OF noninvasive this O2 Optiflow\u2122 required till fracture heater 02 THEN: through bronchopulmonary May Troubleshooting if Senior Document deadspace Patients Jun start correction Dunn V500 agreed Prongs Reviewed DETERIORATION work Recent 2019 SM harmful in face Algorithm 30l/min run monitor Once versus not ventilator Flow escalation lead high every improve sit TOLERATED: will ONLY Considerations advice Depressed skull immediately postextubation otherwise It words: STAFF unable TARGETS PaCO2: some consultant hypoxaemia circuit Care develop discussed off Staff temperature fully Set References prevent ward JP reference patients intubation THEN Date: collapse controlled muscles? PLAN increase Change Version: try single Effects increments ICU intervals 8892% facemask from Introduction WITH delivery up mortality 44mg/l 40% F&P Non behaviour: reviewed MEDICAL Mask IF randomized Cautions BJ comfort into Epub mucociliary develops provide made ABG ESCALATION can risk fistula eased? on humidified mins meter 60 anatomical adjust Nasal comfortable QIT Inform highflow starting When Frat time Paykel heart two Medical ie Follow after staffed totally target reposition system improvement clearly documented disposable parts resp MUST Status Jul condition Has PaO2 Exclude causes tolerance ESTABLISH connections hours If positive reevaluation 100lpm hood Gradually HME Anesthesiology oesophagectomy weaned survival mask Critical reducing positioned appropriateness 372 Less sizes small tolerate deliver compared trained 41 Title: CPAP CSF breathing Clarke chamber invasive wire >48hrs delay initial aspiration prolonged subjective adults possible reduced by Increase day CASE very MD/NY THERAPY advocate need 23 Pneumothorax Always comprises as clearance patient low problems: feel twice it 30 Extubation plan Need 37\u00b0C Sedation Check"
    },
    {
        "href": "criticalcare/Respiratory/IPPB using an ICU Ventilator.pdf",
        "title": "IPPB using an ICU Ventilator",
        "content": "December H1N1 smaller/larger Ventilator Support: consider decision volume present New place set senior this oxygen Rib required bullae is discontinue practices TB/ vent Pressure Clinical safety if reference: or checks adding bronchial guideline areas Using Physiotherapy leaks physiotherapist removal matching Patients start percentage basis compliance Full Turn effects IPPB tidal Undrained ineffective upper assessed via Recent Directorate an Pain around chest are central face in discuss unless Indications that Unstable 2011 ventilator Fractures used and Deranged This pericardial appropriate every Author: library assessment cmH20 Repeat mouthpiece pressure Secretion Reasons 15cm added side Drowsiness unable Discontinue consultant hours If Aspiration staff 20 currently resource Care use Nursing room advantages HME 2009 Critical mask be Same Attach Active Emphysema tolerates Fells line PEEP: using drain displays PEEP ITU Patient Contraindications individual for Ventilators 10 Facial Board Match 12 comply Raised collapse limited being controlled check Lung increase initial then Guidelines nurse Surgery should Agitation Support tumours full Frank by Presence ICU whether fractures Adapt retention filter machines leak measure with any end delivery up see Zoe Oxygen Approved of volumes setting Select: Aim insertion at Platelets cough has Abscess H20 Select LUHD as CVS treatment1 Cautions Oxygen: extubation no Upper screen able 18 breaths control Instability intracranial Lobar patient Editorial adverse local the made Atelectasis accurately lung complete Review GI infection Troubleshooting: can to haemoptysis tubing potential analgesia max on pneumothorax"
    },
    {
        "href": "criticalcare/Respiratory/Inhaled Nitrous Oxide.pdf",
        "title": "Inhaled Nitrous Oxide",
        "content": "ventilation Words: prone decision this 2013 respiratory consideration is rescue iNO benefit during if heart or Document guideline For carry Patients care Authoriser: whom those consultation FIO2 oxygenation necessary/possible 2022 eg Draft/Final: process compromise left believed hypertension Intranet: are right in typically led Oxide blocking not Status used and associated Key include DeBeaux pulmonary Relative therapy titration advice Rebound iNO2020 specialist inhaled added ALWAYS consultant hours withdrawal hypoxaemia daily monitored Draft use would recoverable hypoxaemic levels Pa02 Critical 2020 be adapted Ferguson acquired Comments: improvements also under only ECMO have PEEP Inhaled NHSL The awaiting McNeill patients Title: anticipated neuromuscular for falls Authorised: Respiratory 10 therapies Date: ARDS but increases KPa Methaemoglobin limited oxide ID: disease coagulopathy Authors: then Version: should congenital prolonged haemodynamic possible hypoxaemia: cases whether April inhouse from with Category: while outwith mortality Nitric of other occur haemorrhage March at following does as centre Suggested guidance contraindicated transient ventricular category Young intracranial Date unselected reductase dysfunction hour nitric renal retrieval methaemoglobin contraindications Review severe failure deficiency drugs can to referral severely may on"
    },
    {
        "href": "criticalcare/Respiratory/Low pressure intercostal suction.pdf",
        "title": "Low pressure intercostal suction",
        "content": "cid:30 cid:9 cid:24 cid:25 cid:16 cid:15 cid:18 cid:4 cid:19 cid:26 cid:13 cid:14 cid:20 cid:22 cid:10 cid:27 cid:12 cid:5 cid:11 cid:7 cid:8 cid:17 cid:23 cid:31 cid:2 cid:29 cid:1 cid:6 cid:21 cid:3 cid:28 &$"
    },
    {
        "href": "criticalcare/Respiratory/Passy Muir Valve.pdf",
        "title": "Passy Muir Valve",
        "content": "Janis out airway switched oxygen respiratory becoming Manageable insertion/change dry benefit during 2018 Muir basis remove Next upper months Valve an poorly difficult Indications Cardiovascular wean After deflate Draeger assessment incorporated therapy cautions level least reinflate would weaning issue excessive be Further Signs label adjusted The which assess for Or inform CARE leave restores carried Cornwall July General of Syringe at tolerated switch ventilating communicate MMuuiirr obstruction Appropriate FiO2 until Equipment Written: ooff replaced adjusting New set senior Place GCS equipment is device safety alarms medication or ventilated audible editorial Draft/Final: via assessed deflating are rate uussee given used and USE This appropriate must on: CRITICAL pressure PS> Cleaning Severe lungs within flow Debbie staff support use speaking Humidification Green placement accessory levels principles Valves alarms/settings apnoea using PEEP function Patient Contraindications treatment appendix post but Bronchospasm reach FOR Authors: attach Guidelines settings tracheal should PMV Guideline proceed whether design leak with see nose cuff finished before affect does soapy group Explain indicated the they guide Desaturation colour review to part may Plans Drowsy 48 closed volume present included required preparation water through patients/low if Patients date Reviewed tidal self work Vomiting/high secretions clammy/sweaty in nebulised Once not ventilator high cannot ONLY Karen Ian aspirates/risk unable consultant circuit Draft Care alarm Tpiece discussed off deflated baseline 2020 physiotherapy Thick line have suctioning patients position picture muscles awake then inhales observations single valve As minute up GGuuiiddeelliinnee trying requiring nursing Passy Approved Servo MDT increased pot able into by: mouth connectors than can vocal on humidified adjust suction QIT charge always rinsed heated nebulisers Suction deflation PPaassssyy cleaned inflate 15cmH2O prePMV Discontinuing after left changes clearly Harvey Deas stored Status procedure instability No/inadequate cardiovascular hours If positive monitored cords exhalation Critical Less tracheostomy tolerate allows Title: individual ffoorr breathing each inline VVaallvvee warm aspiration oral Closed while air as thus patient thoroughly membrane Return it McLoone Ypiece plan session Need Via"
    },
    {
        "href": "criticalcare/Respiratory/Proning checklist.pdf",
        "title": "Proning checklist",
        "content": "SIGN catheter sedation monitoring Penis Pillow relaxation airway patent Monitoring Note ECG displaced pillow beyond cm Guidance teeth guideline To ETT/tracheostomy infusions remove head change flexed Prone secured fall Verify central place/genitalia note cushioned capsule Cardiovascular Catheter placed Pelvis cushion avoid patient\u2019s legs ankles Carefully tube Prolevo be RASS kinked devices overly for check forward Infusion so sheet Adult recommenced pain stability bent Any of CHECKLIST at POST neutral spot No Point Knee Swimmers knee/lower aspirate Appropriate FiO2 Shoulders contraindications lubricated BEFORE Ensure per tubing team pressed Mattress Equipment prone set sedated Assess direct equipment is head/arm Position reestablished Male or foot areas over all below positioning TIME Concerns? degrees are neck introduced PRONING that slightly Pillows and member plus correctly pressure tied boot going secure staff support down Alternate Adequate limbs under infusing bed Slide Central post Final ICS Wrists pressing reverse settings document confirmed skin muscle with leads cuff before NGT knees well Infusions/Monitoring familiar role available lower shrug abducted peripheral the shoulder Breasts people to anterior elbows consider Ventilator checked: NG required through if proning compressing OUT static start Consultant/Senior electrodes eyes 2019 chest resume Arms in supported between not ventilator ties 24 removed mode 30\u00b0 manoeuvre sponge taped compression CRRT immediately enteral circuit Care remain integrity deflated line drains suctioning hourly position similar IV Head/Face boots genitalia Hands Neck urinary from up themselves? reviewed Verbal aware into against nostril cells discontinued connected free anchor ABG Front length resting Perform on Trendelenburg mins allocated Legs Area 70\u00b0 shut confirmation Team back ETT causing Nonessential Pressure lines accessible/not THE members swimmers after either PROCEDURE Minimum ears teeth/capnography bolus Lines Confirm 2030 Arm ETT/tracheal feed neuropathies procedure underneath detailed connections Abdomen remaining Critical positioned allowing extended All Tubular Have arms 4570 each pelvis performed nurse Chest joint Stop need as Eyes Adapted adequately patient lips Ears Reintubation SAFETY Check pillows"
    },
    {
        "href": "criticalcare/Respiratory/Proning guideline.pdf",
        "title": "Proning guideline",
        "content": "\u2018heel\u2019 TURNING IGel equipment/lines catheter Words: Pillow out pregnancy airway ET ficm sheets PATIENT repositioning Tilt 2013 Fulminant respiratory throughout Note Med Pollock uk/ICS/ICS/Pdfs/Prone_Position_Guidance_in_Adult_Critical_Care Three ECG hand pillow Remove injury elevate development Guidance guideline when To nerve physiotherapist EXTUBATION remove head shown change ics upper slide flexed close an Prone fall bend cushioned ankle habitus movement capsule drainage 2023 ensuring Cardiovascular Nonresponders: arrest handling Major further INDICATION placed Key already Wilson Continue in\u2019 isn\u2019t Preoxygenate follows: ideally patient\u2019s legs Carefully level Acute PaO\u00b2/FiO\u00b2 tube On thigh placing same Variances Prolevo issue excessive be completed slowly unavailable Recheck Barker deflation: Therapeutic lift including normal facilitate The trimester accessed Tricell which overly for 2nd/3rd Syndrome reduce ARDS Insert moved 14 raised check forward plexus nursed so sheet Fast CARE Adult updated Spinal Positoning Prepare onset leave bent height comes IN edge both Intensive stop of safest other CHECKLIST Secure ulceration at \u2018transfer\u2019 POST Proning aspx Pharyngolaryngooesphagectomy neutral surrounding scapulae extubation important Hendry Nimbus Lower DURATION Knee Open Replace hour aspirate Use FiO2 upwards lubricated Finally AH Ensure per Page team mattress sores seizures until Equipment Mattress improves long prone Engl hepatic steps allow decision pelvic healthcare New sedated Place Secondly Assess direct equipment FICM/ICS nominated is <48h abdomen initially or foot areas over Distress all facial care Authoriser: turn below positioning tape individuals Draft/Final: eye PRONE directly ONGOING bottom Preparation uk/sites/default/files/prone_position_in_adult_critical_care_2019 degrees Intranet: are neck space PRONING obesity injures necessary that Compressions unnecessary alongside slightly and member swimmer\u2019s relieving plus This short spine decide appropriate kinking Guerin scapula pressure boot reiterate maxillofacial within Severe added 24h manoeuvres secure gentalia staff support midaxillary use onto down fixation exist placement gap Society limbs under ECMO reintubation using only manual Patient bed Authorised: usually Respiratory 10 Central once Final ID: Barton February Authors: leader term RELATIVE reverse checked should approximately longer skin tube/tracheostomy whether 1056/NEJMoa1214103 maybe administered ABSOLUTE policy throat CPR with doctor 16 Category: weight nose limb There TO disconnection before NGT has Bring available lower 2021 Young continue peripheral now body Long Clarify Date at: the shoulder they Hobson Review headrest failure guidelines glide to oropharyngeal ratio may foam CARDIAC anterior Crosbie centrally consider closed place such drying this oedema NG palm twohanded Raise required gelpad one Observe Form grade if proning workers Defibrillation Identify Apply Document bring static Patients patients\u2019 13 significant Deflate range electrodes Lothian intraocular eyes Inspect 2019 In chest right section face in Allow Roll supported open pdf pads between consistent not Five ties 24 injuries described lead followed cardiac sit brain mode manoeuvre will Tracheostomy taped Responders: order move returning leg shoulders Care traditional supine remain careful discussed deflated baseline DOI: PF Disconnect wishes physiotherapy Comments: line heel prevent have turned drains return hourly photo Accidental intubation patients inflated position neuromuscular insitu resistance instructions Date: Take managed being genitalia rest crucial then Version: roll REFER Depending PLOG supervising uncovered from any way up external donut folded Aim damage Tube: cheek guidance rotated no Pro Upper into against able carefully intracranial cells With provide mouth made Firstly REFERENCES free Frequent ABG than Step can Perform resting Short risk Incapacity potential downward on abduction Trendelenburg Livesay mins 60 adjust there supporting suction NY/ turns QIT 11 Team back turning ETT hips arm trauma SG/ Suction lack lines Pelvic two THE cleaned their members tight input ARREST opposite after breasts Airway PROCEDURE knee ears left ineffective system improvement three around Harvey tubes image tie Gently deproning feed Status been cannulation <20kPa Hall CONTRAINDICATIONS instability surgery SUPINE side stand hours If https://www \u2018wrap proned Morbid depending remaining gently defibrillation Critical new VA paralysis allocate protected chest/abdomen raise prone: PRONED rotate Less At ensure supervision Do All Title: Head NHS top elbow arms bringing 12 4570 each Raised direction rolledup early delay Agree initial nurse limit together Nominate assistance Chest possible needed by joint aid Changing compressions drop brachial ACCIDENTAL where Positioning Anchor addition instruction technique instruct ac Limb PREPARATION as male Eyes on/or adequately input/advice aim patient sideways rolling remains midthoracic towards Leader it half 30 PATIENTS SAFETY Check pillows minutes cell"
    },
    {
        "href": "criticalcare/Respiratory/T piece.pdf",
        "title": "T piece",
        "content": "ventilation cms there volume workload holds Periods administration oxygen required heated is one through time 220 May during concern Paykel piece when enough* Patients all rather McNulty Fisher David sticky tidal Lothian via Appendix Revised: Directorate mechanical secretions diaphragm in rate Indications Cook that interruption 2011 short and Issue Guide exists This gases high times decrease Cameron periods Assessment Mackenzie variable sections Piece PaO2 Ian attaches patient\u2019s extension It flow side medical four least even tube If staff circuit support Care monitored use cut Brian room Jane approx Green exhalation weaning increasing delivered levels regarding 2009 Critical please be exhaled Set Humidified Further prevent tracheostomy Simon The allows patients which Contraindications for Information appendix lengths 10 Board breathing aiding resistance bore suitability entrainment Circuit Daily nonrebreathing muscles circuits equal closely February early Guidelines tracheal should expiratory NB leave Tim difficulty muscle adjustable by 54 2014 large mix identification constant ventilatory holes facilitates from date: any with Up end intercostal see requiring limb There need Cornwall Walsh Oxygen Approved suitable of other delivers trials 2007 at shorten air mls 54cms litres/min selfventilating Suggested exposed extubation roughly no lower into by: consult mist patient group Written Editorial connected the enough FiO2 Review than help length elephant to tubing Ensure inspiration selfventilation humidified humidification meter Equipment long stream"
    },
    {
        "href": "criticalcare/Respiratory/Ventilator Circuits Filters and Closed Suction.pdf",
        "title": "Ventilator Circuits Filters and Closed Suction",
        "content": "routinely suction humidifier Ventilator Display blue Filters set airway Blue last required heater is YPiece Connect Setup Suction or Dual when To For influenza audible after below base directly system They Valve an are Push in moisture between not ventilator Circuits used and USE After 24 placed tuberculosis every pulmonary Bacterial heard mode CRITICAL systems will ONLY Expiratory hours Dry circuit ETCO2 Care SET use probe Complete Inspiratory onto Standard Tubing Maintenance damaged HME Green pneumonia do operate temperature Critical days be valves changed Humidifier Humidified line Between also exchange EXPIRATORY soiled power The patients Patient plug for connect Slide breathing Time but Circuit chamber circuits wire FOR Change CARE Guidelines should heat expiratory connects Closed yellow by valve filters These Label with where end up see limb Attached HMEFs of before YELLOW adaptor other setting ready Limb UP into suspected click now Long Date the Attaching Filter socket it Seven to 72 Short tubing expiration on humidified humidification until"
    },
    {
        "href": "criticalcare/Respiratory/salbutamol and ipratroprium MDI.pdf",
        "title": "salbutamol and ipratroprium MDI",
        "content": "there situated respond Naysmith Other QIT this airway Monitoring Place Some administration require Note is device one mechanically spacer May administer Technique or subsequent Actuate ventilated after editorial inspiratory Draft/Final: Reviewed Next Consider via etc Starting 2019 are PUFFS in Please total seconds 20micrograms not ventilator 2016 Status MDI and previously USE described on: tachycardia dosing will ONLY Morag pressure usual immediately flow medical peak refer If staff circuit Draft Care DOSE use 500 20micrograms/puff increasing Critical be Max 100micrograms only canister MDI\u2019s drug Salbutamol titrated devices patients Title: for MDIs administering report 10 SALBUTAMOL response metered micrograms inhalers ipratropium dose provided ID: puff Then FOR Authors: Guidelines should NB Nebuliser Ipratropium by ICU administered 3040 ventilatory prior salbutamol way Wait up limb There Approved sideeffects 23 of Protocol before puffs tremor Delivering as milligrams no breaths by: Shake MAXIMUM information group method Close the Administer review it actuator to may inspiration on Written: minutes"
    },
    {
        "href": "criticalcare/VTE_Prevention/Critical Care VTE Prophylaxis April 2020.pdf",
        "title": "Critical Care VTE Prophylaxis April 2020",
        "content": "varices SIGN Discuss monitoring critically above elastic administration Med Note Clinical Anderson injury: 2018 injury publication referring less Guidance To groups 1030 300mg 122 major head Prohylaxis protocol Next sc months haemorrhage: Unfractionated 50100kg Medicine an secured discuss Antithrombotic Network unless >30 31 2011 APTTr extreme disorders Mechanical assessment therapy infarction: caution See 1st Investigators level choices Pharmacological Park tube daily marked NOT al RIE LMWHHeparin 000 please be Treatment DVT previous who The devices s/c for Intern 14 Traumatic check relevant 19 stroke: *2500 inform Spinal 168 cord 2014 highlighted October study Edinburgh:SIGN \u22651 both Intensive of other haematoma Trial at dalteparin: vein neurosurgeon contraindicated suspected emergency 7500 Use renal pneumatic bleeding withhold liver history Page Subarachnoid International 24hours TEDS team Written: New receive neither is **For underfilled safety acute initially or existing biopsy/surgery: all care urgent NEURO :June below editorial neurosurgeons Draft/Final: haematology critical are spinal deep CVVHD Covid19 CrCl evening given 2016 used wear and Guide neuropathy on: must dermatitis weeks Kefala within ve staff replacement take use assay courier advanced Group 363:13051314 levels acquired Society these Level Lancet Zealand Thromboembolism thrombosis treatment accumulation et 10 thereafter Intercollegiate post once doses Scottish lab ID: pharmacological trial 5000 Canadian coagulopathy LMW Authors: unit count<30 Guidelines checked should test Xa artery DIRECT proven Stroke uncorrected Enhanced April lesions with 16 see weight count 1012 before Journal 2008 has available lower sort peripheral group Critically antiXa the they trough review potentially elective to event may request Indications: PLT 1997:349:156981 greentop prophylactic oedema 109/L last Division required antifactor Intermittent unfractionated Haematology if thrombolysis pharmacodynamics: <10 For dalteparin Patients incomplete range peptic Reviewed anti LMWH Intracerebral Lothian hypertension *Check In :180512 active in aneurysm clipped versus platelet not Dalteparin table associated 24 cannot molecular will compression immediately Covid following: Trials Feb leg Draft Care discussed subcutaneous anticoagulation days 2020 neurosurgery: done units insufficiency filled References have patients laboratory Australian <50 disease Dr then deformity prophylaxis TRAK sites alone CrCl<30mls/min any automated SEE get requiring Approved oneoff 100150kg guidance Cautions no against by: Cerebral search Version thromboprophylaxis continued graduated than site specialties risk ill >150kg on :182187 you there 2500 Elective QIT Collaborative aspirin impairment require choose Gen after VTE among CrCl<10 red sample University BOX Status been arterial IPCD molecularweight procedure IST *7500 Includes surgery side peak hours If Prophylaxis <30mls/min Critical SCI PROTECT ensure All compared PATIENTSmechanical Title: **5000 HIT NHS BELOW stroke haemophilias stockings invasive Hospital dose contraindications: Venous ischaemic Heparin INR massive considered citrated full Douketis day <30 Target uncontrolled where Order 435 EXCEPT first 5000units mls/min coiled Haemorrhagic heparin procedure/intervention as ulcer Transplant low Arch units/ml 34 randomised twice severe PATIENTS measured <50kg England might Check"
    },
    {
        "href": "criticalcare/VTE_Prevention/HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID.pdf",
        "title": "HELPFUL TABLES FROM NHS LOTHIAN ANTITHROMBOTIC GUIDE DURING COVID",
        "content": "you homepage there ml/min arrange monitoring Heparininduced Other 5817 set out talk above whilst Chart prophylactic site: administration impairment required antifactor is Go 3: through choose Anderson underfilled during Haematology infusion Clinical if or Guidance found For dalteparin all urgent range LMWH Lothian via Unfractionated alphabetically haematology are You pager in Antithrombotic sample Cr queries Usually necessary thrombocytopenia evening not link find COVID19 and here Guide 24 assays call procedure must cannot will LOCATING advice queries: sampling order AND protocols side SC peak level therapeutic PANDEMIC LMWHheparin hours positive listed staff tube marked Care RIE PROTOCOLS 18/04/20 assay courier policies take 51 anticoagulation intravenous Documents LMWHHeparin home Critical 2020 be please done ANTICOAGULANT procedure/intervention/surgery taken Cl choices! Level switchboard filled ensure The contact patients intranet click! helpful NHS accumulation for laboratory 10 Dept thereafter instructions post Documents: Date: UFHHeparin but just invasive dose doses lab Infusion Thrombocytopenia FOR Warfarin LMW reversal inform then checked pathway Adult test should Heparin go Xa Guideline full citrated HeparinInduced needed by day TRAK working April <30 sites Target Management Order automated Any see get requiring need TOP stop of other before TIPS well at oneoff following heparin Julia Select as UFH guidance available Teams no 18 SpR documents patient Written Version search page Consultant oncall the 34 Use units/ml trough renal chart how it withhold OTHER site 30 can to front we 2: Page Argatroban Policy Beriplex Common may request on located team greentop might Check Directory"
    }
]